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Chiral amines are important building blocks in pharmaceutical compounds. Being 
able to synthesise chiral amines in high yield and enantiopurity is highly desirable 
due to the different physiological activities exhibited by the opposite enantiomers. 
Classical resolution using chiral acids has been the main strategy in preparing 
enantiopure amines at industrial scale, however the processes often lead to high 
waste and intrinsically low yields.  
 
To overcome the limitations of classical resolution of chiral amines, the research 
presented in this work has focused on the development of a resolution-
racemisation-recycle (R3) process which couples diastereomeric crystallisation 
and catalytic racemisation of the undesired enantiomer in the mother liquor. The 
crystallisation was carried out in batch in a continuous-stirred tank reactor (CSTR) 
whilst the racemisation was carried out in flow with a packed-bed reactor (PBR) 
containing the racemisation SCRAM catalyst which was immobilised on a Wang 
resin support, enabling it to be recycled up to 130 times. The two steps were 
separated but linked with tubing and a pump to yield a continuous recirculation 
process. Unlike traditional approaches in asymmetric transformations in which 
the resolution and in-situ racemisation are carried out in one pot, the R3 process 
allows each step to be operated independently under its optimum conditions.  
 
The success of the R3 process depends strongly upon the rate of racemisation, 
the absolute, and difference in, solubility of the diastereomeric salts, the rates of 
growth and dissolution of the less soluble and more soluble diastereomers 
respectively. The system was tested with primary, secondary and tertiary amines 
with up to 50-times improved resolvability observed. For one secondary amine, a 
96% diastereopurity and 78% yield gave a resolvability of 1.5 compared to the 
classical resolution of 0.11. The R3 processes of the primary and tertiary amines 
were less successful, mainly due to the formation of undesired by-products. 
Racemisation of the amine substrates were studied with homogeneous and 
immobilised SCRAM catalysts to better understand the reaction kinetics and 
mechanism. A series of iron- and copper-based metal compounds were also 
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1.1. Importance of chiral amines 
Chiral amines have widespread importance in the pharmaceutical, agrochemical 
and fine chemical industries.1-5 Many therapeutic drugs are either amines or 
contain functional groups derived from amines (Fig. 1.1).6 It is due to their ability 
to interact with biological molecules such as DNA and proteins by hydrogen 
bonding and electrostatic interactions when they protonate or deprotonate.  
 
 
Fig. 1.1 Examples of pharmaceutical drugs containing chiral amine functionalities 
 
Thermodynamically, (R)- and (S)-enantiomers of a chiral molecule are equally 
likely to exist. However most chiral molecules in living organisms are over-
expressed in one enantiomeric form.7-9 This implies that two enantiomers of a 
chiral compound can interact differently with the biological system. This 
phenomenon is particularly important in pharmaceutical development. Different 
therapeutic effects were observed for many chiral drugs. A few examples 




Fig. 1.2 Examples of chiral pharmaceutical compounds exhibiting different physiological 
effects with different enantiomers 
 
In 1992, policy regarding single enantiomer drugs was published by the U.S. 
Food and Drug Administration (FDA), which stated the need for the evaluation of 
pharmacokinetics and toxicity profiles of individual enantiomers and the racemic 
mixture of a chiral drug, manufacturing control over stereoisomer impurities, full 
characterisation of individual enantiomers and their composition in the final drug 
product.11-13 Although some chiral drugs are still administered as racemate, an 
increasing proportion of single enantiomer drugs are introduced into the market.9, 
11, 14 ‘Chiral switches’, which exploit the single enantiomers of existing racemic 
drugs are one of the important features in drug development portfolios.14 Being 
able to synthesise both enantiomers at high enantiopurity is therefore crucial for 
both safety and efficacy studies and the manufacturing of a chiral drug product. 
 
There are three main approaches in accessing enantiopure amines: the utilisation 
of ‘chiral pool’ as the building block which refers to inexpensive and readily 
available enantiomerically pure materials such as carbohydrates and amino 
acids;9 asymmetric syntheses which use chiral catalysts, ligands and auxiliaries 
to introduce asymmetry to prochiral starting materials; and resolution, which 
corresponds to the separation of a racemic mixture of the chiral compound 
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obtained from a non-enantioselective process (Fig. 1.3). These methodologies 
will be discussed briefly in the following sections, highlighting the problems 
encountered in each of them.15 
 
 
Fig. 1.3 Approaches towards enantiopure chiral amines 
 
1.2. Synthetic methodologies of chiral amines 
1.2.1. Chiral Pool 
Chemical modifications of readily available naturally-occurring enantiopure 
materials from the chiral pool represent the most straightforward approach in 
accessing a single enantiomer.16, 17 Commonly used chiral pool materials include 
α-amino acids, hydroxyacids, carbohydrates, terpenes and alkaloids.9, 16-18 The 
enantiopurity of the naturally-occurring chiral compounds is normally 100% and 
their stereogenic centres are directly transferred to the products.17, 19 They are 
also non-toxic and at reasonable prices.18 This approach is especially suitable if 
the target product resembles (part of) the structure of the chiral pool materials. 
One of the examples was the synthesis of monobactam antibiotic Azthreonam 3 
from L-threonine 1 via monbactam nucleus 2 developed by Bristol-Myers Squibb 
(Scheme 1.1).20, 21 
 

















Enantiopure materials from the chiral pool can also be used as auxiliaries and 
chiral ligands in asymmetric catalysis and may be recovered and recycled after 
the synthetic process.9, 22 Although the chiral pool approach is useful to introduce 
a chiral centre into the target molecule, usually, only one of the enantiomers is 
available, while the other has to be synthesised which may be more expensive 
than the naturally-occurring counterpart.18 The number of possible 
transformations that the molecule can undergo may be limited and the synthesis 
can be complex, lengthy and require various functional group protections.15, 16 
Since the stereogenic centre is often introduced early in the process, detailed 
analyses are required in each subsequent step to ensure no erosion of 
enantiopurity occurs.16 
 
1.2.2. Asymmetric synthesis 
(a) Chiral auxiliaries 
Stereogenic centres can be introduced into a molecule by attaching a chiral 
auxiliary to the prochiral starting material. Nucleophilic addition of an imine 
bearing a chiral auxiliary can be used to generate enantioenriched α-branched 
chiral amines.6, 19, 23-25 The asymmetric indium (III) triflate-mediated allylation of 
hydrazones 5 was demonstrated using Friestad’s auxiliary 4 to prepare 
diastereoenriched 6 (Scheme 1.2).6, 19 Higher diastereoselectivity can be 
achieved with aryl-substituted aldehydes compared to alkyl-substituted 
aldehydes. The auxiliary can be removed using samarium diiodide to yield the 
enantioenriched product. 
Scheme 1.2 Diastereoselective allylation of hydrazone 5 by Friestad’s auxiliary 4 
 
One of the advantages of this approach is that the stereochemistry can be 
predicted.17 The resulting adducts are diastereomers which have different 
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physical properties and therefore can be purified easily if the reaction is not 100% 
stereoselective.26 However extra steps are required to attach and remove the 
auxiliaries. The reaction conditions for removing the auxiliary needs to be 
carefully chosen to ensure that the stereopurity of the product is maintained. 
Some enantiopure auxiliaries are readily available from chiral pool but some may 
require synthesis and resolution prior to use.9, 15, 22, 26 Since a full equivalence of 
chiral auxiliary is needed, efficient recovering and recycling of the auxiliaries are 
essential to make this synthetic approach more economical.17  
 
(b) Asymmetric catalysis 
To circumvent the use of stoichiometric amount of chiral-inducing agents, 
asymmetric catalysis represents an alternative to introduce a stereogenic centre 
to a prochiral molecule.17 The commonly employed catalysts include chiral ligand-
derived metal complexes, chiral organocatalysts and biocatalysts. Chiral 
transition metal complexes are widely used in the asymmetric reduction of imines 
to generate chiral secondary amines.27 Noyori’s type ruthenium complexes 7 with 
chiral N-sulfonylated diamine ligands were used successfully in catalysing the 
asymmetric transfer hydrogenation (ATH) of cyclic imines such as 8, using formic 
acid/ triethylamine as the hydrogen source (Fig. 1.4, Scheme 1.3).28, 29  
 
 
Fig. 1.4 Noyori’s catalyst 
 
 





Direct asymmetric reductive amination of ketones is also used to synthesise 
enantiopure amines in which the imines are formed in-situ without isolation.4 (S)-
9 can be synthesised directly from BOC-protected amino-ketone 10 using (p-
cymene) ruthenium(II) chloride dimer and (1R,2R)-TsDPEN in one pot (Scheme 
1.4). However the efficiency and enantioselectivity are lower compared to the 
ATH of imine 8 (Scheme 1.3).30 
 
Scheme 1.4 Synthesis of (S)-9 via asymmetric reductive amination of amino-ketone 10 
using [(p-cymene)RuCl]2 and (R,R)-TsDPEN 
 
A closely related reaction, the amination of alcohols by borrowing hydrogen 
methodology, is a well-known atom-efficient and green approach in synthesising 
amines.5 It starts with dehydrogenation of the alcohol (primary or secondary) to 
make the corresponding carbonyl compound which condenses to imine with the 
amine. The alcohol acts as the hydrogen donor which reduces the imine into 
amine, with water as the only by-product (Scheme 1.5).5, 31-35 No additional 
reductant such as hydrogen gas is required. In 2014, Zhao et al. reported the use 
of iridium catalyst (S,S)-13 and chiral acid 14 in the asymmetric amination of a 
variety of aryl and aliphatic alcohols 11 with aniline derivatives such as 12 in the 
synthesis of secondary amines 15.5 An example is shown in Scheme 1.6. 
Although relatively high yields and ee’s were achieved, high loadings of catalyst 






Scheme 1.5 Borrowing hydrogen methodology in chiral amine synthesis from the 
corresponding alcohol 
 
Scheme 1.6 Selected examples of enantioselective amination of alcohols using Ir 
catalyst 13 and acid 14 by Zhao et al. 
 
In spite of the remarkable success in the development of ligands and catalysts in 
asymmetric synthesis, their industrial implementations are limited.36, 37 The high 
costs of metals and chiral ligands mean that their high turn-over and efficient 
recycling are essential for an economical process especially at large scale. 
However it is very difficult to achieve this for homogeneous systems.38 Another 
problem with homogeneous catalysis is the product contamination by metal 
leaching which is of much concern in the pharmaceutical industries.36 This leads 
to the development of heterogeneous catalytic systems which include 
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immobilisation of metal catalysts onto solid supports, allowing their easy 
separation from the products and their subsequent reuse. This will be further 
discussed in Section 1.5.3. 
 
Another widely developed field of asymmetric catalysis in the synthesis of chiral 
amines is the use of enzymes. Turner et al. reported the use of (R)-imine 
reductase [(R)-IRED], which was over-expressed from Streptomyces sp. GF3587 
in Escherichia coli to create a recombinant whole-cell biocatalyst for the 




Scheme 1.7 Synthesis of chiral cyclic amine 17a to 17c by asymmetric reduction of 16a 
to 16c by (R)-IRED 
 
Other commonly used enzymes include transaminases which catalyse the 
transfer of an amine group to a carbonyl compound such as ketone;6 and the 
combination of alcohol dehydrogenase (ADH) and amine dehydrogenase (AmDH) 
for hydrogen-borrowing cascade reactions discussed above.40 Although 
enzymes have become popular in asymmetric synthesis of chiral amines, their 
sensitivity to temperature and solvent remain major drawbacks. Enzymes are 
relatively substrate-specific and hence enzyme engineering may be required to 
widen the substrate scope. This increases the cost and time spent in developing 
enzymes with optimum activity. 
 
1.2.3. Resolution 
In spite of the advances that have been made in the development of asymmetric 
synthesis, resolution, which separates racemic mixtures, remains the most 
common method to obtain enantiopure compounds at industrial scale, due to its 
relatively low cost and ease of operation.41, 42 However, since the desired 
enantiomers constitute only 50% of the racemate, resolution approaches suffer 
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from the intrinsic drawback of low yield.1, 15, 17, 43 The problem can be overcome 
by recycling the unwanted enantiomers via racemisation which will theoretically 
produce the desired enantiomer in 100% yield and 100% enantiopurity. This 
methodology will be discussed in more detail in Section 1.4. There are three main 
strategies for resolution, they are chromatography, kinetic resolution and 
crystallisation, which will be discussed below. 
 
(a) Chromatography 
Much effort has been made in developing enantioselective chromatographic 
methods to separate racemates for enantiopurity analysis and the preparation of 
enantioenriched material. One of the major approaches in chromatographic 
resolution is based on enantioselective interactions of the racemates with chiral 
stationary phases. Commonly used chiral stationary phases (CSPs) in 
preparative chiral high performance liquid chromatography (HPLC) are 
polysaccharide-based and are shown in Table 1.1.15, 44, 45 Other examples of 
chiral selectors include cyclodextrins (CDs) and chiral crown ethers.46-49 They are 
covalently linked or strongly adsorbed physically onto the chromatographic 
support such as porous silica. When the enantiomers are eluted through the chiral 
column with achiral mobile phases, diastereomeric complexes are formed which 
are retained differently by the stationary phase, allowing resolution to occur.15  
 
For sufficient separation of enantiomers, a long column of CSP is needed which 
increases the cost of the process. As with non-chiral preparative HPLC, the other 
major drawback is the use of large amount of solvents which poses disposal 
problems, especially in large scale processes. These led to the development of 
simulated moving bed (SMB) chromatography. It is operated in a continuous 
mode which increases the productivity of high-purity products with reduced use 
of CSPs and mobile phases compared to traditional batch elution 
chromatography.50, 51 The optimum combination of CSP and mobile phase for a 
specific enantioseparation problem is still mainly based on screening a set of 
available CSPs with various mobile phases, although much progress has been 
made to better understand the underlying principles of chiral recognitions.15, 52 



















Table 1.1 Examples of polysaccharide-based chiral selectors used as the stationary 
phases in chiral chromatography 
 
(b) Kinetic resolution 
Kinetic resolution (KR) is defined as a process where two enantiomers of a 
racemic mixture are transformed into products at different rates, when reacting 
with a chiral reagent or a chiral catalyst (Scheme 1.8).42, 53, 54 An efficient KR 
leads to complete transformation of one of the enantiomers while the other 
enantiomer remains unchanged, allowing the recovery of both of them in high 
yield (close to 50% of each enantiomer) and high enantiopurity (close to 100%). 
Whilst asymmetric synthesis involves product selectivity, KR involves substrate 
selectivity.9 The selectivity of a KR process can be quantified by selectivity factor, 
s (or the E value), based on the ee of the substrate or the product and the 






Scheme 1.8 A classical KR process 
 
ES = 
ln [(1 - C)(1 - eeS)]
ln [(1 - C)(1 + eeS)]
   (Eqn. 1.1) 
 
EP = 
ln [1 - C(1 + eeP)]
ln [1 - C(1 - eeP)]
   (Eqn. 1.2) 
 
Where C is the conversion, eeS and eeP are the ee of the recovered substrate 
and that of the product respectively. 
 
Biocatalysts are most widely employed chiral catalysts in KR and its variants such 
as dynamic kinetic resolution (DKR).55-57 A wide range of commercially available 
enzymes such as hydrolases, transferases and redox enzymes can be used.53 
Enzymatic processes can often be carried out under mild conditions and avoid 
the need of heavy metal reagents, providing an environmentally benign 
alternative to chemical methods.9, 53, 58 Some enzymes have been found to 
operate in  organic solvents, though at reduced rates which increases the 
substrate scope and the types of possible reactions that can be carried out with 
enzymes.53, 57, 59 
 
Lipases are commonly used in the resolution of amino-alcohols and amines due 
to their stability, broad substrate range and non-requirement of co-factors, 
compatibility with organic solvents and the mild reaction conditions required.60 An 
early example was reported for the resolution of racemic 2-aminobutan-1-ol 18.57 
This is a precursor of D-ethambutol 21 used in the treatment of tuberculosis. The 
resolution of rac-18 was achieved by porcine pancreatic lipase (PPL) which 
catalyses the enantioselective amide formation and esterification of (S)-18 with 
methyl acetate as both the acyl donor and solvent, to give (S)-20 with 95% ee; 
whilst PPL can only acetylate the amino group of (R)-18 to form (R)-19 without 
transforming the hydroxyl group (Scheme 1.9). (S)-20 can then be separated from 




Scheme 1.9 Kinetic resolution of rac-18 by PPL 
 
Whilst enzymes have been extensively used in KR (and DKR) processes, the use 
of non-enzymatic chiral catalysts have become more popular in recent years.42, 
61 It is more challenging to develop non-enzymatic KR processes for amines than 
other classes of chiral compounds such as alcohols. This is mainly because of 
the high nucleophilicity of the amines. The rate of reaction between the amine 
and the derivatising agent can be competitive with the catalytic rate, resulting in 
low enantioselectivity.42 One of the solutions to this problem is to use a less active 
electrophile, such as O-acylated azlactone 23 which was employed as an 
acylating agent in the KR of indolines 22 in the presence of a chiral iron catalyst 
24. A selectivity factor of up to 26 was achieved (Scheme 1.10).62 
 
Scheme 1.10 Non-enzymatic KR of indolines 22 with 23 and chiral iron catalyst 24 
 
Although KR processes have been widely applied in the synthesis of 
enantiomerically pure amines, the limited yield that can be achieved leads to the 
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development of a dynamic system involving in-situ racemisation of the 
unconverted enantiomer which will be discussed further in Section 1.4. Whilst the 
slower reacting enantiomer can be obtained at high ee by carrying out the 
reaction to the appropriate conversion, the ee of the product starts to decline as 
the faster reacting enantiomer is depleted since it is more difficult for the chiral 
catalyst to bind to the correct enantiomer in the system. A high ee product can 
only be obtained with reasonable conversion in a simple KR if the E value is high 
(> 100) (Fig. 1.5).9, 63 Separation of the product and the unreacted substrates is 
required which can be difficult and may require additional purification steps. If the 
desired enantiomer is transformed into the product, an additional step such as 
hydrolysis may be required to convert the product back to the substrate. This is 
also true for DKR processes. 
 
 
Fig. 1.5 Dependence of ee of (a) remaining substrate; (b) product on the conversion for 
various E values64 
 
(c) Crystallisation 
Crystallisation remains one of the most important and commonly used resolution 
methods for the synthesis of enantiopure compounds due to their simplicity and 
robustness.9 Crystallisation can also be employed to purify the product chemically 
which makes it more attractive.65 Depending upon the unit cell symmetry, crystal-
forming racemate can be divided into three types. The first type is called 
conglomerate, which refers to a 1:1 mechanical mixture of crystals of pure (S)- 
and (R)-enantiomers. This crystal form accounts for about 5 to 10% of all 
crystalline racemates. The second type is racemic compound, in which both 
enantiomers are present in individual crystals in 1:1 ratio arranged in an ordered 
manner. This is the most common type of crystal form which accounts for 90 to 




a pseudo-racemate or solid solution, in which both enantiomers are present in 
the condensed phase in a non-ordered fashion (Fig. 1.6).7, 9, 66-68 These different 
crystal forms can be distinguished by their melting point diagrams (Fig. 1.7).7, 9, 68 
 
 
Fig. 1.6 Different crystal structures exhibited by racemates. (a) Conglomerates; (b) 
racemic compounds; (c) pseudo racemates (solid solutions) 
 
 
Fig. 1.7 Binary melt phase diagrams of enantiomer mixtures forming (a) conglomerate; 
(b) racemic compound and (c) solid solution. R, S, RS and L correspond to solid R-
enantiomer phase, solid S-enantiomer phase, solid phase for racemic compound RS or 
solid solution RS, and liquid phase respectively. T is temperature and x is mole fraction 
of the mixture 
 
In a conglomerate, pure crystalline enantiomer compounds R and S have the 
highest melting point. The melting point decreases with decreasing enantiomer 
purity since each enantiomer acts as an impurity so lowering the melting 
temperature of the other. It reaches a minimum (eutectic temperature) when the 
mixture constitutes 1:1 ratio of R- and S-enantiomer crystals (x = 0.5) (Fig. 1.7(a)). 
In a racemic compound, slightly decreasing the enantiopurity decreases the 
melting point of the system to a minimum (x = x1 or x2) then increases again 
towards the 1:1 mixture. This is because for the enantiomeric composition 
between x1 and x2, the racemic compound RS is more stable than the pure R- or 
S-enantiomer (Fig. 1.7(b)). For a solid solution, the melting temperature remains 






































(i) Direct crystallisation 
Racemates which exist as conglomerates can be resolved by direct crystallisation 
of the enantiomers, without the need of any chiral auxiliary or the formation of 
diastereomers.15 There are two approaches of direct crystallisation which are 
preferential crystallisation (or entrainment) and simultaneous crystallisation. In 
preferential crystallisation, homochiral crystal seeds of one of the enantiomers 
are added to a supersaturated solution of the racemate which increases the 
crystal growth rate of that enantiomer. This creates a difference in crystal growth 
rates of the two enantiomers, leading to their separation. Consecutive seeding of 
enantiomerically pure crystals of the opposite enantiomers allows both 
enantiomers to be crystallised out separately. This method has been applied in 
smaller scales in batch and is used in the production of some broad-spectrum 
antibiotics such as chloramphenicol 26 and thiamphenicol 27 (Fig. 1.8). In 
simultaneous crystallisation, both enantiomers crystallised out from the 
supersaturated solution of the racemate separately and simultaneously in two 
separate but linked chambers, each is seeded with the crystals of the respective 
enantiomers. This approach can be used in a larger scales in both batch and 
continuous modes,69 and has been used in the production of an α-methyl-L-dopa 
intermediate 28 by Merck (> 100 tonnes/ year) and L-glutamic acid 29 by 
Ajinomoto (13,000 tonnes/ year in 10 years) (Fig. 1.18).9, 15, 70 
 
 
Fig. 1.8 Examples of compounds synthesised via direct crystallisation of their racemates 
by entrainment (26 and 27) and simultaneous crystallisation (28 and 29) 
 
(ii) Classical resolution 
Whilst resolution by direct crystallisation is relatively simple, it is restricted to 
conglomerates which account for < 10% of all crystalline racemates. The majority 
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of crystal-forming racemates exist as racemic compound. They cannot be 
resolved by direct crystallisation since both enantiomers are present in each unit 
cell of the crystal. Instead they are resolved by diastereomeric crystallisation 
which is also called classical resolution. This involves the derivatisation of the 
racemate by an enantiopure chiral reagent to form a mixture of diastereomers. 
This resolution method is of great importance to the synthesis of enantiopure 
chiral amines on industrial scale.1, 2, 43, 71 By reacting the racemic, basic chiral 
amine with a suitable enantiopure chiral acid, a pair of diastereomeric salts is 
formed with different solubility and therefore, allowing their separation by 
crystallisation.9, 15, 72, 73 Some commonly employed chiral acids in the resolution 
of chiral amines are shown in Fig. 1.9. After the resolution process, the desired 
enantiopure amine can be recovered by simple acid-base extraction.  
 
 
Fig. 1.9 Examples of commonly used chiral acids for the diastereomeric resolution of 
chiral amines: Tartaric acid 30, dibenzyl tartaric acid 31, di-p-toluoyl tartaric acid 32, 
malic acid 33, mandelic acid 34, camphoric acid 35, camphorsulfonic acid 36. Only one 
of the enantiomers was shown for each acid 
 
2-Aminobutan-1-ol 18, the precursor of ethambutol 21, which was discussed in 
Section 1.2.3(b) for its kinetic resolution by lipase, was industrially produced by 




Scheme 1.11 Industrial synthesis of ethambutol 21 via diastereomeric crystallisation of 
rac-18 with (S,S)-30 
 
A chronic hepatitis C virus (HCV) NS5B polymerase inhibitor 38 can be prepared 
via the resolution of intermediate ethyl ester 37 using (S)-mandelic acid 34. The 
active diastereomer (1R,2S)-37 was isolated as the salt of (S)-34 in 40% yield 
and 99% de after single recrystallisation (Scheme 1.12). In order to fully 
understand the biological activity of the compound, the opposite diastereomer 
(1S,2R)-37 was also synthesised by precipitating the free-base of the mother 
liquor (ML) by (R)-34, resulting in 99% de of (1S,2R)-37.76, 77 
 
Scheme 1.12 Synthesis of both enantiomers of 38 via the diastereomeric resolution of 
rac-37 by (S)-34, followed by the precipitation of the opposite enantiomer with (R)-34 
 
In classical resolution, extra steps and costs are needed to introduce the chiral 
resolving agent and recover the amine, although the chiral acids (or the resolving 
agent in general) can sometimes be recovered and recycled to reduce waste. As 
with all other resolution processes, the yield never exceeds 50% for each of the 
enantiomers. Usually only one of the enantiomers is desired while the other may 
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be of little or no use, lowering the efficiency of the process and leads to large 
waste stream. This is particularly problematic if the resolution is performed with 
expensive or synthetically challenging products. The problem can be overcome 
if the enantioenriched mixture can spontaneously or catalytically racemise after 
the resolution, increasing the yield and efficiency of the process. This leads to the 
concept of Crystallisation-Induced Diastereomeric Transformation (CIDT) and 
Crystallisation-Induced Asymmetric Transformation (CIAT). It is important to note 
that there have been a few ambiguities in defining the above terms.66 CIDT refers 
to the coupling process of diastereomeric crystallisation and in-situ racemisation; 
while CIAT refers to the direct crystallisation of conglomerate accompanied by in-
situ racemisation. This work will focus on CIDT and will be covered in more detail 
in Section 1.4. The background of racemisation needs to be discussed first. 
 
1.3. Racemisation of chiral amines 
As discussed in Section 1.2.3, resolution is the most commonly employed method 
in obtaining enantiomerically pure compounds. However the process suffers from 
the generation of large quantities of unwanted isomers and limited yield of the 
desired products.78 In order to minimise the environmental and economical 
drawbacks from resolution processes, it is highly desirable to recycle the waste 
enantiomers by racemisation, which can be subject to resolution again.  
 
Racemisation is defined as the irreversible formation of a racemate, which is an 
equimolar mixture of both enantiomers, from a pure enantiomer (or an enantio-
enriched mixture), leading to complete loss of optical activity. For a molecule 
possessing more than one chiral centre, inversion of one of them is called 
epimerisation, which does not lead to total loss of optical activity.79 Examples are 
shown in Scheme 1.13 and Scheme 1.14.  
 
 





Scheme 1.14 Epimerisation of the 1-(N-methyl)amino chiral centre of (1S,2S)-40 
 
Since the difference in interaction between R-R or S-S and R-S enantiomers at 
25 °C is insignificant, the driving force of racemisation is the increase in entropy 
due to the formation of a mixture of enantiomers from a pure enantiomer.79, 80 
 
1.3.1 Racemisation methods of chiral amines 
In 1997, Ebbers et al. published a review on the racemisation strategies of 
different optically active organic compounds and classified racemisation into 
different methods.79, 80 Many of the racemisation procedures in the literature 
focused on alcohols, amino acids and their derivatives, whilst there were far fewer 
reports of the racemisation of chiral amines.1, 78 Recently, more studies have 
been carried out for amine racemisation which mainly involves transition metal-
catalysed redox reactions. This will be discussed in more detail below. Some 
other less commonly employed racemisation methods which have been used for 
chiral amines will also be addressed briefly. 
 
(a) Thermal racemisation 
Some chiral compounds can be racemised by applying heat without additional 
reagent. This may involve bond rotation/ deformation or bond-breakage/ 
rearrangement. One of the examples is alkaloid vincadifformine 41, which can be 
racemised in 20 minutes by microwave irradiation in dimethylformamide via retro-
Diels-Alder/ Diels-Alder reaction (Scheme 1.15).79, 81 Thermal method is relatively 






Scheme 1.15 Thermal racemisation of vincadifformine 41 
 
(b) Base-catalysed racemisation 
Amines such as α-methylbenzylamine 42 and nicotine 43 can be racemised in 
the presence of strong base via the formation of a planar carbanion (Scheme 
1.16 and Scheme 1.17).78, 82, 83 The method requires an acidic proton at the chiral 
centre, or the use of a strong base which is incompatible with molecules 
containing base-sensitive functional groups. However it is often used for the 
racemisation of amino acids.79 
 
 
Scheme 1.16 Base-catalysed racemisaton of (S)-42 
 
 
Scheme 1.17 Based-catalysed racemisation of nicotine 43 
 
(c) Racemisation via Schiff base formation 
The pKa of the proton at the chiral centre of an amine can be lowered by the 
formation of Schiff base using catalytic amount of aldehyde/ ketone which can 
then effect racemisation in the presence of a weak base. This is an important 
method for the racemisation of amino acids and their derivatives, while it is less 
common for amines. Ditrich published a patent on the racemisation of optically 
active primary aryl amines such as (S)-1-(4-chlorophenyl)ethylamine 44 using 
ketone 45 (Scheme 1.18).84  
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Scheme 1.18 Racemisation of (S)-44 via formation of Schiff base with ketone 45 
 
(d) Racemisation via radical formation and redox processes 
The methods mentioned above are relatively substrate-specific and require 
amines to have considerable stability towards harsh racemisation conditions such 
as high temperature and the presence of strong base, or require the presence of 
an acidic proton at the stereocentre. Therefore applications are fairly limited. 
Racemisation using enzymes such as racemases are also common. However 
they are usually employed for amino acids and their derivatives.79, 83 For chiral 
amines, racemisation was generally carried out through radical or oxidation-
reduction mechanisms.79 Escoubet et al. demonstrated the ability of sulfur-based 
radicals to racemise both benzylic and aliphatic amines.85-87 The process involves 
reversible hydrogen abstraction at the chiral centre (Scheme 1.19). Thiols are 
known to be good hydrogen donors.88 On the other hand, thiyl radicals are 





Scheme 1.19 Reversible hydrogen transfer between thiol and Cα-H of the amine 
 
Some examples of chiral amine racemisation from Escoubet using different thiols 
were selected and presented in Fig. 1.10 and Table 1.2.  
 
 
Fig. 1.10 Examples of chiral amines (42, 46 to 49) racemised by thiols as demonstrated 
by Escoubet et al. and the by-products formed (50 and 51) 85, 86 
 






1 42 PhSH (0.2) 6 30 76 50 (20) 
2 42 PhSH (1.2) 6 50 40 50 (17) 
3 46 PhSH (1.2) 6 70 4 51 (10) 
4 47 TolSH (1.2) 7 70 0 - 
5 48 MeOCOCH2SH (1.2) 2 67 0 - 
6 49 n-OctSH (1.2) 6 70 4 - 
Table 1.2 Racemisation results of amines 42, 46 to 49 using thiols as demonstrated by 
Escoubt et al. [a][Amine] = 60 to 67 mM 85, 86 
 
This method is less suitable for primary amines such as 42. The corresponding 
carbon-centred radical 52 is particularly susceptible to oxidation which leads to 
the formation of 50 via dimerisation (Table 1.2, entries 1 and 2; Scheme 1.20). 
Stoichiometric amounts of thiol are required to reduce the lifetime of 52 and 
avoids its oxidation (Table 1.2, entries 2 and 5). Oxidation of carbon-centred 
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radicals formed from non-primary amines such as 46 can also occur and can 
hydrolyse to form acetophenone 51 (Table 1.2, entry 3; Scheme 1.21).  
 
Scheme 1.20 Formation of 50 from 42 via oxidation of intermediate radical 52 and 
subsequent dimerisation 
 
Scheme 1.21 Formation of 51 from 46 via oxidation of intermediate radical 53 and 
subsequent hydrolysis 
 
Both stabilised (Table 1.2, entries 1 to 4) and unstabilised thiyl radicals (Table 
1.2, entries 5 and 6) were able to racemise various aliphatic and benzylic amines. 
However the choice of a suitable thiol is crucial and is based on the bond 
strengths of C-H and S-H bonds. They should match such that both forward and 
backward hydrogen transfer proceed at reasonable rates without forming 
undesired side-products such as 50 and 51.85   
 
The use of transition metal catalysts is by far the most important method in the 
racemisation of chiral amines. It is achieved by oxidation/ dehydrogenation of the 
amine to the imine, which is reduced/ hydrogenated back to the amine non-
stereoselectively. In 1983, Murahashi et al. reported the activity of palladium 
towards the racemisation of (S)-42 when he studied the synthesis of 
unsymmetrical amines via alkyl group exchange reaction between primary and 
secondary amines.90 When (S)-42 was heated in the presence of palladium black 
at 100 °C, imine 50 (which was also observed in the racemisation of (S)-42 by 
thiol as discussed previously) and dimer 54 were observed with 6.6% and 1.7% 





Scheme 1.22 Formation of 50 and 54 from (S)-42 in the presence of Pd 
 
The formation of by-products 50 and 54 is especially pronounced in the 
racemisation of primary amines. With no electron-releasing alkyl substituents 
attached to the nitrogen, the imine intermediate formed after dehydrogenation of 
the amine is more electrophilic and less sterically hindered and therefore, it is 
more susceptible to the attack of another amine substrate (Scheme 1.23).  
 
 
Scheme 1.23 General mechanism of the racemisation of primary amines and the 
dimerisation side-reaction. [M] = metal complex catalyst 
 
Jacobs et al. used palladium with inorganic support such as barium sulfate, 
barium carbonate and calcium carbonate in the presence of hydrogen to 
racemise benzylic amines and to increase the selectivity by suppressing the 
formation of dimeric products.91 The reaction was performed at 70 °C which was 
relatively mild and could also be used to combine with enzymatic resolution. 
However it is limited to benzylic amines and is only suitable for substrates without 
any reducible functional groups. 
  
Bäckvall et al. reported the racemisation of chiral amines by ruthenium-
cyclopentadienone complex 55 (Shvo’s catalyst) and its derivatives 56 and 57 
after realising the potential of 55 in catalysing transfer hydrogenation of imines to 
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amines and transfer dehydrogenation of amines to imines, which are the key 
steps in the racemisation of amines.92-96 The system was applicable to both 
benzylic and aliphatic amines. Bäckvall had demonstrated the use of various 
approaches in reducing the formation of dimeric products for primary amines such 
as 42 (Scheme 1.24; Table 1.3). In using the original Shvo’s catalyst 55, lowering 
the concentration of (S)-42 can reduce the chance of condensation of the imine 
with 42 (Table 1.3, entries 1 to 3). The addition of ammonia can shift the 
equilibrium from the dimers to the imines (Scheme 1.23; Table 1.3, entry 4). 
Adding a hydrogen donor such as 2,4-dimethyl-3-pentanol 58 can facilitate the 
transfer hydrogenation of the imine back to amine 42 (Table 1.3, entry 5).  
 
 
Scheme 1.24 Racemisation of (S)-42 and formation of dimeric side products 50 and 54 



















1 55 (5) - 1 48 0 5 12 29 
2 55 (5) - 0.25 48 6 84 5 11 
3 55 (5) - 0.125 48 3 91 3 6 
4 55 (5) NH3 (1) 0.25 48 2 98 < 1 < 1 
5 55 (5) 58 (0.5) 0.25 48 2 98 < 1 < 1 
6 55 (4) - 0.25 24 53 82 N.R.[a] N.R.[a] 
7 56 (4) - 0.25 24 36 25 N.R.[a] N.R.[a] 
8 57 (4) - 0.25 24 55 95 N.R.[a] N.R.[a] 
Table 1.3 Racemisation results of (S)-42 by 55 to 57 demonstrated by Bäckvall.95, 96 




The racemisation of (S)-42 was also tested with different variants of 55. By using 
electron-withdrawing catalyst 56 with fluorine substituents, a lower ee was 
achieved compared to 55. However the selectivity was much lower (Table 1.3, 
entry 7). The ruthenium centre of 56 is more electron-deficient and therefore 
facilitates the dehydrogenation of the amine substrate. On the other hand, this 
slows down the hydrogenation of the imine intermediate and increases its lifetime, 
which leads to more side reactions. With electron-donating catalyst 57, having a 
methoxy substituent, its catalytic activity is lower than that of 56 and is similar to 
that of 55, but with the highest selectivity (Table 1.3, entry 8). Since the ruthenium 
centre in 57 is more electron-rich, this slows down the dehydrogenation of the 
amine; however this speeds up the hydrogenation of the imine intermediate, 
reducing its lifetime and hence, less side-reactions occur.96  
 
Various primary and secondary benzylic amines were racemised by using 5 mol% 
of 55 at 110 °C in the presence of alcohol 58 (0.5 equiv.).95 Some examples of 
the amine substrates are shown in Fig. 1.11 and their racemisation results are 
summarised in Table 1.4. 
 
 
Fig. 1.11 Examples of chiral amines (39, 42, 59 to 62) racemised by 55 as demonstrated 










Entry Amine[a] t (h) Amine (%) ee (%) 
1 42 24 98 3 
2 59 9 98 3 
3 60 24 95 2 
4 61 48 > 95 57 
5 62 24 98 1 
6 39 1 > 99 0 
Table 1.4 Racemisation results of (S)-39, 42, 59 to 62 by Shvo’s catalyst 55 (5 mol%) in 
the presence of 58 (0.5 equiv.) at 110 °C in toluene. [a]Concentration of amine = 0.125 M 
 
Primary benzylic amines with electron-donating and electron-withdrawing 
substituents can be racemised with minimal side products formed (Table 1.4, 
entries 2 and 3). Secondary amine 39 can racemise completely within one hour 
(Table 1.4, entry 6). Racemisation slowed down dramatically with substrates 
having bulky substituents (Table 1.4, entries 4 and 5).  
 
In addition to ruthenium-based catalysts, Blacker et al. demonstrated the use of 
pentamethylcyclopentadienyliridium (III) iodide dimer (SCRAM) 64 in the 
racemisation of primary, secondary and tertiary chiral amines in relatively mild 
conditions (40 to 90 °C; 0.1 to 1 mol% catalyst).1 Initially pentamethyl-
cyclopentadienyliridium (III) chloride dimer 63 was tested in the racemisation of 
(S)-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 (Scheme 1.25).  
 
 
Scheme 1.25 Racemisation of (S)-9 by catalysts 63 and 64 
 
Although the racemisation of (S)-9 was observed, a significant amount of the 
dehydrogenated side-products 8 and 65 were formed with some other 
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unidentified impurities. Since the rate of racemisation and the lifetime of 
intermediate imine 8 depend on the binding interaction between the substrate 
and the iridium centre, and the tendency for the catalyst to donate or accept a 
hydride ion, this can be modified by changing the ligand on the catalyst. Therefore 
potassium iodide was added into the reaction mixture to form 64 in-situ, which 
resulted in 120-fold increase in the rate of racemisation of (S)-9 and a significant 
reduction of 8 and 65 formed. The use of isolated iodo-catalyst 64 led to similar 
results.1 These indicate the importance of the halide ligand in the catalytic activity 
of pentamethylcyclopentadienyliridium (III) complexes towards racemisation of 
amines.  
 
Catalyst 64 was further tested in the racemisation of other chiral amine substrates 
(Fig. 1.12 and Table 1.5).1 Both secondary and tertiary amines were racemised 
successfully by 64 (Table 1.5, entries 1 to 4, 7 to 9). Cyclic amines tend to 
racemise at higher rates and this may be due to the more stable imine 
intermediate formed (Table 1.5, entries 1 to 3). For amines with more than one 
heteroatom such as 68, it can act as a bidentate ligand and binds to the iridium 
which reduced the activity of the catalyst (Table 1.5, entry 4). Significant dimer 
formation with negligible racemisation was again observed for primary amines 
(Table 1.5, entries 5 and 6). Amines with less bulky and more electron-donating 
substituents were found to racemise at higher rates (Table 1.5, entries 1 and 8). 
These can be due to the stronger binding between the iridium centre and the 
substrates which allows dehydrogenation of the substrates to occur.  
 
 





Entry Amine T (°C) Loading of 64 (mol%) Racemisation t1/2 (min) 
1 (S)-9 40 0.2 45 
2 (S)-66 80 0.5 180 
3 (S)-67 40 0.2 220 
4 (R)-68 80 1 > 7200 
5 (S)-69 80 1 Dimeric impurities 
6 (S)-42 80 1 Dimeric impurities 
7 (S)-46 90 1 1250 
8 (S)-39 80 1 45 
9 (S)-70 80 1 250 
Table 1.5 Racemisation results of chiral amines by SCRAM catalyst 64 
 
Although transition metal catalysts such as 64 are relatively active towards the 
racemisation of a wide variety of amines, these catalysts are expensive. 
Therefore their reuse and recycle after the reaction are highly desirable. However 
this is often difficult to achieve for homogeneous systems. In this work, the activity 
of 64 will be further studied. Its immobilisation which allows its efficient recycle 
will also be discussed. 
 
1.3.2. Mechanism of chiral amine racemisation by SCRAM catalyst 64 
Chiral amine racemisation involves hydrogen transfer reactions between the 
amine substrate and the metal catalyst. Stirling et al. recently proposed a 
mechanism for amine racemisation by catalyst 64 (Scheme 1.26).97 It was 
assumed that initial complex formation between the iridium dimer and the amine 
substrate was required to initiate the racemisation reaction. The Ir-amine complex 
was observed at low temperature (-40 °C) in which the binding constant increases 
with less sterically hindered substrate such as 42, in comparison to 39. However, 
under normal racemisation reaction conditions in which a higher temperature is 
usually required, the binding is not strong and only a small fraction of 64 can be 
converted to the Ir-amine complex. Hydride transfer between the coordinated 
amine to the iridium is the rate-limiting step based on the primary kinetic isotopic 
effect observed for 9 (1-H) and 9 (1-D). An ion pair is formed between the diiodo-
iridium hydride complex which carries a negative charge with the positively 
charged iminium ion. A cross-over experiment with isotopically labelled amines 
was carried out by Stirling which showed that the iminium/ imine intermediate 
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formed can dissociate from the iridium complex. Upon its re-association, hydride 
is transferred from the iridium back to the imine. 
 
 
Scheme 1.26 Plausible mechanism of chiral amine racemisation by SCRAM 64 proposed 
by Stirling et al. A generic secondary amine was shown as an example. Cp* = 
pentamethylcyclopentadienyl 
 
The proposal of the formation of imine/ iminium intermediate upon hydride 
transfer from the amine to the iridium and the re-addition of hydride to the imine/ 
iminium can potentially be used as an indication to determine if an amine 
substrate can be racemised under certain reaction conditions. This can be 
achieved by using either a deuterium-labelled substrate, or deuterium donor such 
as d8-isopropyl alcohol, without the need to carry out the actual racemisation 
reaction with the enantio-enriched material and subsequent chiral analysis. This 
has been investigated in this project and will be addressed in Section 2.5. 
 
1.4. De-racemisation 
As discussed in previous sections, although the resolution of racemates remains 
one of the major methods for the preparation of enantiopure compounds, the 
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theoretical yield of the desired enantiomer can never exceed 50%. Considerable 
effort has been made to overcome this limitation by developing processes which 
convert a racemate into the desired, single stereoisomer in a concurrent fashion 
in which the formation of the undesired stereoisomer can be totally avoided.98 
This is known as ‘de-racemisation’. This term was originally defined as the 
opposite of racemisation (‘de’ means the opposite of) which implied the 
transformation of two enantiomers into one single enantiomer of the same 
compound (Eqn. 1.3).  
 
SR + SS → SR   (Eqn. 1.3) 
 
Where SR and SS are the R- and S-enantiomer of the substrate. 
 
Whilst the enthalpy change of this process is negligible,79 decrease in entropy 
means that this is energetically unfavourable. Faber had re-defined the term ‘de-
racemisation’ as any processes during which a racemate is converted into a non-
racemic product in 100% theoretical yield without intermediate separation of 
materials (Eqn 1.4).98 The unfavourable entropy change can possibly be covered 
by the enthalpy of the reaction. Product PR is a closely related derivative of the 
substrate. In the case of chiral amine, the product can be diastereomeric salts, 
amides and carbamates.  
 
SR + SS → PR   (Eqn. 1.4) 
 
Where PR is the single enantiomer of the product. 
 
De-racemisation can be achieved by re-racemisation and repeated resolution. 
Upon the resolution of a racemic mixture in which the desired enantiomer is 
transformed into the product, the unconverted, undesired enantiomer is 
racemised to a 1:1 mixture of both enantiomers which is subject to resolution 
again (Fig. 1.13).63 Theoretically, an infinite number of cycles is needed for 
complete transformation of the racemate into the single stereoisomer of the 
product. Actually the yield of the product can reach above 96% after only 5 cycles 
and > 99% after 7 cycles, assuming complete racemisation occurs in each cycle 
and no loss of starting material or products. Some commonly employed de-
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racemisation methods in synthesising enantiopure amines utilising repeated 




Fig. 1.13 Overall yield of product after repeated resolution and re-racemisation 
 
1.4.1. Dynamic Kinetic Resolution (DKR) 
Kinetic resolution is based on the different reaction rates of two enantiomers in 
forming the products by chiral catalyst. In order to achieve high enantiopurity, KR 
are often stopped before the conversion reaches 50%, further lowering the 
productivity of the process.63, 99 To circumvent this, KR is combined with in-situ 
racemisation of the slower-reacting enantiomer in one single operation which is 
known as dynamic (kinetic) resolution (DKR) (Fig. 1.14(a)).  
 
For a successful DKR, the rate differences of the enantioselective process of R- 
and S-enantiomers of the substrates need to be large enough, i.e. kR >> kS. This 
indicates a highly selective kinetic resolution process. The E value is typically ≥ 
20. In addition, the rate of racemisation must be higher (or at least equal) to the 
rate of the faster-reacting enantiomer, i.e. krac ≥ kR. This ensures that the 
racemisation step is fast enough to replenish the reacted SR and therefore SS is 
not in excess at any time, allowing the enantioselective reagent to react solely 
with SR. Unlike a kinetic resolution where the ee of the product reaches its 
maximum at the start of the reaction and then declines when the faster-reacting 




















ee of the product is no longer a function of the conversion, but remains constant 
throughout (Fig. 1.14(b)). 
 
 
Fig. 1.14 DKR of a racemate. (a) Dynamic equilibration of SR and SS; kR and kS are the 
rate constants of the enantioselective processes; krac is the racemisation rate constant. 
(b) Comparison of ee profiles of the product (PR) in DKR and KR 63 
 
Enzymes are very commonly used in DKR due to their high stereoselectivity. The 
first DKR process in the synthesis of chiral amine was reported by Reetz et al. in 
1996.1, 100 Racemic 42 (1 mmol scale) was resolved by lipase Candida antarctica 
(NOVOZYM SP435®) via enantioselective N-acylation with ethyl acetate as the 
acyl donor. The undesired (S)-42 was recycled using Pd/ C. Enantiopure (R)-N-
acetyl-N-methyl-α-methylbenzylamine 71 was produced in 99% ee and 64% yield 
after 8 days (Scheme 1.27).  
 
 





Bäckvall et al. had reported the DKR of rac-42 in larger scales using alkyl 
methoxyacetates 72 and 73 as alternative acyl donors, Candida antarctica lipase 
B (CALB) as the enzyme for the KR and Shvo’s catalyst derivative 57 (1.25 mol%) 
as the racemisation catalyst in the presence of alcohol 58 as the hydrogen donor. 
Possibly due to the higher thermal stability of the enzyme, a higher temperature 
(100 °C) was used. Acylated (R)-42 was produced in 90% yield with 97% ee (10 
mmol scale) and 83% yield with 98% ee (45 mmol scale) by using 72 and 73 as 
the acyl donor respectively after 72 hours.101 Bäckvall also reported the DKR 
processes of a wide range of aliphatic and benzylic primary amines using 55 and 
57 as the racemisation catalysts and isopropyl acetate as the acyl donor, 




The formation of amides from the resolution often require harsh conditions to 
hydrolyse in order to recover the enantiopure amine.103 This limits the application 
of DKR on substrates with sensitive functional groups. Blacker et al. reported the 
DKR of rac-9 by using 3-methoxyphenyl propyl carbonate 74 as the acyl donor 
and SCRAM 64 (0.2 mol%) as the racemisation catalyst on a cyclic secondary 
amine 9. The process was carried out on a 3 g scale and 82% yield of (R)-75 in 
96% ee was achieved after 23 hours (Scheme 1.28).1, 2 
 




Ideally both resolution and racemisation in a DKR process should be performed 
under the same conditions. However, racemisation usually requires relatively 
harsh conditions such as high temperature which may not be compatible with the 
enzyme used in the resolution step, although some enzymes are still stable at 
elevated temperature such as CALB, which is the lipase enzyme used in the 
resolution of rac-42 and other primary amines as demonstrated by Bäckvall. 
Compromise is often needed between the racemisation and resolution. Being 
able to carry out the racemisation reaction under mild conditions is beneficial for 
a successful and efficient DKR. 
 
1.4.2. Crystallisation-Induced Diastereomeric Transformation (CIDT) 
Although enzymatic DKR has been widely used in the synthesis of 
enantiomerically pure amines, restrictions on the reaction conditions that can be 
employed due to its limited stability remain the major problems, as discussed in 
Section 1.2.2(b). Therefore in practice, there is still a significant barrier to 
widespread adoption of enzymatic DKR. On the other hand, diastereomeric 
crystallisation is easy to operate, can be highly stereoselective and economical, 
and direct isolation of the desired product in preference to other by-products in 
the reaction by filtration means that product purification is relatively simple and 
straightforward.99, 104 When a racemic mixture of a chiral amine reacts with an 
enantiopure chiral acid, a pair of diastereomeric salts is formed which can be 
separated by crystallisation due to their different solubility. Once-through yields 
of > 50% are feasible if the uncrystallised, undesired diastereomeric salt in the 
ML undergoes catalysed or spontaneous racemisation. This is known as 
crystallisation-induced diastereomeric crystallisation (CIDT) or crystallisation-
induced dynamic resolution (CIDR). Unlike DKR which depends on different rates 
of the enantioselective process of two enantiomers, CIDT is thermodynamically 
controlled. It can also be referred to as dynamic thermodynamic resolution 
(DTR).78 
 
Merck reported the synthesis of a potent antagonist of the gastrointestinal 
hormone cholecystokin (CCK) which involved diastereomeric resolution of 
racemic aminodiazepinone 76 by (1S)-(+)-10-camphorsulfonic acid 36.105 The 
less soluble (S)-76-(S)-36 was crystallised in 91% yield and 99.5% de. The 
undesired (R)-76 was racemised using catalytic amount of 3,5-
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dichlorosalicylaldehyde 77 (Scheme 1.29). A Schiff base was formed between 
(R)-76 and 77 in-situ which has a low pKa proton at the chiral centre of 76 and is 
able to undergo racemisation at ambient temperature via a similar mechanism 
shown in Scheme 1.18. 
 
 
Scheme 1.29 CIDT process for the synthesis of enantiopure (S)-76 using (1S)-36 as the 
resolving chiral acid and aldehyde 77 as the racemisation catalyst 
 
A similar process was reported by Negi et al. in the synthesis of (2R)-1-(4-chloro-
2-pyridyl)-2-(2-pyridyl)ethylamine 78, a key intermediate for their target 
compounds in the field of cardiovascular therapy.106 Enantiopure chiral acid 79 
was used to resolve rac-78, whilst 77 (6 mol%) was used to racemise the 
undesired (S)-78 in the ML (Scheme 1.30). Enantiopure (R)-78 was obtained in 
42% yield after three recrystallisation of (R)-78-(1S,2R)-79 and subsequent acid-
base extraction by sodium hydroxide solution, which is higher than the yield 
achieved in the classical resolution (29%) by more than 10%. 
 
Scheme 1.30 CIDT process for the synthesis of enantiopure (R)-78 using (1S,2R)-79 as 
the resolving chiral acid and aldehyde 77 as the racemisation catalyst 
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1.4.3. The Viedma ripening technique 
Racemic compounds which can crystallise as conglomerates and spontaneously 
racemise in solution can be transformed into enantiopure state via crystallisation-
induced enantiomeric transformation (CIET) or crystallisation-induced 
asymmetric transformation (CIAT). It is also called total spontaneous resolution.78 
Viedma et al. used sodium chlorate, which forms chiral crystals whilst being 
intrinsically achiral in solution, to demonstrate the emergence of solid state 
homochirality by intensively grinding a supersaturated solution of sodium chlorate 
containing crystals of both chiral forms using glass beads.107, 108 The technique is 
known as Viedma ripening. Noorduin et al. extended Viedma ripening to 
intrinsically chiral molecules such as imine 80, which racemises readily in solution 
in the presence of a strong base such as 1,8-Diazabicyclo[5.4.0]undec-7-ene 
(DBU) (Scheme 1.31).109 Upon crystallisation of one of the enantiomers (which is 
in small excess at the beginning of the process), the ML is enriched with the 
enantiomer opposite to the one enriched in the solid phase and is racemised to 
produce more of the enantiomer which is enriched in the solid phase. The attrition 
by glass beads continuously break down the crystals into smaller fragments 
which dissolve and grow onto larger crystals of the same handedness.7 Complete 
de-racemisation is eventually observed. Unlike diastereomeric resolution, no 
chiral acids are required for resolving conglomerates and therefore no 
subsequent free-basing procedures and recycling of resolving agents are 
needed.78 However the scope of Viedma ripening is still limited since 
conglomerate-forming crystalline chiral compound is required which only 
accounts for < 10% of all crystalline racemates. Although various amino acid 
derivatives and some other pharmaceutically-relevant compounds such as 
Naproxen and Clopidogrel intermediate can undergo this attrition-induced de-







Scheme 1.31 In-situ racemisation of 80 in the presence of DBU 
 
1.4.4. Diastereomeric resolution recycle 
For CIDT and Viedma ripening discussed above, in-situ racemisation of the 
undesired stereoisomer relies on the presence of an acidic proton at the chiral 
centre. Being able to use racemisation catalysts that can racemise a wider range 
of chiral amines, such as Shvo’s catalysts 55 to 57 (Scheme 1.24 and Fig. 1.11) 
and SCRAM catalyst 64 (Scheme 1.25 and Fig. 1.12), can broaden the scope of 
the process. However it is often difficult to operate both racemisation and 
crystallisation under the same reaction conditions. Whilst transition metal-
catalysed racemisation of chiral amines usually require high temperature, this can 
increase the dissolution of crystals formed in the resolution. In addition, the 
presence of catalyst can affect nucleation of the crystallisation, subsequent 
crystal growth, and can also contaminate the product formed. Therefore one-pot 
processes utilising crystallisation and in-situ racemisation by transition metal 
catalysts are less feasible and it is preferable to separate the two steps. Semi-
continuous resolution-racemisation recycle processes have been developed in 
batch in an attempt to resolve the incompatibility between crystallisation and 
racemisation and were tested with several industrially relevant chiral amines. Two 
examples will be discussed below. They both involve filtration of the crystal 
product and isolation of the metal catalyst after each cycle. This does not strictly 
fit the definition of de-racemisation which operates ‘without intermediate 
separation of materials’, as discussed at the beginning of the section. However 
these semi-continuous processes can generate pure stereoisomeric products 
from racemic mixtures in 100% yield and therefore this will also be discussed 




Blacker et al. reported the synthesis of Sertraline 40, the active pharmaceutical 
ingredient (API) of an anti-depressant Zoloft from Pfizer, by diastereomeric 
resolution and waste isomer racemisation.43 The process started with the 
resolution of racemic sertraline diastereomers using (R)-mandelic acid 34 in 
which (R)-34 salt of (1S,4S)-40 was selectively crystallised and was filtered. (R)-
34 was recycled by treating the crystals with sodium hydroxide and was further 
processed into the hydrochloric acid salt of (1S,4S)-40. The ML containing the 
waste isomers was free-based and fresh rac-40 was charged. 1-(N-methyl)amino 
chiral centre of 40 was epimerised by SCRAM 64 (0.1 mol%). The catalyst was 
partially recovered by bubbling gaseous ammonia into the system to form an 
insoluble ammonio complex which was added back into the reaction mixture in 
the next cycle. The benzylic chiral centre was epimerised by potassium tert-
butoxide and the racemised reaction mixture was subjected to resolution again 
(Scheme 1.32). Toluene was used as the single solvent throughout the process. 
The process was carried out on 260 g scale of rac-40 and diastereopure enriched 
crystals of (1S,4S)-40-(R)-34 were obtained in 80 to 98% yield (based on the 
equivalence of 34 added) with ≥ 92% de in each cycle. 
 
Scheme 1.32 A simplified scheme showing the semi-continuous resolution-racemisation 




In an unpublished work by the Blacker group, a similar procedure was employed 
in synthesising (S)-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine 81, which 
is a key fragment in a β-adrenoreceptor antagonist drug candidate from Sanofi-
Aventis.78 The resolution of rac-81 was carried out using (R)-34 (0.5 equiv.) in 
tert-butyl methyl ether. The crystalline products were filtered and the ML 
containing the undesired (R)-81 was free-based and racemised with SCRAM 64 
(0.3 mol%) at 110 °C in the same solvent (Scheme 1.33). The catalyst was 
precipitated, filtered, screened and reused. An overall yield of 49% was achieved 
over four cycles without optimisation (based on the amount of rac-81 added) 
which was higher than the single-step resolution (30%). The ee of (S)-81 from 
each cycle was about 80 to 90%.  
 
Scheme 1.33 Resolution-racemisation approach in the synthesis of (S)-81 
 
The two examples demonstrated above required only one single solvent and so 
avoiding the need of solvent-swap. However it is not uncommon that racemisation 
and crystallisation require different solvents. Although the used catalyst 64 could 
be precipitated from the reaction, removed, and recycled, its recyclability was 
unlikely to be high and complete removal of residual metal from the reaction was 
difficult to achieve. As discussed earlier, it is highly desirable to separate 
resolution and racemisation. However it is possible to link them together to 
generate a continuous process.78 The concept of designing a crystallisation-
based resolution process with continuous recirculation of ML over a 
heterogeneous racemisation catalyst was first speculated by Sheldon and it will 




1.5. Continuous processing 
1.5.1. Flow reactors 
Attempts to reduce the number of intermediate isolation and purifications, the 
need for automation and efficient scale up of synthetic processes has driven 
industries to develop continuous flow techniques. Different types of flow reactors 
have been developed recently to accommodate different reaction types. 
 
One of the most simple and commonly used continuous flow reactor is the tubular 
reactor consisting of a stainless steel tube, which can be heated by aluminium 
heating block or thermostatic bath, with one or more feeds at the inlet where the 
reagents are pumped through the tube using a suitable pump. If more than one 
reagent feeds are used, the feeds and the stainless steel tube are linked by a T-
mixer to ensure the reagents are mixed before the reaction starts. The product 
was collected at the other end of the tube (Fig. 1.15).113 The tube can be packed 




Fig. 1.15 Schematic of a continuous flow tubular reactor system 
 
For multiphasic reactions, no or improper mixing of reagents in ordinary tubular 
reactors resulted in segmented or density-separated flows (Fig. 1.16).114 This can 
be overcome by using tubular reactors with built-in static mixer. However they 
require high flow rates and are not suitable for solid-forming reactions.  
 
 
Fig. 1.16 Improper mixing of biphasic reaction in tubular reactors. (a) Segmented flow; 













Multiphasic reactions in flow involving slurries can be accommodated using 
cascade continuous stirred tank reactors (CSTRs).114 With increasing number of 
CSTRs connected, the system tends to perform as a well-mixed plug-flow 
reactor.115 However the conventional cascade CSTRs are often complex, 




Fig. 1.17 Schematic for a conventional cascade CSTR 
 
Solid-forming reactions such as crystallisations have been reported using 
continuous oscillatory baffled crystalliser (COBC) which was shown to provide 
high fluid mixing. The reactor consists of a glass tube with periodically spaced 
baffles perpendicular to the flow of the fluid that is oscillated using a diaphragm 
with movement generated by a motor placed at one end of the reactor (Fig. 
1.18).115, 117, 118 The interaction between the flow and the baffles leads to the 
generation and cessation of eddies which create vigorous axial and radial motion 
of the fluid in each inter-baffle zone, which can be considered as a perfectly mixed 
CSTR and hence the entire reactor behaves as a large number of CSTRs in 
series that exhibit plug-flow characteristics.119 However, the size of the reactor is 
relatively large (litre scale) with complicated construction which may not be 










Fig. 1.18 Schematic for a continuous oscillatory baffled crystalliser (COBC) 
 
AMTech had developed the Coflore® reactors, which are multistage CSTRs 
consisting of a series of loose-fitting polymer inserts that provide mixing when the 
entire reactor was shaken. Different configurations are available which allow 
reactions of different scales to be carried out (Fig. 1.19).120   
 
 
Fig. 1.19 Coflore® reactors from AMTech. (a) Schematic for the Agitated Cell Reactor 
(ACR) with capacities from 10 to 100 mL, reaction times from 10 s to 10 h; (b) Agitator 
Tube Reactor (ATR) with capacities from 1 to 10 L, reaction times from 10 s to > 10 h 
(The photo was provided by AMTech) 
 
In addition to the Coflore®, Blacker et al. reported a miniaturised cascade CSTR 
(the ‘Freactor’) with relatively inexpensive and simple design (Fig. 1.20). Each 




required. They are connected using PTFE ferrules and tubing and are placed 
onto a stirrer motor or a hot plate.114 The stirrer bar in each Freactor allows the 
content to be mixed. A similar design was reported by Jensen et al.121 Reactions 
with residence times (tRes) ranging from two minutes to three hours were tested 
and can be used for multiphasic reactions involving gas, liquid and solid.114  
 
 
Fig. 1.20 A three-stage Freactor system developed by Blacker et al. 
 
1.5.2. Merits and limitations of flow 
Carrying out chemical transformations in flow at lab and/ or industrial scales have 
attracted much interest in recent years. One of the major advantages of using 
flow reactors over batch ones is the better mixing and heat transfer due to their 
large surface area to volume ratio, which allows reactions to be carried out at high 
temperature, high pressure and increased concentrations.37, 122, 123 Unlike a batch 
system, where the reaction is changing over time, steady-state can be achieved 
in flow, resulting in product consistency and minimised impurity accumulation. By 
assembling a line of reactors, multistep reactions can be performed with direct 
transfer of unstable intermediates, with no isolation or purification of materials 
between two steps.124 Online and inline analysis tools can be integrated into the 
flow system, enabling process automation and optimisation.37, 125 One of the other 
most important benefits in employing flow is the ease of recycling precious 
catalysts and reagents in the case of heterogeneous reactions with minimum 
manipulation.124  
 
Despite the potential advantages and opportunities offered by using flow, there 
are problems and limitations which need to be encountered. In achieving steady-
state, large amount of materials are often required and any products formed 






batch process where various probing devices can be used to analyse the 
reactions in-situ, this is currently more difficult in flow reactors due to their small 
sizes. Technical problems such as leaks and blockages are sometimes observed, 
especially in multiphasic reactions which require more complicated engineering 
design of the reactors. 
 
In this work, racemisation of chiral amines in flow will be studied and discussed 
in more detail in Chapter 2, which utilised a packed-bed reactor (PBR) with 
SCRAM catalyst 64 immobilised onto a solid support. The major driving force in 
using flow in racemisation reaction is the ease of recycling the expensive iridium 
catalyst and minimising product contamination. Besides, the PBR can be readily 
coupled with the batch crystallisation reactor to generate a continuous recycle 
process with minimum engineering required. In addition to racemisation, 
continuous crystallisation in flow was also attempted in the Freactors and will be 
briefly addressed in Chapter 3.  
 
1.5.3. Catalyst immobilisation 
In general, homogeneous metal-based catalysts can only be used once due to 
the difficulty in recovering them from the reaction mixture. Although the recovery 
of homogeneous SCRAM 64 during the resolution-racemisation process of 
Sertraline 40 had been made possible via the formation of an insoluble ammonio-
iridium complex, which released the active catalytic species when it was heated,43 
the number of reuses is not likely to be high and rapid drop in catalytic activity 
can be readily observed in subsequent reactions. Difficulties in removing any 
residual metal from the products also raises much concern.38 Covalent 
immobilisation of metal catalysts onto solid supports, such as silica and organic 
polymers, represents one of the best solutions to the above problems. An ideal 
immobilised catalyst should exhibit catalytic activity and selectivity comparable to 
its homogeneous counterpart, be easily recovered from the reaction mixture 
without metal leaching, and can be recycled in many runs without significant loss 
of activity and selectivity.36 However reduced catalytic activity and 
enantioselectivity are often observed when homogeneous chiral catalysts are 
immobilised.4, 6, 29, 36, 126-128 In heterogeneous catalysis, the substrate molecules 
need to diffuse through the porous structure of the supporting matrix in order to 
reach the active site of the catalyst, contributing to the reduced activity 
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observed.36, 129 The geometry of the catalyst is crucial in directing the 
stereochemistry of the product. It can be unintentionally disturbed upon 
immobilisation through the interaction between the catalyst and the solid support, 
leading to reduced enantioselectivity.36 Despite the plethora of work done to date, 
development of suitable immobilisation strategies for homogeneous metal 
catalysts remains a challenge. 
 
Ruthenium complexes with (R,R) or (S,S)-TsDPEN ligand reported by Noyori et 
al. are the most well-known catalysts employed in the ATH reactions of ketones 
and imines.28, 29, 130-132 Their immobilisations have been widely studied to try and 
simplify their separation from the reaction mixture and allow efficient recovery 
and reuse of expensive and toxic catalysts.36, 38, 130, 132-134 Liu et al. reported the 
immobilisation of TsDPEN ligand onto a silica support and the utilisation of the 
immobilised Ru-TsDPEN complex, which was formed in-situ, in the ATH of 
acetophenone 51 in formic acid/ trimethylamine mixture (Scheme 1.34).133 (R)-1-
phenylethanol 83 was synthesised in 99% yield at 97% ee after 6 hours and Ru-
82 could be reused up to 5 times with the enantioselectivity maintained, and only 
a slight drop in yield, although the reaction time was much longer (94% in 44 
hours in run 5).  
 
 
Scheme 1.34 ATH of 51 using silica-supported Ru-TsDPEN complex 
 
Ying et al. reported the immobilisation of Ru-TsDPEN onto siliceous mesocellular 
foam (MCF).132 The main advantage of MCF is its uniform and ultralarge pore 
size (20 to 50 nm) which allows the immobilisation of large catalytic complexes 
within the pores without steric hindrance, and can facilitate mass transfer of the 
substrates. The MCF-supported Ru-TsDPEN catalyst 84 successfully reduced 
imine 8 to amine 9 and had been recycled for 6 runs, achieving 95 to 100% 
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conversion and 90 to 91% ee (Scheme 1.35). It was found that 2 to 5 ppm of 
ruthenium was leached into the reaction after each run. Elemental analysis 
showed a total of 17% loss of ruthenium and 7% loss of ligand after 6 runs. 
 
 
Scheme 1.35 ATH of imine 8 using MCF-supported Ru-TsDPEN catalyst 
 
Catalyst recyclability is one of the major driving forces in the development of 
immobilised catalysts. From the examples discussed above, catalyst recycling 
studies have been reported but they all showed a decline in catalytic activity in 
about 3 to 10 runs. ICP analysis showed a loss of ruthenium into the solution 
phase. This is likely due to the immobilisation via bidentate TsDPEN ligand. The 
resulting coordination between the metal and ligand are not strong enough, 
causing the metal to leach from the catalyst matrices. Blacker et al. reported the 
immobilisation of a series of hydroxyl-tethered Cp*-iridium/ rhodium dichloride 
complexes onto Wang resin via the ƞ5-Cp* ligand 85 (Scheme 1.36).38 This allows 
a stronger coordination of the metal to the ligand and the support, minimising the 




Scheme 1.36 Immobilisation of hydroxyl-tethered dimers 86a, 86b, 87a and 87b onto a 
Wang resin 
 
Immobilised catalyst 88 and 89 were tested against the transfer hydrogenation of 
benzyaldehyde 90 to benzyl alcohol 91, and 89a was found to be the most active 
catalyst and showed the highest recyclability, achieving 98% conversion in 24 
hours at 60 °C when fresh and > 87% conversion in the first 15 runs (Scheme 
1.37). From 16 to 26 runs, the activity of 89a decreased gradually (80% 
conversion after 48 hours in run 26). ICP analysis of recovered resin showed 
minimal leaching of iridium from the immobilised catalyst. The observed decrease 
in the catalytic activity might possibly due to catalyst decomposition and/ or loss 
of resin in the decantation step. 
 
 
Scheme 1.37 Benzaldehyde reduction by 89a 
 
In batch, the immobilised catalysts can be isolated from the reaction by filtration 
or decantation. However, this can result in physical losses of the catalysts, hence 
the productivity in the subsequent reactions may gradually decrease. The 
recycling of catalysts can be made easier by carrying out the reaction in flow. The 
insoluble catalyst remains in the reactor when the reaction mixture is pumped 
through. The catalyst can be readily washed by flushing solvent across and new 
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reagents/ substrates can then pumped through the catalyst again. The reported 
success of homogeneous Shvo’s catalyst 55 and SCRAM 64 in the racemisation 
of amines indicates the potential of using their immobilised versions in flow.  
 
1.6. Research objectives 
The aim of this research is to develop a novel process in synthesising enantiopure 
chiral amines which couples diastereomeric crystallisation in batch with 
racemisation of the ML in flow to yield a continuous resolution-racemisation-
recycle (R3) process. Various primary, secondary and tertiary chiral amines were 
chosen and tested in the R3 system. Racemisation of the amines in batch and 
flow using homogeneous and immobilised SCRAM catalysts respectively were 
first studied in Chapter 2 to better understand the kinetics and mechanism of the 
racemisation reaction, as well as the deactivation mechanism of the catalyst. A 
novel and rapid method based on proton/ deuterium exchange was developed to 
determine the racemisation of chiral amines under a particular set of reaction 
conditions using 1H NMR spectroscopy, which avoided the need of enantio-
enriched material and the development of chiral analytical methods. In Chapter 
3, diastereomeric resolution of the chosen amine substrates with enantiomerically 
pure acids (S)-mandelic acid and di-p-toluoyl-D-tartaric acid were investigated 
and combined with the racemisation of the ML in flow. The two steps operated in 
separate reactors but were linked via external tubing. The batch resolution and 
the R3 process for each substrate were compared to understand the merits and 
limitation of the R3 process. Due to the high cost of iridium, and other commonly 
employed transition metals in the racemisation of chiral amines, a series of 
copper- and iron-based metal salts and complexes were screened and tested 
against racemisation reaction in order to search for cheaper alternatives of 





2. Racemisation of chiral amines 
2.1 Introduction 
Recycling of the undesired enantiomer in a resolution by racemisation and 
recirculation of the racemised material can increase the yield and efficiency of the 
resolution process. One of the racemisation strategies of chiral amines is the 
reversible transformation between amine and imine via oxidation-reduction 
reactions using transition metal catalysts such as palladium, ruthenium and 
iridium.1, 90-92, 95 The use of SCRAM catalyst 64 has been widely studied and its 
application in the diastereomeric transformation to enantiomerically pure amine 
has also been demonstrated.43 Homogeneous SCRAM catalyst 64 and its chloro-
analogue 63 have previously been immobilised onto a Wang resin support.38, 43, 
135 In an unpublished work, the supported SCRAM catalyst 92 was employed by 
J. Breen to improve its recyclability and reusability in the racemisation of (R)-39 
in batch (Scheme 2.1). Although the catalyst could be reused, its activity dropped 
significantly after the first run (Fig. 2.1).  
 
 
Scheme 2.1 Racemisation of (R)-39 using immobilised SCRAM 92 in batch 
 
 
Fig. 2.1 ee of 39 from four consecutive racemisation reactions using the same catalyst 
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Immobilisation of SCRAM 64 allows the catalyst to be used in flow and can be 
recycled much more easily without frequent manipulation. The racemisation of 
(R)-39 was carried out in flow with an average drop of 9% ee after one pass 
through the reactor and the catalyst was used for 25 runs with minimum loss in 
activity (Fig. 2.2). 
 
 
Fig. 2.2 Racemisation of (R)-39 in continuous flow using immobilised SCRAM catalyst 
92 (10 mol%) in EtOAc. [39] = 74 mM, tRes = 7.5 min, T = 75 °C. The same catalyst was 
used for 25 reactions. Data was provided by J. Breen 
 
The aim of this work was to further investigate the racemisation of various 
different chiral amines using homogeneous SCRAM 64 and immobilised SCRAM 
92 in batch and flow respectively to obtain suitable racemisation conditions that 
could be used to couple with the diastereomeric crystallisation process (Chapter 
3). Kinetic and mechanistic studies will be carried out to better understand the 
limitation and deactivation pathways of the catalyst.  
 
2.2 Racemisation in batch 
2.2.1 N-Methyl-α-methylbenzylamine 39 
(a) Kinetics 
Racemisation of N-methyl-α-methylbenzylamine 39 was previously reported by 
Blacker et al. using 1 mol% homogeneous SCRAM 64 in toluene, with a half-life 
of 45 minutes at 80 °C.1 To gain a better understanding of the reaction, it was 
carried out at various concentrations from 0.1 to 2 M. The catalyst loading was 




















Scheme 2.2 Racemisation of (S)-39 with SCRAM 64 (0.2 mol%) in toluene at 105 °C 
 
 
Fig. 2.3 Profiles of ee for the racemisation of (S)-39 at various concentrations with 64 
(0.2 mol%) in toluene at 105 °C. Only the data for t = 0 to 480 min was shown 
 
Racemisation can be described as the formation of a scalemic mixture from an 









) = kract   (Eqn. 2.1) 
 
Where [S]0 and [S]t is the concentration of (S)-39 at time = 0, and [S]t is the 
concentration of (S)-39 in the system at time t excluding that in the RS complex 
and was calculated based on the ee of the system (Eqn. 2.2); krac is the 
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   (Eqn. 2.4) 
 
Where [RS]t and [R]t are the concentration of the racemate and (R)-39 at time t 









) = kract   (Eqn. 2.5) 
 
The value of krac was determined by plotting Eqn. 2.5 where krac is the slope of 
the graph, assuming that the total concentration of 39 remained constant and no 
conversion to any side products occurred (Fig. 2.4).  
 
 
Fig. 2.4 Plots of ln {[S]0/([S]0 – 2[R]t)} against time for the racemisation of (S)-39 by 64 
(0.2 mol%) at various concentrations, assuming no conversion of 39. (a) t = 0 to 480 min. 
(b) t = 0 to 30 min, showing the trend lines with the corresponding R2 values 
 
To be noted is that the total amine concentration remains almost constant making 
the reaction zero order in the amine, but first order in the (S)-enantiomer. Initial 

















































concentration (time = 0 and 5 minutes in this case). It was deduced from this and 
later data that in this reaction, the catalyst deactivation was occurring. The values 











ee (24 h) 
(%)[c] 
51 (24 h) 
(%)[d] 
1 0.1 0.047 15 20 14 0.5 
2 0.25 0.092 8 10 4 0.4 
3 0.5 0.102 7 5-10 6 0 
4 1 0.114 6 5-10 7 0.6 
5 2 0.094 7 15 14 1.8 
Table 2.1 Rate constants, half-lives, ee of 39 and the amount of acetophenone 51 formed 
for the racemisation of (S)-39 at various concentration with 0.2 mol% 64 at 105 °C in 
toluene. [a]Values calculated by Eqn. 2.6. [b]Values obtained from the ee profiles (Fig. 2.3). 
[c]ee was determined by chiral GC after derivatisation by trifluoroacetic anhydride. 
[d]Amount of 51 was determined by GC 
 
 
Fig. 2.5 Racemisation rate constants krac at different concentration of (S)-39 
 
The initial rate increased with increasing concentration of 39 from 0.1 to 1 M. 
However the increase was not linear and slowed down after 0.25 M (Fig. 2.5). No 
further increase in the reaction rate was observed when the concentration of 39 
increased to 2 M. Most of the kinetic plots of ln {[S]0/([S]0 – 2[R]t)} against time 
remained linear for ≤ 30 minutes and then levelled off (Fig. 2.4(a)). A trend line 
was drawn through the data points from time 0 to 30 minutes for each 



















the trend lines were less linear with R2 < 0.9, and that at 2 M showed the largest 
deviation from linearity (R2 ~ 0.6). The half-lives of the reactions were calculated 
using Eqn. 2.6 and were compared to the values obtained directly from the graph 
(Table 2.1). The actual half-life of the 2 M reaction was much longer than the 





   (Eqn. 2.6) 
 
The non-linear time plots shown in Fig. 2.4 and the differences observed between 
the actual and calculated half-lives indicated that the racemisation reaction 
deviates from the first-order model which becomes more significant with 
increasing amine concentration. This might be due to the catalyst deactivation or 
alternatively, the formation of higher order complexes. A further surprising 
observation that corroborates these hypotheses is that the ee of 39 which 
stopped decreasing after 3 to 8 hours and failed to completely racemise at all of 
the concentrations evaluated. In order to test the deactivation of the catalyst, the 
reaction at 0.5 M was spiked with more (S)-39 (0.5 equiv.) after 24 hours and no 
further racemisation was observed, indicating that the catalyst was fully 
deactivated (Fig. 2.6). 
 
 
Fig. 2.6 Racemisation reaction of (S)-39 (0.5 M) with spiking of (S)-39 (0.5 equiv.) after 
24 h 
 
One of the plausible catalyst deactivation pathways was proposed by Blacker et 
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activation of the substrate and the structure was characterised previously by 
mass spectrometry, 1H and 13C NMR spectroscopy (Scheme 2.3).43 Since the 
iridium is coordinationally saturated, oxidation of 39 at the iridium centre is not 
possible and subsequent racemisation cannot proceed. Complex 93 is more 
likely to form at higher reaction concentration. At higher concentration of 2 M, the 
catalyst might degrade early in the reaction, leading to significant deviation from 
the first-order model. 
 
 
Scheme 2.3 Plausible deactivation pathway of 64 – Transformation of 64 into 93 
 
Another plausible deactivation mechanism of 64 is its binding with methylamine, 
which is the by-product from the hydrolysis of imine 94, an intermediate formed 
during the racemisation of 39 (Scheme 2.4).  
 
 
Scheme 2.4 Formation of 51 from the hydrolysis of 94 
 
To investigate the effect of methylamine on the racemisation of (S)-39, both 2 
and 20 equiv. (with respect to iridium) were spiked into the reaction in 
tetrahydrofuran at 60 °C after 30 minutes, which is approximately one reaction 




Fig. 2.7 Racemisation of (S)-39 (0.5 M) with 64 (1 mol%) at 60 °C in THF with spiking of 
MeNH2 (2 and 20 equiv. with respect to Ir) after 30 min 
 
When 2 equiv. of methylamine was spiked, racemisation was halted but resumed 
after about 3 hours. When 20 equiv. of methylamine were spiked, the reaction 
stopped and no further racemisation occurred after 24 hours, indicating an 
inhibitory effect of methylamine to the racemisation of 39 with 64.  
 
(b) Proton NMR titration of SCRAM catalyst 64 with methylamine 
The interaction of methylamine with 64 was further investigated using 1H NMR 
spectroscopy. Methylamine/ methanol solution (2 M) was titrated into a d6-DMSO 
solution containing 64 (5.2 mg mL-1) and benzene as an internal standard. The 
sample was analysed by 1H NMR spectroscopy after each addition (Fig. 2.8) and 
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Fig. 2.8 1H NMR titration of 64 with MeNH2 (2 M in MeOH) in d6-DMSO. Benzene was 
added as the internal standard (7.35 ppm, not shown above) 
 
 
Fig. 2.9 1H NMR Integrations of CH3-Cp* and coordinated CH3-NH2 in the titration 
reaction of CH3NH2 into 64 in d6-DMSO. All integrations were based on benzene which 
was added as the internal standard. (a) 0 to 40 equiv. of MeNH2; (b) Zoom-in version of 
(a) showing 0 to 10 equiv. of MeNH2 
 
The methyl group on the Cp* ligand of 64 appears at 1.87 ppm as a singlet. When 
methylamine was added, the intensity of the peak at 1.87 ppm decreased whilst 
new singlet peaks at 1.84, 1.72 and 1.62 ppm started to emerge. Eventually the 
MeNH2/ MeOH
SCRAM 64 only
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signal at 1.87 ppm disappeared, followed by that at 1.84 ppm. The singlet at 1.72 
reached a maximum when 3 equiv. of methylamine was added and then 
decreased while that at 1.62 ppm continued to increase until 30 equiv. of 
methylamine was added. The total integrations of the signals at 1.87, 1.84, 1.72 
and 1.62 ppm were calculated based on the integration of the benzene peak and 
was found to be 26 to 28 which was close to the total number of Cp* protons of 
64 (30), indicating that the newly formed signals at 1.84, 1.72 and 1.62 ppm 
correspond to Cp* protons in different iridium species (Section 1, Table 8.2).  
 
Identification of the methyl peaks of the coordinated methylamine was also 
attempted. Upon binding to the iridium centre, the methyl signals of the 
methylamine shifted downfield from 2.24 ppm to 2.56, 2.51 and 2.45 ppm. The 
multiplicity of the signal also changed from a singlet for the free methylamine, to 
triplets occurring as a result of coupling of the methyl group to the NH2 which is 
not observed in free methylamine due to rapid proton exchange. The different 
triplets correspond to different Ir-NH2CH3 species formed and the increasing and 
decreasing trends of the methylamine signals correlated to those of the methyl 
signals of the Cp* (Fig. 2.9). The number of methylamine coordinated to the 
iridium in each species was determined by the integration ratio of the methyl 

























































Table 2.2 Correlation between 1H NMR signals of CH3-Cp* and coordinated CH3NH2 and 
proposed structures of the corresponding Ir-species. [a]Average ratio of the integrations 
of CH3-Cp* and coordinated CH3NH2 signals. 
[b]Calculated as 15/ average integration 
ratio of CH3-Cp*/ CH3NH2 signals 
 
Three different methylamine-bound iridium species were suspected to have 
formed during the titration experiment. The singlet signal at 1.84 ppm 
corresponds to the monomeric complex with one methylamine coordinated to the 
iridium, which is indicated from the ratio of the integrations of the signals of Cp* 
and the corresponding bound CH3NH2 (Table 2.2, entry 2). Similarly the signals 
at 1.72 and 1.62 ppm correspond to the complexes with two and three 
methylamines bound to the iridium centre respectively (Table 2.2, entries 3 and 
4). Isolation of each complex was attempted without success. The crude product 
contained a mixture of 64, 95, 96 and 97 which might imply that the four iridium-





Scheme 2.5 Equilibrium between 64, 95, 96 and 97 in the titration of 64 with MeNH2 
 
The observed equilibrium constants, K1 to K3, were calculated at 3 equiv. of 
methylamine, where all of the iridium species, dimer 64, 95, 96 and 97 were 
present. Their integrations were converted to concentrations based on the 
concentration of the internal standard, benzene and were shown in Table 2.3.  
 





Free MeNH2 2.555 
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 [95] × [MeNH2]






 [96] × [MeNH2]




The calculated values of K1 to K3 represent potential equilibrium constants of the 
equilibrium processes shown in Scheme 2.5. It indicates that under this particular 
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set of conditions, the equilibrium lies mainly towards the di-substituted 
methylamine-iridium complex 96; while the formation of tri-substituted 
methylamine-iridium complex 97 is energetically less favoured due to steric 
hindrance. And although 95 is the least sterically demanding, the dissociation of 
64 requires certain amount of activation energy which results in a relatively small 
equilibrium constant. 
 
(c) Racemisation by Shvo’s catalyst 55 
The racemisation reaction of (S)-39 was repeated using Shvo’s catalyst 55, which 
has also been reported for the racemisation of both chiral amines and alcohols. 
Under the same conditions as 64, complete racemisation was observed after 8 
hours using 55, although the reaction was slower (Fig. 2.10).  
 
 
Fig. 2.10 Profiles of ee for the racemisation of (S)-39 with SCRAM 64 and Shvo’s catalyst 
55 (0.2 mol%) in toluene at 105 °C. Only the data for t = 0 to 480 min was shown 
 
The kinetic plot of Eqn. 2.5 for the racemisation of (S)-39 by 55 is shown in Fig. 
2.11. The plot was close to linearity with R2 > 0.99, assuming no conversion of 
39. krac was calculated to be 0.014 min-1 from time 0 to 480 min, corresponding 
to a half-life of 50 minutes, which was close the actual value (50 to 60 minutes). 
This showed that no significant degradation of 55 occurred and the catalyst 


















Fig. 2.11 Plot of ln {[S]0/([S]0 – 2[R]t)} against time for the racemisation of (S)-39 by 55 
(0.2 mol%), assuming no conversion of 39. The trend line and the R2 value were shown 
 
In order to further investigate the activity of 55, the racemisation reaction was 
repeated, which was spiked twice with more (S)-39 after the reaction was 
completed (Fig. 2.12(a)). Complete racemisation was still observed after the first 
spiking and the catalyst still showed activity after the second spiking, although 
the reaction slowed down after each spiking. The racemisation rate constants 
and the corresponding theoretical half-lives were determined from their 
ln{[S]0/([S]0−2[R]t)} verses time plots (Fig. 2.12(b), Table 2.4).  
 
 
Fig. 2.12 Racemisation of (S)-39 (0.5 M) by Shvo’s catalyst 55 (0.2 mol%) with spiking 
of (S)-39 (0.5 equiv.) after 25 and 76 hours. (a) ee profiles; (b) Plots of ln{[S]0/([S]0−2[R]t)} 
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Entry  Spiking krac (min-1) Calc. t1/2 (min) Act. t1/2 (min) 
1 None 0.011 63 60 
2 1st 0.0026 267 240 
3 2nd 0.0004 1733 > 1440 
Table 2.4 Rate constants and half-lives for the racemisation of (S)-39 by Shvo’s catalyst 
55 before and after spiking of (S)-39 
 
 
Scheme 2.6 Dissociation of Shvo's catalyst 55 
 
The racemisation data suggested that 55 has a lower catalytic activity than 64. 
However it is more robust, which can be used for a considerably longer time. 
Based on the reported proposed mechanism of amine racemisation by 55, 
dissociation of 55 gives 55a and 55b, where 55b has a vacant site for the amine 
to bind (Scheme 2.6).95 The ruthenium centre at 55b is at zero oxidation state 
which is much lower than that of iridium of 64 (+III). Also 55b is more hindered 
than the monomer from 64 due to more bulky ligands. Therefore the binding of 
the amine substrate to 55b is more difficult, leading to slower reaction. However 
if the catalyst deactivation of 64 goes through the C-H activation pathway as 
discussed in Section 2.2.1(a) (Scheme 2.3), the formation of any carbon-
metalated species similar to 93 is less likely to occur. Unfortunately to date, an 
immobilised version of 55 has not been reported, preventing its use in fixed-bed 
continuous flow processes. 
 
(d) Solvent effect – alcohol as co-solvent in racemisation 
Previous studies showed that solvents with increasing polarity slow down the 







Reaction solvent 39 (%) ee (%) 
Dimethylformamide 97.6 99.2 
Toluene 93.7 29 
Dimethylacetamide 93.9 93.1 
Chlorobenzene 87.3 50.2 
1,4-Dioxane 93.4 74.6 
Pyridine 98.9 99.6 
Dimethyl sulfoxide 98.1 100 
4-Methyl-2-Pentanone 79.2 55.8 
Table 2.5 Racemisation study of 39 using different solvents 
 
Racemisation of 39 had previously been investigated by J. Breen using C5-
hydroxy-tethered SCRAM 98 in ethyl acetate by varying the amount of methanol 
and found that the presence of methanol inhibited the reaction (Scheme 2.5, 
Table 2.6).  
 
 
Scheme 2.7 Racemisation of (R)-39 (12 mM) using 98 (2 mol%) in EtOAc/ MeOH 
 







Table 2.6 Effect of MeOH in the racemisation of (R)-39 by SCRAM 98 (results by J. 
Breen) 
 
In the development of a Resolution-Racemisation-Recycle (R3) process, it is 
crucial to find a solvent system which is compatible with both racemisation and 
resolution. For diastereomeric crystallisation, it often requires the use of alcohols 
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as the main/ co-solvent. In order to further understand the effect of different 
alcohols to the racemisation reaction, racemisation of (S)-39 was carried out in 
ethyl acetate/ alcohol (20% by volume) using SCRAM 64 (1 mol%). Methanol, 
ethanol and isopropyl alcohol were studied (Fig. 2.13, Table 2.7). 
 
 
Fig. 2.13 Profiles of ee for the racemisation of (S)-39 (0.5 M) in EtOAc/ alcohol (20% by 









Act. t1/2  
(h)[d] 
ee (24 h) 
(%)[e] 
39 (24 h) 
(%)[f] 
1 None 0.639 1.1 1-2 0 93 
2 MeOH 0.536 1.3 8 50 98 
3 EtOH 0.658 1.1 1-2 13 57 
4 iPrOH 0.659 1.1 1-2 6 93 
Table 2.7 Rate constants, half-lives, ee and [39] after 24 h for the racemisation of (S)-39 
in EtOAc/ alcohol with 1 mol% 64 at 60 °C. [a]Values calculated by Eqn. 2.5 using first 
two data points, assuming no conversion of 39. [b]Values calculated by Eqn. 2.6. [c]Values 
obtained from the ee profiles (Fig. 2.13). [d]ee was determined by chiral GC after 
derivatisation by trifluoroacetic anhydride. [e]39 (%) was determined by GC 
 
A control reaction for the racemisation was performed in pure ethyl acetate for 
comparison (Table 2.7, entry 1). Methanol has the largest impact on the 
racemisation of (S)-39 (Table 2.7, entry 2). The initial rate of the reaction was 
lower and the reaction seems to slow down and started to level-off after about 3 
hours (Fig. 2.13). The large deviation of the calculated half-life from the actual 
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methanol to form formaldehyde, which might be toxic to the catalyst or the amine 
substrate; another possibility is the coordination of the alcohol to the metal centre, 
blocking the coordination site. The use of ethanol and isopropyl alcohol as the 
co-solvent led to similar initial rates of racemisation as the reaction using only 
ethyl acetate (Table 2.7, entries 3 and 4). However, for ethanol, significant 
conversion of > 40% of 39 was observed (Table 2.7, entry 3). The new species 
formed had a similar retention time in the GC as the imine 94, however it had a 
m/z value of 163 in the GCMS which is different from that of 94 (m/z 133). Also 
the 1H and 13C NMR spectra did not show the presence of 94 in the crude reaction 
mixture. Instead an additional set of signals with comparable chemical shifts with 
39 and tertiary amine, N,N-dimethyl-α-methylbenzylamine 46 were found, 
indicating that the newly formed species was not 94, but a compound possessing 
similar chemical structure as 39 and 46. It was suggested that an N-alkylated 
product, 100, might have formed via a borrowing hydrogen mechanism (Scheme 
2.8), in which ethanol was first oxidised by 64 to give acetaldehyde, which 
coupled with 39 to form an iminium intermediate 99 with elimination of water, 
followed by transfer hydrogenation to generate 100. However the retention times 
of the unknown product and 46 were significantly different which was not 
expected since they have very similar structures. As the unknown product was 
not isolated, its identity could not be fully confirmed.  
 
Scheme 2.8 Plausible formation of 100 via N-alkylation of 39 with EtOH 
 
For isopropyl alcohol, the reaction proceeded at a similar initial rate as that in 
ethyl acetate without significant formation of impurities. This might be because 
acetone formed upon the oxidation of isopropyl alcohol might be too bulky for 39 
to attack, avoiding the N-alkylation reaction. However, the reaction started to slow 
down slightly after about three hours which might indicate a drop in the activity of 
64. Complete racemisation could not be achieved after 24 hours, unlike the case 
in ethyl acetate. Since isopropyl alcohol can act as an efficient hydrogen donor 
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which can also turn over the catalyst, this may have affected the activity towards 
39.  
 
2.2.2 N-Isopropyl-α-methylbenzylamine 101 
N-isopropyl-α-methylbenzylamine 101 is an analogue of 39 which has an 
isopropyl group attached to the nitrogen. The racemisation of (R)-101 was carried 
out in batch in toluene at 105 °C using SCRAM 64 (0.2 mol%) (Scheme 2.9). The 
reaction was slower than that of 39 with initial rate constant of 0.022 min-1 and a 
half-life of about 32 minutes (calculated, versus actual = 30-45 minutes). However 
complete racemisation was observed after 8 hours (Fig. 2.14).  
 
 
Scheme 2.9 Racemisation of (S)-101 (0.5 M) with 64 (0.2 mol%) in toluene at 105 °C 
 
Fig. 2.14 Reaction profile for the racemisation of (R)-101 (0.5 M) with 64 (0.2 mol%) in 
toluene at 105 °C 
 
Since 101 is more sterically hindered than 39, it is more difficult for it to bind to 
the iridium centre of 64, slowing down the reaction. However the deactivation of 
64 via the C-H activation pathway as shown in Scheme 2.3 is less likely to occur. 
The intermediate imine 102 is also more hindered for the attack by water to 
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methylamine and is more difficult to bind to 64. Therefore 64 maintains its activity 




2.2.3 α-Methylbenzylamine 42 
Racemisation of enantiopure 42 has been reported in the literature.1, 85, 90, 91, 95, 96, 
101-103 Since 42 is a primary amine with no substituents at the nitrogen except 
hydrogen, it is considerably less sterically demanding than 39 or 101. The lack of 
any electron-releasing alkyl substituents at the nitrogen make the intermediate 
imine more electrophilic to nucleophilic attack by surrounding molecules of 42. 
As a result, various dimer products are readily formed (Scheme 1.23). Bäckvall 
et al. reported the use of 2,4-dimethylpentan-3-ol 58 as an effective hydrogen 
donor to suppress the formation of dimers in the racemisation of (S)-42 at low 
concentration (0.25 M) with Shvo’s catalyst 55 (5 mol%).95 Similar procedures 
were attempted using SCRAM 64 as the catalyst (Scheme 2.10, Fig. 2.15). 
 
 
Scheme 2.10 Attempted racemisation of (S)-42 using 64 with and without 58 in toluene 





Fig. 2.15 Reaction profiles for the racemisation of (S)-42 using SCRAM 64 with and 
without alcohol 58 in toluene at 105 °C. (a) Concentration of 42 (%), determined by GC 
with n-decane as internal standard. (b) ee of 42, determined by chiral HPLC after 
derivatisation with benzoyl chloride in the presence of triethylamine 
 
Control experiments were first carried out without alcohol 58. With 0.2 mol% of 
SCRAM 64, a gradual drop in the concentration of 42 in the reaction was 
observed due to the formation of dimers and no racemisation of 42 occurred. A 
higher loading of 1 mol% of 64 was used. A much faster dimerisation was 
observed alongside with the racemisation of 42 from 100% to 61% after three 
hours. To try suppressing the dimerisation, 1 equiv. of 58 was added, which led 
only to a similar rate of conversion and racemisation of 42. Increasing the amount 
of 58 by using it as a co-solvent with toluene in 1:1 (v/v), the racemisation of 42 
was faster and reached 18% ee after four hours. However no improvement was 
observed in reducing the formation of dimers. This indicated that SCRAM 64 is 
less suitable for the racemisation of 42 compared to Shvo’s catalyst 55 under 
similar conditions. 
 
2.2.4 N,N-Dimethyl-α-methylbenzylamine 46 
Racemisation of 46 was previously reported by Blacker et al.1 At 0.2 M, the 
reaction proceeded with a half-life of 21 hours with 1 mol% SCRAM 64 at 90 °C 
in toluene. In order to compare the results with amines 39 and 101, the 
racemisation was carried out at a higher concentration of 0.5 M in toluene at 105 
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Scheme 2.11 Racemisation of (S)-46 (0.5 M) using 64 (0.2 mol%) in toluene at 105 °C 
 
 
Fig. 2.16 Reaction profile for the racemisation of (S)-46 using SCRAM 64 (0.2 mol%) in 
toluene at 105 °C. The ee of 46 was measured by free-basing the sample with Na2CO3 
(aq), derivatised by (S)-mandelic acid 34 and analysed by 1H NMR (CDCl3, 500 MHz) 
 
The racemisation of 46 had a half-life of about 4 hours, without significant 
formation of impurities. It was much slower compared to either amines 39 or 101, 
which is due to its bulky tertiary amine structure, hindering binding to the iridium 
centre. The lack of a NH proton on 46 may affect the energy of formation of the 
intermediate iridium-quaternary iminium complex/ transition state. The 
racemisation rate constant of the reaction was calculated to be 0.304 h-1 (0.005 
min-1) with a half-life of 2.3 hours, based on first-order model (Eqn. 2.5 and 2.6), 
whilst the actual half-life is between 4 to 5 hours. Deviation of the calculated and 
actual half-lives suggested possible degradation of 64. This is also reflected from 
the ee profile which reached a plateau at 16% after 24 hours.  
 
2.2.5 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 
The racemisation of enantiopure 9 was reported by Blacker et al. with 39 and 46.1 
The reaction was very fast with a half-life of 45 minutes at 40 °C in 
dichloromethane, with only 0.2 mol% loading of SCRAM 64. Diastereomeric 
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acetate/ isopropyl alcohol mixture as the solvent system, which will be further 
discussed in Chapter 3.137 As discussed in Section 2.2.1(d), the use of alcohol 
can have a negative impact on the rate of racemisation of 39. However, since the 
racemisation of 9 is much faster, the reaction was also attempted using ethyl 
acetate/ alcohol mixtures to investigate the effect of solvent polarity (Scheme 2.12, 
Fig. 2.17). The reaction was also carried out in toluene for comparison. 
 
 
Scheme 2.12 Racemisation of (R)-9 (0.1 M) using SCRAM 64 (0.2 mol%) at 60 °C 
 
 
Fig. 2.17 Profiles of ee for the racemisation of (R)-9 (0.1 M) using SCRAM 64 (0.2 mol%) 
at 60 °C in various solvent. Only t = 0 to 240 min was shown 
 
The racemisation of (R)-9 was completed within 5 minutes in toluene, with 0.2 
mol% of 64 (Fig. 2.17). When the solvent was changed to ethyl acetate/ alcohol 
mixtures, the racemisation slowed down. The initial rate was lower with longer 
half-lives (both calculated and actual) when methanol was used compared to 
isopropyl alcohol, which is also the case for the racemisation of (S)-39 (Table 2.8, 
entries 2 and 3). However, unlike 39, complete racemisation was still observed 
for 9 after 4 hours. In toluene, a higher conversion of 9 to imine 8 and isoquinoline 
65 was observed which was slightly lower in the presence of methanol or 
isopropyl alcohol. Being a hydrogen donor, isopropyl alcohol can reduce 8 and 














Toluene EtOAc/ MeOH 7:1 EtOAc/ iPrOH 7:1
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1 Toluene N.D.[e] N.D.[e] < 5 83 4 7 
2 
EtOAc/ MeOH 7:1 
(v/v) 
0.02 35 40-50 96 3 3 
3 
EtOAc/ iPrOH 7:1 
(v/v) 
0.093 7.5 5-10 95 4 4 
Table 2.8 Rate constants, half-lives and concentrations of 9, imine 8 and isoquinoline 65 
for the racemisation of (R)-9 using SCRAM 64 (0.2 mol%) at 60 °C in various solvent. 
[a]Values calculated by Eqn. 2.5 using first two data points, assuming no conversion of 9. 
[b]Values calculated by Eqn. 2.6. [c]Values obtained from the ee profiles (Fig. 2.17). 
[d]Values after 8 h, determined by GC. [e]Not determined 
 
Racemisation of 9 is fast compared to amines 39, 101 and 46. This could be due 
to the more stable cyclic imine intermediate 8. Its stability is further enhanced by 
the methoxy substituents on the aromatic ring (Scheme 2.13).  
 
 
Scheme 2.13 Stabilisation of imine 8 by its conjugation with the aromatic ring and the 
MeO substituents 
 
2.2.6 2-Methylpiperidine 103 
2-Methylpiperidine 103 is also a secondary cyclic amine but is non-benzylic. The 
intermediate imine 104 is not stabilised by any conjugation, although the methyl 
group at the chiral centre can stabilise the C=N by inductive effect, making it less 
electrophilic. So it might be expected that enantiopure 103 is racemised more 






The racemisation of (S)-103 was first carried out in toluene at 105 °C with 0.2 
mol% 64 (Scheme 2.14, Fig. 2.18). The reaction was completed in 30 minutes 
with a half-life of < 5 minutes (calculated as 4 minutes). Although it is slower than 
the racemisation of 9, it is faster than acyclic amines 39 and 101. 
 
 
Scheme 2.14 Racemisation of (S)-103 (0.5 M) using 64 (0.2 mol%) in toluene at 105 °C 
 
 
Fig. 2.18 Reaction profile for the racemisation of (S)-103 (0.5 M) using SCRAM 64 (0.2 
mol%) in toluene at 105 °C 
 
The diastereomeric resolution of rac-103, which will be discussed in Chapter 3, 
showed that a relatively high resolvability could be achieved with methyl-tert-butyl 
ether/ alcohol mixture and isopropyl acetate as the solvents. Therefore the 
racemisation of (S)-103 was also carried out in methyl-tert-butyl ether and 
isopropyl acetate (Fig. 2.19). Their initial rates, half-lives and final ee were 
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Fig. 2.19 Profiles of ee for the racemisation of (S)-103 (0.5 M) using 64 (0.2 mol%) in 
toluene at 105 °C, iPrOAc at 80 °C and MTBE at 50 °C 
 







Final ee (%)  
[t (h)] 
1 Toluene 105 0.18 4 < 5 0 [0.5] 
2 iPrOAc 80 0.02 34 40 13 [24] 
3 MTBE 50   N.D.[d]   N.D.[d] ≤ 1440 50 [24] 
Table 2.9 Rate constants, half-lives and the final ee for the racemisation of (S)-103 using 
SCRAM 64 (0.2 mol%) under different conditions. [a]Values calculated by Eqn. 2.5 using 
the first two data points, assuming no conversion of 103. [b]Values calculated by Eqn. 2.6. 
[c]Values obtained from the ee profiles (Fig. 2.18 and Fig. 2.19). [d]Not determined 
 
The racemisation was about 10 times faster in toluene than in isopropyl acetate, 
not only because of the higher temperature, but possibly also due to the lower 
polarity of toluene which favours the reaction. With isopropyl acetate, the 
racemisation of 103 did not reach zero ee. This could be due to catalyst 
deactivation. However, since the racemisation of 103 goes through cyclic imine 
104, its hydrolysis into the corresponding amino-ketone is improbable. Any 
deactivation may be more likely to go via the formation of Ir-103 complexes but 
the exact mechanism involved is not yet known. The use of methyl tert-butyl ether 
led to much slower racemisation due to its low boiling point which limits the 
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2.3 Racemisation in flow 
Although the homogeneous SCRAM catalyst 64 was able to racemise a broad 
range of chiral amines, the catalyst was difficult to reuse/ recycle. To increase its 
recyclability, 64 was immobilised onto a Wang resin support. The immobilised 
version of SCRAM, 92, can be reused in a batch reaction by either filtration, or 
decanting the reaction mixture with subsequent washing of the catalyst. However, 
this can cause physical losses which reduces the effectiveness of the next 
reaction(s). Catalyst 92 can be used in flow, where it is packed into a reactor and 
the reaction mixture can be pumped through the catalyst. Since the catalyst is 
insoluble in the reaction solvent, the catalyst will stay intact in the reactor, 
assuming no leaching or reaction-specific catalyst deactivation occurs. Much less 
manipulation is required to recycle the catalyst and therefore minimising any 
physical losses. A further advantage is that after steady state is reached, any 
change in catalyst can be observed simply, and reaction optimisation can be 
achieved more quickly. 
 
2.3.1 Synthesis of immobilised SCRAM 92 
Immobilised SCRAM 92 was synthesised and provided by Yorkshire Process 
Technology (Scheme 2.15). The iridium dimer 87a was prepared by heating 
iridium trichloride trihydrate with functionalised pentamethylcyclopentadiene (Cp*) 
ligand 85a, followed by halide exchange with sodium iodide, forming 98. Triflated 








2.3.2 Experimental set-up 
The schematic of the flow racemisation set-up was shown in Fig. 2.20. It consists 
of a packed-bed reactor (PBR) which is a stainless steel HPLC column (3 or 4 
mL) packed with a mixture of 92 and sand. The amount of iridium being loaded 
onto the PBR was calculated based on the ICP value of each batch of 92 (Eqn. 
2.7) and was relative to the total amount of amine pumped through the reactor 
throughout the experiment. 
 
Ir loading (mol%) = 
[




   (Eqn. 2.7) 
 
Where m92 is the mass of 92, namine is the total number of moles of the chiral 
amine pumped across the PBR, MIr is the atomic mass of iridium which is 192. 
 
The column was heated inside an aluminium heating block by either a stirrer hot 
plate (Configuration A, Fig. 2.20(a)) or nickel heating cartridges that were 





Fig. 2.20 Flow racemisation set-up. (a) Configuration A: PBR (3 mL) was heated in an 
aluminium block by a stirrer hot plate. (b) Configuration B: PBR (4 mL) was heated in an 
aluminium block by electrically-controlled nickel heating cartridges 
 
The inlet of the PBR was connected to a syringe pump via PTFE tubing (1/16” 
O.D., 1/32” I.D.), which pumps the chiral amine solution through the PBR at a 
specific flow rate. Eluent containing the racemised product was collected at the 
outlet of the PBR in reactor volumes (RV). The residence time, tRes, is defined as 
the time spent by the reactants in the reactor, which can be calculated as, 
 
tRes (min) = 
RV (mL)
Flow rate (mL min-1)
   (Eqn. 2.8) 
 
Where RV is the volume of the reactor (PBR). 
 
2.3.3 Flow racemisation of chiral amines 
Racemisation of the same amines as discussed in Section 2.2 were tested in flow 
using the set-up in Fig. 2.20 except primary amine 42 (Table 2.10). A total of five 
fractions (each fraction corresponds to one RV) were collected in each reaction 
PBR
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and the conversion and ee of each fraction was monitored by GC and chiral GC 
(or chiral HPLC) respectively. The average ee of the substrate after one pass 
through the PBR was calculated across RV2 to RV5, where the reaction was in 
steady state. An example is shown in Fig. 2.21 for the racemisation of (S)-39 in 
flow. The rate of racemisation in flow was approximated by the average drop in 













Drop in ee after 
one pass (%) 
[min-1][c] 
  1[d] (S)-39 100 iPrOAc 5 80 40   42 [1.1][e] 
  2[f] (S)-39 100 
EtOAc/ 
MeOH 8:2 
5 73 12 14 [1.2] 
  3[d] (R)-101 50 EIB[g] 10 80 80 14 [0.2] 
  4[d] (S)-46 50 
iPrOAc/ 
iPrOH 7:3 
10 80 80 11 [0.14] 
  5[d] (S)-46 50 
iPrOAc/ 
iPrOH 7:3 
10 80 120 16 [0.13] 
  6[f] (S)-9 62 
EtOAc/ 
MeOH 7:1 
10 60 6 83 [13.8] 




  64[h] 
EtOAc/ 
MeOH 7:1 
10 60 6 26 [4.3][i] 
  8[d] (S)-103 80 
MTBE/ 
iPrOH 95:5 
5 50 12 0 [0] 
  9[d] (S)-103 100 iPrOAc 5 80 16 79 [4.9] 
Table 2.10 Results for the racemisation of various chiral amines in flow. [a]Ratios referred 
to volume ratios. [b]Relative to the total amount of amine pumped through the catalyst. 
[c]An average value was taken from RV2 to RV5 or from RV3 to RV5. Values in bracket 
correspond to the average drop in ee per minute, assuming the rate of racemisation was 
constant. [d]Configuration B was used. [e]Initial ee of (S)-39 was 86%. [f]Configuration A 
was used. [g]Ethyl isobutyrate. [h]The concentration of 9 was calculated by 1H NMR with 





Fig. 2.21 The ee profile for the racemisation of (S)-39 in flow in iPrOAc at 80 °C with 5 
mol% loading of 92 (Table 2.10, entry 1) 
 
Using a longer tRes led to a bigger drop in ee (Table 2.10, entries 1 and 2; 4 and 
5). In the case of (S)-39, the use of less polar solvent (isopropyl acetate) and 
slightly higher temperature did not have a significant impact on the rate of 
racemisation (Table 2.10, entries 1 and 2). With higher loading of 92 and longer 
tRes, (R)-101 and (S)-46 showed racemisation but were slower compared that of 
(S)-39 (Table 2.10, entries 3 to 5). It is partly due to their more sterically hindered 
structures, which is also observed in batch, and possibly the lower concentrations 
used. As shown in batch, the racemisation of 9 was very fast compared to the 
other substrates tested. In flow, (S)-9 was successfully racemised by over 80% 
in 6 minutes (Table 2.10, entry 6). The mother liquor (ML) from the diastereomeric 
resolution of rac-9 with (S)-mandelic acid 34 was also racemised without removal 
of the acid (Table 2.10, entry 7). The slower racemisation rate of the ML 
compared to enantiopure 9 may be explained by the weaker binding of the 
substrate to iridium due to protonation at the nitrogen of 9 by 34. The lower 
starting ee of the ML compared to enantiopure substrate also led to smaller drop 
in ee. Racemisation of (S)-103 did not occur in flow in methyl tert-butyl ether/ 
isopropyl alcohol mixture (Table 2.10, entry 8). It is likely to be due to the lower 
temperature and short tRes used; whilst in batch, (S)-103 racemised by 50% in 24 
hours in methyl tert-butyl ether at the same temperature. By switching the solvent 
to isopropyl acetate which has a higher boiling point, a higher temperature can 
be used and (S)-103 was racemised by nearly 80% in 16 minutes (Table 
2.10,entry 9). Some of the solvent systems used in the flow racemisation study 
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the corresponding racemic substrate, which will be discussed further in Chapter 
3. 
 
2.4 Attempted reactivation of immobilised SCRAM 92 
As part of a collaborative project with our group, Syngenta studied the 
deactivation of immobilised catalyst 92 by monitoring the racemisation of (S)-39 
in continuous flow for 10 days (Fig. 2.22). The approximate rate of deactivation 
was about 6.5% per day under the employed reaction conditions. 
 
 
Fig. 2.22 Deactivation study of 92 via continuous flow racemisation of (S)-39. Data was 
provided by L. Conway from Syngenta 
 
As discussed in Section 2.2.1, one of the plausible mechanisms for the 
deactivation of homogeneous SCRAM 64 is the binding of small amines to the 
iridium centre such as methylamine, which is one of the by-products from the 
hydrolysis of imine 94 formed from the racemisation of 39. Spiking excess 
methylamine into the racemisation of 39 led to the inhibition of the reaction, whilst 
the titration of 64 with methylamine showed the formation of various Ir-MeNH2 
species 95 to 97 and the disappearance of 64 in the presence of excess 
methylamine. Nguyen et al. previously reported the deactivation of immobilised 
[Cp*IrCl2]2 89a, the chloro-version of 92, after repeated use in the transfer 
hydrogenation of benzaldehyde 90 in batch using isopropyl alcohol in the 





Scheme 2.16 Catalytic transfer hydrogenation of benzaldehyde 90 by isopropyl alcohol 
using 89a as the pre-catalyst in batch 
 
Alkoxide ions from both the added base and deprotonated isopropyl alcohol bind 
to the iridium centre and replace all the chloride ions. The strong Ir-OR bonds do 
not allow the substrate to bind, preventing the catalyst from turning over. 
Temporary reactivation was achieved by stirring the 89a with 1 M hydrochloric 
acid, which protonated the bound alkoxide ligands that can dissociate more 
readily, allowing the substrate to bind again. In an analogous fashion, 
methylamine can replace the iodide ligands in homogeneous SCRAM 64/ 
immobilised catalyst 92 easily and the bound methylamine can be difficult to 
dissociate from the iridium due to its small size, hindering the binding of any 
incoming substrates. A similar strategy of reactivating 92 was attempted using 
hydroiodidic acid, which should protonate the bound amines, making them more 
labile and allow the iodide ions to bind back to the iridium. The iodide is important 
to the catalytic activity of 64/ 92 as shown from the racemisation of (S)-9 by 
[Cp*IrCl2]2 63 which led to 12 times slower reaction with increased concentrations 
of imine 8 and isoquinoline 65.1 
 
2.4.1 Reactivation of immobilised SCRAM 92 by hydroiodic acid 
Reactivation of 92 was studied using the catalyst that was previously used in the 
Resolution-Racemisation-Recycle (R3) process of 101 which will be discussed in 
detail in Chapter 3. Its activity was assessed via the racemisation of (S)-103 in 
flow (Scheme 2.17). The average ee of 103 after one pass through the catalyst 






Scheme 2.17 Racemisation of (S)-103 in flow to assess the activity of 92 
 
In the R3 process of 101, about 13% of acetophenone 51 was observed, 
indicating the hydrolysis of the intermediate imine 102, which also generated 
isopropylamine as the by-product. Although it is more bulky compared to 
methylamine, it can also bind to the iridium, reducing the activity of the catalyst 
similar to the case for methylamine. 
 
Reactivation of the partially deactivated 92 was attempted with relatively mild 
conditions, in which the catalyst/ sand mixture (27 mg mL-1 of 92) was stirred in 
aqueous hydroiodic acid solution (0.1 M) at room temperature for two hours. The 
reaction was carried out in batch since hydroiodic acid can corrode the stainless 
steel column. After the reaction, the slurry was washed with isopropyl alcohol/ 
water mixture and decanted. The washing process was repeated until pH of the 
decant became neutral. The solid was further washed with isopropyl alcohol and 
dried in the vacuum oven. The treated 92/ sand mixture was reloaded into the 
stainless column and its activity was checked by performing the racemisation of 
(S)-103 in flow. The ee of 103 decreased to an average of 46% which indicated 
an increase in the catalytic activity of 92 (Fig. 2.23). The reactivation procedure 
was repeated with the same batch of 92 with more concentrated hydroiodic acid 






Fig. 2.23 Catalytic activity of partially deactivated 92 after treatment with various 
concentrations of HI (aq) 
 
Further treatment of 92 with higher concentrations of hydroiodic acid only led to 
slight increase in its activity. When the column was heated up to 80 °C during the 
equilibration with isopropyl acetate before carrying out the racemisation of (S)-
103, the eluent was yellow in colour which became colourless again when more 
solvent was pumped through. This indicated that the iridium might have leached 
from the support. Although acid can aid the removal of amine ligands from the 
catalyst, treatment of 92 with strong acid can also cleave the tether of 92 (Scheme 
2.18). The ICP of 92 was not checked after the reactivation procedures, therefore 
the extent of leaching, if any, could not be quantified. 
 
Scheme 2.18 Plausible mechanism of iridium leaching from 92 in the presence of acid 
 
The reactivation procedures were repeated using immobilised catalyst 92 that 
was fully depleted. This was prepared by pumping an isopropyl acetate solution 
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for about 4 days. The average ee of amine 103 after one pass was 82% (from 
100%), so it still showed some activity. The catalyst was stirred in hydroiodic acid 
(1 M) for 8 hours, then overnight. The racemisation profiles of (S)-103 are shown 
in Fig. 2.24. 
 
 
Fig. 2.24 Catalytic activity of ‘fully deactivated’ 92 after treatment with 1 M HI (aq) 
 
The average ee of amine 103 decreased from 82% to 69%, showing some 
catalyst reactivation. Increasing the time the catalyst was stirred with hydroiodic 
acid from 8 hours to overnight led to further decrease of ee from 100% to 57%. 
However, the activity of catalyst 92 fell when the racemisation of (S)-103 was 
repeated, where the ee of amine 103 was increased to 65% rather than 57%. 
Iridium might have started to leach upon prolonged treatment with hydroiodic acid.  
 
2.4.2 Proton NMR titration of methylamine-bound SCRAM 64 with 
hydroiodic acid 
In order to understand the reactivation of immobilised catalyst 92 with hydroiodic 
acid, initial titration experiments were done with methylamine-bound 64. The 
homogeneous SCRAM 64 was first treated with 20 equiv. of methylamine (in 
methanol, 2 M) in d6-DMSO, then aqueous hydroiodic acid (1.5 M) was added 
and the sample was analysed by 1H NMR spectroscopy (Fig. 2.25). The 
integrated Cp* and CH3NH2 peaks were plotted against the equivalences of 
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Fig. 2.25 1H NMR titration of MeNH2-bound 64 with HI (1.5 M) in d6-DMSO. MeNH2/ 
MeOH (2 M, 20 equiv. with respect to Ir) was added to 64 prior to the addition of HI. 
Benzene was added as the internal standard (7.38 ppm, not shown above) 
 
 
Fig. 2.26 1H NMR Integrations of CH3-Cp* and coordinated CH3-NH2 in the titration 
reaction of HI (aq) into 64 in d6-DMSO. All integrations were based on benzene which 
was added as the internal standard. B and C correspond to the Cp* protons of di-
substituted Ir-MeNH2 species 96 and tri-substituted Ir-MeNH2 species 97 respectively; E 
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As shown in Section 2.2.1(b), the addition of excess methylamine to 64 led to the 
formation of di- and tri-methylamine-bound iridium species (96 and 97 
respectively), whilst 64 and the mono-substituted species 95 disappeared 
completely. When aqueous hydroiodic acid was added to the sample, the singlet 
signal corresponding to 97 (1.65 ppm) started to decrease whilst that of 96 (1.75 
ppm) increased. These changes were accompanied by a fall and an increase in 
the integrations of the bound-CH3NH2 signals at 2.47 and 2.54 ppm respectively. 
After 10 equiv. of hydroiodic acid was added, a singlet at 1.89 ppm was observed 
which became more intense when more acid was added. However, the CH3NH2 
signal corresponding to mono-methylamine-bound species 95 was not observed. 
Also the titration experiment of 64 with methylamine showed that the 
concentration of species 95 remained low and did not accumulate in the system 
(Fig. 2.8 and Fig. 2.9). Therefore, it was suggested that the signal at 1.89 ppm 
corresponded to the dimer 64. The addition of hydroiodic acid protonated the 
bound-methylamine, causing it to dissociate from the iridium to regenerate the 
less/ non-substituted species (Scheme 2.19).  
 
 
Scheme 2.19 Interconversion of 64, 95, 96 and 97 in the presence of MeNH2 and HI 
 
We would like to determine which of the species 95, 96 and 97 were active and 
inactive in racemisation. The concentration changes of the species were 
determined with excess methylamine and hydroiodic acid (Table 2.11). Based on 
the NMR titration experiments with the homogeneous catalyst 64 in excess 







Concentration (based on 1H NMR integration, %) 
MeNH2 (20 equiv.) HI (20 equiv.) 
64 0 31 
95 0 0 
96 14 21 
97 86 48 
Table 2.11 Concentrations of 64, 95, 96 and 97 after addition of excess MeNH2 and 
excess HI in the 1H NMR titration experiment of 64, calculated based on the integrations 
of NMR signals 
 
When three methylamine are bound to the iridium, the species 97 formed is 
unlikely to be active towards racemisation. Furthermore, as there is no 64 or 95 
was observed, the only species left is 96. Since it has one iodide ligand that might 
be displaced by the incoming substrate, it could be responsible for any remaining 
activity. 
 
We now sought to relate the activity of the homogeneous catalyst 64 to that of 
immobilised catalyst 92. The activities of immobilised catalyst 92 before and after 
reactivation were expressed in terms of the conversion of (S)-103 to (R)-103 









Catalytic activity (Conversion 
of (S)- to (R)-103) (%)[b] 








57 79 21 
Table 2.12 Catalytic activity of 92 before and after reactivation, expressed in terms of the 
conversion of (S)-103 to (R)-103 during racemisation. [a]Calculated as 50 + (ee/2). 
[b]Catalytic activity = 100 – [(S)-103] (%) 
 
When excess methylamine solution was pumped through immobilised catalyst 
92, its activity decreased from 39% (when it was fresh) to 9% (Table 2.12, entries 
1 and 2). However, the catalyst still showed some activity, which indicated that 
the resulting species could still turnover. After reactivation of 92 with excess 
89 
 
hydroiodic acid, its activity increased from 9% to 21% (Table 2.12, entry 3), which 
could be due to the regeneration of 92 (or its monomer) and the immobilised 
equivalences of 96 from 97. Only about 12% reactivation was observed, 
compared to about 52% reactivation of homogeneous catalyst 64, as inferred 
from the NMR titration results of 64 (Table 2.11, the sum of [64] and [96]). This 
discrepancy might be explained by the nature and activity of species 64 and 92. 
Immobilisation of 64 to the resin has a significant impact on the interaction 
between the catalyst and the amine, the ease of protonation of the methylamine 
and its ease of dissociation. Also, iridium might have leached from 92 after 
prolonged treatment with hydroiodic acid (as shown from the decline in activity in 
the second run of racemisation of (S)-103 after overnight treatment of 92 with 1 
M hydroiodic acid (Fig. 2.24)), so the increase in activity by excess hydroiodic 
acid was lower than expected.  
 
2.5 Rapid screening methodology for determining chiral amine 
racemisation 
2.5.1 Background 
The traditional method in determining whether a chiral amine can be racemised 
under certain conditions is to carry out the racemisation reaction and analyse the 
ee of the amine. However this method requires enantiopure/ enantio-enriched 
material which can be expensive and/ or difficult to synthesise. Besides, analytical 
methods such as chiral GC, HPLC or NMR are needed to monitor the reaction 
but the development of these can be time-consuming and costly. Therefore, a 
more rapid and low cost procedure is highly desirable and a deuterium-labelling 
method was evaluated. Part of this work was carried out by an MChem student 
(Caitlin Davies). In addition to this, a deuterium/ proton exchange reaction of 
amine 39 in the presence of 64 and d8-isopropyl alcohol was studied by Syngenta 
as part of a collaborative project with our group. 
 
The aim of the method was to correlate the replacement of the α-hydrogen by 
deuterium into the amine with racemisation. One of the advantages of this method 
is that either the racemate or the enantiopure substrate can be used, depending 
on their availability. It was proposed that racemisation of 39 proceeds via the 
formation of imine 94 (Scheme 2.20). Deuterium incorporation can occur at 
90 
 
position a, if imine 94 is reduced by an iridium-deuteride species (Path A). The 
iridium-deuteride species can only be formed by oxidation of d8-isopropyl alcohol 
by 64 (Scheme 2.21). It can be inferred that because oxidation of the non-
deuterated amine by 64 only results in iridium-hydride complex, to show 
deuterium incorporation at position a, the imine has to be de-coordinated from 
this complex and coordinate with an iridium-deuteride species, assuming no Ir-D 
and Ir-H exchange occurs. This provides important mechanistic information that 
the imine can de-coordinate from the iridium centre. Imine 94 can also 
tautomerise into enamine 105 to deuterate at position b (Path B). Reaction of a 
deuteron with the enamine is required, and the deuteron can come from d8-
isopropyl alcohol, O-D. Deuterium incorporation at either positions a or b indicate 
the racemisation of 39. Another alternative imine 106 can be formed by 
isomerisation of 94 or by direct oxidation of 39 by 64, and deuteration can also 
occur at position c (Path C). However the formation of 106 does not indicate the 
racemisation of 39. By locating the position of deuteration in the molecule, one 
can determine whether the amine can be racemised under the employed 
conditions.  
 
Scheme 2.20 Possible pathways of deuterium incorporation of 39 
91 
 
Scheme 2.21 Formation of Ir-D complex from 64 via oxidation of d8-
iPrOD 
 
2.5.2 Methodology and results 
A deuteration procedure was developed by C. Davies in which 1 M of chiral amine 
was dissolved into a mixture of d8-isopropyl alcohol/ d8-toluene (2.5:1 by volume) 
with 2.5 mol% 64.140 The reaction mixture was heated to 110 °C under pressure 
for 4 hours by microwave (Scheme 2.22). 
 
 
Scheme 2.22 General deuteration procedures of chiral amines by d8-
iPrOD 
 
Proton/ deuterium exchange can be readily observed by 1H NMR spectroscopy 
since any deuterium incorporation leads to a decrease in integration of the 
corresponding signal. The reaction was sampled for 1H NMR analysis after each 
hour of heating. However, it is important to note that this method can only provide 
a qualitative indication on whether an amine can be racemised. During 
racemisation, the imine/ enamine can also pick up a hydride/ proton which does 
not result in any changes in the NMR integrations. Therefore, the rate of change 
of the NMR integrations due to deuterium incorporation does not quantitatively 
relate to the rate nor extent of racemisation. 
 
(a) N-Methyl-α-methylbenzylamine 39 
The deuteration procedure described in Scheme 2.22 was first tested with 39. 






Fig. 2.27 1H NMR spectra for the H/ D exchange reaction of 39 with d8-
iPrOD in the 
presence of 64. The spectra were measured with a d6-DMSO insert
140 
 
The broad singlet at about 6.3 ppm was believed to be the OH of deuterated 
isopropyl alcohol (d7-iPrOH). A similar signal was present in all experiments with 
different amine substrates, including 46 which is a tertiary amine lacking an NH 
proton (Fig. 8.4). At t = 0, the amount of d7-iPrOH in the reaction mixture was 
minimal. When it was turning over the catalyst, proton-deuterium exchange 
occurred with the NH of the substrate, leading to increased concentration of d7-
iPrOH, therefore the signal became more intense. Since no change in multiplicity 
was observed in Hd to Hf, there was no proton/ deuterium exchange occurred in 
the aromatic region and therefore, they were used as a reference for integrating 
t = 4 h
t = 3 h
t = 2 h
t = 1 h







other signals and no internal standard was added to the reaction mixture (Fig. 
2.28).  
 
Fig. 2.28 Percentage drop in 1H NMR integrations of Ha to Hc of 39 with time (h). Hd to Hf 
were used as reference and integrated to be 5.00 in every sample, assuming no H/ D 
exchange occurred at the aromatic region. Hd, He and Hf were not shown 
 
The most significant change in integration was observed for Hb which dropped by 
70% after 4 hours, indicating that deuterium incorporation occurred most rapidly 
at position b resulting from the formation of enamine 105. Ha also showed a drop 
in integration by 21%, therefore deuterium incorporation also occurred at position 
a. This implies that most of the imine 94 remains coordinated to the iridium-
hydride complex while only some de-coordinates from it and binds to another 
iridium complex possessing a deuteride. On the other hand, the integration of Hc 
stayed virtually constant throughout the reaction and no deuterium/ proton 
exchange happened at position c. The oxidation of an N-methyl is energetically 
unfavourable. Furthermore, since the C=N bond in imine 106 is not conjugated 
to the aromatic ring, it is thermodynamically less stable than 94 and therefore not 
formed. 
 
(b) Other substrates 
The proton/ deuterium exchange reaction was further used to assess the 
deuterium incorporation pattern of various chiral amines and determine their 








































Fig. 2.29 D-incorporation pattern of various substrates. The percentages of deuteration 
were determined by 1H NMR. *Results were obtained by C. Davies 
 
(i) Benzylic acyclic amines 101, 107 and 46 
Amines 101, 107 and 46 were structurally similar to 39. All showed deuteration 
at positions a and b, indicating the formation of the corresponding imine and 
enamine which are responsible for their racemisation. However, the degree of 
deuteration at position a is higher (> 55%) than that of 39. This may be because 
they have more bulky structures than 39, and their imine intermediates cannot 
bind to the iridium-hydride complex as strongly, and are more likely to de-
coordinate and interact with an iridium-deuteride species. Substrate 101 also 
showed a high degree of deuteration at position c, which is much less significant 
for 107 and 46, and was not observed for 39. This implies the occurrence of 
dehydrogenation of 101 at the isopropyl group at position c. Imine 112 is formed 
which is more stable compare to those formed from position c in 39, 107 or 46, 
due to the presence of two electron-donating methyl substituents adjacent to the 
C=N bond (Scheme 2.23). Tautomerisation of 112 into enamine 113 led to proton/ 





Scheme 2.23 Formation of imine 112 and enamine 113 which accounts for the D-
incorporation at positions c and d of 101 respectively 
 
(ii) Non-benzylic cyclic amines 103 and 108 
Non-benzylic cyclic secondary amines 103 and 108 were also tested using this 
procedure. The 1H NMR spectra of 2-methylpiperidine 103 were shown in Fig. 
2.30. The signals of different protons are relatively close to one another in the 
region of 2.7 to 1.9 ppm. They also become broader and less resolved upon 






Fig. 2.30 1H NMR spectra for the H/ D exchange reaction of 103 with d8-
iPrOD in the 
presence of 64140 
 
Based on the visual inspection of the spectra, there was a significant decrease in 
the integration of the methyl group signal (Hb), indicating possible deuterium 
incorporation of the corresponding enamine 114 (Scheme 2.24). Under the 
reaction conditions, amine 103 can be racemised, which is apparent from the 
racemisation reactions of 103 discussed in Sections 2.2.6 and 2.3.3.  
 
 
Scheme 2.24 Formation of imine 104 from 103 and its tautomerisation to enamine 114 
 
For 3-methylmorpholine 108, the proton signals are better separated than those 
of 103 (Fig. 2.31). However overlapping of signals is still observed and the lack 
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Fig. 2.31 1H NMR spectra for the H/ D exchange reaction of 108 with d8-
iPrOD in the 
presence of 64140 
 
Nevertheless, visual inspection of the spectra showed a significant decrease in 
the integration of the methyl signal (Hb) which indicated its deuteration due to the 
formation of enamine 116 from imine 115, similar to that of 103 (Scheme 2.25). 
Therefore amine 108 can likely be racemised by SCRAM 64 under these 
conditions. The multiplet at 3.69 ppm corresponds to the NCH protons Ha, Hc1 
and Hc2 which showed a decrease in integration visually. Due to the overlap of 
signals of these protons, it was difficult to confirm exactly which proton was 
exchanged. However imine 115 was more stable and more likely to form than 
imine 118, Ha was more readily exchanged with the deuteride. The dd signal at 
t = 0 h
t = 1 h
t = 2 h
t = 3 h
t = 4 h




3.98 ppm correspond to one of the OCH protons (He1) which also showed a drop 
in integration. This may indicate the formation of enamine 117 from imine 115. 
 
 
Scheme 2.25 Formation of imines 115 and 118 from 108 and tautomeriation of 115 
 
(iii) Rasagiline (R)-109 
Rasagiline, (R)-109 is an irreversible inhibitor of monoamine oxidase-B used to 
treat Parkinson diseases.141, 142 It is interesting to test if (R)-109 can be racemised 
using SCRAM 64, which will allow the use of resolution-racemisation-recycle (R3) 
methodology for its synthesis. Using the proton/ deuterium exchange procedure 
on rac-109, deuteration was observed mainly at position d since Hd is the most 




Scheme 2.26 H/ D exchange at position d of 109 
 
Positions a and c were also found to deuterate by about 50%. Imine 119 formed 
from c is relatively stable due to its conjugation with the alkyne group, resulting 
in deuterium incorporation at c (Scheme 2.27). However it does not correspond 




Scheme 2.27 Stabilisation of imine 119 via conjugation with the adjacent alkyne group 
 
On the other hand, deuteration at a may indicate the possibility of racemisation 
under the employed conditions. For positions b and e, the two protons at each 
position showed both an increase and decrease in integrations. It was unclear 
where deuteration took place. To confirm if 109 can be racemised by 64, a batch 
racemisation was attempted using the same conditions as the proton/ deuterium 
exchange experiment, with the use of non-deuterated solvents (Scheme 2.28). 
 
 
Scheme 2.28 Attempted racemisation of (R)-109 in batch using 64 (2.5 mol%) in iPrOH/ 
toluene (2.5:1 by volume) in 110 °C by microwave heating 
 
No racemisation was observed after 4 hours. However the concentration of 109 
decreased to only 27% which indicated the formation of side-products (Fig. 2.32). 
The impurities could not be identified from GC/ GCMS. From this, it was 
suspected that the decrease in integrations of some of the proton signals might 
be due to formation of the side products instead of deuterium incorporation. On 
the other hand, some of the newly formed peaks in the NMR may also overlap 
with other signals, resulting in an increase in integrations which makes the NMR 





Fig. 2.32 Reaction profile of the attempted racemisation of (R)-109 using 64 (2.5 mol%) 
in iPrOH/ toluene (2.5:1 by volume) at 110 °C by microwave heating 
 
(iv) Ephedrine and derivatives 
Ephedrine (R,S)-120 and pseudoephedrine (S,R)-120 are bronchodilators and 
prevent low blood pressure.143 They are diastereomeric amino-alcohols and may 
be useful to understand if the amino group can be racemised by 64 in the 
presence of the hydroxyl group. The proton/ deuterium exchange experiment was 
carried out on the N-methyl derivative of 120, (1S,2R)-N-methylephedrine 110, 
and was found to have no change in the integrations of the 1H NMR signals. The 
substrate 110 can act as a bidentate ligand in asymmetric transfer hydrogenation, 
in which both the hydroxyl and amino groups coordinate to the iridium centre, 




To block the hydroxyl group and prevent it from binding to the iridium, (S,R)-110 
was acetylated at the hydroxyl group, converting it into 111 (Scheme 2.29). The 
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Scheme 2.29 Synthesis of 111 via acetylation of the hydroxyl group of 110 
 
The proton signals at positions a, b and c showed a decrease in integrations. 
However the changes in NMR integrations were relatively small, the degree of 
deuteration was only about 10%. Since 111 is non-benzylic, imine 121 formed 
from the dehydrogenation at position a was not stabilised. Besides, the presence 
of the electron-withdrawing ester group may destabilise the C=N bond and its 
formation is less favoured. Enamines 122 and 123 are formed upon the 
tautomerisation of imine 121 (Scheme 2.30). Enamine 123 is much more stable 
than 122 due to the neighbouring benzyl group. A higher level of deuteration was 
observed at position c (23%) than position b (9%). The overall result indicated 
that 111 may be able to epimerise at both the amino and acetylated hydroxyl 
chiral centres by 64 under similar reaction conditions. However the actual 
racemisation experiment is needed to confirm this. 
 
 
Scheme 2.30 Tautomerisation of imine 121 
 
2.5.3 Proposed mechanism 
The 1H NMR proton/ deuterium exchange method for determining the 
racemisation of chiral amines confirmed the formation of an imine as the 
intermediate during racemisation. The imine can remain coordinated or de-
coordinated from the iridium centre of the catalyst, which may depend on the size 
of the imine/ amine substrate. The imine also tautomerises into the enamine. The 
mechanism leading to deuterium incorporation at positions a and b are 
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summarised in Scheme 2.31, which also corresponds to the plausible mechanism 
of racemisation.  
 
 
Scheme 2.31 Plausible mechanism of H/ D exchange at positions a and b of a chiral 
amine in the presence of 64. A generic structure of an enantiomerically pure amine was 
shown to illustrate its racemisation via the same pathways. Pathway A led to deuteration 
at position b; pathway B led to deuteration at both positions a and b 
 
2.5.4 Limitations 
The newly developed deuteration procedure provides a rapid method to 
determine if a chiral amine can be racemised by homogeneous SCRAM 64 (and 
potentially by immobilised SCRAM 92) without the need to carry out the actual 
racemisation which requires enantio-enriched material and a chiral analytical 
method. However upon deuteration, both chemical shifts and multiplicities of the 
signals will change which can affect the accuracy in determining their integrals. 
Conversion of the substrate to unknown side-products can also result in the 
change of integrations, leading to misinterpretations of the spectra. For more 
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complicated structures, overlapping of signals of both substrate and product are 
readily observed, which makes the assignment and integrations of individual 
signals difficult. Another problem is that there is no correlation of the rates of 
deuteration and racemisation. This is because 1H NMR spectroscopy can only 
detect the deuteride/ deuterium incorporating into the substrate, while the 
incorporation of hydride/ proton into the imine/ enamine cannot be observed. 
Therefore this method can only be used qualitatively. It can also be challenging 
to find an internal standard whose signals do not overlap with any of the substrate 
peaks, is non-volatile, can withstand the reaction conditions, and is chemically 
inert towards any hydrogen transfer/ C-H activation by 64, further limiting its use 
in quantitative analysis. 
 
2.6 Conclusion 
The racemisation of various chiral amines was carried out in batch using 
homogeneous catalyst 64. The effect of varying concentration was studied for the 
racemisation of amine 39 and the reaction rate was found to increase from 0.1 M 
to 1 M but eventually dropped when the concentration of 39 increased further. 
With 0.2 mol% of 64, complete racemisation was not observed for 39 in toluene 
at 105 °C. Deactivation of 64 might have occurred via the formation of C-H 
activation complex 93 with 39, and/ or the coordination of methylamine, a by-
product from the hydrolysis of imine 94, to the iridium centre of 64, forming 
iridium-methylamine complexes which inhibit the binding of 39. The binding 
interaction of methylamine with 64 was studied using a 1H NMR titration 
experiment and the mono-, di- and tri-methylamine-bound iridium complexes 
were observed, in which the tri-methylamine-bound complex was believed to be 
the major species that stopped 64 from turning over.  The racemisation of 39 was 
also carried out in ethyl acetate with different alcohols as co-solvent, and it was 
found that methanol reduced the activity of 64 more significantly than ethanol or 
isopropyl alcohol. Racemisation of other bulky substrates 101 and 46 proceeded 
more slowly than 39 due to more hindered interaction with 64. Racemisation of 
primary amine 42 mainly led to formation of dimers with minimal racemisation. 
Cyclic secondary amines 103 and 9 were successfully racemised by 64 and 
proceeded at much higher rates than acyclic amines, probably due to the more 
stable imine intermediates formed. 
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Racemisation of 39, 101, 46, 9 and 103 were also carried out in flow using 
immobilised SCRAM 92. The catalyst was packed in a HPLC column and the 
substrate solution was pumped through the reactor at elevated temperature to 
effect racemisation. The extent of racemisation can be increased by increasing 
the tRes of the reaction which depends on the flow rate (and reactor volume). The 
de-activated 92 was found to regain its activity by about 12% after re-activation 
by hydroiodic acid which protonate and remove some of the bound-methylamine 
from the iridium.  
 
A non-quantitative method was developed to determine the racemisation of chiral 
amines by locating the positions of deuteration of the molecule using 1H NMR 
spectroscopy, which does not need the use of enantio-enriched substrates or a 
chiral analytical method for determining the ee. This procedure also confirmed 
the formation of imine and enamine as the intermediate during racemisation 
which can remain bound or de-coordinate from the catalyst before converting 
back to the amine. However, deuterium incorporation causes changes in 
chemical shifts and multiplicities, and the overlapping of signals of the substrates 
and formation of side products make the spectral interpretations difficult. To 
further confirm the positions of deuteration, if any, deuterium NMR may be used 
which shows only deuterium signals. On the other hand, substrates deuterated 
at various positions may have to be prepared that can be used as references in 





3. Resolution-Racemisation-Recycle (R3) 
3.1 Introduction 
The maximum theoretical yield of the desired enantiomer from a resolution 
process is only 50%. The yield is often compromised further when attempting to 
increase the enantiopurity of the product.9, 63 As discussed in chapters 1 and 2, 
the undesired enantiomer in the resolution can be recycled by racemisation which 
produces a racemate that can be subjected to resolution again. By repeating the 
resolution-racemisation processes, the desired enantiomer can be synthesised 
in theoretical yield of 100%.  
 
Crystallisation-Induced Diastereomeric Transformation (CIDT) is one of the 
widely employed strategies in the asymmetric transformation of chiral amines by 
combining diastereomeric crystallisation with racemisation in one pot to obtain 
the desired enantiomer in high yield and ee (Scheme 3.1).66  
 
Scheme 3.1 CIDT process. The less soluble diastereomer crystallises from solution 
whilst the more soluble diastereomer resides in the ML which undergoes in-situ 
racemisation 
 
The undesired enantiomer in the mother liquor (ML) can be racemised via Schiff 
base formation in the presence of catalytic amount of an aldehyde.66 The 
configuration is lost either by the formation of an anion or 1,3-isomerisation of the 
imine. However the method has limited scope since it requires the amine to have 
an acidic proton at the chiral centre. Alternatively, transition metal catalysts such 
as SCRAM catalyst 64, Shvo’s catalyst 55, Pd/ C, Pd/ inorganic salt such as 
barium sulfate have been used in the racemisation of chiral amines. These 
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catalysts do not rely on low pKa protons and can potentially widen the scope of 
the CIDT process. In developing a one-pot procedure, the compatibility of both 
reactions have to be considered. Racemisation by transition metal catalysts often 
requires high temperature which also causes dissolution of the crystals. The 
metal residues from the catalyst can affect the crystallisation and contaminate the 
product. Therefore an alternative design of a CIDT-type process is necessary.  
 
The aim of this work is to develop a Resolution-Racemisation-Recycle (R3) 
process by combining diastereomeric crystallisation and SCRAM 64-catalysed 
racemisation. The results of racemisation of chiral amines using 64 was 
discussed in Chapter 2; the work demonstrated that 64 could be immobilised onto 
a Wang resin support and used in continuous flow. The racemisation substrate in 
the R3 process is the ML from the diastereomeric crystallisation containing 
enantio-enriched chiral amine that was pumped through a packed-bed reactor 
(PBR) containing the immobilised SCRAM catalyst 92. This enables the 
racemisation to be carried out independently from the crystallisation, allowing 
each process to be operated under its optimum conditions. The continuous stirred 
tank reactor (CSTR) for crystallisation and the racemisation PBR were linked via 
a pump and tubing to yield a continuous, recirculation process. The process was 
used to investigate the syntheses of a series of chiral amines (Fig. 3.1). 
Limitations and learning from the system are also discussed in this chapter. 
 
 
Fig. 3.1 Chiral amines tested on the R3 system 
 
3.2 Experimental set-up  
The experimental set-up consisted of two parts, diastereomeric crystallisation in 
batch and racemisation in flow (Fig. 3.2(a)). The crystallisation was carried out in 
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a glass CSTR (50 mL). The CSTR was fitted to a PTFE lid with three ports (3 mm 
O.D.) (Fig. 3.3(a)). The racemic amine, resolving acid (0.5 to 0.98 equiv.) and 
reaction solvent (20 mL) were added into the CSTR. An inline filter/ frit (40 μm 
pore sizes) was held inside the CSTR which allowed only the ML to leave the 
CSTR. It was connected to the inlet of a HPLC pump (Knauer PS4.1 or Jasco 
pump) via one of the ports with PTFE and marprene tubing (Fig. 3.3(b)). The 
outlet of the pump was connected to the inlet of the PBR (4 mL), which is a 
stainless steel HPLC column packed with 92 to allow racemisation to occur when 
the ML was pumped through. Two configurations were used during the 
development of the R3 process. Initially the PBR was heated with a stirrer hot 
plate (Fig. 3.2(a)), however the heating was uneven and suboptimal. An improved 
design employing an aluminium block containing nickel heating cartridges was 
then used which were electrically controlled, where more efficient heating and 
better temperature control of the PBR was achieved (Fig. 3.2(b)). The outlet from 
the PBR was fed into the CSTR via one of the ports using PTFE tubing (1/16” 
O.D., 1/32” I.D.). For experiments that required slow addition of the resolving acid, 
an additional syringe pump was connected to the CSTR via one of the ports for 
adding the acid solution into the crystallisation mixture. 
 
The total reactor volume of the system (RV) was determined by pumping a known 
volume of reaction solvent from a beaker through the whole set-up until the CSTR 
was filled with 20 mL of solvent. RV equals the difference in the original and the 
remaining volumes of the solvent in the beaker, which were 25 mL and 28.5 mL 







Fig. 3.2 Schematic of the two configurations used in the R3 process. (i) CSTR (50 mL), 
(ii) Frit, (iii) Magnetic stirrer, (iv) HPLC pump (Knauer PS4.1 or Jasco pump), (v) PBR 
packed with immobilised SCRAM 92, (vi) Syringe pump for acid addition. (a) PBR was 














































Fig. 3.3 The glass CSTR used in the diastereomeric crystallisation of the R3 process. (a) 
PTFE lid fitted to the CSTR with three ports. (b) The frit and PTFE tubing fitted via the 
ports on the lid 
 
In the R3 process, the racemic amine and the resolving acid were stirred inside 
the CSTR. After the crystals were formed, the ML which was enriched with the 
more soluble diastereomer (corresponded to the undesired enantiomer of the 
amine) was pumped out from the CSTR at a designated flow rate, which passed 
through the PBR containing the immobilised 92 where the ML was racemised and 
then returned to the CSTR. The desired enantiomer was formed in the PBR as 
the ML was racemised. The racemised ML was introduced into the crystalliser, 
allowing further resolution with the resolving acid and precipitation of the desired 
diastereomer.  
 
3.3 R3 processes for different chiral amine substrates using 
(S)-mandelic acid 34 as resolving agent 
Diastereomeric resolution of various racemic chiral amines were studied to obtain 
suitable conditions which could be combined with the racemisation in flow to 
develop the R3 process. The yields of all resolutions reported in this work were 
calculated using Eqn. 3.1. The equation is a function of the quantity of amines in 
the system irrespective of the amount of chiral acids charged, assuming the 
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 × 100%    (Eqn. 3.1) 
 
Where mcrystals is the mass of crystals obtained from the resolution; namine is the 
number of moles of amine in the system; r is the ratio of amine: acid in the salt; 
Msalt is the molar mass of the salt formed. 
 
For diastereomeric resolutions, especially in non-dynamic systems (with no 
racemisation of the ML), product with high de often gives low yield and vice versa. 
While yield and de are both important, it is very difficult to compare different 
processes based on two quantities. Therefore a single quantitative term called 
resolvability (S) was introduced which combines both yield and de. It can be used 
to measure the efficiency of a diastereomeric resolution (Eqn. 3.2).145  
 
S = 2 × Yield × de    (Eqn. 3.2) 
 
For a simple resolution, where the undesired diastereomer is not recycled, the 
maximum de and yield of the product are 100% and 50% respectively. Therefore 
the maximum value of S is 1; whilst a dynamic resolution can theoretically lead 
to 100% de and 100% yield and therefore its S has a maximum value of 2. 
  
Based on Eqn. 3.2, two processes having the same value of S may have very 
different yield and de. For example, a diastereomeric resolution leading to product 
with 100% de and 50% yield has the same resolvability as that with 50% de and 
100% yield. This term has to be used in caution and the information on both yield 
and de of the resolution process have to be known to draw any definite 
conclusions. Nevertheless, the term enables comparison of different resolution 
processes. 
 
3.3.1 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 
(a) Diastereomeric crystallisation in batch 
Enantiopure amine 9 has been readily racemised by both homogeneous SCRAM 
64 and immobilised SCRAM 92 in batch and flow, as shown in Sections 2.2.5 and 
2.3.3 and by Blacker et al.1 The diastereomeric resolution of rac-9 was also 
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reported by Shi et al. which used (S)-mandelic acid 34 as the resolving acid.137 
With some preliminary knowledge regarding both racemisation and resolution, 9 
was chosen to be the model substrate in the development of the R3 process. 
 
Racemic 9 was synthesised from 3,4-dimethoxyphenethylamine 124, which was 
first acetylated to acetamide 125, followed by Bischler-Napieralski cyclisation to 
form imine 8. Subsequent reduction of imine 8 using excss sodium borohydride 
gave rac-9 (Scheme 3.2).137  
 
 
Scheme 3.2 Synthesis of rac-9 from amine 124 
 
The diastereomeric resolution of rac-9 was previously reported using 0.5 equiv. 
of (S)-34 and stirred under reflux in ethyl acetate/ isopropyl alcohol 5:1. The 
resulting crystals were purified by suspending them under reflux in ethyl acetate/ 
isopropyl alcohol 7:1. The diastereopure (R)-9-(S)-34 was obtained in 41% yield 
(based on 9) with > 98% de.137 The conditions were further investigated at 





Scheme 3.3 Diastereomeric resolution of rac-9 by (S)-34 at room temperature 
 
Entry Alcohol (S)-34 (equiv.) Yield (%)[a] de (%)[b] S 
  1[c] MeOH 0.5 28 98 0.549 
  2[c] EtOH 0.5 30 95 0.570 
  3[c] iPrOH 0.5 34 86 0.585 
4 MeOH 1 59 27 0.319 
5 EtOH 1 74 14 0.207 
6 iPrOH 1 80 7 0.112 
Table 3.1 Condition screening of diastereomeric crystallisation of rac-9 with (S)-
34 at room temperature in ethyl acetate/ alcohol 7:1 (v/v). [a]Seed was excluded 
from the yield calculation. [b]De was determined by 1H NMR (in CDCl3, 500 MHz). 
[c]The reaction was seeded with (R)-9-(S)-34 (5% w/w) 
 
A suitable solvent system was determined by changing the alcohol co-solvent. 
With the same amount of (S)-34 added, the use of methanol led to higher de but 
lower yield compared to the other solvent systems (Table 3.1, entries 1 and 4); 
whilst the use of isopropyl alcohol resulted in lower de and higher yield (Table 
3.1, entries 3 and 6). With the use of 0.5 equiv. of (S)-34, crystals of higher de 
were obtained, leading to higher resolvability (Table 3.1, entries 1 to 3). Although 
the yields were higher when (S)-34 was increased to 1 equiv., the significant drop 
in de led to much lower resolvability (Table 3.1, entries 4 to 6). One of the possible 
reasons behind the dramatic changes in the de and yield of the crystals upon 
changing the alcohol from methanol to ethanol and isopropyl alcohol especially 
with 1 equiv of (S)-34 is the absolute solubility of (R)-9-(S)-34 and (S)-9-(S)-34 
which decreases considerably from ethyl acetate/ methanol to ethyl acetate/ 
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isopropyl alcohol 7:1 (v/v) (Fig. 3.4). More of both salts are likely to crystallise out 
from solution, leading to lower de and higher yield.  
 
Fig. 3.4 Solubility of (R)-9-(S)-34 and (S)-9-(S)-34 in EtOAc/ alcohol 7:1 (v/v) at r.t. 
 
(b) Diastereomeric crystallisation in flow 
The diastereomeric resolution of rac-9 with (S)-34 was also carried out in 
continuous flow using cascade CSTRs called Freactors (Fig. 3.5).114 Each 
Freactor is a 1.8 mL CSTR fitted with a magnetic stirrer which provides effective 
mixing of reagents. The Freactors can be connected in series using HPLC 1/8” 
O.D. ferrules and tube fittings. Previous studies showed that the Freactor(s) 
display plug-flow characteristics up to a tRes of three hours and are capable of 
performing multiphasic reactions.114 The diastereomeric crystallisation of 9 by 
mixing (S)-34 and rac-9 was found to be successful in this system, showing its 
remarkable ability in handling solids generated within a reaction. 
 
 
Fig. 3.5 Schematic of the experimental set-up for diastereomeric crystallisation in flow 
by connecting five Freactors in series (1.8 mL volume each) using PTFE tubing (1/8” 
























EtOAc/ MeOH 7:1 EtOAc/ EtOH 7:1 EtOAc/ iPrOH 7:1
Acid solution
Amine solution
Crystals collected as slurry
Magnetic stirrer bar in each Freactor
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Based on the results of diastereomeric crystallisation of 9 with (S)-34 in batch, 
ethyl acetate/ methanol 7:1 was chosen to be the solvent system in flow and only 
0.5 equiv. of (S)-34 was used. The effects of tRes on the yield and de of the crystals 
were investigated by varying the flow rate and the total volume of the system 
















1 5 10 5 2 23 86 0.396 
  2[b] 3 1.2 0.5 2.5 14 91 0.255 
3 2 4 0.5 8 19 88 0.334 
4 5 10 1 10 24 87 0.418 
5 5 10 0.5 20 24 91 0.437 
6 5 10 0.25 40 19 91 0.346 
Table 3.2 Variation of RV and flow rate in the diastereomeric crystallisation of 9 with (S)-
34 in flow using Freactors. [a]De was determined by 1H NMR (in CDCl3, 500 MHz). 
[b]The 
Freactors were not fully filled and contained air bubbles 
 
 
Fig. 3.6 Diastereomeric crystallisation of 9 with (S)-34 in flow. (a) Cumulative yield of 
crystals formed; (b) De of the crystals collected from each RV, measured by 1H NMR 
(CDCl3, 500 MHz) 
 
One of the benefits of continuous flow methods in chemical processing is the 
ability to achieve steady state which minimises the variations of reaction 
outcomes. With tRes of 2.5 minutes where the system contained air bubbles (Table 
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yield as reflected by the cumulative yield plot being less smooth than the others 
(Fig. 3.6(a)). The de of the crystals was also found to be less consistent across 
the RVs (Fig. 3.6(b)). Properly filling the Freactors ensured no air bubbles in the 
system, leading to more consistent flow throughout the crystallisation. 
 
With the same RV (Table 3.2, entries 1, 4 to 6), crystals were formed more quickly 
when flow rate was increased, as shown from the higher yield of solids in RV 2 
(Fig. 3.6). This showed the importance of initial mixing to the reaction rate. The 
overall yield (including the washing) was virtually unaffected by the flow rate. At 
tRes 40 minutes, the system started to block relatively quickly and was not able to 
reach steady state, which may explain the slightly lower yield compared to the 
other systems. With shorter tRes of 2 and 10 minutes (Table 3.2, entries 1 and 4), 
lower de of the crystals was observed compared to those obtained at longer tRes 
(Table 3.2, entries 5 and 6).  
 
One of the main problems with micro-reactors is their gradual blockage when 
crystallisation proceeds. At tRes 2, 10 and 40 minutes, the reactors started to get 
blocked at RVs 9, 8 and 7 respectively. At tRes 20 minutes, however, no blockage 
was observed for 12 RVs (Fig. 3.6(a)). Significant amount of solid was found to 
accumulate in the first reactor and may account for the blockages. The solids at 
the bottom of the reactor were not able to enter into the suspension and started 
to stick together to form large agglomerates, eventually blocking the reactor. 
Agglomeration is more likely to happen especially in reactive crystallisations such 
as amine-acid neutralisations due to the high supersaturation levels present upon 
precipitate formation.146 It may also be facilitated by electrostatic charges built up 
on the particles.  
 
In addition to varying flow rate, tRes was varied by changing the volume, i.e. the 
number of reactors. With only two reactors flowing (4 mL) at 0.5 mL min-1 (tRes = 
8 minutes), a slight drop in yield and de were observed (Table 3.2, entry 3). 
Blockage occurred from RV10. The reason was unclear as no blockage was 
found with 5 reactors at the same flow rate. 
 
Diastereomeric resolution of rac-9 with (S)-34 in continuous flow showed a 
slightly lower resolvability compared to that carried out in batch but with much 
116 
 
shorter crystallisation times (2 to 40 minutes) compared to 6 hours in batch. The 
lower de crystals containing less (R)-9-(S)-34 and/ or more (S)-9-(S)-34 may be 
formed as the kinetic product at the start of the crystallisation process. Upon 
prolonged stirring of the reaction mixture, the most thermodynamically stable 
product will be formed, in which more (R)-9-(S)-34 (the less soluble solid) 
crystallises out where more (S)-9-(S)-34 (the more soluble solid) dissolves, 
leading to higher de of the final crystal product. A shorter diastereomeric 
crystallisation of 9 with (S)-34 was previously carried out in batch for 2 hours in 
ethyl acetate/ methanol 7:1 (v/v) which also led to a lower de of only 83%.  
 
(c) R3 process of amine 9 with (S)-34 
Since a higher resolvability of rac-9 with (S)-34 was achieved in ethyl acetate/ 
methanol 7:1, and this solvent system has been used in the racemisation of 
enantiopure 9 using both homogeneous SCRAM 64 and immobilised SCRAM 92, 
it was initially chosen as the solvent system for the R3 process of 9 (Scheme 3.4). 
 
Scheme 3.4 R3 process of 9. tRes for the whole cycle = 25 mL/ 0.5 mL min
-1 = 50 min 
 
At the start of this work, it was believed that acids might have an inhibitory effect 
on the racemisation, as shown by J. Breen during the racemisation of (S)-39 by 
C5-hydroxy-tethered SCRAM 98 in the presence of (S,S)-32 (Fig. 3.7). Acids 
would be expected to affect Ir-N coordination of the amine, imine or iminium, react 
with hydride to produce hydrogen, and coordinate to the iridium as a carboxylate 





Fig. 3.7 Profiles of ee for the racemisation of (R)-39 in the presence of (S,S)-32 by 
SCRAM 98 in EtOAc/ MeOH (17% by volume) (results by J. Breen) 
 
During the early stage of R3 process development, the amount of (S)-34 was kept 
at its minimum concentration to ensure the system was as basic as possible. At 
the start of the diastereomeric crystallisation, only 0.5 equiv. of (S)-34 was added 
which reacted with half of the amount of rac-9. The remaining 0.5 equiv. of (S)-
34 was added slowly into the CSTR by a syringe pump (Fig. 3.2(a)). Its rate of 
addition was based on the approximate drop in ee of the ML after each pass 
through the catalyst. This corresponds to the amount of (R)-9 formed from (S)-9 
after each cycle. As (R)-9-(S)-34 crystallised preferentially due to its lower 
solubility, the total amount of 9 in the system decreased after each cycle, 
therefore the rate of acid addition was reduced accordingly. The assumptions and 
approximations of the addition rate of (S)-34 are described in Section 8.4. The 
ML was pumped through the system at 0.5 mL min-1 which equated to a tRes of 8 
minutes and 50 minutes for racemisation and one recycle of the R3 process 
respectively. The first attempt of R3 process of 9 is shown in Fig. 3.8. The ML was 
recirculated for 17 cycles corresponding to a process time of 14 hours. The 
overall process cycle time is calculated as the product of tRes (one whole cycle) 
and the number of times recirculated (Eqn. 3.3).  
 
Process time = tRes(whole cycle) × no. of cycles     (Eqn. 3.3) 
 
Samples were taken from the reaction solution in order to determine the 
concentrations of amine 9, imine 8 and isoquinoline 65 in the ML by GC. Chiral 
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each sample. The total yield of the crystals obtained at the end of the process 
included those from each sample and was calculated using Eqn. 3.1. 
 
 
Fig. 3.8 The first attempt of R3 process of 9 with (S)-34 in EtOAc/ MeOH 7:1 (v/ v) (Table 
3.3, entry 1). A total of 0.92 equiv. of (S)-34 was added 
 
The concentration of 9 decreased for about 8 cycles and eventually levelled-off. 
The amine was transformed with (S)-34 into crystals and impurities such as imine 
8 and isoquinoline 65. These latter compounds were formed, presumably, by loss 
of hydrogen as a result of acid quenching of the Ir-H catalytic intermediate. The 
concentration of 9 did not reach zero since some of the diastereomeric salts 
remained in solution, as defined by their solubility. Interestingly, the de of the 
crystals gradually increased from 80 to 99% and their overall yield was 55% 
(including the crystals isolated during reaction sampling), resulting in an S value 
of 1.09 (Table 3.3, entry 1). This showed a significant improvement over the batch 
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Entry 1 2 3 4[a] 
Reaction 
conditions 
Alcohol[b] MeOH MeOH iPrOH MeOH 
Average acid addition rate during 
recirculation (mg min-1)[c] 
0.22 0.43 0.63 0.63 
No. of cycles 17 11 8 8 
Process time (h) 14.2 9.2 6.7 6.7 
Results 
Initial crystal de (%) N.D.[d] 76 65 76 
Final crystal de (%) 99 99 96 97 
Yield (%) 55 52 65 33 
9 in ML (%) 18 15 9 66 
8 in ML (%) 16 13 5 0.8 
65 in ML (%) 1 1.4 0.5 1.2 
ML ee (%) 0.6 3 69 55 
S 1.089 1.030 1.248 0.640 
Table 3.3 R3 process of 9 with slow addition of (S)-34. [a]Formic acid (1 equiv.) was added 
into the crystallisation. [b]All solvent system contained ethyl acetate/ alcohol 7:1 (v/v). 
[c]Average addition rate of (S)-34 was calculated by summation of the rates of all cycles 
divided by the number of cycles in which 34 was added (Section 8.4). [d]Not determined 
 
In the R3 process, there are six species in equilibrium (Scheme 3.5). During 
racemisation of the ML, amine (R)-9 was formed from (S)-9, and with the acid 
(S)-34, the least soluble diastereomeric salt crystallised as a solid. As the 
concentration of (R)-9 in solution decreased, racemisation allowed the 
equilibrium to shift from (S)-9 towards (R)-9. Any (S)-9-(S)-34 which was formed 
initially as a solid started to dissolve to form the desired, less soluble (R)-9-(S)-
34 (solid), increasing both the yield and diastereopurity of the crystals. In this 
regard, neither optimisation of the racemisation, nor the resolution was necessary, 
as the process was driven by the system’s thermodynamics. Any difference in 
solubility of the diastereomeric salts will create an excess of one of the 
enantiomers/ diastereomers in the ML. If the ML can be racemised, the 
equilibrium will eventually shift towards the less soluble diastereomeric salt. 
Mandelic acid (S)-34 or the mandelate ion is unlikely to racemise under the 
conditions employed for the R3. Control experiments were carried out in batch 
using 92 and no racemisation was observed. However, phenylglyoxylate ion 126 
was formed in the case of triethylammonium (S)-34, indicating that 34 is able to 
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dehydrogenate at the chiral centre, but subsequent reduction does not occur 
(Scheme 3.6, Fig. 3.9). 
 
 
Scheme 3.5 Equilibrium between (R)-9, (S)-9 and their salts of (S)-34 in solution and 
solid states. (R)-9-(S)-34 was the less soluble diastereomer (highlighted in blue) 
 
 
Scheme 3.6 Formation of phenylglyoxylate ion 126 from (S)-mandelate 34 in the 
presence of 92 without racemisation 
 
 
Fig. 3.9 Attempted racemisation of Et3N-(S)-34 with 92. (a) Reaction profile showing 
constant ee and HPLC peak area ratio of 126 and mandelate; (b) 1H NMR spectra 
showing the formation Et3N-126 
 
Following the success of the first attempt of the recycle, different conditions were 
evaluated to further optimise the R3 process (Table 3.3, entries 2 to 4). During 
the first attempt, (S)-34 was added slowly throughout the process which required 
17 cycles to add 0.92 equiv. of (S)-34 into the reaction. This corresponded to 14 








































































hours of process time. In order to improve the efficiency, higher addition rate was 
used which did not cause significant change in the de and only a slight decline in 
the yield of the crystals was observed (Table 3.3, entry 2). Although the 
resolvability of the R3 system were significantly improved over the batch 
resolution with much higher product de (Table 3.3, entries 1 and 2; Table 3.1, 
entries 1 and 4), the yields of the R3 processes were still low (≤ 55%) due to the 
loss of 9 to impurities imine 8 and isoquinoline 65. In this regard, isopropyl alcohol 
was used as a co-solvent instead of methanol, as this could act as a hydrogen 
donor to reduce 8 and 65 in-situ back to 9 (Table 3.3, entry 3). This led to an 
increase in isolated yield to 65% with only small decrease in de. Formic acid was 
tested as an alternative hydrogen donor and was successful in reducing the levels 
of 8 and 65, but changed the pH of the system, affecting the solubilities of both 
(R)-9-(S)-34 and (S)-9-(S)-34, and causing a drop in yield (Table 3.3, entry 4).  
 
Despite the concerns over the system acidity, it was shown that increasing the 
rate of (S)-34 addition had no significant impact on the yield or de of the crystals. 
It was decided that instead of adding (S)-34 slowly, it might be added at the start 
of the process (Table 3.4). The system was kept slightly basic with small excess 
of free amine present by adding less than 1 equiv. of (S)-34 (0.9 to 0.98 equiv.) 
to initiate the racemisation reaction (Scheme 3.5).9 Adding acid at the beginning 
did not affect the resolution nor the racemisation reactions when methanol was 
used as the co-solvent, as shown by the similar yields and de of the products as 
previous experiments (Table 3.4, entries 1 and 2). When isopropanol was used, 
a lower de was observed after 12 cycles (Table 3.4, entry 3). When the process 
was run for 30 cycles, a higher de (96%) was observed with a yield of 78% and 
resolvability of 1.5 (Table 3.4, entry 5; Fig. 3.10). High de (97%) could also be 
achieved after 12 cycles by using a mixture of methanol/ isopropyl alcohol (8:2 









Entry 1[a] 2 3 4 5 6[b] 
Reaction 
conditions 





No. of cycles 8 12 12 12 30 12 
Process time (h) 6.7 10 10 10 25 10 
Results 
Initial crystal de 
(%) 
76 76 43 67 50 41 
Final crystal de 
(%) 
98 99 72 97 96 60 
Yield (%) 62 63 72 68 78 75 
9 in ML (%) 16 11 10 13 4 8 
8 in ML (%) 10 3.5 4 6 2 1.3 
65 in ML (%) 0.3 3 0.2 0.5 0.3 0.2 
ML ee (%) 18 10 64 14 6 81 
S 1.215 1.247 1.037 1.319 1.498 0.900 
Table 3.4 R3 process of 9 with 0.98 equiv. of (S)-34 added at the beginning of the process 
with no further addition of acid. [a]0.9 equiv. of (S)-34 was added. [b]The PBR was 
electrically heated in an aluminium block. [c]All solvent system contained ethyl acetate/ 
alcohol 7:1 (v/v) 
 
 
Fig. 3.10 R3 process of 9 with (S)-34 in EtOAc/ iPrOH 7:1 (v/ v) (Table 3.4, entry 5). The 
process was run for 30 cycles (25 h) 
 
In the R3 processes listed in Table 3.3 and Table 3.4 (entries 1 to 5), the flow 
racemisation reactions were carried out at approximately 60 °C by heating the 
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heating, the column was inserted into an aluminium block with two thermocouples 
attached and was electrically heated to 60 °C (Fig. 3.2(b)). The R3 process of 9 
was repeated in ethyl acetate/ isopropanol using the modified set-up (Table 3.4, 
entry 6). A similar yield but lower de were observed as compared to the original 
set-up (Table 3.4, entry 3). This might be explained by the repeated use of the 
same catalyst and deactivation might have started to occur.  
 
In the R3 processes of 9 described, the same catalyst 92 was reused after each 
reaction without unloading from the PBR. The catalyst was recycled for a total of 
130 times (108 hours of reuse). In order to assess its activity, a racemisation of 
(S)-9 was carried out in flow. The eluent collected was re-introduced into the PBR 
five times. The ee of 9 was monitored, which dropped gradually from 100% to 
47% after five passes through the catalyst respectively, indicating that the 130-
times used 92 still showed activity (Fig. 3.11). As discussed in Section 2.3.3, 
racemisation of (S)-9 in flow at 60 °C using fresh 92 with tRes of 6 minutes resulted 
in a drop of ee from 100 to 17% after one pass. This showed that the catalyst was 
about 8 times less active after 130 uses. The cause of deactivation might be the 
coordination of amine to the iridium with C-H insertion to generate a Ir-Carom 
complex, as discussed in Section 2.2.1. 
 
Fig. 3.11 Activity check of immobilised SCRAM 92 after 130 uses in the R3 process of 9, 
via the racemisation of (S)-9 in flow at 60 °C in EtOAc/ MeOH 7:1 (by volume); Ir loading 
= 10 mol% 
 
3.3.2 2-Methylpiperidine 103 
Piperidine derivatives form part of the alkaloid group and can be found in plant 















chemicals.150 The resolution of a simple piperidine derivative, 2-methylpiperidine 
103, by enantiopure 34 was reported using mainly diethyl ether as the solvent 
which is too low boiling to be useful in racemisation reactions.149, 151 Therefore 
other solvents with higher boiling points were screened (Scheme 3.7, Table 3.5).  
 
 











1 0.14 MTBE No 78 3 0.047 
2 0.14 MTBE/ MeOH (4% by volume) No 29 87 0.505 
3 0.14 MTBE/ iPrOH (5% by volume) No 35 83 0.581 
  4[d] 0.28 DME No 11 91 0.200 
  5[d] 0.28 EtOAc No 24 82 0.394 
  6[d] 0.14 iPrOAc No 22 87 0.383 
7 0.14 iPrOAc Yes 26 85 0.442 
8 0.25 iPrOAc Yes 48 27 0.259 
9 0.35 iPrOAc Yes 53 20 0.212 
Table 3.5 Condition screen of diastereomeric resolution of rac-103 with (S)-34. [a](R)-
103-(S)-34 (5% w/w) was used as the seed. [b]Seeds were not included in yield 
calculations. [c]De were determined by 1H NMR (in CDCl3, 500 MHz). 
[d]Crystals 
precipitated from solution after ≥ 1 h 
 
Methyl tert-butyl ether (MTBE) was first used which is a less volatile ether solvent 
than diethyl ether (Table 3.5, entry 1). Virtually no resolution was observed. 
Therefore an alcohol was added as a co-solvent which led to improved 
resolvability (Table 3.5, entries 2 and 3). However the boiling point of MTBE was 
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still relatively low. Racemisation of (S)-103 in MTBE at 50 °C in batch was slow 
with a half-life of ≤ 24 hours (Section 2.2.6). In addition, the MTBE-containing 
systems require an alcohol for resolution to occur which can slow down the 
racemisation of ML. Dimethoxyethane (DME) and ethyl acetate require a higher 
concentration of 103 and a long stirring time for crystals to precipitate, indicating 
a slow nucleation (Table 3.5, entries 4 and 5). The highest de was observed using 
DME but the yield was very low (Table 3.5, entry 4). Crystallisation in isopropyl 
acetate was also slow although it can be carried out at 0.14 M (Table 3.5, entry 
6). The system was seeded with diastereopure (R)-103-(S)-34 to speed up the 
nucleation step (Table 3.5, entry 7). The resolutions were repeated at higher 
concentrations but the resolvability of the systems dropped significantly (Table 
3.5, entries 8 and 9). Isopropyl acetate allows the racemisation of (S)-103 to 
proceed at higher temperature (80 °C) at reasonable rates in both batch and flow, 
as discussed in Sections 2.2.6 and 2.3.3. Therefore it was chosen to be the 
solvent for the R3 process development of 103 (Scheme 3.8). 
 




Development of the R3 process for amine 9 showed that the amount of acid 34 in 
the system did not have any impact upon its performance, therefore 0.9 equiv. of 
(S)-34 was added with amine 103 at the start of the process, without adding more 
during the ML recirculation. Since the rate of racemisation of 103 is lower than 
that of 9, a longer tRes (16 minutes) was employed, using a flow rate of 0.25 mL 
min-1. This made the recirculation of the whole volume longer (tRes = 114 minutes). 
The crystallisation was seeded with diastereopure (R)-103-(S)-34 (5% w/w) to 
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encourage crystal growth from the start. The conditions and the results for the R3 
processes of 103 were shown in Table 3.6.  
 
Entry 1 2 3 
Reaction 
conditions 
[103] (M) 0.14 0.25 0.35 
Ir loading (mol%) 7 4 2.8 
No. of cycles 6 12 16 
Process time (h) 10 22.8 30.4 
Results 
Initial crystal de (%)[a] 70 62 73 
Final crystal de (%)[a] 90 90 89 
Yield (%)[b] 26 44 52 
103 in ML (%)[c] 47 39 22 
ML ee (%)[d] 16 9 26 
S 0.468 0.792 0.926 
Activity of 92 Average ee of 103 (%)[e] 20 34 42 
Table 3.6 Experimental conditions attempted for the R3 process of 103 with 0.9 equiv. of 
(S)-34 added at the beginning of the process with no further addition of acid. [a]De was 
determined by 1H NMR (CDCl3, 500 MHz). 
[b]Crystals from each sample were included 
while the seeds were excluded from yield calculation. [c]Amount of 103 was determined 
by GC after free-based with Na2CO3 (aq). 
[d]ee of 103 in ML was determined by chiral 
GC after derivatisation with acetic anhydride [e]After one pass through the catalyst 
 
A concentration of 0.14 M of 103 was used, as it gave the highest resolvability of 
those tested in isopropyl acetate (Table 3.6, entry 1). An increased loading of 92 
(7 mol% Ir) was used to increase the rate of racemisation. Under these conditions, 
the overall yield of the process was only 28% which was similar to the resolution-
only process (Table 3.5, entry 7). Gratifyingly, the de of the crystals increased 
very slowly from 70% to 90% after 6 cycles (Fig. 3.12(a)). Since the amount of 
103 in the ML did not change significantly over time whilst its ee was decreasing 
gradually, this indicated that the ML was slowly racemising and the concentration 
of (R)-103 was increasing in the system. However the amount of solid formed 
was low, as it stayed in the ML without precipitating out as the mandelate salt. 





Fig. 3.12 The R3 processes of 103 at different concentration of 103 and process time. (a) 
0.14 M, 6 cycles; (b) 0.25 M, 16 cycles 
 
The concentration of 103 in the crystallisation was increased to 0.25 M with 
increased process time of 16 cycles (Table 3.6, entry 2; Fig. 3.12(b)). Whilst the 
de of the crystals fluctuated, a gradual increase from 62% to 90% was observed. 
The concentration of 103 in the ML slowly decreased from 72% to 39%. Whilst 
the isolated yield was better than the first attempt. It was still below 50% so the 
concentration was increased further to 0.35 M (Table 3.6, entry 3). In this case 
the yield increased to 52%, with similar de of 89%. This also indicate that the rate 
of nucleation/ growth of the less soluble diastereomer might be rate-limiting. 
 
After each repeated reaction, the activity of the used 92 was assessed by the 
racemisation of (S)-103 in flow (Fig. 3.13, Table 3.6). With fresh catalyst, the ee 
decreased from 100% to an average of 21% with 5 mol% iridium loading at 80 °C 
with tRes of 16 minutes. Catalytic activity started to drop after the second and third 
R3 processes (Table 3.6, entries 2 and 3) which resulted in an average ee of 33 
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Fig. 3.13 Activity check of 92 after each R3 process of 103, via the racemisation of (S)-
103 in flow at 80 °C in iPrOAc; tRes = 16 min; Ir loading = 5 mol% 
 
In the batch resolutions, an increasing concentration of 103 led to a drop in 
resolvability due to the significant fall in diastereopurity (Table 3.5, entries 7 to 9). 
The best resolution gave a resolvability of 0.44. In the R3 process, higher 
concentration led to faster crystal growth, improving both the yield and de of the 
product, and increased the resolvability of the system to 0.93.  
 
3.3.3 N-Methyl-α-methylbenzylamine 39 
N-Methyl-α-methylbenzylamine 39 was used as a model substrate for the study 
of amine racemisation by homoegeneous SCRAM 64, as discussed in Section 
2.2.1. However the diastereomeric resolution of 39 has not been previously 
reported in literature. Synthesis of rac-39 was carried out via reductive amination 
of 51 by methylamine and sodium borohydride (Scheme 3.9).  
 
Scheme 3.9 Synthesis of rac-39 
 
Diastereomeric resolution of rac-39 had been studied previously in the group by 
screening various chiral acid resolving agents. In particular, the use of di-p-
toluoyl-tartaric diacid (S,S)-32 in the resolution and CIDT of 39 were studied in 
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meantime, acid (S)-34 was used and a brief solvent screen was carried out 
(Scheme 3.10, Table 3.7). 
 
Scheme 3.10 Diastereomeric resolution of rac-39 by (S)-34 
 
Entry Solvent Seeded?[a] Yield (%)[b] De (%)[c] S 
1 EIB[d] No 60 24 0.288 
  2[e] EIB[d] No 67 18 0.241 
3 EIB[d]/ iPrOH (5%) Yes 49 35 0.343 
4 EIB[d]/ iPrOH (10%) Yes 35 47 0.329 
5 iPrOAc Yes 49 37 0.363 
    6[e][f] iPrOAc Yes 56 30 0.336 
Table 3.7 Solvent screen of diastereomeric crystallisation of 39 (0.2 M) with (S)-34 (1 
equiv.). [a](R)-39-(S)-34 (5% w/w) was used as the seed. [b]Seeds were not included in 
yield calculations. [c]De were determined by 1H NMR (in CDCl3, 500 MHz). 
[d]Ethyl 
isobutyrate. [e][39] = 0.3 M. [f]Alcohol 58 (1 equiv. with respect to 39) was added 
 
Ethyl isobutyrate (EIB) was tested in the resolution of 39 with (S)-34 without 
seeding. Only a de of 24% was achieved (Table 3.7, entry 1). Increasing the 
concentration of 39 from 0.2 M to 0.3 M led to lower resolvability (Table 3.7, entry 
2), whilst the addition of isopropyl alcohol co-solvent improved the resolvability 
(Table 3.7, entries 3 and 4). The crystallisations were also seeded with 
diastereopure (R)-39-(S)-34 to speed up the nucleation. Isopropyl acetate gave 
slightly higher resolvability compared to the ethyl isobutyrate/ isopropyl alcohol 




The R3 process of 39 with (S)-34 was attempted using isopropyl acetate (Scheme 
3.11). With slower racemisation of 39 compared to 9 and 103, the flow rate of the 
process was lowered to 0.1 mL min-1. By using the Jasco pump, the tRes for the 
racemisation and the whole process were about 40 and 285 minutes (4.75 hours) 
respectively.  
 
Scheme 3.11 R3 process of 39. tRes for the whole cycle = 28.5 mL/ 0.1 mL min
-1 = 285 
min (4.75 h) 
 
At 0.2 M of 39 with 0.9 equiv. of (S)-34 added at the start of the process, de of 
the crystals increased very slowly from 37% to 60% over 40 cycles (190 hours). 
A higher crystal de was achieved compared to the batch resolution, but there was 
no improvement in the overall resolvability for the R3 process due to the decrease 
in yield (Table 3.8, entry 1; Fig. 3.14(a)). One of the possible reasons was the 
formation of methylamine from the hydrolysis of acetophenone 51, which can 
deactivate 92, as discussed in Sections 2.2.1 and 2.4.1, lowering the efficiency 
of the process. Another cause might be the low rate of precipitation of the less 
soluble solid (R)-39-(S)-34 due to its high absolute solubility (See Section 6.3.3), 











Entry 1 2[a] 
Reaction 
conditions 
[39] (M) 0.2 0.3 
Ir loading (mol%) 3.8 3 
Crystallisation T (°C) r.t. 12 
No. of cycles 40 70 
Process time (h) 190 333 
Results 
Initial crystal de (%)[b] 37 20 
Final crystal de (%)[b] 60 43 
Yield (%)[c] 30 53 
39 in ML (%)[d] 50 24 
51 in ML (%)[d] 14 14 
ML ee (%)[e] 3 -4 
S 0.36 0.46 
Activity of 92 Average ee of 103 (%)[f] 77 77 
Table 3.8 Experimental conditions attempted for the R3 process of 39. [a]Alcohol 58 (1 
equiv.) was added into the crystallisation mixture at the start. [b]De was determined by 1H 
NMR (CDCl3, 500 MHz). 
[c]Crystals from each sample were included while the seeds 
were excluded from the yield calculation. [d]Amount of 39 and 51 from the ML were 
determined by GC after free-based with Na2CO3 (aq). 
[e]ee was determined by chiral GC 
after derivatisation with acetic anhydride. [f]After one pass through the catalyst  
 
 
Fig. 3.14 R3 processes of 39 with (S)-34 at different concentration of 39 and process 
time. (a) 0.2 M, 40 cycles (190 h); (b) 0.3 M, 1 equiv. of 58, 70 cycles (333 h) 
 
The R3 process of 39 was attempted at 0.3 M concentration at resolution 
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entry 2; Fig. 3.14(b)). The solvent was degassed and dried over molecular sieves 
to remove any water in the system and minimise the hydrolysis of the imine 
intermediate. Alcohol 58 (1 equiv.) was also added into the crystallisation which 
acted as a hydrogen donor to reduce any imine back to 39. The slurry in the 
CSTR was stirred for 1 hour before starting recirculation of the ML to allow the 
system to reach equilibrium. 
 
The higher concentration of 39 and lower resolution temperature led to an 
increased yield, compared to the first attempt. On the other hand, the initial de of 
the crystals was lower, indeed less than the batch reaction (Fig. 3.14(b)). Similar 
to the case at 0.2 M, the de of the crystals increased gradually during the process, 
from 20% to 43% over 70 cycles (333 h), i.e. higher than the batch resolution, 
with resolvability increased from 0.34 to 0.46 (Table 3.7, entry 6). About 9% of 51 
was still formed after 40 cycles, less than the first attempt (14%). Unlike 9 and 
103, the concentration of 39 remained relatively constant throughout both R3 
processes with de increasing over time. Overall the results are relatively poor, 
and a different resolving agent was tested (Section 3.4.2).  
 
The catalyst activity was again assessed by carrying out the racemisation of (S)-
103 in flow (Table 3.8). In both cases, ee of 103 dropped from 100% to an 
average of 77% after one pass through the catalyst, which was much higher than 
that of fresh catalyst (21%). This indicated a significant loss of activity of the 
catalysts and could be the result of the formation of methylamine and the carbon-
metalated complex as discussed in Section 2.2.1(a) which hindered the 
racemisation reaction. 
 
3.3.4 N-Isopropyl-α-methylbenzylamine 101 
N-Isopropyl-α-methylbenzylamine 101 is an analogue of 39 with the N-substituent 
being a more bulky isopropyl group. Racemic 101 was synthesised by reacting 
rac-42 with acetone to form an intermediate racemic imine 102, which was then 




Scheme 3.12 Synthesis of rac-101 
 
The diastereomeric resolution of rac-101 by (S)-34 was carried out in three 
different solvents and similar resolvability was observed with similar yields and 
de (Scheme 3.13, Table 3.9).  
 
 
Scheme 3.13 Diastereomeric resolution of rac-101 by (S)-34 
 
Entry Solvent Yield (%) De (%)[a] S 
1 iPrOAc 48 67 0.643 
2 tBuOAc 49 63 0.617 
3 EIB[b] 48 70 0.672 
Table 3.9 Solvent screen for diastereomeric crystallisation of rac-101 (0.1 M) with (S)-34 
(1 equiv.). [a]De were determined by 1H NMR (in CDCl3, 500 MHz). 
[b]Ethyl isobutyrate 
 
The yields from the resolutions of 101 by (S)-34 were nearly 50% with de.s of 60 
to 70%, leading to much higher resolvability of the system (> 0.6) compared to 
the resolutions of 39 by (S)-34 (> 0.3). The solubility of the diastereopure crystals 
of (R)/ (S)-39-(S)-34 and (R)/ (S)-101-(S)-34 were determined in isopropyl 
acetate and ethyl isobutyrate respectively and the solubility difference between 
(R)- and (S)-101-(S)-34 was much higher than that between (R)- and (S)-39-(S)-
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34 (See Section 6.3.3). In addition, no seeding was required for the 
diastereomeric resolution of 101 by (S)-34 as the crystals formed quickly. This 
result indicates that the nitrogen substituent has a significant impact upon packing 
within the crystal structure, and the rate of both nucleation and crystal growth. 
 
With the more bulky substituent at the nitrogen atom in 101, the racemisation by 
SCRAM 64/ 92 is much slower than that of 39, as shown by their racemisation 
half-life in the homogeneous batch systems and the tRes required in flow (Sections 
2.2.2 and 2.3.3). Therefore, in developing the R3 process of 101, the same low 
flow rate of 0.05 mL min-1 was used as that in the flow racemisation study. The 
tRes for the racemisation and the whole process were 80 minutes and 9.5 hours 
respectively with the use of Jasco pump (Scheme 3.14). The conditions and 
results for the R3 processes of 101 were summarised in Table 3.10. 
 
 
Scheme 3.14 R3 process of 101. tRes for the whole cycle = 28.5 mL/ 0.05 mL min
-1 = 570 












Entry 1 2 3 
Reaction 
conditions 
Solvent EIB[a] iPrOAc EIB[a] 
Equiv. of (S)-34 added at the start 0.9 0.9 0.98 
No. of cycles 11 20 30 
Process time (h) 105 190 285 
Results 
Initial crystal de (%)[b] 39 57 64 
Final crystal de (%)[b] 85 83 89 
Yield (%)[c] 56 58 62 
101 in ML (%)[d] 18 17 5 
51 in ML (%)[d] 9 13 15 
ML ee (%)[e] N.D.[f] 34 17 
S 0.95 0.96 1.1 
Activity of 92 Average ee of 103 (%)[g] 53 64 51 
Table 3.10 Experimental conditions attempted for the R3 process of 101. [a]Ethyl 
isobutyrate. [b]De was determined by 1H NMR (CDCl3, 500 MHz). 
[c]Crystals from each 
sample were included in the yield calculation. [d]Amount of 101 and 51 from ML was 
determined by GC after free-based with Na2CO3 (aq). 
[e]ee was determined by chiral GC 
after derivatisation with trifluoroacetic anhydride. [f]Not determined. [g]After one pass 
through the catalyst 
 
Resolvability of the R3 systems increased over the resolution-only processes, 
with improvement on both yield and de. Switching solvent between ethyl 
isobutyrate and isopropyl acetate, increasing the number of recirculation cycles 
and charging more (S)-34 at the start of the process did not result in significant 
improvement in the results. The third attempt of the R3 process of 101 was 
illustrated in Fig. 3.15 (Table 3.10, entry 3). Increasing the process time increased 
the amount of 51 formed in the reaction. The R3 processes of 101 were more 
successful than those of 39, mainly due to the larger solubility difference of 
diastereomers of 101, the higher rates of dissolution of the more soluble (S)-101-
(S)-34 and precipitation of (R)-101-(S)-34, which outweigh the slower 






Fig. 3.15 R3 process of 101 with 0.98 equiv. of (S)-34 added at the start of the process 
(Table 3.10, entry 3) 
 
3.3.5 α-Methylbenzylamine 42 
α-Methylbenzylamine 42 is a primary amine which has been used as a resolving 
agent for racemic chiral acids such as 34.153, 154 Therefore, the resolution of rac-
42 was tested with (S)-34 and a various solvent systems were screened (Scheme 
3.15, Table 3.11).  
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Entry [42] (M) Solvent De (%)[a] Yield (%) S 
1 0.28 EtOH 96 18 0.346 
2 0.14 iPrOH 92 37 0.681 
3 0.14 Toluene/ MeOH (10%) 94 31 0.583 
4 0.14 Toluene/ MeOH (5%) 86 41 0.705 
5 0.14 Toluene/ iPrOH (20%) 81 46 0.745 
6 0.14 Toluene/ iPrOH (10%) 13 85 0.221 
Table 3.11 Solvent screen for diastereomeric crystallisation of rac-42 with (S)-34 (1 
equiv.) at r.t. [a]De of crystals were determined as the ee of the free amine by chiral HPLC, 
after free-based with Na2CO3 (aq) and derivatised with benzoyl chloride in the presence 
of triethylamine 
 
The resolution was first attempted using ethanol which had been reported in the 
literature for studying the separability of the diastereomeric salts formed between 
acid 34 and amine 42 (Table 3.11, entry 1).153 A high de of 96% was achieved 
but the yield was only 18% even at a higher concentration compared to the use 
of other solvents. With the use of isopropyl alcohol at a lower concentration, the 
resolvability of the system was better compared to that using ethanol due to 
higher yield with minimal drop in de (Table 3.11, entry 2). Since the use of polar 
solvents such as pure alcohols can inhibit racemisation by SCRAM 64, solvent 
systems with lower polarity such as toluene/ alcohol mixtures were used (Table 
3.11, entries 3 to 5). Resolution using methanol as co-solvent led to higher de but 
lower yield than using isopropyl alcohol (Table 3.11, entries 3 and 4). Reducing 
the amount of isopropyl alcohol from 20 to 10% resulted in a significant drop in 
the resolvability of 42 by (S)-34. 
 
The R3 process of 42 was developed using the Knauer PS4.1 pump and a flow 
rate of 0.25 mL min-1 was employed. The tRes of racemisation and the whole 
process were 16 and 100 minutes respectively (Scheme 3.16). In both R3 





Scheme 3.16 R3 process of 42. The tRes for the whole cycle = 25 mL/ 0.25 mL min
-1 = 
100 min (1.7 h) 
 









Initial crystal de (%)[a] 87 79 
Final crystal de (%)[a] 83 93 
Yield (%)[b] 42 29 
42 in ML (%)[c] 14 12 
Dimers in ML (%)[c] 29 28 
101 in ML (%)[c] N.A. 22 
ML ee (%)[a] 45 4 
S 0.7 0.54 
Table 3.12 Experimental conditions attempted for the R3 process of 42. (S)-34 (0.8 equiv.) 
was added at the start of the process. No. of cycles = 6. Total process time = 600 min 
(10 h). [a]De of crystals and ee of ML were determined as the ee of the free amine by 
chiral HPLC after free-based with Na2CO3 (aq) and derivatisation with benzoyl chloride 
in the presence of triethylamine. [b]Crystals from each sample were included in the 
calculation of yield. [c]Amount of 42, dimers and amine 101 were determined by GC after 
free-based the samples 
 
As discussed in Section 2.2.3, the major problem of the racemisation of primary 
amines such as 42 is the formation of various dimer impurities (Scheme 1.23). In 
the R3 process, it was hoped that the low concentration of 42 in the ML after 
crystallisation could reduce the formation of dimers. However, significant dimer 
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formation was still observed (Table 3.12). Using methanol as co-solvent did not 
result in any improvement in either yield or de compare to the resolution-only 
process (Table 3.12, entry 1; Fig. 3.16). 
 
 
Fig. 3.16 R3 process of 42 with 0.8 equiv. of (S)-34 added at the start of the process 
(Table 3.12, entry 1) 
 
Although isopropyl alcohol can act as a hydrogen donor which may reduce dimer 
formation, it can also react with 42 to form amine 101 via borrowing hydrogen 
mechanism (Scheme 3.17),32 further lowering the yield and the overall 
resolvability, though the de of the product was found to increase over the batch 
resolution-only process (Table 3.12, entry 2).  
 
Scheme 3.17 Formation of 101 from 42 in the presence of 92 (and 64) 
 
The R3 processes of 42 were less successful compared to other substrates 
mainly due to significant by-product formation during racemisation. Alternative 
(immobilised) catalysts that can mitigate the problem are needed to develop an 
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3.4 Diacid as a resolving agent for diastereomeric 
transformation of chiral amines 
3.4.1 Resolution of N-Methyl-α-methylbenzylamine 39 with di-p-toluoyl-D-
tartaric acid 32 in batch 
Resolution of N-Methyl-α-methylbenzylamine 39 using (S)-34 was discussed in 
Section 3.3.3. The resolvability achieved in batch resolution was only 0.36 in 
isopropyl acetate and could only be improved slightly to 0.46 by applying the R3 
process (Table 3.8, entry 2). Therefore, an alternative chiral acid, (S,S)-32 was 
used as the resolving acid (Scheme 3.18).  
 
Scheme 3.18 Diastereomeric resolution of 39 with (S,S)-32 
 
Entry Alcohol (%)[a] [39] (M) (S,S)-32 (Equiv.) Yield (%) de (%)[b] S 
1 MeOH (20) 0.14 0.5 27 84 0.43 
2 MeOH (15) 0.14 0.5 79 3 0.10 
3 MeOH (10) 0.14 0.5 79 4 0.13 
4 MeOH (20) 0.07 0.5 21 88 0.37 
5 MeOH (20) 0.21 0.5 73 5 0.07 
6 MeOH (20) 0.14 0.25 19 90 0.34 
7 MeOH (20) 0.14 0.125 8 91 0.15 
8 MeOH (20) 0.21 0.25 22 86 0.38 
9 iPrOH (20) 0.21 0.25 36 54 0.39 
10 iPrOH (20) 0.21 0.5 84 1.6 0.03 
Table 3.13 Condition screen of diastereomeric resolution of rac-39 with (S,S)-32 at r.t. 
[a]Volume ratio. [b]De was determined as the ee of the free amine by chiral GC after 




Screening of conditions was initially performed at room temperature by varying 
the solvent system, concentration of amine 39 and the equivalence of acid (S,S)-
32 (Table 3.13). With 0.5 equiv. of 32, neutral diastereomeric salts containing two 
amines and one acid are formed, as determined by 1H NMR spectroscopy. The 
use of 20% v/v methanol solution gave a much better de than either 10% or 15% 
concentrations of methanol, leading to higher resolvability (Table 3.13, entry 1). 
It is surprising that such a small change of in the concentration of methanol has 
a drastic effect on the resolvability (Table 3.13, entries 2 and 3). An increase in 
de but lower yield was observed when a lower concentration of 39 was used; 
whilst increasing the concentration of 39 reduced the resolvability of the system 
significantly (Table 3.13, entries 4 and 5). A higher de was also achieved with 
less resolving acid (Table 3.13, entries 6 to 8). Using 20% (v/v) methanol at 0.21 
M and halving 32 to 0.25 equiv. greatly increased the de of the product and 
significantly improved the system resolvability (Table 3.13, entries 5 and 8). A 
similar trend was observed when 20% (v/v) isopropyl alcohol was used, in which 
the resolvability dropped drastically when 32 was increased from 0.25 to 0.5 equiv. 
(Table 3.13, entries 9 and 10). The use of isopropyl alcohol led to higher yield but 
lower de compared to the resolution using methanol as co-solvent, with similar 
overall resolvability (Table 3.13, entries 5, 8 to 10).  As with the concentration of 
methanol and isopropyl alcohol, the system is also remarkably sensitive to the 
acid: amine stoichiometry. This will be investigated in the following study. 
 
Before developing the R3 process of 39 with (S,S)-32, one-pot recycle reactions 
were carried out by stirring rac-39 and (S,S)-32 with soluble SCRAM 64 and 
Shvo’s catalyst 55 in ethyl acetate with 20% (v/v) methanol (Fig. 3.17). The 
reactions were performed at room temperature with supersaturation, ensuring a 
slurry of the crystals remained in solution. Racemisations are usually carried out 
at elevated temperatures, so at ambient temperature the diastereomeric 
transformation was very slow. Under these conditions, the optical excesses and 
concentration of 39 remained constant for about 25 hours. De of the crystals was 
about 75% whilst ee of the ML was 40%. However after 30 hours a sudden fall in 
the crystal de to < 5% was observed, which is much lower than that of the batch 
resolution process (Table 3.13, entry 1). The concentration of 39 in solution 




Fig. 3.17 One-pot recycle reactions of 39 with (S,S)-32 in the presence of homogeneous 
racemisation catalysts at room temperature in EtOAc/ MeOH (20% v/v). (a) SCRAM 64; 
(b) Shvo’s catalyst 55 
 
To investigate any effect of the catalysts in the resolution of 39 with (S,S)-32, a 
simple batch crystallisation reaction was carried out without them at 25 °C with 
controlled temperature and stirring (Fig. 3.18). After initially forming crystals of 
about 80% de, after about 5 hours, the de fell rapidly, as did the solution 
concentration of the amine and the ML ee. The drop in de is not a result of the 
racemisation catalysts.  
 
 
Fig. 3.18 Diastereomeric resolution of rac-39 with (S,S)-32 at 25 °C, 400 rpm stirring, 
with no racemisation catalysts 
 
The low de crystals, obtained at 25 °C, were analysed by differential scanning 
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compared with those of the pure diastereomers and a 1:1 mixture of the pure 
diastereomers (Fig. 3.19). The peaks on the DSC graph correspond to the melting 
points of each species (Fig. 3.19(a)). The different melting temperatures 
observed for the low de crystals and the 1:1 mixture of diastereomers indicated 
that they are different entities. TGA showed a drop in mass of all species at about 
130 to 150 °C (Fig. 3.19(b)). It was likely to be thermal decomposition instead of 
solvent loss from the crystals due to the relatively high temperatures at which the 
drop of mass occurred.  
 
 
Fig. 3.19 Thermal analysis of [(R)-39]2-(S,S)-32, [(S)-39]2-(S,S)-32, 1:1 mixture of [(S)-
39]2-(S,S)-32 and [(R)-39]2-(S,S)-32 (1:1 mix) and crystals with low de from 
diastereomeric resolution of 39 with (S,S)-32 at 25 °C by (a) DSC; (b) TGA. The 
measurements were carried out by T. Howell from School of Chemical and Process 
Engineering, University of Leeds 
 
Since the fall in crystal diastereopurity was not a result of the formation of a 
mixture of pure diastereomers (e.g. by tartrate racemisation/ epimerisation), it 
indicated a switch in crystal form. The formation of solvate was ruled-out from the 
TGA. So it was suspected that an exchange of amine enantiomers was occurring 
to go from [(S)-39]2-(S,S)-32 and [(R)-39]2-(S,S)-32 (with the former in excess), 
to a ‘racemic’ diamine salt which contains both (R)-39 and (S)-39, i.e. (S)-39-
(S,S)-32-(R)-39 (Fig. 3.20). The working hypothesis is that the diastereopure 
diamine salts are kinetic products which are formed first, whilst the racemic 
diamine salt is initially formed below its critical concentration, and remains in 





































solution and solid phases and cause the concentration of (S)-39-(S,S)-32-(R)-39 
to increase and eventually reach its critical concentration, where crystallisation of 
the more thermodynamically favoured ‘racemic’ diamine salt occurs.  
 
Fig. 3.20 Structures of diastereopure di-toluoyl-D-tartrate salts of 39 and racemic diamine 
salt containing both (R)-39 and (S)-39 
 
The hypothesis was further verified with X-ray analysis of the crystals. Powder X-
ray diffraction (XRD) data were collected for [(S)-39]2-(S,S)-32, [(R)-39]2-(S,S)-
32, 1:1 mixture of [(S)-39]2-(S,S)-32 and [(R)-39]2-(S,S)-32 and the low-de 
crystals obtained from the batch resolution at 25 °C (Fig. 3.21(a) to (d)). The XRD 
spectrum of the low-de crystals was different from that of the diastereopure salts, 
and their 1:1 mixture, indicating they were different species. Initially, the small 
size of the low-de crystals precluded diffraction, but with the help of the National 
Crystallography Service (NCS) from University of Southampton, a single crystal 
X-ray structure was obtained which showed a racemic 2:1 salt of 39 and (S,S)-
32 containing one (R)-39 and one (S)-39 (Fig. 3.22(a)). The powder XRD data 
predicted from the single crystal X-ray structure resembles that collected from the 
actual crystals (Fig. 3.21(e)). The single crystal X-ray structures of the 





Fig. 3.21 Powder XRD data of (a) [(S)-39]2-(S,S)-32; (b) [(R)-39]2-(S,S)-32; (c) 1:1 
mixture of [(S)-39]2-(S,S)-32 and [(R)-39]2-(S,S)-32; (d) Low-de crystals from 
diastereomeric resolution of 39 with (S,S)-32; (e) XRD data predicted from the single 





Fig. 3.22 Single crystal structures of (a) low-de crystals obtained from diastereomeric 
resolution of 39 with (S,S)-32 showing a stoichiometric ratio of 2:1 of 39/ 32 and the 
opposite stereochemistry of the two molecular ions of 39; (b) Diastereopure [(S)-39]2-
(S,S)-32; (c) Diastereopure [(R)-39]2-(S,S)-32. The hydrogen atoms were omitted for 
clarity. All atoms are displaced as ellipsoid, which are depicted at 50% probability. The 
chiral carbon, nitrogen and oxygen atoms are numbered. The nitrogen and oxygen atoms 
are highlighted (blue and red respectively)  
 
The crystals obtained from the diastereomeric resolution of rac-39 with (S,S)-32 
in ethyl acetate/ methanol mixtures were analysed by XRD to further investigate 
the effect of the amount of methanol in the resolvability of the system (Table 3.13, 
entries 1 to 3; Fig. 3.23). With 20% (by volume) methanol where the de of the 
crystals is relatively high (Table 3.13, entry 1), its X-ray diffraction pattern shows 
a mixture of pure diastereomers with [(S)-39]2-(S,S)-32 in excess (Fig. 3.23(a)). 
Resolution with both 10 and 15% (by volume) methanol resulted in low de crystals 
(Table 3.13, entries 2 and 3). However their XRD patterns are different. The 
crystals obtained from 10% methanol correspond to a mixture of [(S)-39]2-(S,S)-
32 and [(R)-39]2-(S,S)-32 (Fig. 3.23(c)); whilst those obtained from 15% methanol 
correspond to (S)-39-(S,S)-32-(R)-39 (Fig. 3.23(b)). This explains the drastic drop 





both pure diastereomers have very low solubility in the solvent system. After they 
are formed at the beginning of the resolution, their dissolution and hence the 
exchange of (S)- and (R)-39 between the solid and solution phases is so slow 
that the concentration of (S)-39-(S,S)-32-(R)-39 remains low and not able to 
nucleate. Therefore the crystals of (S)-39-(S,S)-32-(R)-39 was not observed. 
 
 
Fig. 3.23 XRD data of the crystals from diastereomeric resolution of 39 with (S,S)-32 in 
ethyl acetate/ methanol mixture. (a) 20% MeOH; (b) 15% MeOH; (c) 10% MeOH. All 
percentages are by volume 
 
The switching of crystal forms was further investigated under different 
experimental conditions (Fig. 3.24). It was found that the rate of switching 
depends on temperature, concentration of 39 and 32, stirring speed and the types 
of seed crystals present. The switching of crystal form occurred later in the 
process at lower temperatures since (S)-39-(S,S)-32-(R)-39 is the 
thermodynamic product which requires more energy to form (Fig. 3.24(a)). At 
lower concentrations of 39 and 32, the concentration of (S)-39-(S,S)-32-(R)-39 
formed is likely to be below its critical concentration, which avoids it from growing 
and precipitating out from solution (Fig. 3.24(b) and (c)). When the system was 
stirred at a higher speed, the switching occurred faster. The crystals were broken 
down into smaller sizes more quickly, facilitating their dissolution and the 
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exchange between (R)- and (S)-39 in the solid/ solution phases and speeds up 
the formation of (S)-39-(S,S)-32-(R)-39. Switching of crystal form was still 
observed without stirring but at a lower rate (Fig. 3.24(d)). Seeding the resolution 
with pure [(S)-39]2-(S,S)-32 had no observable impact on the crystal switching. 
However when the system was seeded with (S)-39-(S,S)-32-(R)-39, the switching 
occurred much faster. The seed provided the nuclei for (S)-39-(S,S)-32-(R)-39 to 
grow, which was indicated by the lower de of the crystals at the start compared 
to the systems without seeding (Fig. 3.24(e)). 
 
 













































































































































Seeding with pure [(S)-1]2-(S,S)-2
Seeding with (S)-39-(S,S)-32-(R)-39
(a) Temperature (b) Equivalence of (S,S)-32




The changes in the salt form observed here have not been previously reported, 
but appear to be the opposite to that seen by Viedma in spontaneous 
deracemisation of conglomerate crystals. In the Viedma ripening process, the 
system is initially at a thermodynamic minimum, but under racemising conditions 
and mechanically-induced attrition. The grinding causes the system to be 
kinetically controlled, with small crystals trying to grow in the supersaturated, 
racemising system but being continuously broken down. As described by Gibbs-
Thompson rule, the small crystals exert a higher supersaturation causing growth 
to larger ones, eventually leading to the evolution of a single enantiomer.7, 107, 108, 
155, 156 
 
3.4.2 R3 process of N-Methyl-α-methylbenzylamine 39 with di-p-toluoyl-D-
tartaric acid 32 
Enantiomerically pure diacids are common resolving agents for racemic chiral 
amines.73 However if the possibility of them forming the racemic neutral diamine 
salts is general, it might pose a limitation on the R3 process. The formation of (S)-
39-(S,S)-32-(R)-39 or the switching from the diastereopure salts is dependent on 
temperature, stirring, concentration of 39 and the amount of 32 added. It is 
necessary to take these factors into consideration in developing the R3 process 
of 39, using 32 as the resolving acid (Scheme 3.19). The conditions employed 
and the results are summarised in Table 3.14. 
 
Scheme 3.19 R3 process of 39 with (S,S)-32. tRes for the whole cycle = 28.5 mL/ 0.1 mL 






Entry 1 2 3 4 
Reaction 
conditions 
[39] (M) 0.14 0.21 0.21 0.21 
Alcohol[a] MeOH MeOH MeOH iPrOH 
Ir loading (mol%) 5 4 4 4 
Crystallisation T (°C) 0 5 12 12 
Racemisation T (°C) 65 65 65 70 
Acid addition rate during 
recirculation (mg min-1) 
0[b] 0[b] 0.1 0.1 
No. of cycles 41 10 25 35 
Process time (h) 195 48 119 166 
Results 
Initial crystal de (%)[c] 68 64 42 63 
Final crystal de (%)[c] 91 20 50 86 
Yield (%)[d] 20 58 35 78 
39 in ML (%) 59 28 41 5 
51 in ML (%) 15 3 4.4 0.4 
94 in ML (%) 0 3 12 0 
ML ee (%) 4 14 19 20 
S 0.36 0.23 0.35 1.34 
Activtiy of 92 Average ee of (S)-103 (%)[e] 58 36 N.D.[f] 23 
Table 3.14 Experimental conditions attempted for the R3 process of 39 with (S,S)-32. 
[a]All solvent system contained ethyl acetate/ alcohol (20% v/v). [b]0.49 equiv. of (S,S)-32 
was added at the start of the process without further addition during the ML recirculation. 
[c]de of crystals were determined as the ee of the free amine by chiral GC, after free-
based with Na2CO3 (aq) and derivatised with trifluoroacetic anhydride. 
[d]Crystals from 
each sample were included in the calculation of yield. [e]After one pass through the 
catalyst. [f]Activity was not determined 
 
To delay the switching of crystal form during the R3 process, the crystallisation 
was first carried out at 0 °C (Table 3.14, entry 1). Despite the negative impact of 
stirring on the resolvability, it is still necessary, since it facilitates dissolution of 
the more soluble diastereomer ([(R)-39]2-(S,S)-32) which allows more (R)-39 to 
racemise by 92. The de of the crystals remained high throughout the whole 
process (Fig. 3.25(a)), however the yield was low (20%). This was partly because 
of the formation of side product acetophenone 51 from hydrolysis of the 
intermediate imine 94. Furthermore, crystallisation of the less soluble [(S)-39]2-
(S,S)-32 might be slow at the operating concentration. To overcome this, the 
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concentration of 39 was increased to 0.21 M. Degassed and dried solvents were 
used and the temperature of crystallisation was also increased to 5 °C to reduce 
the amount of water condensation in the system and minimise the formation of 
51. Although it was previously shown that a high concentration of 39 is 
undesirable in the resolution by 32, with the aid of the racemisation process, the 
amount of (R)-39 in solution may decrease to a level where the formation of (S)-
39-(S,S)-32-(R)-39 can be suppressed. However it was observed that the de of 
the crystals dropped to 20% after 5 cycles (Table 3.14, entry 2; Fig. 3.25(b)), 
which indicated that the racemisation was not fast enough to remove the excess 
(R)-39 in the ML. 
 
One strategy to limit the formation of (S)-39-(S,S)-32-(R)-39 is to lower the 
concentration of 32 in the system. An initial quantity of 0.25 equiv. of (S,S)-32 
was added, and recirculation continued for 5 cycles. Then an additional 0.25 
equiv. of 32 was pumped slowly into the crystalliser at 0.1 mg min-1 (as a solution). 
The de of the crystals was maintained at > 80% for 10 cycles after which it started 
to drop to 50% after 25 cycles (Table 3.14, entry 3; Fig. 3.25(c)). This result 
indicated that with slow addition of 32, (S)-39-(S,S)-32-(R)-39 is kept below its 
critical concentration by giving time for (R)-39 to racemise and lowering its 
concentration. Although the switching behaviour was still observed, the final de 
of the crystals was higher than that when 0.49 equiv. of 32 was added in one 
portion (Table 3.14, entry 2), leading to a higher resolvability.  
 
Whilst the formation of acetophenone 51 was minimised using dried solvents, its 
precursor, imine 94, was found to accumulate in the system instead (Table 3.14, 
entry 3). It could be reduced in-situ back to 39 using isopropyl alcohol as a 
hydrogen donor which can also be used as co-solvent (Table 3.14, entry 4). As 
described above, 0.25 equiv. of (S,S)-32 was added and stirred for one hour to 
reach equilibrium before recirculation of the ML started. After two cycles, the de 
of the crystals increased from 63% to 79%, while the amount of 39 decreased 
from 52 to 41% and the ee of the ML from 60% to 40% (Fig. 3.25(d)). Both the de 
and the yield of crystals (based on the concentration of 39 in the ML) were 
significantly higher than the batch resolution process (Table 3.13, entry 9). The 
ML were recirculated for 7 cycles (33 hours) and an additional 0.25 equiv. of 
(S,S)-32 was pumped into the resolution mixture slowly. The amount of 39 
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dropped gradually, while the de of the crystals stayed at about 84%. The ee of 
the ML started increasing when (S,S)-32 was added, since more [(S)-39]2-(S,S)-
32 crystallised out from solution and the crystallisation was faster than ML 
racemisation. However it slowly decreased after complete addition of 32, as the 
racemisation was now faster than that of the precipitation of [(S)-39]2-(S,S)-32. 
The de of the crystals did not increase above 86% despite further stirring of the 
system. An overall yield of 78% was achieved, with a resolvability of 1.34 which 
was 45 times higher than the batch resolution process (S = 0.03).  
 
 
Fig. 3.25 The R3 processes of 39 with (S,S)-32 under the conditions described in Table 
3.14. (a) Entry 1; (b) Entry 2; (c) Entry 3; (d) Entry 4 
 
Acetophenone 51 was not observed in the process while only a small amount of 
imine 94 (0.4%) was formed after 35 cycles (166 hours), showing that isopropyl 
alcohol could efficiently prevent its accumulation. Preventing the formation of 51 
had the benefit of stopping the formation of methylamine, avoiding catalyst 
deactivation. The catalyst activity was checked by the racemisation of (S)-103 in 
flow and an average of 23% ee was achieved after one pass through the catalyst 
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The high de and yield achieved indicated that (S)-39-(S,S)-32-(R)-39 was not 
formed. In comparison with the previous R3 process of 39 with 32 (Table 3.14, 
entry 3), one of the main differences was the use of isopropyl alcohol instead of 
methanol as the co-solvent. In using isopropyl alcohol, ee of the ML, which was 
enriched with (R)-39, was higher before recirculation than that when methanol 
was used, which facilitated its racemisation. In addition, isopropyl alcohol had 
less negative impact on the racemisation of 39 as shown in Section 2.2.1(d), and 
it allowed a higher racemisation temperature to be used which can increase the 
racemisation rate further. Therefore (R)-39 was converted to (S)-39 more quickly 
and the concentration of (R)-39 in the system remained low enough throughout 
the process. The slow addition of (S,S)-32 further reduce the concentration of 
(S)-39-(S,S)-32-(R)-39 formed in solution, avoiding its nucleation. Also the 
absolute solubility of [(S)-39]2-(S,S)-32 was lower in ethyl acetate/ isopropyl 
alcohol than that in ethyl acetate/ methanol which speeded up the rate of 
precipitation of [(S)-39]2-(S,S)-32. The significant reduction of impurity formation 
also led to improved yield of the process. 
 
3.4.3 N,N-Dimethyl-α-methylbenzylamine 46 
Unlike amine 39, N,N-dimethyl-α-methylbenzylamine 46 forms an acidic salt with 
(S,S)-32, where the ratio of 46:32 is 1:1 when 0.5 or 1 equiv. of (S,S)-32 was 
added (Scheme 3.20). This was also shown by the 1H NMR spectra (Section 
6.1.16) and the single crystal structures of the diastereopure salts prepared 
(Section 8.5). A solvent screen was carried out using isopropyl acetate as the 
main solvent with the addition of either ethanol or isopropyl alcohol as the co-
solvent (Table 3.15).  
 




Entry Alcohol (% by volume) [46]/ M Yield (%) De (%)[a] S 
  1[b] - 0.3 34 52 0.360 
2 - 0.14 83 2 0.034 
3 iPrOH (10%) 0.14 79 6 0.092 
4 iPrOH (30%) 0.14 65 19 0.248 
5 EtOH (10%) 0.14 78 7 0.109 
6 EtOH (20%) 0.14 53 38 0.399 
7 EtOH (30%) 0.14 42 59 0.494 
8 EtOH (30%) 0.21 50 45 0.452 
Table 3.15 Condition screen of diastereomeric resolution of rac-46 with (S,S)-32 (1 
equiv.). [a]De was determined as the ee of the free amine by 1H NMR (CDCl3, 500 MHz) 
after derivatisation with (S)-34. [b]0.5 equiv. of (S,S)-32 was added and stirred for 24 h 
 
Using 0.5 equiv. of (S,S)-32, a much higher resolvability was achieved at 0.3 M 
of 46 compared to 0.14 M with 1 equiv. of (S,S)-32 (Table 3.15, entries 1 and 2). 
The resolvability of the system was improved with ethanol or isopropyl alcohol as 
co-solvent (Table 3.15, entries 3 to 8). Higher percentage of alcohol gave a higher 
de of the product, although the yield was lower. Isopropyl acetate/ ethanol 30% 
(by volume) gave the best resolvability, and increasing the concentration of 46 to 
0.21 M reduced the resolvability slightly (Table 3.15, entries 7 and 8). 
 
An R3 process of 46 was developed as shown in Scheme 3.21. Since the 
racemisation of 46 in flow was found to be very slow (Section 2.3.3), a long tRes 
of two hours and 14.3 hours were employed for the racemisation and the whole 
process respectively.  
 
Scheme 3.21 R3 process of 46. tRes for the whole cycle = 28.5 mL/ 0.0333 mL min
-1 = 
856 min (14.3 h) 
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Ir loading (mol%) 5 6 
No. of cycles 17 15 
Process time (h) 242 215 
Results 
De of crystals (%)[a] 77 - 
Yield of crystals (%)[b] 17 - 
46 in ML (%) 86 98 
51 in ML (%) 1.3 4 
ML ee (%) 16 N.D.[c] 
S 0.262 0 
Activity of 92 Average ee of (S)-103 (%) 47 36 
Table 3.16 Conditions attempted and results of the R3 process of 46. (S,S)-32 (0.9 equiv.) 
was added at the start of the process. [a]De was determined by 1H NMR (CDCl3, 500 
MHz) after free-based with Na2CO3 (aq) and derivatised by (S)-34. 
[b]Crystals from each 
sample were included in the yield calculation. [c]Not determined 
 
 
Fig. 3.26 The R3 processes of 46 with (S,S)-32 under the conditions described in Table 
3.16, entry 1 
 
Since 46 and 32 formed a 1:1 acid salt, 0.9 equiv. of (S,S)-32 was added at the 
beginning of the process. When the recirculation proceeded, a gradual increase 
in de of the solid was observed. Surprisingly, the amount of 46 in the ML 
increased slowly, indicating dissolution of the amine salt crystals. The ML ee 
dropped, indicating that racemisation is occurring (Fig. 3.26). One explanation of 
this behaviour is that crystallisation of the less soluble (S)-46-(S,S)-32 is 
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32. To test this hypothesis, a different solvent was used, with 30% (by volume) 
isopropyl alcohol in isopropyl acetate, in which the solubility of both (R)-46-(S,S)-
32 and (S)-46-(S,S)-32 are lower, however no improvement in either de or yield 
were observed, instead all of the crystals dissolved after 15 cycles of recirculation 
(Table 3.16, entry 2). There are three possible explanations for this observation. 
First, epimerisation of (S,S)-32 might have occurred, forming (S)-46-(S,R)-32 and 
(R)-46-(S,R)-32 which are very soluble, leading to complete dissolution. This 
needs to be further verified by attempting the racemisation/ epimerisation 
reaction of (S,S)-32 and a non-ammonium salt of (S,S)-32 using catalyst 92 at 
elevated temperature with analysis using chiral HPLC, 1H NMR and/ or [α]D 
measurements. Second, the thermodynamic minimum of this system may be 
controlled by the entropy of the amine salt in solution rather than the enthalpy of 
the solid, the solution phase of both diastereomers may be the most 
thermodynamically stable phase which leads to complete dissolution of the solid. 
A control experiment will be required in which the R3 process is repeated without 
the racemisation of ML by 92. Complete dissolution of solid will still be observed 
if it is caused by the thermodynamics of the system. Lastly, since iminium ion 127 
was formed as the intermediate during racemisation of 46 and it can also 
tautomerise into the corresponding enamine 128. Both of them can act as 
nucleation inhibitors which inhibit the crystallisation of both (S)-46-(S,S)-32 and 
(R)-46-(S,S)-32. Samples of 127 and 128 can be prepared and added into the 
crystallisation mixture at the start and/ or during the crystallisation to examine any 




3.5 Conclusion and future work 
Resolution-racemisation-recycle (R3) processes have been successfully 
developed for several secondary amines that couple diastereomeric resolution in 
a CSTR and continuously recirculating the ML across a fixed-bed racemisation 
catalyst. The resolution and racemisation are separate but linked with tubing and 
a pump to allow each reaction to be carried out at their optimal condition. By 
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applying the R3 process, screening of the optimised resolution conditions, such 
as chiral acid and solvent, the equivalence and the concentration of amine, could 
be avoided as long as the solubility of the diastereomeric salts are different and 
are low enough to form a solid. The difference in solubility between the 
diastereomeric salts creates an enantiomeric excess of the amine in the ML, 
which upon racemisation, replenishes the enantiomer of the amine which forms 
the less soluble diastereomeric salt. Theoretically, a complete transformation to 
a single diastereomer will occur. Six different chiral amine substrates, which 
include primary, secondary (cyclic and acyclic) and tertiary amines were tested 
with the R3 system. A summary of the results comparing both the yields and de 
in the R3 and batch resolution processes under similar conditions are shown in 
Fig. 3.27.  
 
 
Fig. 3.27 Comparison of selected R3 and batch resolution-only processes under similar 
conditions. (a) de; (b) Yield; (c) Resolvability; (d) Conditions of selected R3 and batch 
resolution-only processes. [a]Alcohol 58 (1 equiv.) was added in the crystallisation mixture. 
[b]Ethyl isobutyrate 
 
For all of the substrates tested, higher de was achieved when using the R3 
process, except for amine 42 which was slightly lower. The most dramatic 
increase in de was observed for systems S1 and S6 which led to a significant 
improvement in their resolvability by 13 and 45 times for amines 9 and 39 

















































System Substrate [Substrate] (M) Acid Solvent
S1 9 0.14 (S)-34 EtOAc/ iPrOH (12.5% by volume)
S2 103 0.35 (S)-34 iPrOAc
S3[a] 39 0.3 (S)-34 iPrOAc
S4 101 0.1 (S)-34 EIB[b]
S5 42 0.14 (S)-34 Toluene/ MeOH (5% by volume)
S6 39 0.21 (S,S)-32 EtOAc/ iPrOH (20% by volume)
S7 46 0.14 (S,S)-32 iPrOAc/ EtOH (30% by volume)
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in the batch resolution processes, that of S4 showed considerable improvement, 
whilst that in S7 showed a decline in yield.  
 
The efficiency and success of the R3 process depends strongly on the rate of 
racemisation, the solubility difference between the diastereomeric salts formed, 
and their solubility in the selected solvent, the rate of dissolution of the more 
soluble diastereomeric salt, and the rate of crystallisation of the less soluble one. 
The rate of racemisation by 92 is limited to the maximum temperature (≤ 80 °C) 
that can be applied without causing iridium leaching from the catalyst, or 
breakdown of the polymer support. The maximum yield depends on the solubility 
of the diastereomeric salts in the solvents used. Increasing the concentration of 
the system can lead to higher yield. Continuous dissolution and precipitation of 
the diastereomers and racemisation of the ML causes the de to increase 
gradually over the course of the process. Formation of by-products such as amine 
dimers from 42 and ketone 51 from the dehydrogenated precursor also resulted 
in low yield of their R3 processes. Suppression of these by-products is important 
as methylamine and ammonia formed during racemisation of 39 and 42 
respectively can deactivate the catalyst.  
 
The use of diacid (S,S)-32 was studied in the resolution of 39 and 46, which forms 
neutral and acid salts respectively. In the resolution of 39 with (S,S)-32, the 
crystal form switched from pure diastereomeric salts to less soluble racemic (R)-
39-(S,S)-32-(S)-39 crystal form upon prolonged stirring. This greatly affects the 
resolvability of the system. The speed at which the switching occurred was 
increased by seeding with the racemic salt, stirring and increased concentration 
of the system. In spite of the formation of (R)-39-(S,S)-32-(S)-39, amine 39 was 
successfully resolved by slow addition of the acid and fast racemisation. These 
conditions were critical in minimising the concentration of acid and one of the 
enantiomers of the amine in the system ((R)-39 in this case), to avoid nucleation 
and precipitation of the racemic salt. 
 
Diastereomeric crystallisation of rac-9 with (S)-34 was carried out in flow using a 
cascade CSTR system (the Freactors) which were built in-house. Although the 
system has slightly lower resolvability compared to that of batch due to shorter 
crystallisation time in flow (tRes = 2 to 40 min), being able to carry out continuous 
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crystallisation is beneficial since the reaction can reach steady state and produce 
crystals with more consistent quality. Projects regarding self-optimisation of 
reactions in flow have been ongoing in the group, in which the flow reactors can 
incorporate online analysis with a feedback control loop which uses self-
optimising algorithm to keep generating new reaction conditions until an optimum 
is reached.125 By connecting the Freactors to the self-optimisation system, 
variables such as yield and de of the crystals can be optimised by changing 
parameters such as flow rate of each of the amine and acid solution with online 
(chiral) HPLC analysis.  
 
The work discussed has only covered relatively simple amine substrates 
containing one chiral centre. In other work in the group, other substrates such as 
diastereomeric amines, are being tested. The R3 methodology may also be 
applied in the asymmetric transformation of chiral carboxylic acids using 
enantiomerically pure amines as the resolving agents; chiral alcohols which 
possess an adjacent chiral (or achiral) amino or carboxylic group that can be 
resolved by a chiral acid or amine respectively are also potential substrates. 
However, suitable racemisation catalysts need to be identified that show higher 
activity towards carboxylic acids and/ or alcohols. 
 
The rate of racemisation and by-product formation during racemisation can pose 
a limit in developing an efficient R3 process. Alternative catalysts to SCRAM 64 
and 92 are needed that are more active and stable at higher temperature. Shvo’s 
catalyst 55 was found to racemise 42 in the presence of alcohol 58 with minimal 
formation of dimers, which cannot be achieved with 64 under similar conditions. 
Immobilisation of 55 onto a solid support may allow it to be applied in flow and 
overcome the problem of low yield in the R3 process of 42 and other primary 
amines. It would be useful to carry out a larger scale R3 process to demonstrate 
its scalability and its potential in industrial application. However the cost of the 





4. Alternative racemisation catalysts for chiral amines 
4.1 Introduction 
SCRAM catalysts 64 and 92 are iridium-based catalysts used for the racemisation 
of chiral amines.1, 2, 43, 78, 135, 157 Other known racemisation catalysts for chiral 
amines include ruthenium, rhodium and palladium-based complexes.158 Their 
limited availability, high prices and significant toxicity have driven the search for 
cheaper and more environmentally benign alternatives.158-161 First row transition 
metals such as iron, cobalt, nickel and copper are cheap, abundant and relatively 
non-toxic. Catalytic systems have been developed based on copper and iron 
complexes/ salts in combination with appropriate ligands, bases and various 
reducing agents in the asymmetric hydrogenation and transfer hydrogenation 
reactions of ketones.159, 160, 162 Copper(I) hydride complexes, such as Stryker’s 
reagent ([(PPh3)CuH]6), has been used to catalyse the reduction of electrophilic 
double bonds, including α,β-unsaturated compounds in the presence of 
stoichiometric amount of reducing agents such as silanes and hydrogen gas. The 
reactions were highly regioselective depending on the reaction conditions.160, 163-
165 Beller et al. reported the asymmetric hydrogenation of acetophenone 51 using 
copper(II) acetate with monodentate binaphthophosphepine ligands such as 129 
in the presence of potassium tert-butoxide at 50 bar of hydrogen gas to give 99% 
of the alcohol product (R)-83 with 72% ee (Scheme 4.1).160 The same ketone 
substrate was shown to be reduced by an iron carbonyl cluster 
[Et3NH][HFe3(CO)11] with 130 and potassium hydroxide. However, a lower 
conversion of 92% with 56% ee were achieved.  
 
 
Scheme 4.1 Asymmetric hydrogenation of acetophenone 51 by copper(II) acetate with 





Zhao et al. reported the transfer hydrogenation of various imines by iron complex 
132 assisted by Lewis acid using isopropyl alcohol as the hydrogen donor.158 
Imine 131 was reduced to the amine product 133 with 97% yield using iron(III) 
acetylacetonate (Scheme 4.2).  
 
Scheme 4.2 Transfer hydrogenation of 131 by 132 and iron(III) acetylacetonate 
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Self-condensation of primary amines such as benzylamine 134 was reported by 
Mizuno et al. using copper(0) supported onto aluminium oxide (Scheme 4.3),166 
whilst the use of 0.5 mol% copper(I) chloride in air solely gave 136.161  
 
 
Scheme 4.3 Self condensation of 134 by Cu/ Al2O3 under hydrogen atmosphere
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The use of iron- and copper-based compounds in amine oxidations and imine 
reductions suggested that they can potentially be used in catalysing the 
racemisation of chiral amines. In this chapter, a series of iron- and copper-based 
complexes and salts were screened for racemisation using (R)-9 as the major 
substrate. Compounds which showed the desired racemisation capability and the 
ability to oxidise the substrate to its imine will be identified. 
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4.2 Screening of iron- and copper-based metal compounds 
A series of iron- and copper-based metal salts and complexes A to Q were 
screened for their activity in the racemisation of (R)-9 (Scheme 4.4, Table 4.1). 
The compounds contain metal centre(s) which can achieve various oxidation 
states; and are either coordinatively unsaturated or contain labile ligands which 
allow the substrate to bind. 
 
 



















D FeBr3 41 M CuI 14 
E Fe3(CO)12 12 N [(MeCN)4Cu]+ BF4- 23 
F Fe(OCH2CH3)3 30 O [CpCu(PEt3)] 13 







I [Cp*Fe(CO)2]2 13 
Table 4.1 Fe- and Cu-based metal compounds used in the catalyst screening of 
racemisation of (R)-9. [a]Average amount of compound used (in mol%) over three 
screening experiments carried out in three different solvents (toluene, PhCl and iPrOAc)  
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The initial screening was carried out inside the glove box using a 48-well plate 
under nitrogen atmosphere in toluene at 105 °C. Samples were taken after 4 and 
22 hours and were analysed by chiral supercritical fluid chromatography (SFC). 
Under the reaction conditions employed, only E was able to racemise (R)-9 from 
100 to 73% after 22 hours (Fig. 4.1). The screening was repeated in 
chlorobenzene and isopropyl acetate (Table 4.2). In chlorobenzene, no 
racemisation was observed with the use of E, further showing the negative effect 
of solvents with increasing polarity on racemisation (Table 4.2, entry 2). In 
isopropyl acetate, E was able to racemise (R)-9 but to a lower extent compared 
to the reaction in toluene since lower temperature was used (Table 4.2, entry 3).  
 
The amount of imine formed was also monitored throughout the reaction by imine 
8/ amine 9 peak area ratio (Fig. 4.2). Not much 8 was formed using E. Although 
K did not racemise (R)-9, significant formation of 8 was observed which 
suggested that K can transfer dehydrogenate 9. Both catalysts E and K were 
further studied by closely monitoring the racemisation/ transfer dehydrogenation 
reaction of 9. Other amine substrates will also be attempted using E. 
 
 
Fig. 4.1 ee of 9 after 4 and 22 h in the catalyst screen at 105 °C in toluene. The reactions 
were carried out at 50 mM of (R)-9 in a 0.5 mL scale under nitrogen atmosphere inside 

















4 h 22 h
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Entry Solvent T (°C) ee of 9 using E (%) 
1 Toluene 105 73 
2 Chlorobenzene 120 100 
3 Isopropyl acetate 80 83 
Table 4.2 Racemisation of (R)-9 by E in the catalyst screen in different solvents after 22 
h (toluene) and 20 h (chlorobenzene and isopropyl acetate) 
 
 
Fig. 4.2 SFC peak area ratio of imine 8/ amine 9 after 4 and 22 h in the catalyst screen 
at 105 °C in toluene 
 
4.3 Racemisation of chiral amines by triiron dodecacarbonyl 
(Compound E) 
Racemisation of (R)-9 was repeated under different conditions using 10 mol% E 
in toluene. The ee of 9 dropped slowly from 100 to 53% after 24 hours when the 
reaction was carried out inside the glove box under nitrogen atmosphere (Fig. 
4.3(a); Table 4.3, entry 1). The amount of imine 8 remained low (< 1%) throughout 
the reaction. This can be beneficial for substrates such as primary amines where 
dimeric by-products are formed readily from the reaction between the amine and 
the imine. The kinetic plot of ln {[R]0/([R]0 – 2[S]t)} against time is non-linear, 
indicating that the racemisation deviates from first order kinetic model which is 
likely to be the result of catalyst deactivation (Fig. 4.3(b)). In a separate 
experiment, more E (further 10 mol%) was added after 6 hours when the 
racemisation slowed down. The reaction rate increased and ee dropped to 25% 

































Fig. 4.3(a) Full reaction profile of the racemisation of (R)-9 (0.1 M) by E (10 mol%) carried 
out inside the glove box. IS = Internal standard (4,4’-di-tert-butylbiphenyl); (b) Plot of ln 
{[R]0/([R]0 – 2[S]t)} against time for the racemisation of (R)-9 by E 
 
 
Fig. 4.4 Profiles of ee of (R)-9 (0.1 M) with and without spiking of E after 6 h. Initial loading 
of E = 10 mol % 
 
When the reaction was carried out in air, the racemisation did not proceed (Fig. 
4.5; Table 4.3, entry 3). The reaction was also repeated outside the glove box but 
under nitrogen. The racemisation stopped after one hour (Fig. 4.5; Table 4.3, 
entry 2). The insertion of a needle during sampling might have introduced air into 







































































ee (no spiking of E) (%) ee (spiking of E) (%)








ee after 1 h 
(%) 
ee after 24 h 
(%) 
1 Nitrogen atmosphere inside glove box 83 53 
2 Nitrogen atmosphere outside glove box[a] 87 87 
3 Air 91 92 
Table 4.3 ee of 9 after 1 and 24 h under different reaction conditions. All reactions were 
carried out at 100 °C in toluene. [a]The reaction was carried out in an Amigo reaction tube 
under nitrogen 
 
To understand the substrate scope of E, racemisation of (S)-39, (S)-103 and (S)-
42 were attempted using 10 mol% of E (Table 4.4). The reactions mixtures were 
prepared in sealed ampoule tubes under nitrogen to avoid any air. The reactions 
were then heated in degassed toluene for 24 hours. (S)-103 was racemised to 
58% ee (Table 4.4, entry 1), whilst no racemisation was observed for (S)-39 and 
(S)-42 (Table 4.4, entries 3 and 4). It showed that E was more active towards 
cyclic secondary amines then acyclic substrates. This can possibly due to the 
more stable cyclic imines which are more easily formed during racemisation, 
allowing enough time for transfer hydrogenation to occur. Although a high loading 
of E is required for the racemisation of (R)-9 and (S)-103 (10 mol% E, 30 mol% 
iron), the turnover numbers were calculated to be 1.5 and 1.4 respectively which 
are larger than 1 (Section 8.6). Therefore, E is still regarded as a catalyst. 
However, it is much less efficient compared to other commonly used racemisation 














Amigo (N2) Glovebox Air
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Entry Substrate T (°C) ee after 24 h (%) 
1[a] (S)-Methylpiperidine 103 105 58[b] 
   2[a][c] (S)-Methylpiperidine 103 105 91[b] 
 3[d] (S)-N-methyl-α-methylamine 39 100 96[e] 
 4[d] (S)-α-Methylbenzylamine 42 100 100[f] 
Table 4.4 Attempted racemisation of (S)-103, (S)-39 and (S)-42 (0.1 M) with E (10 mol%). 
The reactions were heated in sealed ampoule tubes for 24 h outside the glove box. 
[a]Reaction mixtures were prepared in an atmosbag filled with nitrogen. [b]Ee was 
determined by chiral GC after derivatisation with benzoyl chloride. [c]Elemental mercury 
(90 equiv.) was added at the start of the reaction prior to heating. [d]Reaction mixtures 
were prepared in a glovebox under nitrogen atmosphere. [e]Ee was determined by chiral 
GC after derivatisation with trifluoroacetic anhydride. [f]Ee was determined by chiral 
HPLC after derivatisation with triethylamine and benzoyl chloride 
 
Decomposition of E to form iron and iron oxide nanoparticles at elevated 
temperatures had been reported in the literature.167, 168 In the presence of excess 
carbon monoxide, E can decompose to Fe(CO)5 at ambient temperature; while 
in the absence of carbon monoxide, both Fe(CO)5 and HFe3(CO)11− clusters are 
produced in solvents such as acetonitrile, dimethylformamide, dimethylsulfoxide 
and tetrahydrofuran.169 E was found to catalyse alkene isomerisation by 
intramolecular hydrogen shift mechanism, probably via the formation of 
HFe(CO)3(π-allyl) species.170, 171 Racemisation of 9 may involve the binding of 9 
to the Fex(CO)y clusters with subsequent loss of carbon monoxide. Hydride 
transfer from 9 to iron can lead to the formation of imine and [HFex(CO)y] species 
which can transfer the hydride to the imine to form back 9 non-enantioselectively. 
On the other hand iron and/ or iron oxide nanoparticles may also be the catalytic 
species. In order to investigate whether any nanoparticles were involved in the 
catalysis, a poisoning experiment was carried out by adding elemental mercury 
(90 equiv.) into the reaction mixture containing both (S)-103 and 10 mol% of E in 
toluene prior to heating. A control experiment without mercury was carried out at 
the same time for comparison and the reactions were analysed by chiral GC after 
being heated to 105 °C for 24 hours (Table 4.4, entries 1 and 2). Much lower 
activity was observed in the presence of mercury, indicating that nanoparticles 
might have initially formed in the catalytic cycle, which formed amalgam with 




4.4 Attempted racemisation/ transfer dehydrogenation of (R)- 
6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 by 
copper(II) acetate (Compound K) 
Although (R)-9 was not racemised by K under the employed conditions during 
the catalyst screen, a significant amount of imine 8 was formed which suggests 
that K was turning over to dehydrogenate 9 (Scheme 4.5). The reaction was 
repeated in toluene with 10 mol % K and was monitored more closely (Fig. 4.6). 
Imine 8 was formed at the expense of 9. The ee of 9 is not shown as it remained 
at 100%. The reaction was also carried out in 1:1 toluene/ 2,4-dimethyl-3-
pentanol 58. Alcohol 58 was used as a hydrogen donor in the racemisation of 
(S)-α-methylbenzylamine 42 using Shvo’s catalyst 55 to suppress the formation 
of dimeric products.95 However, with the use of K, imine formation was not 
reduced in the presence of 58 and no racemisation was observed (Fig. 4.6).  
 
 
Scheme 4.5 Transfer dehydrogenation of (R)-9 by K 
 
 
Fig. 4.6 Transfer dehydrogenation of (R)-9 (0.1 M) by K (10 mol%) in toluene and 


























Amine 9/ IS (toluene only) Imine 8/ IS (toluene only)
Amine 9/ IS (with alcohol 58) Imine 8/ IS (with alcohol 58)
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Copper-catalysed enantioselective hydrogenation of ketones had been reported 
by Beller et al.160 Compound K was employed with monodentate 
binaphthophosphepine ligands under hydrogen atmosphere in the presence of 
potassium tert-butoxide. The main purpose of the ligand is to induce 
stereoselectivity of the product. In the case of racemisation, the ligand may not 
be needed. Potentially, a combination of K and hydrogen may be sufficient to 
reduce 8 back to 9. In addition, silanes can serve as hydrogen donors. Various 
silanes such as alkylsilanes, phenylsilanes and polymethylhydrosiloxanes 
(PMHS) had been used to reduce ketones and aldehydes to their respective 
alcohols.163, 164 Blackwell et al. reported the use of dimethyl(phenyl)silane to 
reduce benzaldimines and ketimines to their respective amines.173 Therefore, 
different hydrogenating conditions were employed in an attempt to reduce any 















  1[c] 10 100 8 -  26 100 
  2[d] 20 98[e] 8 Hydrogen gas[f] 12 100 
3 10 165[g] 1 PMHS (1.1) 10 100 
4 10 165[g] 1 PhSiH3 (1.5) 3 95 
5 10 165[g] 1 PhMe2SiH (4.5) 6 100 
6 10 165[g] 1 - 16 100 
Table 4.5 Attempted racemisation of (S)-9 (0.1 M) by K under different hydrogenating 
conditions. [a]Conversion was determined by GC. [b]ee was determined by chiral HPLC. 
[c]The entry corresponds to the reaction presented in Fig. 4.6 in toluene. [d](R)-9 was used. 





Fig. 4.7 Attempted racemisation of (R)-9 (0.1 M) by K (20 mol%) under H2 atmosphere 
 
Under hydrogen atmosphere, the conversion of 9 was only 12% after 8 hours 
which is lower than that in the absence of hydrogen, which reached 26% 
conversion after 8 hours with lower loading of K (Table 4.5, entry 2; Fig. 4.7). 
However no racemisation was observed. The use of silanes were not successful 
either (Table 4.5, entries 3 to 5). No racemisation occurred except in the case of 
using phenylsilanes but only 95% ee was achieved which was not satisfactory 
(Table 4.5, entry 4). The presence of silanes were also found to suppress the 
formation of 8. Reactions were also carried out without any additional hydrogen 
donors under sealed conditions to avoid any loss of hydride in the form of 
hydrogen but only 8 was formed with no subsequent reduction (Table 4.5, entry 
6). It indicated that the Cu-H species are either not formed or it is too unstable to 
reduce the imine before it decomposes. 
 
4.5 Conclusion and future work 
A series of iron- and copper-based metal salts and complexes were tested in the 
racemisation of (R)-9. Iron carbonyl complex E were found to be active towards 
the racemisation of (R)-9. However, 10 mol% of E is required to racemise (R)-9 
from 100 to 53% over 24 h, which is equivalent to 30 mol% of iron. Its low activity 
makes it less applicable in industrial processes. Besides, E is very air-sensitive 
and can only be used under rigorously inert atmosphere. Any air introduced into 
the system during sampling is sufficient to inhibit the reaction. The racemisation 
of (R)-9 by E might involve iron nanoparticles which were tested in the presence 
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Among the substrates tested, E was only able to racemise (R)-9 and (S)-103 
which are cyclic secondary amines whilst acyclic amines such as (S)-39 and (S)-
42 were not racemised by E under the employed conditions. Transfer 
dehydrogenation of 9 was observed using K but no racemisation was observed 
under hydrogen atmosphere or in the presence of silanes indicating that the Cu-
H species are either not formed or too unstable to reduce imine 8 back to amine 
9. 
 
Further investigation is needed to gain more insight on the mechanism of the 
transfer (de)hydrogenation reactions by E via nanoparticle formation to better 
understand the limitation of the substrate scope and the types of nanoparticles 
involved. Other metal carbonyl analogues may also be studied. Immobilisation of 
E onto a solid support such as graphite nanofibers may also be made possible 







In this research, a novel resolution-racemisation-recycle (R3) process was 
developed for the synthesis of chiral amines, by coupling diastereomeric 
resolution of the racemic amine with catalytic racemisation of the undesired 
enantiomer in the ML, without any isolation of intermediate. The major drawback 
of a classical resolution is the limiting yield which can never exceed 50% in 
obtaining the desired enantiomer. Several approaches have been developed to 
overcome this intrinsic limitation, including DKR, CIDT and CIAT processes which 
were discussed in Chapter 1. One of the merits of using the R3 process over the 
traditional asymmetric transformation is the segregation of the resolution and 
racemisation processes, allowing them to operate separately under different 
conditions and no compromise between the two steps is required. And they are 
connected together with a flow engineering design, generating a continuous 
process. The utilisation of flow technology also enables the use of immobilised 
metal catalysts which can be recycled much more easily, making this process 
commercially useful and attractive. 
 
Six different chiral amines were selected in the development of the R3 process, 
which are 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9, 2-
methylpiperidine 103, N-methyl α-methylbenzylamine 39, N-isopropyl α-
methylbenzylamine 101, α-methylbenzylamine 42 and N,N-dimethyl α-
methylbenzylamine 46. Firstly, their racemisation was studied using 
homogeneous SCRAM in batch, in order to understand the kinetics and 
mechanism of the reaction. Amine 39 was used as the model substrate and was 
found to racemise faster compare to other analogous acyclic amines 46 and 101 
which are more sterically hindered, but slower compare to cyclic amines 9 and 
103 which can be due to the formation of more stable cyclic imine intermediates. 
Primary amine 42 does not racemise properly, but form various dimeric products. 
Catalyst deactivation was observed for amines 39 and 46 under the reaction 
conditions studied, as reflected from incomplete racemisation. One of the 
possible reasons is the formation of methylamine from imine hydrolysis that can 
bind to the catalyst and causes deactivation. This was further investigated by 1H 
NMR titration of SCRAM 64 with methylamine. Suspected formation of mono-, di- 
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and tri-methylamine substituted iridium species 95 to 97 were observed. However, 
their isolation was not successful to date and their activities could not be tested.  
 
Racemisation in flow was also investigated using a packed-bed reactor which 
was packed with immobilised SCRAM catalyst 92. Using immobilised catalyst in 
flow simplifies the reuse/ recycle of precious metal catalyst. Product 
contamination with metal residues can also be minimised. Racemisation times, 
which were controlled by setting different flow rate of the system, were shorter 
compare to the total reaction time in batch and therefore leading to a smaller 
degree of racemisation after one pass through the catalyst. However, the amine 
can be pumped through the catalyst several times to achieve complete 
racemisation. The reactivation of the used immobilised catalyst was also 
attempted and found to regain its activity temporarily using hydroiodic acid, which 
potentially protonates the bound amine (methylamine), facilitating its de-
coordination from the iridium centre for substrate to bind again. 
 
A relatively rapid qualitative method was developed to determine if an amine can 
be racemised under certain conditions, which involved proton-deuterium 
exchange in the amine substrate in the presence of SCRAM 64  and d8-isopropyl 
alcohol and was monitored by 1H NMR. A decrease in the integration of a signal 
indicates deuterium incorporation at the corresponding position. If this occurs at 
the chiral centre (α-position) and/ or the β-position, imine/ enamine must have 
been formed respectively and the amine can be racemised under the operating 
conditions. This method can avoid the need of developing chiral analytical 
methods in the early stage and do not require enantiopure/ enantioenriched 
materials.  
 
Secondly, diastereomeric crystallisation of the chosen amine substrates was 
investigated in batch at ambient temperature in general, using (S)-mandelic acid 
34 and di-p-toluyl-D-tartaric acid (S,S)-32 as the resolving acid. Solvent and 
concentration screens were carried out briefly without full optimisation of reaction 
conditions. Diastereomeric resolution of amine 9 was also carried out in 
continuous flow using the Freactors with different tRes. A slightly lower resolvability 




Based on the sub-optimal conditions for the racemisation and diastereomeric 
resolution of individual chiral amines, both steps were coupled by connecting the 
batch crystalliser (CSTR) to a Jasco/ HPLC pump which was also connected to 
the packed-bed racemisation flow reactor containing the immobilised SCRAM 92. 
The racemised ML re-entered the crystalliser for further resolution. By using the 
R3 process, a higher de was achieved for most substrates, since the ML which is 
enriched with the (undesired) enantiomer racemises to replenish the (desired) 
enantiomer which crystallises from solution as the less soluble diastereomeric 
salt. In theory, no optimisation of individual steps is required, as long as the amine 
can be racemised by 92 and there is a solubility difference between the 
diastereomers. However in reality, the efficiency of a R3 process also depends 
on the rate of racemisation and the absolute solubilities of the diastereomers. 
With the use of monoacid (S)-34, the R3 process of 9 showed the biggest 
improvement in resolvability, a 13-times increase compared to batch resolution 
alone, achieving a de of 96% and yield of 78% which is much higher than the 
maximum limit of a classical resolution of 50%. Although amine 39 also showed 
an increase in de and resolvability when the R3 process was employed, the 
results were less satisfactory compared to amines 9, 101 and 103. An alternative 
chiral acid, (S,S)-32 was used which is a diacid. However, the formation of neutral, 
racemic salt containing both enantiomers of 39 led to a significant drop in 
resolvability of the system. By controlling the rate of acid addition, the 
concentration of the racemic salt in solution was minimised, avoiding its 
nucleation and subsequent crystallisation, leading to a 45-times improvement in 
the resolvability compared with batch resolution alone, with a de of 83% and yield 
of 78%. The R3 processes of primary amine 42 and tertiary amine 46 with (S)-34 
and (S,S)-32 respectively were less successful due to the formation of various 
side-products. The used immobilised SCRAM catalyst was tested after each R3 
processes with either the racemisation of 9 or 103 as the standard reaction. The 
catalyst could be recycled up to 130 times over 100 hours, and still remained 
active. However, the catalyst was not analysed for potential leaching. Therefore 
any decrease in activity could not be quantified. 
 
Lastly, due to the high cost and toxicity of transition metal catalysts, a series of 
iron- and copper-based salts and complexes were tested for their potential 
racemisation activity, using (R)-9 as the model compound. It was found that triiron 
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dodecacarbonyl complex (compound E) was active towards the racemisation of 
(R)-9 and (S)-103. However, it is very air-sensitive and a high loading of 10 mol% 
(30 mol% iron) is required to racemise 39 by about 50% after 24 hours. Copper(II) 
acetate (compound K) was found to be able to oxidise 9 to its imine but no 
subsequent reduction was observed, even in the presence of hydrogen sources 
such as hydrogen gas and silanes. Therefore SCRAM 64/ 92 and Shvo’s catalyst 
55 still remained the most promising racemisation catalysts for chiral amines. 
 
5.2 Future Work 
Detailed mechanistic investigation of chiral amine racemisation is ongoing in our 
group. Racemisation monitoring by flow NMR has been in progress in the 
Dynamic Reaction Monitoring (DReaM) facility in the University of Bath with the 
observation of hydride formation. DFT study may be helpful in understanding the 
energies of different transition states and provide more evidences on the binding 
of intermediate imine/ enamine, if any, and if the hydride transfer occurs through 
outer- or inner-sphere mechanism and how it depends on the substrate itself.  
 
Primary amine racemisation has been problematic due to the formation of dimeric 
by-products. Whilst SCRAM 64 (and 92) is not able to eliminate the problem at 
this stage, the use of Shvo’s catalyst 55 under dilute conditions, in the presence 
of ammonia or a hydrogen donor was previously proven to help minimising the 
formation of dimers and allow the amine to racemise to a significant extent. 
Immobilisation of Shvo’s catalyst will allow its use in flow and in the R3 process. 
This can extend the substrate scope of the R3 process to primary amines.  
 
The method developed for determining chiral amine racemisation involves 
proton-deuterium exchange monitored by the disappearance of proton signals in 
the 1H NMR spectra. This method can be tested with fully-deuterated substrates 
instead which produces proton signals upon deuterium-proton exchange, leading 
to clearer spectra and simplify their assignment. Alternatively, 2D NMR can also 
be used as a complimentary approach in monitoring deuterated species 
formation. Partially deuterated amine substrates will have to be prepared which 




Diacids have been commonly used in the resolution of chiral amines. Although 
the possibility of racemic salt formation as occurred in the case of amine 39 and 
(S,S)-32 was reported, it had not been studied in detail. In order to generalise this 
phenomenon, previously failed resolutions using diacids reported in the literature 
can be investigated. By controlling the crystallisation of the less soluble racemic 
salt, if any, the scope of the R3 process can be further extended with the use of 
a wider range of resolving acids. 
 
Through the collaboration with AstraZeneca, 4 g of iridium(III) chloride trihydrate 
is available which will be used to synthesise the immobilised SCRAM 92 for a 
large scale R3 process. This is an important study as it provides information on 
the scalability and potential industrial applications of the process. Whilst the 
substrates chosen for the development of the R3 process are relatively simple 
involving cyclic and acyclic benzylic/ non-benzylic amines, other substrate 
classes including chiral aliphatic amines, carboxylic acids, amino-alcohols, chiral 
compounds bearing a non-chiral amine/ acid groups, and chiral compounds 
containing more than one chiral centres can all be tested with the R3 process. For 
substrates involving the resolution of carboxylic acids, enantiomerically pure 
amines can be used as the resolving agent. Development of alternative catalysts 
may be required for non-amine racemisation. 
 
Although the triiron dodecacarbonyl complex E was identified in the catalyst 
screen for the racemisation of 9 and 103, understanding of the mechanism is 
limited at this stage. The involvement of nanoparticles in the catalytic cycle may 
indicate the potential use of nanoparticles directly in the racemisation and its 
subsequent immobilisation may also be possible, increasing its stability and 












6.0.1 Chemicals and analytical methods 
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich, Fisher 
Scientific, Alfa Aesar or Fluorochem and were used without further purification. 
Immobilised SCRAM catalyst 92 was obtained from Yorkshire Process 
Technology and was used without further purification. All solvents used were 
HPLC grade. All syringe pumps used were Harvard Apparatus Model 11 from 
Scientific Support. Column chromatographic purifications were performed using 
Biotage (Isolera™ Spektra One, silica column = RediSep®Rf). Nuclear Magnetic 
Resonance (NMR) spectra were recorded on Bruker 500 UltraShieldTM 
Spectrometer operating at 500 MHz (1H NMR) and 126 MHz (13C NMR), or  
Bruker DX300 Spectrometer operating at 300 MHz (1H NMR) and 75 MHz (13C 
NMR), or Bruker ADVANCE III HD-400 Spectrometer operating at 400 MHz (1H 
NMR). The atoms in the compounds are numbered to aid assignment. Liquid 
Chromatography-Mass Spectrometry (LCMS) was performed on an Agilent 
Technologies 1200 Series LC system with a C18 column (Phenomenex Luna 5u 
C18(2), 50 mm × 2 mm × 5 μm) eluted with acetonitrile/ water gradient (15-95% 
acetonitrile, 0.1% formic acid over 3 minutes) and a Bruker Daltonics HCT®Ultra 
system equipped with an ion trap MS detector; or a Thermo Ultimate 3000 
UHPLC system with a C18 column (Phenomenex Kinetex, 50 mm × 2.1 mm × 
2.6 μm) eluted with acetonitrile/ water gradient (2-95% acetonitrile, 0.1% formic 
acid over 1 minute) and a Bruker Amazon Speed ion trap mass spectrometer. 
Gas Chromatography-Mass Spectrometer (GCMS) was performed on A HP6890 
series GC system with A HP5973 mass selective detector and helium flow gas. 
High resolution mass spectrometry (HRMS) was performed on a Bruker Maxis 
Impact Electron Spray Ionisation (ESI) spectrometer. For clarity in the assignment 
of MS peaks of the amine salts, the cationic and anionic fragments were assigned 
as X and Y respectively. Melting points were recorded using Stuart Scientific 
SMP3 melting point apparatus. Fourier-transform infrared (FT-IR) spectroscopy 
was recorded using Bruker Platinum-ATR spectrometer. Optical rotations ([α]D) 





T  = 
Rotation × 100
c × l
    (Eqn. 5.1) 
 
Where T = temperature; c = concentration of sample in g per 100 mL; l = path 
length which is the length of the cell in dm (the cell used was 1 dm). 
 
Achiral and chiral gas chromatography (GC) were performed using a HP6890 
series GC system, Agilent Technologies 7683 series injector and HP7683 series 
autosampler, with an FID detector and hydrogen flow gas. Both the GCMS and 
achiral GC used the HP-5 column (5% phenyl methyl siloxane; 30 m × 0.32 mm 
× 0.25 μm). Chiral High Performance Liquid Chromatography (HPLC) was 
performed on an Agilent Technologies 1290 Infinity system or an Agilent 1100 
Series system. Chiral SFC was performed on the WATERS Aquity UPC2 system 
in AstraZeneca. 
 
Single crystal structures were obtained at 120 K on an Agilent SuperNova 
diffractometer equipped with an Atlas CCD detector and connected to an Oxford 
Cryostream low temperature device using mirror monochromated Cu K radiation 
( = 1.54184 Å) from a Microfocus X-ray source. The structure was solved by 
intrinsic phasing SHELXT174 and refined by a full matrix least squares technique 
based on F2 using SHELXL2014.175 The exception was the single crystal 
structure of (R)-39-(S,S)-32-(S)-39 from UK National Crystallography Service 
(NCS), which was obtained on a Rigaku 007HF diffractometer equipped with 
Varimax confocal mirrors and an AFC11 goniometer and HyPix 6000 detector. 
The crystal was kept at T = 100(1) K during data collection. Using Olex2,176 the 
structure was solved with ShelXT structure solution program,174 using the Intrinsic 
Phasing solution method. The model was refined with version 2014/7 of ShelXL 
using Least Squares minimisation.175 The powder X-ray diffraction (XRD) data 
were collected using a Bruker AXS D2Phaser diffractometer at room temperature 
using Cu-Kα (λ = 1.54184 Å) radiation. Diffraction patterns were recorded with a 
step size of 0.02° from 5° to 50° (1 s per step). Experimental data was processed 
using Diffrac.Eva. 
 
The racemisation reactions of (R)-9 by iron complex E (Section 5.4.2(a)(ii) and 
(iii)) and its transfer dehydrogenation by Copper(II) acetate K (Section 5.4.3(a)) 
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were carred out in the First Generation Amigo Workstation from Amigochem with 
automated sampler. These reactions and the racemisation catalyst screening 
experiments (Section 6.4.1) were carried out in AstraZeneca. 
 
6.0.2 GC calibrations 
Stock solutions of known concentrations of internal standards, amines 9, 103, 39, 
101, 42, 46, imine 8 and acetophenone 51 were prepared (Table 6.1). For each 
calibration sample, a known volume of the stock solutions of an internal standard 
(50 mM, 20 μL) and the compound of interest were diluted into ethyl acetate to 
make up 1 mL. The samples were analysed by achiral GC. The calibration curves 
were produced by plotting the peak area ratio of the compounds to the internal 
standard against the concentration of the compound (Fig. 6.1 to 6.8).  
 
Compound [Stock solution] (mM) Internal standard 
(R)-9 81 n-Hexadecane 
rac-103 100 n-Decane 
(R)-39 100 n-Decane 
rac-101 100 n-Decane 
rac-42 100 n-Decane 
(S)-46 100 n-Decane 
Imine 8 10 n-Hexadecane 
Ketone 51 10 n-Decane 








Fig. 6.1 GC calibration for 9. Method, column = HP-5 (5% phenyl methyl siloxane; 30 m 
× 0.32 mm × 0.25 μm); oven temperature = 2 °C min-1 ramped from 150 °C to 180 °C, 




Fig. 6.2 GC calibration for 103. Method, column = HP-5 (5% phenyl methyl siloxane; 30 
m × 0.32 mm × 0.25 μm); oven temperature = 35 °C isothermal for 10 min, 50 °C min-1 
ramped to 300 °C and isothermal for 5 min; inlet pressure = 10 psi. tR, n-decane = 7.1 









































































Fig. 6.3 GC calibration for 39. Method, column = HP-5 (5% phenyl methyl siloxane; 30 
m × 0.32 mm × 0.25 μm); oven temperature = 60 °C isothermal for 10 min, 5 °C min-1 
ramped to 100 °C and isothermal for 3 min, then 50 °C min-1 ramped to 300 °C and 
isothermal for 5 min; inlet pressure = 10 psi. tR, decane = 1.9 min; 39 = 2.9 min 
 
 
Fig. 6.4 GC calibration for 101. Method (i), column = HP-5 (5% phenyl methyl siloxane; 
30 m × 0.32 mm × 0.25 μm); oven temperature = 60 °C isothermal for 10 min, 5 °C min-
1 ramped to 100 °C and isothermal for 3 min, then 50 °C min-1 ramped to 300 °C and 










































































Fig. 6.5 GC calibration for 42. Method (i), column = HP-5 (5% phenyl methyl siloxane; 
30 m × 0.32 mm × 0.25 μm); oven temperature = 60 °C isothermal for 10 min, 5 °C min-
1 ramped to 100 °C and isothermal for 3 min, then 50 °C min-1 ramped to 300 °C and 
isothermal for 5 min; inlet pressure = 10 psi. tR, decane = 1.9 min; 42 = 2.4 min 
 
 
Fig. 6.6 GC calibration for 46. Method (i), column = HP-5 (5% phenyl methyl siloxane; 
30 m × 0.32 mm × 0.25 μm); oven temperature = 50 °C isothermal for 2 min, 4 °C min-1 
ramped to 70 °C and isothermal for 10 min, then 50 °C min-1 ramped to 300 °C and 





































































Fig. 6.7 GC calibration for 8. Method, column = HP-5 (5% phenyl methyl siloxane; 30 m 
× 0.32 mm × 0.25 μm); oven temperature = 2 °C min-1 ramped from 150 °C to 180 °C, 




Fig. 6.8 GC calibration for 51. Method, column = HP-5 (5% phenyl methyl siloxane; 30 
m × 0.32 mm × 0.25 μm); oven temperature = 60 °C isothermal for 10 min, 5 °C min-1 
ramped to 100 °C and isothermal for 3 min, then 50 °C min-1 ramped to 300 °C and 







































































6.0.3 Chromatograms of racemic and optically pure materials 
 
Fig. 6.9 Chiral HPLC traces of 9. Method; column = Chiralcel® OD-H 250 mm × 4.6 mm 
× 5 μm; hexane/ iPrOH/ Et2NH 80: 20: 0.1 isocratic for 60 min; flow rate = 0.5 mL min
-1; 
λ = 280 nm; T = 25 °C. (a) Racemate; (b) (R)-9 (21.8 min); (c) (S)-9 (17.3 min) 
 
 








































Fig. 6.10 Chiral HPLC traces of (S)-34 salts of enantiopure 9. Method, column = 
Chiralcel® OD-H 250 mm × 4.6 mm × 5 μm; hexane/ iPrOH/ Et2NH 80: 20: 0.1 isocratic 
for 60 min; flow rate = 0.5 mL min-1; λ = 280 nm; T = 25 °C.  (a) (R)-9-(S)-34 (21.8 min); 
(b) (S)-9-(S)-34 (17.5 min) 
 
  

























Fig. 6.11 Chiral SFC traces of amine 9 and imine 8. Method, column = Chiralpak® AD-
H 150 mm × 4.6 mm × 3 μm; A = CO2 (150 bar), B = 
iPrOH/ iPrNH2 99.9:0.1, A/ B ramped 
from 95:5 to 50:50 over 8 min; flow rate = 2.5 mL min-1; λ = 280 nm; T = 35 °C. (a) 
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Fig. 6.12 Chiral HPLC traces of acids 34 and 126. Method, column = Chiralpak® AD-H 
250 mm × 4.6 mm × 5 μm; hexane/ iPrOH/ CF3CO2H 95: 5: 0.1 isocratic for 35-40 min; 
flow rate = 1 mL min-1; λ = 230 nm; T = 25 °C.  (a) rac-34; (b) (S)-34 (24.3 min); (c) (R)-








Fig. 6.13 Chiral GC traces of acetylated 103. Method (i), column = CP-CHIRASIL-DEX 
column (25 m × 0.25 mm × 0.25 μm);  oven temperature = 100 °C isothermal for 5 min; 
1 °C min-1 ramped to 120 °C and isothermal for 5 min, 50 °C min-1 to 200 °C and 
isothermal for 5 min; inlet pressure = 7.5 psi; samples were derivatized with acetic 
anhydride before measurements were taken. (a) Acetylated racemate; (b) Acetylated 








Fig. 6.14 Chiral GC traces of benzoylated 103. Method (ii), column = CP-CHIRASIL-DEX 
column (25 m × 0.25 mm × 0.25 μm); oven temperature = 80 °C isothermal for 40 min, 5 
°C min-1 to 180 °C and isothermal for 10 min; inlet pressure = 15 psi; samples were 
derivatized with benzoyl chloride before measurements were taken. (a) Benzoylated 








Fig. 6.15 Chiral GC traces of trifluoroacetylated 39. Method, column = CP-CHIRASIL-
DEX column (25 m × 0.25 mm × 0.25 μm); oven temperature = 80 °C isothermal for 4 
min, 5 °C min-1 ramped to 100 °C and isothermal for 30 min; inlet pressure = 7.5 psi. (a) 
Trifluoroacetylated racemate; (b) Trifluoroacetylated (R)-39 (20.3 min); (c) 








Fig. 6.16 Chiral GC traces of trifluoroacetylated 101. Method, column = CP-CHIRASIL-
DEX column (25 m × 0.25 mm × 0.25 μm); oven temperature = 80 °C isothermal for 60 
min, 40 °C min-1 ramped to 180 °C and isothermal for 10 min; inlet pressure = 15 psi. (a) 
Trifluoroacetylated racemic 101; (b) Trifluoroacetylated (R)-101 (30.4 min); (c) 








Fig. 6.17 Chiral GC traces of 109. Method, column = CP-CHIRASIL-DEX column (25 m 
× 0.25 mm × 0.25 μm); oven temperature = 100 °C isothermal for 5 min, 2 °C min-1 
ramped to 130 °C and isothermal for 10 min, 25 °C min-1 ramped to 200 °C and 







Fig. 6.18 Chiral HPLC traces of benzoylated 42. Method; column = Chiralpak® AD-H 
250 mm × 4.6 mm × 5 μm; hexane/ iPrOH ramped from 5% to 10% iPrOH over 40 min; 
flow rate = 1 mL min-1; λ = 254 nm; T = 25 °C. (a) Benzoylated racemate; (b) Benzoylated 
















6.0.4 1H NMR spectra of diastereopure salts of chiral amines 
 
Fig. 6.19 1H NMR spectra of (S)-34 salts of enantiopure 9 recorded in CDCl3 (500 MHz, 
32 scans, relaxation delay = 2.49 s, acquisition time = 2.1825 min), showing the benzylic 
CH protons in 7 as a quartet (highlighted in blue). (a) (S)-9-(S)-34, 3.98 ppm (q, J = 6.6 
Hz); (b) (R)-9-(S)-34, 4.17 ppm (q, J = 6.6 Hz) 
 
 
Fig. 6.20 1H NMR spectra of (S)-34 salts of enantiopure 103 recorded in CDCl3 (500 MHz, 
32 scans, relaxation delay = 2.49 s, acquisition time = 2.1825 min), showing one of the 
CH2 protons adjacent to NH2 (highlighted in blue). (a) (R)-103-(S)-34, 2.98 ppm (d, J = 








Fig. 6.21 1H NMR spectra of (S)-34 salts of enantiopure 39 recorded in CDCl3 (500 MHz, 
32 scans, relaxation delay = 2.49 s, acquisition time = 2.1825 min), showing the benzylic 
CH in 39 as a quartet (highlighted in blue). (a) (R)-39-(S)-34, 3.68 ppm (q, J = 6.9 Hz); 
(b) (S)-39-(S)-34, 3.42 ppm (q, J = 6.8 Hz) 
 
 
Fig. 6.22 1H NMR spectra of (S,S)-32 salts of enantiopure 39 recorded in d6-DMSO (500 
MHz, 32 scans, relaxation delay = 2.49 s, acquisition time = 2.1825 min), showing CH3 
at the chiral centre in 39 as a doublet (highlighted in blue). (a) (R)-39-(S,S)-32, 1.35 ppm 








Fig. 6.23 1H NMR spectra of (S)-34 salts of enantiopure 101 recorded in CDCl3 (500 MHz, 
32 scans, relaxation delay = 2.49 s, acquisition time = 2.1825 min), showing the benzylic 
CH in 101 as a quartet (highlighted in blue). (a) (R)-101-(S)-34, 3.99 ppm (q, J = 6.7 Hz); 
(b) (S)-101-(S)-34, 3.66 ppm (q, J = 6.6 Hz) 
 
 
Fig. 6.24 1H NMR spectra of (S)-34 salts of enantiopure 46 recorded in CDCl3 (500 MHz, 
64 scans, relaxation delay = 2 s, acquisition time = 3.0672 min), showing CH3 at the 
chiral centre in 46 as a doublet (highlighted in blue). It was used to determine the ee of 
46 in its racemisation and resolution reactions. (a) (R)-46-(S)-34, 1.59 ppm (d, J = 6.8 







6.1 Synthesis of starting materials and reference compounds 
6.1.1. N-(3,4-Dimethoxyphenethyl)acetamide 125177 
 
3,4-Dimethoxyphenethylamine 124 (97%, 9.9 g, 53.1 mmol) was charged to a 
mixture of dichloromethane (50 mL) and triethylamine (12 mL, 86.3 mmol) and 
the mixture was cooled to 0 °C. With stirring, acetyl chloride (5 mL, 70.3 mmol) 
was charged dropwise to the reaction mixture over 0.5 hour. The pH was checked 
to ensure the reaction mixture stayed basic. The reaction mixture was warmed to 
room temperature and stirred overnight. The content was then poured into ice-
cold water and was acidified by aqueous hydrochloric acid (1 M). The organic and 
aqueous layers were separated and the aqueous layer was further extracted with 
dichloromethane (3 × 50 mL). The combined organic layer was washed with water 
(100 mL), dried by anhydrous MgSO4 and filtered. The solvent was removed in 
vacuo to yield a pale yellow solid (12.1 g). The product was recrystallised in 
hexane/ ethyl acetate 1:1 (v/v) to yield 125 as off-white crystals (9.2 g, 78%).  
 
M.p. 98-100 °C {lit.177 100-101 °C}; δH in ppm (500 MHz, CDCl3); 6.82 (d, J = 8.0 
Hz, 1H, H-4), 6.74–6.71 (m, 2H, H-3 and H-6), 5.43 (br s, 1H, NH), 3.88 (s, 3H, 
H-14 or H-16), 3.87 (s, 3H, H-14 or H-16), 3.50 (q, J = 7.0 Hz, 2H, H-8), 2.76 (t, 
J = 7.0 Hz, 2H, H-7), 1.95 (s, 3H, H-11); δc in ppm (126 MHz, CDCl3); 170.0 (C-
10), 149.1 (C-1 or C-2), 147.8 (C-1 or C-2), 131.4 (C-5), 120.6 (C-4), 111.9 (C-3 
or C-6), 111.4 (C-3 or C-6), 56.0 (C-14 or C-16), 55.9 (C-14 or C-16), 40.8 (C-7), 
35.2 (C-8), 23.4 (C-11); νmax/ cm-1; 3249, 3078, 2992, 2928, 2839, 1632, 1563, 
1515, 1471, 1261, 1233. The spectral data correspond to those reported in the 
literature.177 HRMS, calculated for C12H18NO3+ [M+H]+: 224.128669, found by 




6.1.2. 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline 8178 
 
Acetamide 125 (6.0 g, 27.0 mmol) was added to toluene (30 mL, dried over 
molecular sieve 4 Å, 1-2 mm beads) in a round bottom flask fitted with an air 
condenser and calcium chloride drying tube. The mixture was warmed to 40 °C. 
Phosphoryl chloride (6 mL, 64.4 mmol) was charged dropwise into the mixture 
over 20 minutes. When the addition was complete, the mixture was heated to 
reflux for 3 hours. The reaction mixture was then cooled to 0 °C for 2 hours. The 
mixture was decanted and water was charged to the remaining solid at 0 °C. The 
content was warmed to room temperature and stirred overnight. The reaction 
mixture was basified by aqueous sodium hydroxide (5 M) and extracted with 
dichloromethane (4 × 50 mL). The combined organic layer was dried over 
anhydrous MgSO4, filtered and the solvent was removed in vacuo to yield 8 as 
an orange solid (5.4 g, 97%). The product was used in the next step without 
purification.  
 
M.p. = 103-105 °C {lit.137 m.p. 108-109 °C}; δH in ppm (500 MHz, CDCl3); 6.99 (s, 
1H, H-3), 6.69 (s, 1H, H-6), 3.92 (s, 3H, H-13 or H-15), 3.91 (s, 3H, H-13 or H-
15), 3.63 (dt, J = 7.5 and 1.4 Hz, 2H, H-9), 2.64 (t, J = 7.5, 2H, H-10), 2.36 (t, J = 
1.4 Hz, 3H, H-11); δc in ppm (126 MHz, CDCl3); 163.1 (C-7), 150.4 (C-1 or C-2), 
147.0 (C-1 or C-2), 130.7 (C-5), 122.0 (C-4), 109.8 (C-6), 108.6 (C-3), 55.8 (C-
13 or C-15), 55.5 (C-13 or C-15), 46.6 (C-9), 25.3 (C-10), 22.9 (C-11); νmax/ cm-1; 
2941, 2924, 2837, 1625, 1603, 1571, 1512, 1286, 1272, 1211. The spectral data 
correspond to those reported in the literatures.137  HRMS, calculated for 
C12H16NO2+ [M+H]+: 206.118104, found by LCMS, ESI-MS [M+H]+: 206.0 {lit.137 








6.1.3. Racemic 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9137 
 
Imine 8 (4.3 g, 21.0 mmol) was dissolved into methanol (70 mL) and was cooled 
to 0 °C. Sodium borohydride (4.0 g, 105.5 mmol) was added slowly in portions 
over 20 minutes. The reaction mixture was stirred at room temperature overnight. 
The reaction mixture was acidified by aqueous hydrochloric acid (1 M) and then 
concentrated in vacuo. The white solid obtained was basified with aqueous 
sodium hydroxide (1 M) and extracted with dichloromethane (3 × 100 mL). The 
combined organic layer was washed with brine (1 × 50 mL) and dried over 
anhydrous MgSO4, filtered and the solvent was removed in vacuo to yield a light 
brown oil. The crude product was purified by column chromatography using 
Biotage (ethyl acetate/ triethylamine gradient, 95 to 96.5% ethyl acetate by 
volume); TLC: Silica plate, ethyl acetate/ triethylamine 95:5 (v/v), visualisation by 
UV (254 nm; Rf of product = 0.15) to yield rac-9 as a pale yellow oil. Off-white 
solid was formed overnight (3.7 g, 84 %).  
 
M.p. = 35-38 °C {lit.137 m.p. 48-49 °C}; δH in ppm (500 MHz, CDCl3); 6.63 (s, 1H, 
H-3), 6.57 (s, 1H, H-6), 4.05 (q, J = 6.7 Hz, 1H, H-7), 3.85 (s, 3H, H-13 or H-15), 
3.84 (s, 3H, H-13 or H-15), 3.25 (dt, J = 13.0 and 5.2 Hz, 1H, H-9), 3.00 (ddd, J 
= 13.0, 8.8 and 4.9 Hz, 1H, H-9), 2.79 (ddd, J = 15.9, 8.8 and 5.2 Hz, 1H, H-10), 
2.65 (dt, J = 15.9 and 4.9 Hz, 1H, H-10), 1.82, (br s, 1H, NH), 1.44 (d, J = 6.7 Hz, 
3H, H-11); δc in ppm (126 MHz, CDCl3); 147.3 (C-2), 147.2 (C-3), 132.6 (C-5), 
126.9 (C-4), 111.8 (C-3), 109.1 (C-6), 56.0 (C-13 or C-15), 55.9 (C-13 or C-15), 
51.3 (C-7), 41.9 (C-9), 29.6 (C-10), 22.9 (C-11); νmax/ cm-1; 3311, 2931, 2831, 
1609, 1509, 1462, 1404, 1253, 1220. The spectral data correspond to those 
reported in the literatures.137 HRMS, calculated for C12H18NO2+ [M+H]+: 










Formic acid (7.2 mL) was added to acetonitrile (20 mL) under nitrogen and stirred 
at 0 °C. Triethylamine (10.6 mL) was added slowly to maintain the temperature 
to below 10 °C. After the addition was complete, the reaction mixture was warmed 
to room temperature. Ru(p-cymene)(R,R-TsDPEN) (0.2 g, 0.3 mmol) was 
dissolved in acetonitrile (25 mL) and added to the formic acid-triethylamine 
mixture. The content was stirred for 15 minutes. A solution of imine 8 (6.2 g, 30.3 
mmol) in acetonitrile (35 mL) was charged to the reaction mixture and was 
warmed to 30 °C. The reaction was stirred overnight. After the reaction was 
complete, the reaction mixture was cooled to room temperature and concentrated 
in vacuo. The residue was acidified aqueous hydrochloric acid (2 M) and washed 
with toluene (2 × 20 mL). The aqueous layer was basified with aqueous sodium 
hydroxide (5 M) and was extracted with dichloromethane (3 × 50 mL). The 
combined organic layer was dried with anhydrous MgSO4, filtered and the solvent 
was removed in vacuo to give a dark brown oil (ee = 100% by chiral HPLC). The 
crude product was purified by column chromatography using Biotage (ethyl 
acetate/ triethylamine gradient, 95-96.5% ethyl acetate by volume); TLC: Silica 
plate, ethyl acetate/ triethylamine 95:5 (v/v), visualisation by UV (254 nm; Rf of 
product = 0.15) to yield (S)-9 as a pale brown oil (5.4 g, 88%). 
 
[α]D 23 = -54.4° (c 1.10, ethanol) {lit.137  [α]D 20 = -41.3° (c 1.10, ethanol)}. The 











Similar procedures as (S)-9 were employed in the synthesis of (R)-9 with Ru(p-
cymene)(S,S-TsDPEN). Toluene was used instead of dichloromethane in the 
extraction of product from the aqueous layer during work-up. A pale brown oil (5.7 
g, 94%) was obtained with ee of 96% (by chiral HPLC). 
 
[α]D 23 = +52.3° (c 1.13, ethanol) {lit.137 [α] D 20 = +59.7° (c 1.10, ethanol)}. The 
spectral and MS data correspond to those reported for rac-9. 
 




A solution of (S)-34 (0.3 g, 1.9 mmol) in ethyl acetate/ methanol 7:1 (v/v, 2 mL) 
was added to a solution of (R)-9 (0.4 g, 1.9 mmol) in ethyl acetate/ methanol 7:1 
(2 mL). The mixture was heated to reflux. More solvent (ethyl acetate/ methanol 
7:1) was added until all solids dissolved. Then stirring was stopped and the heat 
was switched off. The mixture was cooled to room temperature. The slurry was 
filtered to give an off-white crystalline solid (0.4 g, 47%) with de 100% (by 1H NMR 
in CDCl3, 500 MHz). Single crystal structure was obtained by XRD analysis. 
 
M.p. = 172-174 °C; [α]D 23 = +66.3° (c 1.10, chloroform); δH in ppm (500 MHz, 
CDCl3); 7.31-7.23 (m, 2H, H-19 and H-21), 7.20-7.15 (m, 3H, H-16, H-17 and H-
18), 6.55 (s, 1H, H-3), 6.48 (s, 1H, H-6), 4.74 (s, 1H, H-22), 4.17 (q, J = 6.6 Hz, 
1H, H-7), 3.87 (s, 3H, H-13 or H-15), 3.86 (s, 3H, H-13 or H-15), 3.24-3.13 (m, 
1H, H-9), 2.95-2.84 (m, 2H, H-9 and H-10), 2.79-2.68 (m, 1H, H-10), 1.41 (d, J = 
6.6 Hz, 3H, H-11); δc in ppm (126 MHz, CDCl3); 178.8 (C-23), 148.6 (C-2), 148.3 
202 
 
(C-1), 142.1 (C-20), 127.9 (C-16 and C-18), 127.0 (C-17), 126.4 (C-19 and C-21), 
125.7 (C-4), 123.6 (C-5), 111.3 (C-3), 108.7 (C-6), 74.4 (C-22), 56.1 (C-13 or C-
15), 56.0 (C-13 or C-15), 50.3 (C-7), 38.9 (C-9), 25.3 (C-10), 19.6 (C-11); νmax/ 
cm-1; 3188, 3061, 2832, 2757, 2656, 2573, 2525, 2493, 1582, 1518, 1366, 1244, 
1211. HRMS, calculated for C12H18NO2+ [M−Y]+: 208.133754, found by LCMS, 
ESI-MS/MS (+) [M−Y]+: 208.53; HRMS, calculated for C8H7O3- [M−X]-: 151.03952; 




A similar procedure as in Section 5.1.5(a) was used to synthesise (S)-9-(S)-34. 
Ethyl acetate/ methanol 15:1 was used as the solvent mixture. (S)-9-(S)-34 was 
isolated as an off-white crystalline solid (0.2 g, 32%) with de 100% (by 1H NMR 
in CDCl3, 500 MHz). Single crystal structure was obtained by XRD analysis. 
 
M.p. = 163-166 °C; [α]D 23 = +39.6° (c 1.10, chloroform); δH in ppm (500 MHz, 
CDCl3); 7.31 (d, J = 7.0 Hz, 2H, H-19 and H-21), 7.24-7.14 (m, 3H, H-16, H-17 
and H-18), 6.53 (s, 1H, H-3), 6.47 (s, 1H, H-6), 4.77 (s, 1H, H-22), 3.98 (q, J = 
6.6 Hz, 1H, H-7), 3.87 (s, 3H, H-13 or H-15), 3.86 (s, 3H, H-13 or H-15), 3.16 (dt, 
J = 12.5 and 5.5 Hz, 1H, H-9), 2.98 (ddd, J = 12.5, 8.0 and 5.5 Hz, 1H, H-9), 2.85-
2.76 (m, 1H, H-10), 2.72 (dt, 1H, J = 17.0 and 5.5 Hz, H-10), 1.45 (d, J = 6.6 Hz, 
3H, H-11); δc in ppm (126 MHz, CDCl3); 178.8 (C-23), 148.6 (C-2), 148.3 (C-1), 
142.2 (C-20), 128.0 (C-16 and C-18), 127.0 (C-17), 126.5 (C-19 and C-21), 125.6 
(C-4), 123.6 (C-5), 111.3 (C-3), 108.7 (C-6), 74.4 (C-22), 56.1 (C-13 or C-15), 
55.9 (C-13 or C-15), 50.3 (C-7), 39.0 (C-9), 25.2 (C-10), 19.8 (C-11); νmax/ cm-1; 
3410, 3001, 2836, 2580, 2533, 2410, 1577, 1512, 1360, 1257, 1218; HRMS, 
calculated for C12H18NO2+ [M−Y]+: 208.133754, found by LCMS, ESI-MS/MS (+) 
[M−Y]+: 208.06; HRMS, calculated for C8H7O3- [M−X]-: 151.03952, found by 





6.1.6. Diastereopure (S)-mandelate salts of 2-methylpiperidine 103 
(a) (R)-103-(S)-34 
 
(S)-34 (2.3 g, 15.1 mmol) was added to a solution of rac-103 (1.5 g, 15.1 mmol) 
in methyl tert-butyl ether (MTBE)/ methanol 4% (v/v, 20 mL). The mixture was 
heated to reflux. More solvent (MTBE/ methanol 4% v/v) was added until all solid 
dissolved. The mixture was cooled to room temperature and stirred overnight. 
The slurry was filtered to yield a white solid which was recrystallised from MTBE/ 
methanol 4% to give a white crystalline solid (0.7 g, 19%) with de 100% (by 1H 
NMR in CDCl3, 500 MHz). Crystals suitable for XRD analysis were grown by slow 
diffusion of hexane into a saturated solution of (R)-103-(S)-34 in MTBE/ methanol 
4% (v/v). 
 
M.p. = 119-122 °C {lit.148 m.p. 119 °C}; [α]D 20 = +76.3° (c 1.0, chloroform) {lit.148 
[α]D 22 = +78.0° (c 1.0, chloroform)}; δH in ppm (500 MHz, CDCl3); δ 7.46 (d, J = 
7.3 Hz, 2H, H-11 and H-13), 7.28 (t, J = 7.3 Hz, 2H, H-8 and H-10), 7.21 (t, J = 
7.3 Hz, 1H, H-9), 4.86 (s, 1H, H-14), 2.98 (d, J = 12.5 Hz, 1H, H-2), 2.70-2.64 (m, 
1H, H-4), 2.25-2.20 (m, 1H, H-2), 1.69 (d, J = 13.5 Hz, 1H, H-1), 1.57-1.51 (m, 
3H, H-5 and H-6), 1.29-1.19 (m, 1H, H-5), 1.16-1.09 (m, 4H, H-1 and H-7); δc in 
ppm (126 MHz, CDCl3); 178.3 (C-15), 142.6 (C-12), 128.0 (C-8 and C-10), 127.0 
(C-9), 126.6 (C-11 and C-13), 74.5 (C-14), 52.3 (C-4), 43.8 (C-2), 30.2 (C-5), 22.5 
(C-6), 21.8 (C-1), 19.1 (C-7). νmax/ cm-1; 3153, 2696, 2590, 2544, 1593, 1491, 
1477, 1444, 1381, 1267. The spectral data correspond to those reported in the 
literatures.148, 149 HRMS, calculated for C6H14N+ [M−Y]+: 100.112624, found by 
LCMS, ESI-MS/MS (+) [M−Y]+: 100.27 {lit.148 HRMS [M−Y]+: 100.1125}; HRMS, 







A solution of (S)-103 (0.50 g, 5.0 mmol) in MTBE (10 mL) and a solution of (S)-
34 (0.77 g, 5.0 mmol) in MTBE (10 mL) were mixed and the slurry was heated to 
reflux. More tert-butyl methyl ether was added (20 mL) followed by methanol until 
all solid dissolved. The reaction was cooled to r.t. with reduced stirring. After 2 h, 
the mixture was filtered to give a white fluffy solid (1.0 g, 81 %) with de 100% (by 
1H NMR in CDCl3, 500 MHz). Crystals suitable for XRD analysis were grown by 
slow diffusion of hexane into a saturated solution of (S)-103-(S)-34 in MTBE/ 
methanol 4% (v/v). 
 
M.p. = 92-95 °C; [α]D 20 = +63.9° (c 1.0, CHCl3); δH in ppm (500 MHz, CDCl3); δ 
7.46 (d, J = 7.6 Hz, 2H, H-11 and H-13), 7.28 (t, J = 7.6 Hz, 2H, H-8 and H-10), 
7.21 (t, J = 7.6 Hz, 1H, H-9), 4.87 (s, 1H, H-14), 3.05 (d, J = 12.5 Hz, 1H, H-2), 
2.50 (td, J = 12.5 and 3 Hz, 1H, H-2), 2.44-2.34 (m, 1H, H-4), 1.66 (d, J = 10.5 
Hz, 1H, H-6), 1.58 (d, J = 14.5 Hz, 1H, H-5), 1.51 (d, J = 14.0 Hz, 1H, H-1), 1.39-
1.16 (m, 3H, H-1, H-5 and H-6), 1.04 (d, J = 6.5 Hz, 3H, H-7); δc in ppm (126 MHz, 
CDCl3); 178.3 (C-15), 142.6 (C-12), 128.0 (C-8 and C-10), 127.0 (C-9), 126.6 (C-
11 and C-13), 74.4 (C-14), 52.1 (C-4), 44.0 (C-2), 30.4 (C-5), 22.5 (C-6), 21.7 (C-
1), 19.1 (C-7). νmax/ cm-1; 3184, 2695, 2582, 2541, 1627, 1574, 1497, 1449, 1382, 
1337, 1213. HRMS, calculated for C6H14N+ [M−Y]+: 100.112624, found by LCMS, 
ESI-MS/MS (+) [M−Y]+: 100.27; HRMS, calculated for C8H7O3- [M−X]-: 151.03952, 
found by LCMS,ESI-MS/MS (-) [M−X]-: 150.97. 
 
6.1.7. (R)-2-Methylpiperidine (R)-103 
 
(R)-103-(S)-34 (0.25 g, 0.99 mmol) was dissolved into aqueous ammonia solution 
(10%, 10 mL) and was extracted with dichloromethane (20 mL). The mixture was 
separated and the aqueous layer was further extracted with dichloromethane (2 
205 
 
× 10 mL). The combined organic layer was dried with anhydrous MgSO4, filtered 
and the solvent was removed in vacuo to yield a pale yellow oil (0.063 g, 63%) 
with ee 100% (by chiral GC after derivatisation with acetic anhydride). 
 
[α]D 20 = -3.65° (c 2.0, methanol) {lit.181 [α]D22 = -8.5° (c 0.5, methanol)}; δH in ppm 
(500 MHz, CDCl3); δ 3.09-3.01 (m, 1H, H-2), 2.64 (td, J = 11.8 and 3.0 Hz, 1H, 
H-2), 2.61-2.55 (m, 1H, H-4), 1.80-1.72 (m, 1H, H-1), 1.62-1.52 (m, 3H, H-1, H-5 
and NH), 1.44-1.28 (m, 2H, H-6), 1.12-0.99 (m, 4H, H-5 and H-7); δc in ppm (300 
MHz, CDCl3); 52.3 (C-4), 47.1 (C-2), 34.6 (C-5), 26.1 (C-6), 24.3 (C-1), 23.0 (C-
7). The spectral data correspond to those for rac-3. νmax/ cm-1; 3270, 2925, 2854, 
2795, 1441, 1375, 1325, 1306. HRMS, calculated for C6H14N+ [M+H]+: 
100.112624, found by LCMS, ESI-MS/MS [M+H]+: 100.58 {lit.182 LCMS [M+H]+: 
100.1}. 
 
6.1.8. N-methyl-α-methylbenzylimine 94 
 
Acetophenone 51 (10 g, 83.2 mmol) and degassed ethanol (40 mL) were added 
to a round bottom flask containing molecular sieve (3 Å, 16 g) which was purged 
with nitrogen, followed by the addition of methylamine solution in ethanol (33 % 
w/w, 22 mL). The mixture was stirred at room temperature for 48 hours. The 
reaction was then filtered through celite and was washed with dichloromethane. 
The solvent was removed in vacuo to give a yellow oil (12.5 g) which contained 
about 10% 51 (by 1H NMR). The E/Z isomeric ratio of crude product 94 was not 
determined and was used directly in the next step without further purification. 
 
δH in ppm (500 MHz, CDCl3); 7.74 (dd, J = 6.5 and 3.0 Hz, 2H, H-4 and H-6), 
7.39-7.34 (m, 3H, H-1, H-2 and H-3), 3.34 (s, 3H, H-10), 2.22 (s, 3H, H-9); δc in 
ppm (126 MHz, CDCl3); 167.1 (C-7), 141.2 (C-5), 129.4 (C-2), 128.2 (C-4 and C-
6), 126.4 (C-1 and C-3), 39.5 (C-10), 15.1 (C-9). The spectral data correspond to 




6.1.9. Racemic N-methyl-α-methylbenzylamine 39 
 
Imine 94 (12.4 g, 93.1 mmol) was dissolved into methanol (200 mL). The mixture 
was cooled to < 0 °C. Sodium borohydride (18.3 g, 484.5 mmol) was added slowly 
in portions over 2 hours to maintain the temperature to < 10 °C. After the addition 
was complete, the reaction mixture was warmed to room temperature. After 24 
hours of stirring, the reaction was cooled to 0-5 °C and was acidified by aqueous 
hydrochloric acid (2 M, 250 mL). The mixture was concentrated in vacuo to give 
a white solid which was basified by aqueous sodium hydroxide (3 M, 200 mL). 
Dichloromethane (100 mL) was added and the mixture was separated. The 
aqueous layer was further extracted with dichloromethane (2 × 100 mL). The 
combined organic layer was dried by anhydrous MgSO4, filtered and the solvent 
was removed in vacuo to give a yellow oil (9.3 g). The crude product was purified 
by column chromatography using Biotage (ethyl acetate/ triethylamine gradient, 
95-96.5% ethyl acetate by volume); TLC: Silica plate, ethyl acetate/ triethylamine 
95:5 (v/v), visualisation by UV (254 nm; Rf of product = 0.33) to yield rac-39 as a 
pale yellow oil (7.9 g, overall yield from acetophenone 51 = 70%). 
 
δH in ppm (500 MHz, CDCl3); 7.36-7.26 (m, 4H, H-1, H-3, H-4 and H-6), 7.29-
7.24 (m, 1H, H-2), 3.64 (q, J = 6.5 Hz, 1H, H-7), 2.31 (s, 3H, H-10), 1.45 (br s, 
1H, NH), 1.35 (d, J = 6.5 Hz, 3H, H-9); δc in ppm (128 MHz, CDCl3); 145.4 (C-5), 
128.4 (C-1 and C-3), 126.9 (C-2), 126.6 (C-4 and C-6), 60.3 (C-7), 34.5 (C-10), 
23.9 (C-9). The spectral data correspond to those reported in the literature.183 
νmax/ cm-1; 3284, 3025, 2787, 1603, 1493, 1475, 1449, 1281, 1222. HRMS, 
calculated for C9H14N+ [M+H]+: 136.112624, found by LCMS, ESI-MS [M+H]+: 











(S)-34 (0.11 g, 0.74 mmol) was dissolved into ethyl isobutyrate (2 mL) and the 
solution was added to (R)-39 (0.10 g, 0.74 mmol). The slurry was heated to reflux 
until all solid dissolved. The mixture was cooled to room temperature with 
reduced stirring and was filtered to give a white solid which was dried in air 
overnight (0.17 g, 82%) with de = 100% (by 1H NMR in CDCl3, 500 MHz). Crystals 
suitable for XRD analysis were grown by slow diffusion of hexane into a saturated 
solution of (R)-39-(S)-34 in isopropyl acetate. 
 
M.p. = 109-111°C; [α]D23 = +62.3° (c 0.49, MeOH); δH in ppm (500 MHz, CDCl3); 
7.48 (d, J = 7.5 Hz, 2H, H-4 and H-6), 7.32 (m, 5H, H-1, H-2, H-3, H-11 and H-
13), 7.24 (m, 3H, H-12, H-14 and H-16), 4.91 (s, 1H, H-17), 3.68 (q, J = 6.9 Hz, 
1H, H-7), 1.99 (s, 3H, H-10), 1.46 (d, J = 6.9 Hz, 3H, H-9); δc in ppm (128 MHz, 
CDCl3); 178.5 (C-18), 142.6 (C-5), 136.3 (C-15), 129.2 (C-1 and C-3), 129.1 (C-
2), 128.1 (C-11 and C-13), 127.6 (C-14 and C-16), 127.3 (C-12), 126.8 (C-4 and 
C-6), 74.6 (C-17), 59.1 (C-7), 30.2 (C-10), 19.5 (C-9). νmax/ cm-1; 3029, 2698, 
2460, 1622, 1556, 1509, 1491, 1453, 1363, 1330, 1302, 1273. HRMS, calculated 
for C9H14N+ [M−Y]+: 136.112624, found: 136.1118; calculated for C8H7O3 [M−X]-: 






(S)-34 (0.11 g, 0.74 mmol) was dissolved into ethyl isobutyrate (1 mL) and the 
solution was added to (S)-39 (0.10 g, 0.74 mmol). The mixture was stirred 
overnight at room temperature for solid to precipitate which was then heated to 
reflux. After all solid dissolved, the mixture was cooled to room temperature with 
reduced stirring overnight. The slurry was filtered and the solid collected was 
dried in air overnight (0.14 g, 67%) with de = 100% (by 1H NMR in CDCl3, 500 
MHz). Crystals suitable for XRD analysis were grown by slow diffusion of hexane 
into a saturated solution of (S)-39-(S)-34 in isopropyl acetate. 
 
M.p. = 93-94 °C; [α]D23 = +37.5° (c 0.50, MeOH); δH in ppm (500 MHz, CDCl3); 
7.44 (m, H-4 and H-6), 7.36 (m, 3H, H-1, H-2 and H-3), 7.27 (m, 5H, H-11, H-12, 
H-13, H-14 and H-16), 4.89 (s, 1H, H-17), 3.42 (q, J = 6.8 Hz, 1H, H-7), 2.00 (s, 
3H, H-10), 1.37 (d, J = 6.8 Hz, 3H, H-9); δc in ppm (128 MHz, CDCl3); 178.5 (C-
18), 142.5 (C-5), 136.5 (C-15), 129.2 (C-1 and C-3), 129.1 (C-2), 128.1 (C-11 and 
C-13), 127.6 (C-14 and C-16), 127.2 (C-12), 126.8 (C-4 and C-6), 74.6 (C-17), 
59.0 (C-7), 30.3 (C-10), 19.9 (C-9). νmax/ cm-1; 3301, 2706, 2465, 1623, 1578, 
1451, 1380, 1359, 1330, 1314, 1279, 1220. HRMS, calculated for C9H14N+ [M−Y]+: 
136.112624, found: 136.1114; calculated for C8H7O3 [M−X]-: 151.039520, found: 
151.0398. 
 




(S,S)-32 (72.5 mg, 0.19 mmol) was dissolved into ethyl acetate/ methanol 10:1 
(v/v, 2.9 mL) and was added to (R)-39 (50.7 mg, 0.38 mmol). The mixture was 
stirred at room temperature overnight and then filtered. The solid was dried in air 
to obtain a white solid (0.1 g, 80%) with de 100% (by 1H NMR in d6-DMSO, 500 




M.p. = 160-163 °C; [α]D 20 = +102.2° (c 0.11, MeOH); δH in ppm (500 MHz, d6-
DMSO); 7.86 (d, J = 8.0 Hz, 4H, H-4 and H-6), 7.35 (m, 14H, H-1, H-2, H-3, H-
12, H-13, H-15, H-16, H-32, H-33, H-35 and H-36), 5.63 (s, 2H, H-20 and H-21), 
3.95 (q, J = 6.8 Hz, 2H, H-7), 2.37 (s, 6H, H-37 and H-38), 2.23 (s, 6H, H-10), 
1.35 (d, J = 6.8 Hz, 6H, H-9); δc in ppm (126 MHz, d6-DMSO); 169.6 (C-17 and 
C-23), 165.1 (C-26 and C-27), 143.1 (C-5), 139.1 (C-14 and C-24), 129.3 (C-4 
and C-6), 129.0 (C-13, C-15, C-32 and C-36), 128.6 (C-12, C-16, C-33 and C-
35), 128.1 (C-2), 127.8 (C-11 and C-34), 127.4 (C-1 and C-3), 74.3 (C-20 and C-
21), 57.9 (C-7), 30.7 (C-10), 21.1 (C-37 and C-38), 20.1 (C-8). νmax/ cm-1; 3016, 
2878, 1714, 1633, 1611, 1566, 1455, 1371, 1329, 1265. HRMS, calculated for 
C9H14N+ [M−Y]+: 136.112624, found: 136.1117; calculated for C20H17O8- 




A similar procedure as in Section 5.1.11(a) was used to synthesise [(S)-39]2-
(S,S)-32 using (S)-39 (50.2 mg, 0.37 mmol). A white solid was obtained (0.1 g, 
80%) with de 100% (by 1H NMR in d6-DMSO, 500 MHz). Crystals were 
recrystallised from ethyl acetate/ methanol 9:1 (v/v) for XRD analysis. 
 
M.p. = 179-182 °C; [α]D 20 = +69.3° (c 0.12, MeOH); δH in ppm (500 MHz, d6-
DMSO); 7.90 (d, J = 8.5 Hz, 4H, H-4 and H-6), 7.41 (dd, J = 7.0 and 1.5 Hz, 4H, 
H-13, H-15, H-32 and H-36), 7.32 (m, 10H, H-1, H-2, H-3, H-12, H-16, H-33 and 
H-35), 5.66 (s, 2H, H-20 and H-21), 3.99 (q, J = 6.8 Hz, 2H, H-2), 2.38 (s, 6H, H-
37 and H-38), 2.20 (s, 6H, H-10), 1.38 (d, J = 6.8 Hz, 6H, H-9); δc in ppm (126 
MHz, d6-DMSO); 169.1 (C-17 and C-23), 165.0 (C-26 and C-27), 143.2 (C-5), 
139.6 (C-14 and C-24), 129.3 (C-4 and C-6), 129.0 (C-13, C-15, C-32 and C-36), 
128.6 (C-12, C-16, C-33 and C-35), 128.0 (C-2), 127.6 (C-11 and C-34), 127.3 
(C-1 and C-3), 73.6 (C-20 and C-21), 58.0 (C-7), 31.0 (C-10), 21.1 (C-37 and C-
38), 20.5 (C-8). νmax/ cm-1; 3017, 2870, 1712, 1637, 1612, 1594, 1455, 1371, 
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1337, 1268; HRMS, calculated for C9H14N+ [M−Y]+: 136.112624, found: 136.1118; 
calculated for C20H17O8- [M−2X+H]-: 385.092345, found: 385.0919. 
 
6.1.12. Racemic N-Isopropyl-α-methylbenzylamine 101  
 
The crude product was prepared by Dr. Lisa Thompson. Acetone (250 mL) was 
added to rac-42 (10.0 g, 82.5 mmol) and the mixture was heated to reflux. After 
24 hours, the reaction was cooled to room temperature and the solvent was 
removed in vacuo to give a yellow oil. Methanol (200 mL) was added and the 
solution was cooled on ice. Sodium borohydride (5.6 g, 148.0 mmol) was added 
and the mixture was stirred on ice for 1.5 hours and for a further 2.5 hours at 
room temperature. The mixture was acidified by aqueous hydrochloric acid (2 M) 
and the solvent was removed in vacuo to give a white solid. Water and 
dichloromethane were added and the mixture was basified with aqueous sodium 
hydroxide (1 M). The layers were separated and the organic layer was washed 
with brine, dried with anhydrous MgSO4 and the solvent was removed in vacuo 
to give a yellow oil (8.5 g). The crude product was purified by column 
chromatography using Biotage (ethyl acetate/ triethylamine gradient, 96.3-98.5 
% ethyl acetate by volume; TLC: Silica plate, ethyl acetate/ triethylamine 95:5 
(v/v), visualisation by UV (254 nm; Rf of product = 0.49) to yield rac-101 as a pale 
yellow oil (7.4 g, 55%). 
 
δH in ppm (500 MHz, CDCl3); 7.34-7.30 (m, 4H, H-1, H-3, H-4 and H-6), 7.22 (tt, 
J = 1.8, 7 Hz, 1H, H-2), 3.88 (q, J = 6.5 Hz, 1H, H-7), 2.62 (hept, J = 6.2 Hz, 1H, 
H-10), 1.33 (d, J = 6.5 Hz, 3H, H-9), 1.02 (d, J = 6.2 Hz, 3H, H-11 or H-12), 0.99 
(d, J = 6.2 Hz, 3H, H-11 or H-12); δc in ppm (126 MHz, CDCl3); 146.2 (C-5), 128.4 
(C-1 and C-3), 126.7 (C-2), 126.5 (C-4 and C-6), 55.1 (C-7), 45.5 (C-10), 24.9 (C-
9), 24.1 (C-11 or C-12), 22.2 (C-11 or C-12). The spectral data correspond to 
those reported in the literature.184 νmax/ cm-1; 2960, 1602, 1492, 1465, 1451, 1367, 
1336. HRMS, calculated for C11H18N+ [M+H]+: 164.143924, found by LCMS, ESI-
MS [M+H]+: 164.41 {lit.184 HRMS (ESI) [M+H]+: 164.1434}. 
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6.1.13. Enantiopure N-isopropyl-α-methylbenzylamine 101 
(a) (R)-N-isopropyl-α-methylbenzylamine (R)-101 
 
Same procedures as the synthesis of rac-101 were applied to synthesise (R)-101 
using (R)-42 (2 g, 16.5 mmol). 
 
Yield = 1.8 g (68%); ee = 100% (by chiral GC after derivatisation with 
trifluoroacetic anhydride). [α]D23 = +56.1° (c 0.52, chloroform); 1H and 13C NMR, 
IR and MS data correspond to those reported for the racemate. 
 
(b) (S)-N-isopropyl-α-methylbenzylamine (S)-101 
 
Same procedures as the synthesis of rac-101 were applied to synthesise (S)-101 
using (S)-42 (1 g, 8.3 mmol). 
 
Yield = 0.64 g (48%); ee = 98% (by chiral GC after derivatisation with 
trifluoroacetic anhydride). [α]D23 = -61.9° (c 0.40, chloroform); 1H and 13C NMR, 












(S)-34 (0.094 g, 0.62 mmol) and (R)-101 (0.1 g, 0.62 mmol) were dissolved into 
isopropyl acetate (1.5 mL and 0.5 mL respectively). The two solutions were mixed 
and more isopropyl acetate (8 mL) was added. The mixture was heated to reflux. 
Isopropanol was added until all solid dissolved. The mixture was then cooled to 
room temperature with reduced stirring and was filtered to give a white fluffy solid 
(0.14 g, 74%) with de = 100% (by 1H NMR in CDCl3, 500 MHz). Single crystal 
structure was obtained by XRD analysis. 
 
M.p. = 169-174 °C; [α]D23 = +61.5° (c 0.39, methanol); δH in ppm (500 MHz, 
CDCl3); 7.52 (d, J = 7.5 Hz, 2H, H-4 and H-6), 7.32 (m, 7H, H-1, H-2, H-3, H-13, 
H-15, H-16 and H-18), 7.22 (t, J = 7.5 Hz, 1H, H-14), 4.94 (s, 1H, H-19), 3.99 (q, 
J = 6.6 Hz, 1H, H-7), 2.72 (hept, J = 6.5 Hz, 1H, H-10), 1.46 (d, J = 6.6 Hz, 3H, 
H-9), 1.12 (d, J = 6.5 Hz, 3H, H-11 or H-12), 0.96 (d, J = 6.5 Hz, 3H, H-11 or H-
12); δc in ppm (128 MHz, CDCl3); 177.2 (C-20), 142.4 (C-5), 136.9 (C-17), 129.1 
(C-1 and C-3), 128.8 (C-2), 128.0 (C-13 and C-15), 127.7 (C-16 and C-18), 127.1 
(C-14), 126.7 (C-4 and C-6), 74.7 (C-19), 55.5 (C-7), 47.2 (C-10), 20.6 (C-11 or 
C-12), 19.9 (C-11 or C-12), 17.6 (C-9). νmax/ cm-1; 3040, 2866, 2679, 2461, 1617, 
1568, 1518, 1490, 1446, 1364, 1329, 1265, 1217. HRMS, calculated for C11H18N+ 










(S)-34 (0.093 g, 0.61mmol) and (S)-101 (0.1 g, 0.61mmol) were dissolved into 
isopropyl acetate (1.5 mL and 0.5 mL respectively) at room temperature. The two 
solutions were mixed and was dried in vacuo to give a thick oil which solidified 
upon standing (0.17 g, 90%); de = 100% (by 1H NMR in CDCl3, 500 MHz). Single 
crystal structure was obtained by XRD analysis. 
 
M.p. = 97-102 °C; [α]D23 = +36.2° (c 0.51, methanol); δH in ppm (500 MHz, CDCl3); 
7.47 (d, 2H, H-4 and H-6), 7.40 (m, 5H, H-1, H-2, H-3, H-13 and H-15), 7.27 (m, 
3H, H-14, H-16 and H-18), 4.97 (s, 1H, H-19), 3.70 (q, J = 6.7 Hz, 1H, H-7), 2.69 
(m, 1H, H-10), 1.33 (d, J = 6.7 Hz, 3H, H-9), 1.09 (d, J = 6.5 Hz, 3H, H-11 or H-
12), 0.99 (d, J = 6.5 Hz, 3H, H-11 or H-12); δc in ppm (128 MHz, CDCl3); 177.3 
(C-20), 141.9 (C-5), 136.8 (C-17), 129.2 (C-1 and C-3), 128.9 (C-2), 128.0 (C-13 
and C-15), 127.6 (C-16 and C-18), 127.3 (C-14), 126.7 (C-4 and C-6), 74.4 (C-
19), 55.4 (C-7), 47.3 (C-10), 20.7 (C-11 or C-12), 19.7 (C-11 or C-12), 17.7 (C-
9). νmax/ cm-1; 3385, 2985, 2716, 2514, 1709, 1625, 1596, 1454, 1390, 1357, 1276, 
1214. HRMS, calculated for C11H18N+ [M−Y]+: 164.143924, found: 164.1429; 
calculated for C8H7O3- [M−X]-: 151.039520, found: 151.0395. 
 
6.1.15. Diastereopure (S)-mandelate salts of α-methylbenzylamine 42 
(a) (R)-42-(S)-34 
 
(S)-34 (0.13 g, 0.83 mmol) as dissolved into isopropyl acetate (2 mL) and was 
added to (R)-42 (0.1 g, 0.83 mmol). The mixture was heated to reflux. Isopropyl 
acetate/ methanol (10% v/v, 4.4 mL) was added until solid dissolved. Stirring was 
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stopped. The reaction mixture was cooled to room temperature and filtered to 
give a white crystalline solid (0.12 g, 52%). Small amount of crystals was 
dissolved into aqueous sodium carbonate solution (10% w/v, 1 mL) and extracted 
with ethyl acetate (1 mL). The organic layer was dried with anhydrous MgSO4, 
filtered through a plug of celite and dried in vacuo. The residue was re-dissolved 
into methanol (1 mL). Triethylamine (10 μL) was added followed by benzoyl 
chloride (5 μL) and the sample was analysed by chiral HPLC to determine the ee 
of 42 (100%) which corresponds to the de of the crystals. Single crystal structure 
was obtained by XRD analysis. 
 
M.p. = 108-109 °C; [α]D 20 = +69.9° (c 1.0, water); δH in ppm (400 MHz, d6-DMSO); 
7.44 (d, J = 7.2 Hz, 2H, H-4 and H-6), 7.41-7.29 (m, 5H, H-1, H-2, H-3, H-13 and 
H-15), 7.23 (t, J = 7.3 Hz, 2H, H-10 and H-12), 7.15 (t, J = 7.3 Hz, 1H, H-11), 4.53 
(s, 1H, H-16), 4.29 (q, J = 6.8 Hz, 1H, H-7), 1.42 (d, J = 6.8 Hz, 3H, H-8); δC in 
ppm (75 MHz, d6-DMSO); 174.6 (C-17), 144.0 (C-5), 141.5 (C-14), 129.0 (C-1 
and C-3), 128.4 (C-2), 127.8 (C-4 and C-6), 127.0 (C-13 and C-15), 126.8 (C-10 
and C-12), 126.5 (C-11), 73.8 (C-16), 50.4 (C-7), 22.1 (C-8); νmax/ cm-1; 3434, 
2844, 1634, 1574, 1537, 1448, 1378, 1351. HRMS, calculated for C8H12N+ 





A similar procedure as in Section 5.1.15(a) was used to synthesise (S)-42-(S)-34. 
Isopropyl acetate/ methanol (25% v/ve, 10 mL) was added to the hot solution of 
(S)-42/ (S)-34 in isopropyl acetate for complete dissolution of the precipitate. (S)-
42-(S)-34 was isolated as a white crystalline solid (0.16 g, 71%) with de = 100% 





M.p. = 172-175 °C; [α]D 20 = +65.6° (c 1, water); δH in ppm (400 MHz, d6-DMSO); 
7.44 (d, J = 6.8 Hz, 2H, H-4 and H-6), 7.41-7.29 (m, 5H, H-1, H-2, H-3, H-13 and 
H-15), 7.24 (t, J = 7.3, 7.2 Hz, 2H, H-10 and H-12), 7.16 (t, J = 7.3 Hz, 1H, H-11), 
4.54 (s, 1H, H-16), 4.28 (q, J = 6.8 Hz, 1H, H-7), 1.43 (d, J = 6.8 Hz, 3H, H-8); δC 
in ppm (75 MHz, d6-DMSO); 174.3 (C-17), 143.5 (C-5), 140.8 (C-14), 128.5 (C-1 
and C-3), 127.9 (C-2), 127.3 (C-4 and C-6), 126.5 (C-13 and C-15), 126.3 (C-10 
and C-12), 126.0 (C-11), 73.3 (C-16), 49.9 (C-7), 21.5 (C-8); νmax/ cm-1; 3301, 
2915, 1610, 1565, 1530, 1450, 1379. HRMS, calculated for C8H12N+ [M−Y]+: 
122.096974, found: 122.0931; calculated for C8H7O3- [M−X]-: 151.039520, found: 
151.0400. 
 




(S,S)-32 (0.26 g, 0.67 mmol) and (R)-46 (99.7 mg, 0.67 mmol) were dissolved 
into isopropyl acetate (3 mL and 2 mL respectively). The two solutions were 
mixed and heated to reflux with stirring. More isopropyl acetate (9 mL) was added 
until all solid dissolved. Stirring was stopped. The reaction mixture was cooled to 
room temperature and filtered to give a white crystalline solid (0.24 g, 67%). Small 
amount of crystals was dissolved into aqueous sodium carbonate solution (10% 
w/v, 1 mL) and extracted with ethyl acetate (1 mL). The organic layer was dried 
with anhydrous MgSO4 and filtered through a plug of celite. A solution of (S)-34 
in methanol (21 mg mL-1, 100 μL) was added and the mixture was sonicated, then 
dried in vacuo. The residue was analysed by 1H NMR (CDCl3, 500 MHz) to 
determine the ee of 46 (100%) which corresponds to the de of the crystals. Single 
crystal structure was obtained by XRD analysis. 
 
M.p. = 129-130 °C; [α]D 20 = +128.4° (c 0.5, methanol); δH in ppm (500 MHz, d6-
DMSO); 7.83 (d, J = 8.0 Hz, 4H, H-14, H-16, H-28 and H-32), 7.45-7.39 (m, 2H, 
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H-4 and H-6), 7.39-7.34 (m, 3H, H-1, H-2 and H-3), 7.31 (d, J = 8.0 Hz, 4H, H-13, 
H-17, H-29 and H-31), 5.67 (s, 2H, H-22 and H-23), 4.10 (br d, J = 7.3 Hz, 1H, H-
7), 2.44 (s, 6H, H-10 and H-11), 2.35 (s, 6H, H-18 and H-39), 1.45 (d, J = 7.3 Hz, 
H-8); δC in ppm (75 MHz, d6-DMSO); 168.1 (C-19 and C-25), 164.8 (C-33 and C-
34), 143.8 (C-15 and C-26), 136.7 (C-5), 129.3 (C-14, C-16, C-28 and C-32), 
129.3 (C-13, C-17, C-29 and C-31), 129.1 (C-2), 128.8 (C-5), 128.7 (C-4 and C-
6), 128.5 (C-1 and C-3), 126.7 (C-18 and C-39), 72.0 (C-22 and C-23), 64.4 (C-
7), 21.2 (C-18 and C-39), 16.8 (C-8); νmax/ cm-1; 2984, 2731, 1719, 1680, 1610, 
1456, 1406, 1388, 1338, 1265, 1252, 1232. HRMS, calculated for C10H15N+ 
[M−Y]+: 150.128274, found: 150.1249; calculated for C20H17O8- [M−X]-: 




A similar procedure as in Section 5.1.16(a) was used to synthesise (S)-46-(S,S)-
32. After more isopropyl acetate was added to the hot solution of (S)-46/ (S,S)- 
32, isopropyl alcohol (8 mL) was added for the complete dissolution of the 
precipitate. (S)-46-(S,S)-32 was isolated as a white crystalline solid (0.26 g, 73%) 
with de = 100% (determined as the ee of 46). Single crystal structure was 
obtained by XRD analysis. 
 
M.p. = 140-141 °C; [α]D 20 = +200.2° (c 0.5, methanol); δH in ppm (500 MHz, d6-
DMSO); 7.84 (d, J = 8.0 Hz, 4H, H-14, H-16, H-28 and H-32), 7.45-7.39 (m, 2H, 
H-4 and H-6), 7.35 (t, J = 3.3 Hz, 3H, H-1, H-2 and H-3), 7.31 (d, J = 8.0 Hz, 4H, 
H-13, H-17, H-29 and H-31), 5.68 (s, 2H, H-22 and H-23), 4.13 (q, J = 6.7 Hz, 1H, 
H-7), 2.43 (s, 6H, H-10 and H-11), 2.36 (s, 6H, H-18 and H-39), 1.47 (d, J = 6.7 
Hz, H-8); δC in ppm (75 MHz, d6-DMSO); 168.0 (C-19 and C-25), 164.8 (C-33 
and C-34), 143.8 (C-15 and C-26), 136.8 (C-5), 129.3 (C-14, C-16, C-28 and C-
32), 129.2 (C-13, C-17, C-29 and C-31), 129.1 (C-2), 128.8 (C-5), 128.6 (C-4 and 
C-6), 128.5 (C-1 and C-3), 126.7 (C-18 and C-39), 71.9 (C-22 and C-23), 64.3 
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(C-7), 21.2 (C-18 and C-39), 16.8 (C-8); νmax/ cm-1; 2955, 2701, 1719, 1681, 1611, 
1458, 1408, 1325, 1251. HRMS, calculated for C10H15N+ [M−Y]+: 150.128274, 
found: 150.1248; calculated for C20H17O8- [M−X]-: 385.092345, found: 385.0818. 
 
6.1.17. Racemic proparyl aminoindan 109 
 
Racemic 1-aminoindan (4.0 g, 29.8 mmol) was dissolved into toluene (15 mL) in 
a 100 mL three-neck round bottom flask under nitrogen. Aqueous sodium 
hydroxide solution (1.6 M, 32 mL) was added and the mixture was heated to 40 
°C. A solution of propargyl benzenesulfonate (96%, 6.2 g, 30.3 mmol) in toluene 
(5 mL) was added slowly over one hour. The reaction was stirred at 45 °C for 5 
hours. After the reaction was complete, water (20 mL) was added and the mixture 
was separated. The aqueous later was further extracted with toluene (2 × 20 mL). 
The combined organic layer was washed with aqueous sodium hydroxide 
solution (5 M, 20 mL) followed by water (20 mL). The organic layer was dried with 
anhydrous MgSO4, filtered and concentrated in vacuo to give a brown oil with fine 
precipitate. Ethyl acetate was added and the crude mixture was filtered. The 
filtrate was dried in vacuo and was purified by column chromatography using 
Biotage (ethyl acetate/ petroleum 40-60 gradient, 20 to 80% ethyl acetate by 
volume); TLC: Silica plate, ethyl acetate/ trimethylamine 95:5 (v/v), visualisation 
by UV (254 nm; Rf of product = 0.84) to yield the rac-109 as a brown oil (2.8 g, 
54%). 
 
δH in ppm (300 MHz, CDCl3); 7.37-7.27 (m, 1H, H-3), 7.26-7.13 (m, 3H, H-1,H-2 
and H-6), 4.39 (t, J = 6.2 Hz, 1H, H-7), 3.49 (t, J = 2.4, 1.5 Hz, 2H, H-11), 3.02 
(ddd, J = 15.6, 8.7 and 6.6 Hz, 1H, H-9); 2.80 (ddd, J = 15.6, 8.7 and 6.6 Hz, 1H, 
H-9), 2.45-2.30 (m, 1H, H-8), 2.24 (t, J = 2.4 Hz, 1H, H-13), 1.91-1.76 (m, 1H, H-
8), 1.62 (br s, NH); δc in ppm (75 MHz, CDCl3); 144.5 (C-4), 143.8 (C-5), 127.7 
(C-3), 126.3 (C-2), 124.9 (C-1), 124.2 (C-6), 82.5 (C-12), 71.5 (C-13), 61.9 (C-7), 
36.2 (C-11), 33.3 (C-8), 30.5 (C-9); νmax/ cm-1; 3290, 3231, 2940, 2851, 2129, 
1636, 1558, 1478, 1328. The spectral data correspond to those reported in the 
literature.185 HRMS, calculated for C12H14N [M+H]+: 172.112624, found: 172.0679. 
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6.1.18. Diastereopure (S)-mandelate salt of Rasagiline (R)-109 (for the 
preparation of pure (R)-109) 
 
Rasagiline mesylate (1.0 g, 3.7 mmol) was dissolved into aqueous ammonia 
solution (10%, 20 mL) and aqueous sodium hydroxide solution (4 M, 25 mL). 
MTBE (40 mL) was added and the mixture was stirred at room temperature. The 
mixture was separated and the aqueous layer was further extracted with MTBE 
(2 × 20 mL). The combined organic layer was dried with anhydrous MgSO4, 
filtered and dried in vacuo to give a pale yellow oil (0.58 g, 91%, 82% ee). MTBE/ 
methanol (4% v/v) (10 mL) was added to a mixture of crude (R)-109 (0.53 g, 3.1 
mmol) and (S)-34 (0.47 g, 3.1 mmol) and was stirred and heated to reflux. More 
solvent was added until all solid dissolved (30 mL). The mixture was cooled to 
room temperature with reduced stirring. After about 4 hours, the slurry was filtered 
to give a white fluffy solid (0.61 g, 61% from crude (R)-109). A small amount of 
crystals was dissolved into aqueous sodium carbonate solution (10% w/v, 600 
μL) and extracted with ethyl acetate (600 μL). The organic layer was dried with 
anhydrous MgSO4 and filtered through a plug of celite. The filtrate was analysed 
by chiral GC to determine the ee of 109 (100%) which corresponds to the de of 
the crystals. 
 
M.p. = 108-110 °C; [α]D 20 = +75.6° (c 0.5, ethanol); δH in ppm (500 MHz, CDCl3); 
7.37 (d, J = 7.0 Hz, 2H, H-17 and H-19), 7.35-7.18 (m, 6H, H-1, H-2, H-3, H-6, H-
14 and H-16), 7.12 (t, J = 7.3 Hz, 1H, H-15), 6.77 (br s, 3H, OH and NH2+), 4.86 
(s, 1H, H-20), 4.58 (dd, J = 7.5, 3.5 Hz, 1H, H-7), 3.38 (qd, J = 16.8, 2.4 Hz, 2H, 
H-11), 3.04 (dt, J = 16.0, 8.3 Hz, 1H, H-9), 2.77 (ddd, J = 16.0, 8.3, 4.0 Hz, 1H, 
H-9), 2.33 (t, J = 2.4 Hz, 1H, H-13), 2.31-2.20 (m, 1H, H-9), 2.07-1.96 (m, 1H, H-
9); δC in ppm (75 MHz, CDCl3); 177.9 (C-22), 144.7 (C-4), 141.0 (C-18), 138.5 
(C-5), 129.3 (C-2), 128.1 (C-1), 127.5 (C-15), 126.8 (C-6), 126.6 (C-17 and C-
19), 125.3 (C-3), 125.2 (C-14 and C-16), 75.6 (C-13), 73.8 (C-20), 60.9 (C-7), 
34.0 (C-11), 30.3 (C-9), 29.7 (C-8); νmax/ cm-1; 3404, 3232, 2133, 1637, 1557, 
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1453, 1405, 1328, 1312. HRMS, calculated for C12H14N+ [M−Y]+: 172.112624, 
found: 172.1090; calculated for C8H7O3- [M−X]-: 151.039520, found: 151.0406. 
 
6.1.19. Rasagiline (R)-109 
 
(R)-109-(S)-34 (79.6 mg, 0.25 mmol) was dissolved into aqueous potassium 
carbonate solution (0.1 M, 20 mL). Dichloromethane (20 mL) was then added and 
was stirred for about 10 minutes. The mixture was separated and the aqueous 
layer was further extracted with dichloromethane (2 × 20 mL). The combined 
organic layer was dried by anhydrous MgSO4 and filtered. The solvent was 
removed in vacuo to yield (R)-109 as a brown oil (35.6 mg, 85%). 
 
[α]D 20 = +25.4° (c 1.0, chloroform) {lit.185 [α]D 20 = +17.6° (c 1.0, chloroform)}. The 
spectral and MS data correspond to those reported for rac-109 and from the 
literature. 
 
6.1.20. O-Acetyl-(1S,2R)-N-methylephedrine 49 
 
(1S,2R)-N-Methylephedrine 110 (99.8 mg, 0.56 mmol) was dissolved in 
dichloromethane (3 mL) and the solution was cooled in ice. Triethylamine (156 
μL) was added followed by acetyl chloride (60 μL). The slurry was stirred at room 
temperature overnight. The reaction mixture was diluted with dichloromethane (5 
mL) and basified with aqueous sodium hydroxide solution (1 M, 5 mL) and the 
mixture was separated. The aqueous layer was further extracted with 
dichloromethane (2 × 5 mL). The combined organic layer was washed with 
aqueous sodium hydroxide solution (1 M, 5 mL), dried in anhydrous MgSO4 and 
filtered. The solvent was removed in vacuo to yield (1S,2R)-111 as a brown oil 
(0.1 g, 81%). The crude product was used without further purification. 
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δH in ppm (500 MHz, CDCl3); 7.34-7.29 (m, 2H, H-4 and H-6), 7.29-7.21 (m, 3H, 
H-1, H-2 and H-3), 5.94 (d, 1H, H-7), 2.90-2.83 (m, 1H, H-8), 2.28 (s, 6H, H-12 
and H-13), 2.09 (s, 3H, H-16), 1.05 (d, J = 6.5 Hz, 3H, H-10); δc in ppm (75 MHz, 
CDCl3); 170.0 (C-14), 140.1 (C-5), 128.2 (C-4 and C-6), 127.5 (C-2), 126.3 (C-1 
and C-3), 75.5 (C-7), 63.6 (C-8), 41.4 (C-12 and C-13), 21.3 (C-16), 9.5 (C-10); 
νmax/ cm-1; 2971, 2939, 2866, 2825, 2779, 1738, 1639, 1453, 1372, 1232. HRMS, 
calculated for C13H20NO2 [M+H]+: 222.149404, found: 222.0944. 
 
6.1.21. Triethylammonium (S)-mandelate 34 
 
Triethylamine (0.7 mL, 5.0 mmol) and (S)-34 (0.3 g, 2.0 mmol) were stirred in 
ethyl acetate (10 mL) at room temperature for 3 hours. The solvent was removed 
in vacuo to yield Et3N-(S)-34 as a colourless oil (0.47 g, 94%).  
 
[α]D 20 = +62.1° (c 1.0, methanol); δH in ppm (500 MHz, d6-DMSO); 7.39 (d, J = 
7.3 Hz, 2H, H-4 and H-6), 7.28 (t, J = 7.3 Hz, 2H, H-1 and H-3), 7.22 (t, J = 7.3 
Hz, 1H, H-2), 4.71 (s, 1H, H-7), 2.93 (q, J = 7.3 Hz, 4H, H-13, H-15 and H-17), 
1.10 (t, J = 7.3 Hz, 6H, H-12, H-16 and H-18); δc in ppm (126 MHz, d6-DMSO); 
174.7 (C-8), 142.5 (C-5), 127.6 (C-1 and C-3), 126.5 (C-2), 126.4 (C-4 and C-6), 
73.1 (C-7), 45.1 (C-13, C-15 and C-17), 8.8 (C-12, C-16 and C-18). νmax/ cm-1; 
3324, 2984, 2431, 1732, 1599, 1494, 1478, 1452, 1339. HRMS, calculated for 
C6H16N+ [M−Y]+: 102.128274, found by LCMS, ESI-MS/MS (+) [M−Y]+: 102.3; 
HRMS, calculated for C16H14O6Na- [M−X+Y+Na]-: 325.068809, found by LCMS, 
ESI-MS/MS (-) [M−X+Y+Na]-: 325.1. 
 




Triethylamine (0.35 mL, 2.5 mmol) and phenylglyoxylic acid (0.15 g, 1.0 mmol) 
were stirred in ethyl acetate (5 mL) at room temperature overnight. The solvent 
was removed in vacuo to yield Et3N-126 as a thick pale yellow oil (0.24 g, 95%).  
 
δH in ppm (500 MHz, d6-DMSO); 7.85 (m, 2H, H-4 and H-6), 7.62 (tt, J = 7.3 and 
1.5 Hz, 1H, H-2), 7.52 (m, 2H, H-1 and H-3), 3.10 (q, J = 7.4 Hz, 6H, H-13, H-15 
and H-17), 1.21 (t, J = 7.4 Hz, 9H, H-12, H-16 and H-18); δc in ppm (126 MHz, 
d6-DMSO); 195.1 (C-7), 169.6 (C-8), 134.1 (C-2), 133.0 (C-5), 128.9 (C-4 and C-
6), 128.5 (C-1 and C-3), 45.4 (C-13, C-15 and C-17), 8.5 (C-12, C-16 and C-18). 
νmax/ cm-1; 2987, 2639, 2489, 1676, 1594, 1475, 1450, 1398, 1311, 1224. HRMS, 
calculated for C6H16N+ [M−Y]+: 102.128274, found by LCMS, ESI-MS/MS (+) 
[M−Y]+: 102.3; HRMS, calculated for C16H10O6Na- [M−X+Y+Na]-: 321.037509, 
found by LCMS, ESI-MS/MS (-) [M−X+Y+Na]-: 321.1. 
 
6.2 Racemisation of chiral amines 
6.2.1. General procedures for racemisation in batch  
The racemisation of (S)-39 (0.5 M) in toluene by SCRAM 64 was described as an 
example. Catalyst 64 (5.1 mg, 4.4 μmol) and a stirrer bar were added into a three-
neck round bottom flask and was flushed with nitrogen for 10 minutes. (S)-39 (0.3 
g, 2.2 mmol, 323 μL) and n-decane (31.2 mg, 0.22 mmol, 43 μL) were dissolved 
into toluene (4 mL, dried over molecular sieves). The solution was added to the 
catalyst. The reaction was stirred and heated to 105 °C for 24 hours. The reaction 
was sampled (20 μL) before heating and during the reaction by diluting the 
sample into ethyl acetate (980 μL). The samples were analysed by GC for 
conversion and chiral GC for the determination of ee, after derivatisation with 
trifluoroacetic anhydride (30 μL).  
 
A similar procedure was employed for the racemisation of other substrates under 
designated conditions (Table 6.2). The ee of the samples were determined by 



















(S)-39 0.1 64 (0.2) Toluene 105 0.1   20[d] 
(S)-39 0.25 64 (0.2) Toluene 105 0.1 40 
(S)-39 0.5 64 (0.2) Toluene 105 0.1 20 
(S)-39 1 64 (0.2) Toluene 105 0.1 10 
(S)-39 2 64 (0.2) Toluene 105 0.1 5 
(S)-39[e] 0.25 64 (1) EtOAc 60 0.2   4[d] 
(S)-39[e] 0.25 64 (1) EtOAc/ MeOH (20%) 60 0.2   4[d] 
(S)-39[e] 0.25 64 (1) EtOAc/ EtOH (20%) 60 0.2   4[d] 
(S)-39[e] 0.25 64 (1) EtOAc/ iPrOH (20%) 60 0.2   4[d] 
(S)-39 0.5 55 (0.2) Toluene 105 0.5 40 
(R)-101 0.5 64 (0.2) Toluene 105 0.1 20 
(S)-46 0.5 64 (0.2) Toluene 105 0.1 20 
(R)-46 0.1 64 (0.2) Toluene 105 0.5   20[f] 
(R)-46 0.1 64 (1) Toluene 105 0.2   50[f] 
(R)-46 0.1 64 (1) Toluene/ 58 (1.4%) 105 0.2   50[f] 
(R)-46 0.1 64 (1) Toluene/ 58 (50%) 105 0.2   50[f] 
(R)-9 0.1 64 (0.2) Toluene 60 0.1   10[f] 
(R)-9 0.1 64 (0.2) 
EtOAc/ MeOH 
(12.5%) 
60 0.1   10[f] 
(R)-9 0.1 64 (0.2) 
EtOAc/ iPrOH 
(12.5%) 
60 0.1   10[f] 
(S)-103 0.5 64 (0.2) MTBE 50 NA   20[e] 
(S)-103 0.5 64 (0.2) iPrOAc 80 0.1   20[f] 
(S)-103 0.5 64 (0.2) Toluene 105 0.1   20[f] 
Table 6.2 Reaction conditions for the racemisation of chiral amines. [a]The percent in 
bracket refers to volume percent. [b]Internal standard. n-Decane was used for all except 
(R)-9 which used n-hexadecane. [c]The samples were diluted to 1 mL by EtOAc. [d]The 
samples were diluted to 200 μL. [e]Volume of reaction is 2.2 mL. [f]MeOH was used as 








Amine ee Method Derivatisation of samples (μL) 
39 Chiral GC (Fig. 6.15) Trifluoroacetic anhydride (30-50) 
101 Chiral GC (Fig. 6.16) Trifluoroacetic anhydride (100) 
46 
1H NMR (CDCl3, 500 MHz)  
(Fig. 6.24)[a] 
(S)-34 (100)[b] 
42 Chiral HPLC (Fig. 6.18) 
Triethylamine (10) followed by 
benzoyl chloride (3) 
9 Chiral HPLC (Fig. 6.9) NA 
103 Chiral GC (Fig. 6.13 and Fig. 6.14) 
Acetic anhydride (10) or  
benzoyl chloride (10) 
Table 6.3 Methods for ee analysis of different amine substrates. [a]A solution of (S)-34 in 
MeOH (21 mg mL-1, 100 μL) was added to the sample, sonicated for 5-10 min and dried 
in vacuo. The residue was analysed by 1H NMR (CDCl3, 500 MHz). 
[b](S)-34 was added 
as a 21 mg mL-1 solution in MeOH (100 μL) 
 
6.2.2. General procedures for the racemisation of (S)-39 (0.5 M) in batch 
with spiking of (S)-39 
A similar procedure as in Section 1 was employed. After 25 to 26 hours where 
the racemisation stopped, or reached 0% ee, (S)-39 (0.5 equiv. with respect to 
the original amount of (S)-39 in the reaction) and n-decane (0.25 equiv.) were 
dissolved into toluene and was charged into the reaction mixture at 105 °C. The 
reaction was sampled immediately after the addition and at specific times. When 
Shvo’s catalyst 55 was used, the same spiking procedure was repeated two times. 
 
6.2.3. Racemisation of (S)-39 (0.5 M) in batch with spiking of methylamine 
(2 equiv. with respect to iridium) 
A similar procedure as in Section 1 was employed. SCRAM 64 (25.8 mg, 22.2 
μmol) and tetrahydrofuran (4 mL) were used and the reaction was heated to 60 
°C. After 30 minutes, where ee of 39 reached approximately 50%, methylamine/ 
tetrahydrofuran solution (1.7 M, 52.2 μL, 88.7 μmol) was added. The reaction was 
sampled 15 minutes after the addition and at specific times for 24 hours. The 
same procedures were repeated for spiking 20 equiv. of methylamine (520 μL, 




6.2.4. NMR titration of SCRAM 64 with methylamine 
Catalyst 64 (3.1 mg, 2.7 μmol, 5.3 μmol iridium) and benzene (9.1 mg, 10 μL, 
0.117 mmol) were dissolved into d6-dimethylsulfoxide (0.6 mL). The sample was 
analysed by 1H NMR (500 MHz). Methylamine/ methanol solution (2 M) was 
added as shown in Table 6.4. After each addition, the sample was shaken for 60 




Total MeNH2 (μmol) 
Total vol. of MeNH2 
(in MeOH) (μL) 
Vol. of MeNH2 (in 
MeOH) added (μL) 
0 0 0 0 
0.5 2.7 1.33 1.33 
1 5.3 2.67 1.34 
2 10.7 5.33 2.66 
3 16.0 8 2.67 
4 21.3 10.7 2.7 
5 26.7 13.3 2.6 
7.5 40.0 20 6.7 
10 53.3 26.7 6.7 
15 80.0 40 13.3 
20 106.7 53.3 13.3 
30 160.0 80 26.7 
40 213.3 106.7 26.7 






6.2.5. General procedures for racemisation in flow 
(a) (S)-N,α-Dimethylbenzylamine 39 
(i) Configuration A (Fig. 2.20(a) and Fig. 6.25) (Table 2.10, entry 2) 
 
Fig. 6.25 Configuration A for flow racemisation (corresponds to the schematic in Fig. 
2.20(a)) 
 
The experimental set-up for configuration A was shown in Fig. 6.25. Catalyst 92 
(ICP 6.3%, 0.24 g, 79.3 μmol Ir) was loaded onto an empty stainless HPLC 
column (3 mL). The column was equilibrated with ethyl acetate/ methanol (20% 
v/v) at 0.25 mL min-1 by a syringe pump and was heated to 73 °C by a hot plate. 
A solution of (S)-39 (0.21 g, 1.6 mmol) and n-decane (10.5 mg, 73.8 μmol) in 
ethyl acetate/ methanol (20% v/v) (15 mL) was pumped through the column at 
0.25 mL min-1 (tRes = 12 minutes) at 73 °C. The eluent was collected in reactor 
volumes (RV). When all reaction mixture was pumped through, the column was 
washed with ethyl acetate/ methanol mixture whilst cooling to room temperature. 
The reaction was sampled before pumping through the column and from the 
eluent collected. Each sample (200 μL) was diluted into ethyl acetate (800 μL) 
and analysed by GC for determining the conversion of 39 and chiral GC for 
determining the ee after derivatising the samples with trifluoroacetic anhydride 
(60 μL) (Table 6.5). 
 
 
Aluminium heating blockStainless steel column (3 mL)
Collection 
flask












RV 39 (%) ee of 39 (%) 
0 100 100 
1 84 90 
2 100 84 
3 100 86 
4 99 86 
5 98 87 
Average (RV2-5) 99 86 
Drop[a] 1 14 
Table 6.5 Results for the racemisation of (S)-39 in flow at 73 °C in EtOAc/ MeOH (20% 
v/v) (tRes = 12 min) using configuration A. 
[a]Drop = RV0 – average (RV2-5) 
 
(ii) Configuration B (Fig. 2.20(b) and Fig. 6.26) (Table 2.10, entry 1) 
 
Fig. 6.26 Configuration B for flow racemisation (corresponds to the schematic in Fig. 2.20 
(b)) 
 
The racemisation of (S)-39 was also carried out in flow using configuration B (Fig. 
6.26). A similar procedure as in configuration A was employed. Catalyst 92 (ICP 
6.3%, 0.32 g, 0.11 mmol iridium) and sand (5.5 g) were mixed and loaded onto a 















acetate. A solution of (S)-39 (0.3 g, 2.1 mmol, ee 86%) and n-decane (28.4 mg, 
0.2 mmol) in isopropyl acetate (20 mL) was pumped through the catalyst at 80 °C 
at 0.1 mL min-1 (tRes = 40 minutes). The column was flushed with isopropyl alcohol 
after the reaction whilst cooled to room temperature. Each sample (100 μL) from 
each RV was diluted into ethyl acetate (900 μL) and analysed by GC and chiral 
GC as described for configuration A (Table 6.6). 
 
RV 39 (%) ee of 39 (%) 
0 100 86 
1 85 48 
2 97 43 
3 98 44 
4 98 44 
5 98 43 
Average (RV2-5) 98 44 
Drop[a] 2 42 
Table 6.6 Results for the racemisation of (S)-39 in flow at 80 °C in iPrOAc (tRes = 40 min) 
using configuration B. [a]Drop = RV0 – average (RV2-5) 
 
(b) (R)-N-Isopropyl-α-methylbenzylamine 101 (Table 2.10, entry 3) 
Configuration B was used for the racemisation of (R)-101 in flow. A similar 
procedure as in Section 5.2.5(a)(ii) was employed. Catalyst 92 (ICP 6.3%, 0.32 
g, 0.11 mmol) and sand (5.5 g) were mixed and loaded onto the stainless steel 
HPLC column (4 mL). The column was equilibrated with ethyl isobutyrate. A 
solution of (R)-101 (0.17 g, 1 mmol) was dissolved into ethyl isobutyrate (20 mL) 
was pumped through the catalyst at 80 °C at 0.05 mL min-1 (tRes = 80 minutes). 
Each sample (100 μL) from each RV was diluted into ethyl acetate (900 μL) and 
analysed by chiral GC as described in Section 5.2.5(a) (Table 6.7). Conversion 
















Average (RV2-5) 86 
Drop[a] 14 
Table 6.7 Results for the racemisation of (S)-101 in flow at 80 °C in ethyl isobutyrate (tRes 
= 80 min) using configuration B. [a]Drop = RV0 – average (RV2-5) 
 
(c) (S)-N,N-Dimethyl-α-methylbenzylamine 46 (Table 2.10, entries 4 and 
5) 
Configuration B was used for the racemisation of (S)-46 in flow. A similar 
procedure as in Section 5.2.5(a)(ii) was employed. Catalyst 92 (ICP 7.7%, 0.25 
g, 0.1 mmol) and sand (5.7 g) were mixed and loaded onto the stainless steel 
HPLC column (4 mL). The column was equilibrated with isopropyl alcohol then 
isopropyl acetate/ isopropyl alcohol (30%). A solution of (S)-46 (0.15 g, 1 mmol) 
in isopropyl acetate/ isopropyl alcohol (30%) (20 mL) was pumped through the 
catalyst at 0.05 mL min-1 (tRes = 80 minutes) at 80 °C. A methanol solution of (S)-
34 (21 mg mL-1, 100 μL) was added to each sample (200 μL) from each RV. The 
sample was sonicated and dried in vacuo and analysed by 1H NMR (CDCl3, 500 
MHz) to determine the ee of 46 (Table 6.8). Conversion was not measured. The 














ee of 46 (%) 
tRes = 80 min tRes = 120 min 
0 100 100 
1 100 N.D.[a] 
2 87 68 
3 89 82 
4 89 86 
5 90 85 
Average (RV2-5) 89 84 
Drop[b] 11 16 
Table 6.8 Results for the racemisation of (S)-46 in flow at 80 °C in iPrOAc/ iPrOH (30% 
by volume) (tRes = 80 and 120 min) using configuration B. 
[a]Not determined.  [b]Drop = 
RV0 – average (RV2-5) 
 
(d) (R)-6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 (Table 
2.10, entries 6 and 7) 
Configuration A was used for the racemisation of (R)-9 in flow. A similar 
procedure as in Section 5.2.5(a)(i) was employed. Catalyst 92 (ICP 7.7%, 0.19 g, 
74.8 μmol iridium) and sand (4 g) were mixed and loaded onto the stainless steel 
HPLC column (3 mL). The column was equilibrated with isopropyl alcohol 
followed by ethyl acetate/ methanol 7:1. A solution of (R)-9 (0.16 g, 0.75 mmol) 
and n-hexadecane (0.17 g, 0.75 mmol) in ethyl acetate/ methanol 7:1 (v/v, 15 mL) 
was pumped through the catalyst at 60 °C at 0.5 mL min-1 (tRes = 6 minutes). Each 
sample (6 μL) from each RV was diluted into methanol (294 μL). The samples 













RV 9 (%) 8 (%) 65 (%) ee of 9 (%) 
0 100 0 0 100 
1 49 20 0 17 
2 87 11 0 11 
3 90 4 0 14 
4 92 5 0 17 
5 94 4 0 20 
Average (RV3-5) 92 4 0 17 
Drop[a] 8 NA NA 83 
Table 6.9 Results for the racemisation of (R)-9 in flow at 60 °C in EtOAc/ MeOH 7:1 (v/v) 
(tRes = 6 min) using configuration A. 
[a]Drop = RV0 – average (RV3-5) 
 
Configuration A was also used for the racemisation of the ML in flow from 
diastereomeric crystallisation of rac-9 with (S)-34. A similar procedure as in 
Section 5.2.5(d) was employed. Catalyst 92 (ICP 7.4%, 0.33 g, 0.13 mmol iridium) 
was loaded onto the stainless steel HPLC column (3 mL) with no sand. The 
column was equilibrated with ethyl acetate/ methanol 7:1. n-Hexadecane (22.8 
mg, 0.11 mmol) was added to the ML from a previous diastereomeric 
crystallisation of rac-9 in flow (Table 3.2, entry 1, 64 mM from 1H NMR). The 
reaction mixture was sampled (200 μL) into ethyl acetate (800 μL) and basified 
with aqueous sodium carbonate solution (10% w/v, 1 mL). The top organic layer 
was removed and analysed by GC and chiral HPLC for the conversion and ee of 
9 respectively. The ML solution was pumped through the catalyst at 60°C at 0.5 
mL min-1 (tRes = 6 minutes). The first RV (RV1) was discarded and the remaining 
eluent (RV2 to 6) was collected into one single flask. It was sampled and analysed 
as described above (Table 6.10). 
 
RV 9 (%) 8 (%) 65 (%) ee of 9 (%) 
0 99 1 0 37 
2-6 93 7 0 11 
Drop 6 NA NA 26 
Table 6.10 Results for the racemisation of ML from the diastereomeric crystallisation of 
rac-9 in flow at 60 °C in EtOAc/ MeOH 7:1 (v/v) (tRes = 6 min) using configuration A. 




(e) (S)-2-Methylpiperidine 103 (Table 2.10, entries 8 and 9) 
Configuration A was used for the racemisation of (S)-103 in flow in MTBE/ 
isopropyl alcohol 95:5 (v/v) at 50 °C (Table 2.10, entry 8). A similar procedure as 
in Section 5.2.5(a)(i) was employed. Catalyst 92 (ICP 6.3%, 0.24 g, 78.8 μmol 
iridium) was loaded onto the stainless steel HPLC column (3 mL) with no sand. 
A solution of (S)-103 (0.16 g, 1.6 mmol) and n-decane (14.2 mg, 99.8 μmol) in 
MTBE/ isopropyl alcohol 95:5 (20 mL) was pumped through the catalyst at 50 °C 
at 0.25 mL min-1 (tRes = 12 min). The first RV (RV1) was discarded and the 
remaining eluent (RV2 to 6) was collected into one single flask. The eluent was 
sampled (200 μL) by diluting into ethyl acetate (800 μL). The sample was 
analysed by GC for conversion and chiral GC for determining the ee of 103 after 
derivatisation with acetic anhydride (10 μL). No conversion or racemisation was 
observed. 
 
Configuration B was also used for the racemisation of (S)-103 in flow in isopropyl 
acetate at 80 °C (Table 2.9, entry 9). Catalyst 92 (ICP 6.3%, 0.32 g, 0.11 mmol 
iridium) and sand (5.5 g) were mixed and loaded onto the stainless steel HPLC 
column (4 mL). The column was equilibrated with isopropyl acetate. A solution of 
(S)-103 (0.21 g, 2.1 mmol) in isopropyl acetate (20 mL) was pumped through the 
catalyst at 80 °C at 0.25 mL min-1 (tRes = 16 minutes). Each sample (50 μL) from 
each RV was diluted into ethyl acetate (950 μL) and methanol (100 μL). Benzoyl 
chloride (10 μL) was added and the samples were analysed by chiral GC (Table 
6.11). Conversion was not measured.  
 







Average (RV2-5) 21 
Drop[a] 79 
Table 6.11 Results for the racemisation of (S)-103 in flow at 80 °C in iPrOAc (tRes 16 min) 
using configuration B. [a]Drop = RV0 – average (RV2-5) 
232 
 
6.2.6. General procedures for reactivation of immobilised SCRAM 92 with 
hydroiodic acid  
Previously used/ reactivated 92 (0.32 g)/ sand (5.5 g) mixture was unloaded into 
a beaker from the stainless steel HPLC column after its activity was checked via 
the racemisation of (S)-103 (Section 6.2.7). Aqueous hydroiodic acid at a specific 
concentration (15 mL) was added and the slurry was stirred at room temperature. 
After the designated stirring time, isopropyl alcohol/ water 2:1 (v/v) was added 
until all solid sank and the mixture was decanted. The procedure was repeated 
until the pH of the decant became neutral and colourless. The solid was further 
washed with more isopropyl alcohol, decanted and dried in the vacuum oven. The 
conditions of re-activation were shown in Table 6.12. 
 






Table 6.12 Conditions for reactivation of 92 
 
6.2.7. Catalyst activity check of immobilised SCRAM 92 via the 
racemisation of (S)-103 in flow 
A similar procedure as in Section 5.2.5(e) was employed using configuration B of 
the flow racemisation set-up (Fig. 2.20(b) and Fig. 6.26). The reactivated/ 
deactivated 92/ sand mixture was loaded onto the stainless steel column (4 mL). 
The column equilibrated with isopropyl alcohol followed by isopropyl acetate. A 
solution of (S)-103 (0.21 g, 2.1 mmol) in isopropyl acetate (20 mL) was pumped 
through the catalyst at 80 °C at 0.25 mL min-1 (tRes = 16 minutes). Each sample 
(50 μL) from each RV was diluted into ethyl acetate (950 μL) and methanol (100 
μL). Benzoyl chloride (10 μL) was added and the samples were analysed by chiral 
GC. The catalyst/ sand mixture was unloaded after the reaction, washed with 
isopropyl alcohol and decanted. The solid was dried in vacuum oven for further 




6.2.8. Deactivation of immobilised SCRAM 92 with methylamine in flow 
The deactivation procedure was carried out using configuration B of the flow 
racemisation set-up (Fig. 2.20(b) and Fig. 6.26). Used 92 (0.32 g)/ sand (5.5 g) 
mixture was loaded onto the stainless steel column (4 mL). The column was 
equilibrated with isopropyl alcohol at 0.25 mL min-1 by a syringe pump at 80 °C. 
A 0.2 M solution of methylamine/ tetrahydrofuran (1.7 M, 6 mL) in isopropyl 
acetate (44 mL) was pumped through the catalyst at 0.01 mL min-1 at 80 °C (tRes 
= 6.7 hours) for 4 days. The activity of the catalyst was then checked via the 
racemisation of (S)-103 in flow using the procedures described in Section 6.2.7. 
 
6.2.9. NMR titration of methylamine-bound SCRAM 64 with hydroiodic acid 
Catalyst 64 (3.1 mg, 2.7 μmol, 5.3 μmol iridium) and benzene (8.3 mg, 10 μL, 0.1 
mmol) were dissolved into d6-dimethyl sulfoxide (0.64 mL). The sample was 
analysed by 1H NMR (500 MHz). Methylamine/ methanol solution (2 M, 53.3 µL, 
0.11 mmol) was added and the mixture was shaken for 60 seconds. 1H NMR was 
recorded. Aqueous hydroiodic acid (1.5 M) was added as shown in Table 6.13. 





Total HI (μmol) 
Vol. of HI (aq) added 
(μL) 
Total vol. of HI (aq) 
(μL) 
0 0 0 0 
0.5 2.7 1.8 1.8 
1 5.4 3.6 1.8 
2 10.7 7.1 3.5 
5 26.7 17.8 10.7 
10 53.3 35.5 17.7 
15 80.0 53.3 17.8 
20 106.7 71.1 17.8 




6.2.10. General procedures for deuterium/ proton exchange of chiral 
amines by d8-isopropyl alcohol  
Catalyst 64 (29.1 mg, 25.0 μmol) was added to a microwave tube with a magnetic 
stirrer. The chiral amine (1 mmol) was dissolved into d8-isopropyl alcohol (766 μL) 
and d8-toluene (306 μL). The mixture was analysed by 1H NMR (300 MHz). Then 
it was added to 64 and the reaction mixture was heated to 110 °C by microwave. 
After each hour of heating, the reaction mixture was cooled down to room 
temperature and was sampled for 1H NMR analysis after which the NMR sample 
was poured back to the reaction mixture and heated to 110 °C by microwave 
again. The heating, cooling and sampling process was repeated for 4 to 6 hours. 
For amines 39 and 101, a d6-DMSO insert (which was prepared by filling a melting 
point capillary tube with d6-DMSO and sealed at both ends) was placed into the 
NMR sample for analysis. 
 
6.2.11. Attempted racemisation of Rasagiline (R)-109 by microwave 
Catalyst 64 (29.2 mg, 25.1 μmol) was added to a microwave tube with a magnetic 
stirrer. (R)-109 (0.17 g, 0.99 mmol) and n-hexadecane (15.4 mg, 68 μmol) was 
dissolved into isopropyl alcohol (766 μL) and toluene (306 μL). The mixture was 
sampled (10 μL) and diluted into methanol (990 μL) and was analysed by chiral 
GC. The solution of (R)-109/ n-hexadecane was then added to 64 and the 
reaction mixture was heated to 110 °C by microwave. After each hour of heating, 
the reaction mixture was cooled down to room temperature and was sampled for 
chiral GC analysis. The reaction mixture was heated to 110 °C by microwave 
again. The heating, cooling and sampling process was repeated for 4 hours. 
Chiral GC showed about 73% drop in the peak area ratio of (R)-109/ n-
hexadecane whilst the racemisation of (R)-109 was not observed. 
 
6.3 Resolution-Racemisation-Recycle (R3) 
6.3.1. Diastereomeric resolution of chiral amines 
(a) 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 (Table 3.1) 
Racemic 9 (0.15 g, 0.72 mmol) and (S)-34 (0.11 g, 0.72 mmol) were both 
dissolved into ethyl acetate/ alcohol 7:1 (v/v) (4 mL and 1 mL respectively). The 
solution of 9 was added to the solution of (S)-34 to produce a slurry which was 
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stirred at room temperature for 6 hours and then filtered. The reaction flask was 
rinsed with small amount of ML to wash off any residual solid. The solid was dried 
in air and analysed by 1H NMR (in CDCl3, 500 MHz) for de determination. 
 
(b) 2-Methylpiperidine 103 (Table 3.5) 
Using a similar procedure as for 9 (Section 5.3.1(a)), (S)-34 (0.21 g, 1.4 mmol) 
was dissolved into the designated solvent and added to rac-103 (0.14 g, 1.4 
mmol). Their mixture was seeded with diastereomerically pure (R)-103-(S)-34 
(7.0 mg, 27.9 μmol, 5% w/w) and stirred for 6 hours before filtration. The solid 
was analysed by 1H NMR (in CDCl3, 500 MHz) for de determination. 
 
(c) N-Methyl-α-methylbenzylamine 39  
(i) Using (S)-34 as resolving acid (Table 3.7) 
Using a similar procedure as for 9 (Section 5.3.1(a)), (S)-34 (0.11 g, 0.72 mmol) 
was dissolved into the designated solvent (3.7 mL) and added to rac-39 (0.1 g, 
0.74 mmol). The mixture was seeded with diastereomerically pure (R)-39-(S)-34 
(5.0 mg, 17.4 μmol, 5% w/w) and stirred for 6 h before filtration. The solid was 
analysed by 1H NMR (in CDCl3, 500 MHz) for de determination. 
 
(ii) Using (S,S)-32 as resolving acid (Table 3.13, entries 1 to 3) 
Using a similar procedure as for 9 (Section 5.3.1(a)), (S,S)-32 (0.14 g, 0.35 mmol) 
and rac-39 (96.6 mg, 0.70 mmol) were both dissolved into the designated solvent 
mixture (4 and 1 mL respectively). The solution of (S,S)-32 was added to the 
solution of 39 and the mixture was stirred at room temperature for 6 h and then 
filtered. A sample of the isolated solid was dissolved into aqueous Na2CO3 (10% 
w/v, 700 µL) and extracted with ethyl acetate (700 µL). The ethyl acetate layer 
was dried by anhydrous MgSO4 and filtered through a plug of celite. The sample 
was reacted with trifluoroacetic anhydride (80 µL) and analysed by chiral GC for 
ee determination of the free amine (equivalent to de of the crystals). Similar 
procedures were employed by changing the concentration of 39 (Table 3.13, 
entries 4 and 5), equivalence of (S,S)-32 (Table 3.13, entries 6 to 8) and replacing 
methanol with isopropyl alcohol (Table 3.13, entries 9 and 10). The volume was 




Diastereomeric crystallisations of 39 with (S,S)-32 at larger scale (20 mL) were 
carried out using a similar procedure described above. The reaction was sampled 
and monitored with time (Fig. 3.24). 
 
Sampling method 
A sample (300 µL) was removed and filtered through a syringe filter (0.45 µm 
pore). The filtrate was diluted into ethyl acetate (1.2 mL) and basified with 
aqueous sodium carbonate solution (10% w/v, 1.5 mL). The ethyl acetate layer 
was dried by anhydrous MgSO4 and filtered by a plug of celite. The sample was 
analysed by achiral GC and was then reacted with trifluoroacetic anhydride and 
further analysed by chiral GC. The solid collected in the syringe filter was 
dissolved into methanol and dried in vacuo. The residue was weighed, dissolved 
into aqueous sodium carbonate solution (10% w/v, 700 µL) and extracted with 
ethyl acetate (700 µL). The ethyl acetate layer was treated as described for the 
filtrate. A sample was also taken prior to the addition of (S,S)-32. However no 
filtration was required. 
 
Racemic 39 (0.27 g, 2.0 mmol) and n-decane (14.6 mg, 0.1 mmol) were dissolved 
into ethyl acetate/ methanol 8:2 (20 mL) in a glass CSTR (50 mL) at the 
designated temperature (Huber-controlled). The mixture was sampled. (S,S)-32 
(0.38 g, 0.98 mmol) was added and the mixture was stirred at the designated rate. 
A slurry was formed and the reaction was sampled after 2 min. The reaction was 
continuously stirred and sampled throughout the reaction at specific times. After 
the designated time, the reaction mixture was filtered. The CSTR was rinsed with 
minimum amount of the ML and the solid was dried in air. The conditions 























1 0.14 0.49 0 300-500 52 6 60 
2 0.14 0.49 10 300-500 55 6 64 
3 0.14 0.49 25 300-500 30 6 65 
4 0.14 0.49 40 300-500 30 9 55 
5 0.14 0.49 25 0 52 18 51 
6 0.14 0.49 25 100 30 4 69 
7 0.14 0.49 25 400 36 4 68 
8 0.14 0.49 25 1000 30 1   44[d] 
9 0.07 0.49 25 400 36 76 23 
10 0.21 0.49 25 400 12 3 76 
11 0.14 0.25 25 400 36 83 22 
  12[e] 0.14 0.49 25 400 30 7 67 
  13[f] 0.14 0.49 25 400 30 5 71 
Table 6.14 Experimental conditions employed in temperature-controlled diastereomeric 
crystallisation of 39 with (S,S)-32 with reaction monitoring. [a]Temperature was controlled 
by Huber. [b]De corresponds to the ee of the free amine. [c]The mass of all samples were 
included in the calculation of the total yield and any seeds were excluded. [d]Some 
crystals were lost during filtration. [e]The reaction was seeded with pure [(S)-39]2-(S,S)-
32 (5% w/w). [f]The reaction was seeded with (S)-39-(S,S)-32-(R)-39 (5% w/w) 
 
(d) N-Isopropyl-α-methylbenzylamine 101 (Table 3.9) 
Using a similar procedure as for 9 (Section 5.3.1(a)), (S)-34 (93 mg, 0.61 mmol) 
was dissolved into the designated solvent (6 mL) and added to rac-101 (0.10 g, 
0.61 mmol). The mixture was stirred for 6 hours before filtration. 
 
(e) α-Methylbenzylamine 42 (Table 3.11) 
Using a similar procedure as for 9 (Section 5.3.1(a)), (S)-34 (0.11 g, 0.70 mmol) 
was dissolved into the designated solvent (5 mL) and was added to rac-42 (85.7 
mg, 0.7 mmol). The mixture was stirred for 6 hours before filtration. A sample of 
the isolated solid was dissolved into aqueous Na2CO3 (10% w/v, 2 mL) and 
extracted with ethyl acetate (2 mL). The ethyl acetate layer was dried by 
anhydrous MgSO4 and filtered through a plug of celite. The solvent was removed 
in vacuo and the residue was re-dissolved into methanol (1 mL). Triethylamine 
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(20 µL) and benzoyl chloride (10 µL) were added to the sample and was analysed 
by chiral HPLC for ee determination of the free amine (equivalent to de of the 
crystals). 
 
(f) N,N-Dimethyl-α-methylbenzylamine 46 (Table 3.15) 
Using a similar procedure as for 9 (Section 5.3.1(a)), (S,S)-32 (0.23 g, 0.67 mmol) 
and rac-46 (0.1 g, 0.67 mmol) were both dissolved into the designated solvent 
(3.8 and 1 mL respectively). The solution of (S,S)-32 was added to the solution 
of 46 and the mixture was stirred at room temperature for 6 hours and then filtered. 
A small sample of the isolated solid was dissolved into aqueous Na2CO3 (10% 
w/v, 1 mL) and extracted with ethyl acetate (1 mL). The ethyl acetate layer was 
dried by anhydrous MgSO4 and filtered through a plug of celite. (S)-34 solution in 
methanol (0.14 M, 100 µL) was added and the mixture was sonicated for 5 to 10 
minutes. The solvent was removed in vacuo and the residue was analysed by 1H 
NMR (in CDCl3, 500 MHz) for ee determination of the free amine (equivalent to 
de of the crystals). 
 
6.3.2. General procedures for the diastereomeric resolution of 6,7-
dimethoxy-1-methtyl-1,2,3,4-tetrahydroisoquinoline 9 with (S)-
mandelic acid 9 in flow  
 
Fig. 6.27 (a) Experimental set-up of the Freactors in series; (b) Inner assembly of the 
electrical motor beneath each Freactor for stirring 
 
The diastereomeric resolution of rac-9 described in Table 3.2, entry 5 was 
described as an example. Five Freactors (volume of each = 2 mL) were 
connected, with the first Freactor having three pots whilst the other four Freactors 
having two pots (Fig. 6.27). Two syringes (20 mL) filled with ethyl acetate/ 












whole set up was held in a vertical orientation with the syringes at the bottom. 
The Freactors were fully filled with the solvent mixture by pushing the syringes 
manually. The Freactors were placed onto the magnetic stirrer motors. They were 
further flushed with the same solvent at a total of 0.5 mL min-1 (0.25 mL min-1 for 
the solvent from each syringe) to ensure no leakage and air bubbles present in 
the system. Racemic 9 (3.48 g, 16.8 mmol) and (S)-34 (1.28 g, 8.4 mmol) were 
dissolved separately into ethyl acetate/ methanol 7:1 (v/v) (60 mL each). The 
solution of 9 was warmed to about 40 °C with stirring until all solid dissolved and 
was cooled back to room temperature. The solutions of amine 9 and acid 34 were 
pumped through the Freactors at 0.25 mL min-1 each with stirring. The slurry was 
collected at the outlet of the last Freactor in RVs. After all solutions in the syringes 
were consumed, the system was flushed with ethyl acetate/ methanol 7:1 (v/v) 
until all solids were washed out. All collected fractions, including all the washings, 
were filtered to yield a white powdery solid (1.4 g in total, 24%) with an average 
de of 91% from 1H NMR in CDCl3 (500 MHz). 
 
The flow resolution reactions were carried out with different number of Freactors 
at different flow rates (Table 3.2). The scale of all reactions was based on 12 RVs. 
In most cases, the reactors were blocked at the middle of the run. When blockage 
was observed (in which the syringes stopped moving), the pumps were stopped 
and the system was flushed with ethyl acetate/ methanol 7:1 (v/v) to wash out the 
solids from the Freactors. The yields were calculated based on the amount of 9 
which reacted with 34. 
 
6.3.3. Crystal solubility measurement 
Diastereomerically pure crystals prepared as described in Section 6.1 were 
added to the designated solvents/ solvent mixtures until some remained 
undissolved. Each slurry was stirred at room temperature overnight and was 
filtered to yield a saturated solution. A known volume of the filtrate was removed 
and dried in vacuo. The residue was dissolved into CDCl3 or d6-DMSO, with 
known amount of external standard added. The sample was analysed by 1H NMR 
and the mass of the crystal present in the NMR sample (hence in the known 
















   (Eqn. 5.2) 
 
Where m(x) and m(IS) are the masses of the crystals in the sample and internal 
standard in mg; P(x) and P(IS) are the purities of the crystals and internal standard 
which were assumed to be 100%; MW(x) and MW(IS) are the molecular weights of 
the crystal and internal standard in g mol-1; nH(x) and nH(IS) are the number of 
protons generating the signals of the crystals and internal standard selected for 
integration in the 1H NMR; A(x) and A(IS) are the integrations of the selected signals 
correspond to the crystals and internal standard, all respectively. 
 





    (Eqn. 5.3) 
 
Where V is the volume of the saturated solution removed in mL and dried in vacuo. 
 
The solubility of various pure diastereomeric salts was determined and 
























(S)-9-(S)-34 EtOAc/ MeOH 7:1 n-Decane 10.2 
4 
(R)-9-(S)-34 EtOAc/ MeOH 7:1 n-Decane 2.9 
(S)-9-(S)-34 EtOAc/ iPrOH 7:1 n-Decane 3 
4 
(R)-9-(S)-34 EtOAc/ iPrOH 7:1 n-Decane 0.7 
(S)-9-(S)-34 EtOAc/ EtOH 7:1 n-Decane 4.5 
3.6 
(R)-9-(S)-34 EtOAc/ EtOH 7:1 n-Decane 1.3 
(S)-103-(S)-34 iPrOAc n-Decane 7.5 
3 
(R)-103-(S)-34 iPrOAc n-Decane 2.4 
(S)-101-(S)-34 EIB[c] Toluene 145.3 
484 
(R)-101-(S)-34 EIB[c] Toluene 0.3 
(S)-39-(S)-34 iPrOAc n-Decane 25.2 
7 
(R)-39-(S)-34 iPrOAc n-Decane 3.6 
[(S)-39]2-(S,S)-32 EtOAc/ MeOH 9:1 
nBuOAc 0.5 
6 
[(R)-39]2-(S,S)-32 EtOAc/ MeOH 9:1 
nBuOAc 3 
[(S)-39]2-(S,S)-32 EtOAc/ MeOH 85:15 
nBuOAc 0.4 
23 
[(R)-39]2-(S,S)-32 EtOAc/ MeOH 85:15 
nBuOAc 9.3 
[(S)-39]2-(S,S)-32 EtOAc/ 
iPrOH 8:2 nBuOAc 0.9 
4.5 
[(R)-39]2-(S,S)-32 EtOAc/ 
iPrOH 8:2 nBuOAc 0.2 
[(S)-39]2-(S,S)-32 EtOAc/ MeOH 8:2 
nBuOAc 2.3 
11 
[(R)-39]2-(S,S)-32 EtOAc/ MeOH 8:2 
nBuOAc 24.9 
(S)-46-(S,S)-32[d] iPrOAc/ iPrOH 7:3 nBuOAc 3.7 
4 
(R)-46-(S,S)-32[d] iPrOAc/ iPrOH 7:3 nBuOAc 14.2 
(S)-46-(S,S)-32[d] iPrOAc/ EtOH 7:3 nBuOAc 9.5 
5 
(R)-46-(S,S)-32[d] iPrOAc/ EtOH 7:3 nBuOAc 44.1 
Table 6.15 Solubility data of various diastereomeric salts determined by 1H NMR (500 
MHz, 32 scans, relaxation delay = 2.49 s, acquisition time = 2.1825 min). CDCl3 and d6-
DMSO were used as the NMR solvents for the salts of (S)-34 and (S,S)-32 respectively. 
[a]The ratios correspond to volume ratios. [b]The difference was determined as the 
solubility ratio of the less soluble salt to the more soluble salt. [c]Ethyl isobutyrate. [d]NMR 




6.3.4. DSC and TGA measurements for the diastereomeric salts of 39 with 
(S,S)-32 
The measurements were carried out by T. Howell from School of Chemical and 
Process Engineering, University of Leeds. Known amounts of diastereopure [(S)-
39]2-(S,S)-32, [(R)-39]2-(S,S)-32, a 1:1 mixture of [(S)-39]2-(S,S)-32 and [(R)-
39]2-(S,S)-32, and the low de crystals from one of the diastereomeric resolution 
reactions were weighed into separate alumina pans. An empty alumina pan, 
which acted as a blank, and all four samples were heated under nitrogen from 30 
to 200 °C at 5 °C min-1 in the TGA2 machine. The energy input and weight loss 
of the samples were monitored.  
 
6.3.5. General procedures for one-pot resolution-racemisation process 
reaction of N-methyl-α-methylbenzylamine 39 with di-p-toluoyl-D-
tartaric acid (S,S)-32 
Racemic 39 (0.38 g, 2.8 mmol) and n-decane (14.2 mg, 99.8 μmol) were 
dissolved into ethyl acetate/ methanol 8:2 (v/v, 20 mL) in a 50 mL round bottom 
flask. The mixture was sampled (300 μL) and diluted into ethyl acetate (1.2 mL), 
which was basified with aqueous sodium carbonate solution (10% w/v, 1.5 mL). 
The organic layer was separated, dried with anhydrous MgSO4, filtered through 
a plug of celite and analysed by achiral GC. Then the sample was derivatised with 
trifluoroacetic anhydride (60 μL) and analysed by chiral GC. (S,S)-32 (0.53 g, 
1.34 mmol) was added to the solution of rac-39/ n-decane and the mixture was 
stirred at room temperature until it turned cloudy. After 2 minutes, the slurry (300 
μL) was sampled and filtered through a syringe filter (0.45 μm). The filtrate was 
treated as described above. The solid collected from the syringe filter was 
dissolved into methanol and dried in vacuo. The white solid was weighed and 
analysed by 1H NMR in d6-DMSO (500 MHz). SCRAM 64 or Shvo’s catalyst 55 
(56.3 μmol) was then added and the reaction was sampled at specific times for 
55 hours. After the reaction, the mixture was filtered to give a coloured solid. The 
solid and the filtrate were analysed as described above. The conditions and 






Entry 1 2 
Reaction 
conditions 
Catalyst (mg) 64 (65.4) 55 (62) 
(S,S)-32 (g) [mmol, Equiv.] 0.53 [1.34, 0.49] 0.5 [1.26, 0.45] 
Results 
Crystal colour Orange Yellow 
Yield (%) 63 57 
Initial crystal de (%) 72 71 
Final crystal de (%) 2 5 
39 in ML (%) 27 32 
ML ee (%) 16 17 
Table 6.16 Reaction conditions and results for the one-pot resolution-racemisation 
reaction of 39 with (S,S)-32 using racemisation catalyst 64 or 55 
 
6.3.6. Resolution-Racemisation-Recycle (R3) processes of chiral amines 
(a) 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 
 
Fig. 6.28(a) Experimental set-up for the R3 processes of 9; (b) The frit held in the CSTR 
















The experimental set-up for the R3 processes of 9 was shown in Fig. 6.28(a). A 
50 mL glass CSTR was fitted with a PTFE lid with two ports (3 mm I.D.). A frit 
was held inside the CSTR and connected to the inlet of a HPLC pump (Knauer 
PS4.1) via a port with PTFE tubing (Fig. 6.28(b)). The outlet of the pump was 
connected to the inlet of the reactor column and the outlet was fed into the CSTR 
via another port (Fig. 6.28(b)). 
 
The total reactor volume of the system (RV, 25 mL) was determined by pumping 
a known volume of reaction solvent from a beaker through the whole set-up until 
the CSTR was filled with 20 mL solvent. RV equals the difference in the original 
and the remaining volumes of the solvent in the beaker. Residence times were 
determined as, 
tRes (Racemisation) = 
Volume of packed bed column (mL)












 process) = 
Total volume of R
3
 system (mL)
Flow rate (mL min-1)
 




 = 50 min 
 
(i) Sampling method 
The reaction was sampled throughout for achiral and chiral HPLC analysis. A 
sample (200 μL) was filtered with a syringe filter (0.45 μm) and diluted into ethyl 
acetate (800 μL). It was then basified by equal volume of aqueous sodium 
carbonate solution (10% w/v, 1 mL). The organic layer was separated and 
analysed by achiral GC. The solid collected in the filter was dissolved in 
dichloromethane and the solvent was removed in vacuo to give a white solid, 
which was weighed and dissolved in methanol for chiral HPLC analysis. An initial 
sample was taken prior to the addition of (S)-mandelic acid 34. Samples were 
taken after each tRes of the process (50 min) for the designated number of cycles. 
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(ii) General Procedure A: with slow addition of (S)-34 
A stainless steel HPLC column (4 mL) was packed with immobilised SCRAM 92 
(ICP 7.4%, 0.36 g, 0.14 mmol iridium) and was equilibrated with the reaction 
solvent at 0.5 mL min-1 at room temperature. Then the column was wrapped with 
aluminium foil and heated to about 60 °C using a hotplate. In the CSTR, rac-7 
(0.58 g, 2.8 mmol) and n-hexadecane (22.5 mg, 0.099 mmol) were dissolved in 
the designated solvent system (20 mL). (S)-34 (0.21 g, 1.4 mmol) was added to 
the solution of 9 at the start of the reaction. The mixture slowly turned milky upon 
stirring at room temperature. After 2 minutes the pump was started (t = 0). More 
(S)-34 (0.21 g, 1.4 mmol) was dissolved in the reaction solvent (5 mL) and added 
to the CSTR via a syringe pump from cycle 2 onwards. Detailed calculations of 
the flow rate employed for each cycle was shown in the Appendix (Section 8.4). 
After the final cycle, the reaction mixture was filtered. The solid was dried in air 
overnight. Both the solid and the filtrate were analysed as described in the 
sampling method (i). The column was washed by pumping ethyl acetate/ 
methanol through whilst cooling to room temperature and reused for further 
experiments without unloading the column. The conditions of the R3 reaction of 9 
with slow addition of (S)-34 were varied and summarised in Table 3.3. 
 
(iii) General Procedure B: complete addition of (S)-34 before ML 
recirculation 
A stainless steel HPLC column (4 mL) was packed with immobilised SCRAM 92 
(ICP 7.4%, 0.36 g, 0.14 mmol iridium) and was equilibrated with the reaction 
solvent at 0.5 mL min-1 at room temperature. Then the column was wrapped with 
aluminium foil and heated to about 60 °C using a hotplate. In the CSTR, rac-9 
(0.58 g, 2.8 mmol) and n-hexadecane (22.5 mg, 0.099 mmol) were dissolved in 
the reaction solvent (20 mL). Samples were taken as described after each tRes 
(50 min) for the designated number of cycles. (S)-34 (0.42 g, 2.7 mmol) was 
added into the amine solution and the mixture slowly turned milky upon stirring at 
room temperature. After 2 minutes the pump was started (t = 0). After the final 
cycle, the reaction mixture was filtered. The solid was dried in air overnight. Both 
the solid and the filtrate were analysed as described in the sampling method (i). 
The column was washed by pumping ethyl acetate/ methanol through whilst 
cooling to room temperature and reused for further experiments. The R3 reaction 
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conditions of 9 were varied and summarised in Table 3.4. After the last R3 process 
of 9, the racemisation of (S)-9 was carried out in flow to assess the activity of the 
catalyst (Section 6.3.9). 
 
(b) 2-Methylpiperidine 103 
A similar procedure as General Procedure B was used. The experimental set-up  
was modified for amines 103, 39, 101 and 46 (Fig. 6.29). The column was heated 
in an aluminium block by an electrical heating unit. A Jasco pump was used to 
recirculate the ML. The parameters used for the R3 processes of 103 were shown 
in Table 6.17. The reactions were seeded with (R)-103-(S)-34 (5% w/w) and the 
slurry was stirred for 10 minutes before recirculation of the ML. The reactions 
were sampled using similar sampling method described for amine 9 whilst the 
organic layer was dried with MgSO4 and filtered through a plug of celite. After the 
samples were analysed by achiral GC, they were derivatised with acetic 
anhydride (10 μL) to form the corresponding amide for chiral GC analysis. The 
final crystals and those from each sample were analysed by 1H NMR in CDCl3 
(500 MHz). The same packed catalyst was used in all three R3 processes of 103. 
Racemisation of 103 was carried out in flow after each R3 process to assess the 
activity of the catalyst (Section 6.2.7). 
 
 





















1 2 3 
rac-103 (mmol) 2.8 5 7 
Solvent iPrOAc iPrOAc iPrOAc 
(S)-34 added before ML recirculation (equiv.) 0.9 0.9 0.9 
ICP of 92 (%) 6.3 6.3 6.3 
Loading of Ir (mmol%) 7 4 2.8 
Internal standard, n-decane (mmol) 0.2 0.4 0.4 
Sampling volume  (μL) 200 150 150 
Volume of diluent in samples, EtOAc (μL) 1800 2850 2850 
Racemisation T (°C) 80 80 80 
Crystallisation T (°C) r.t. r.t. r.t. 
Column volume (mL) 4 4 4 
Total RV (mL) 28.5 28.5 28.5 
Flow rate (mL min-1) 0.25 0.25 0.25 
Racemisation tRes (min) 16 16 16 
Overall tRes (min) 114 114 114 
No. of cycles 6 16 16 
Process time (h) 10 30 30 
Table 6.17 Parameters of the R3 processes of 103. The entries correspond to those in 
Table 3.6 
 
(c) N-Methyl-α-methylbenzylamine 39 
(i) (S)-34 as the resolving acid 
A similar procedure as General Procedure B was used. The catalyst was mixed 
with sand and was filled into the column. The parameters used were shown in 
Table 6.18. The reaction was seeded with (R)-39-(S)-34 (5% w/w) and the slurry 
was stirred for 10 minutes before recirculation of the ML. The reactions were 
sampled using similar sampling method described for amine 9 while the organic 
layer was dried with MgSO4 and filtered through a plug of celite. After the samples 
were analysed by achiral GC, they were derivatised with trifluoroacetic anhydride 
(60 to 80 μL) to form the corresponding amide for chiral GC analysis. The final 
crystals and those from each sample were analysed by 1H NMR in CDCl3 (500 
MHz). Fresh immobilised SCRAM 92 was used after each R3 process. 
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Racemisation of (S)-103 was carried out in flow after each R3 process to assess 





rac-39 (mmol) 4 6 
Solvent iPrOAc iPrOAc 
Additives (equiv.) - 58 (1) 
(S)-34 added before ML recirculation (equiv.) 0.9   0.9[a] 
ICP of 92 (%) 6.3 7.7 
Loading of Ir (mol%) 3.7 3 
Internal standard, n-decane (mmol) 0.2 0.4 
Sampling volume  (μL) 100 75 
Volume of diluent, EtOAc (μL) 900 1425 
Racemisation T (°C) 80 80 
Crystallisation T (°C) r.t. 12 
Column volume (mL) 4 4 
Total RV (mL) 28.5 28.5 
Flow rate (mL min-1) 0.1 0.1 
Racemisation tRes (min) 40 40 
Overall tRes (min) 285 285 
No. of cycles 40 70 
Process time (h) 190 333 
Table 6.18 Parameters of the R3 processes of 39 with (S)-34. The entries correspond to 
those in Table 3.8. [a]The slurry of 39/ (S)-34 was stirred for 1 h before ML recirculation 
 
(ii) (S,S)-32 as the resolving acid 
General Procedure B was used for entries 1 and 2 in Table 3.14 and General 
Procedure A was used for entries 3 and 4 in Table 3.14. The parameters used 










1 2 3 4 
General Procedure B B A A 
rac-39 (mmol) 2.8 4.2 4.2 4.2 
Co-solvent[a] MeOH MeOH MeOH iPrOH  
(S,S)-32 added before ML 
recirculation (Equiv.) 
0.49 0.49 0.25   0.25[b] 
Rate of (S,S)-32 addition as a 4 mL 
solution (μL min-1) 
- -   10[c]   10[d] 
ICP of 92 (%) 7.7 7.7 7.7 7.7 
Loading of Ir (mol%) 5 4   4[e] 4 
Internal standard, n-decane (mmol) 0.1 0.2 0.2 0.2 
Sampling volume  (μL) 150 75 75 75 
Volume of diluent, EtOAc (μL) 750 675 675 675 
Racemisation T (°C) 65 65 65 70 
Crystallisation T (°C) 0 5 12 12 
Column volume (mL) 4 4 4 4 
Total RV (mL) 28.5 28.5 28.5 28.5 
Flow rate (mL min-1) 0.1 0.1 0.1 0.1 
Racemisation tRes (min) 40 40 40 40 
Overall tRes (min) 285 285 285 285 
No. of cycles 41 10 25 35 
Process time (h) 195 48 119 166 
Table 6.19 Parameters of the R3 processes of 39 with (S,S)-32. The entries correspond 
to those in Table 3.14. [a]All solvent systems contained EtOAc (80% v/v) and alcohol as 
the co-solvent (20% v/v). [b]The slurry of 39/ (S,S)-32 was stirred for 1 h before ML 
recirculation.  [c]The solution of (S,S)-32 was pumped into the CSTR after 5 cycles of 
recirculation. [d]The solution of (S,S)-32 was pumped into the CSTR after 7 cycles of 
recirculation. [e]The catalyst from entry 2 was reused without unloading from the column 
 
The catalyst was mixed with sand and was filled into the column. The slurry of 
39/ (S,S)-32 in the CSTR was stirred for 10 minutes before recirculation of the 
ML. The reactions were sampled using similar sampling method described for 
amine 9 while the organic layer was dried with MgSO4 and filtered through a plug 
of celite. After the samples were analysed by achiral GC, they were derivatised 
with trifluoroacetic anhydride (60 to 80 μL) to form the corresponding amide for 
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chiral GC analysis. The final crystals and those from each sample were dissolved 
into aqueous sodium carbonate solution (10% w/v, 700 μL) and extracted with 
ethyl acetate (700 μL). The organic layer was dried by anhydrous MgSO4, filtered 
through a plug of celite and derivatised with trifluoroacetic anhydride (80 μL). The 
sample was analysed by chiral GC. Fresh immobilised SCRAM 92 was used after 
each R3 process. Racemisation of (S)- 103 was carried out in flow after each R3 
process to assess the activity of the catalyst (Section 6.2.7). When General 
Procedure A was used, (S,S)-32 (0.41 g, 1.1 mmol, 0.25 equiv.) was added into 
the CSTR as a solution (4 mL reaction solvent) by a syringe pump at 10 μL min-
1 after 5 or 7 cycles of ML recirculation. 
 
(d) N-Isopropyl-α-methylbenzylamine 101 
A similar procedure as General Procedure B was used. The catalyst was mixed 
with sand and was filled into the column. The parameters used were shown in 
Table 6.20. The slurry containing 101 and (S)-34 was stirred for 10 minutes 
before recirculation of the ML. Two separate samples were prepared during each 
sampling: Both samples (60 μL) were filtered and diluted into ethyl acetate (540 
μL). One sample was basified by aqueous sodium carbonate solution (10% w/w, 
600 μL) whilst the other sample was basified by aqueous sodium hydroxide 
solution (0.2 M, 600 μL). The organic layers were dried with MgSO4 and filtered 
through a plug of celite. The former sample was for achiral GC analysis. The latter 
sample was derivatised with trifluoroacetic anhydride (150 μL) for chiral GC 
analysis. The final crystals and those from each sample were analysed by 1H 
NMR in CDCl3 (500 MHz). Fresh immobilised SCRAM 92 was used after each R3 
process. Racemisation of (S)-103 was carried out after each R3 process to 














1 2 3 
rac-101 (mmol) 2 2 2 
Solvent   EIB[a] iPrOAc   EIB[a] 
(S)-34 added before ML recirculation (Equiv.) 0.9 0.9 0.98 
ICP of 92 (%) 6.3 6.3 6.3 
Loading of Ir (mol%) 5.3 5.3 5.3 
Internal standard, n-decane (mmol) 0.2 0.2 0.2 
Sampling volume  (μL) 60 60 60 
Volume of diluent, EtOAc (μL) 540 540 540 
Racemisation T (°C) 80 80 80 
Crystallisation T (°C) r.t. r.t. r.t. 
Column volume (mL) 4 4 4 
Total RV (mL) 28.5 28.5 28.5 
Flow rate (mL min-1) 0.05 0.05 0.05 
Racemisation tRes (min) 40 40 40 
Overall tRes (min) 570 570 570 
No. of cycles 11 20 30 
Process time (h) 105 190 285 
Table 6.20 Parameters of the R3 processes of 101. The entries correspond to those in 
Table 3.10. [a]Ethyl isobutyrate 
 
(e) α-Methylbenzylamine 42 
A similar procedure as General Procedure B was used. The Knauer PS4.1 pump 
was used while the column was heated in an aluminium block by the electrical 
heating unit. The parameters used were shown in Table 6.21. The 42/ (S)-34 
slurry was stirred for 10 minutes before recirculation of the ML. The reactions 
were sampled using similar sampling method described for amine 9 while the 
organic layer was dried with MgSO4 and filtered through a plug of celite. After the 
samples were analysed by achiral GC, the sample was dried in vacuo and the 
residue was re-dissolved into methanol (1 mL). Triethylamine (20 μL) and benzoyl 
chloride (20 μL) were added and the sample was analysed by chiral HPLC. The 














(S)-34 added before ML recirculation (Equiv.) 0.8 0.8 
ICP of 92 (%) 7.4 7.4 
Loading of Ir (mol%) 5 5 
Internal standard, n-decane (mmol) 0.1 0.1 
Sampling volume  (μL) 400 400 
Volume of diluent, EtOAc (μL) 1600 1600 
Racemisation T (°C) 100 105 
Crystallisation T (°C) r.t. r.t. 
Column volume (mL) 4 4 
Total RV (mL) 25 25 
Flow rate (mL min-1) 0.25 0.25 
Racemisation tRes (min) 16 16 
Overall tRes (min) 100 100 
No. of cycles 6 6 
Process time (h) 10 10 
Table 6.21 Parameters of the R3 processes of 42. The entries correspond to those in 
Table 3.12 
 
(f) N,N-Dimethyl-α-methylbenzylamine 46 
A similar procedure as General Procedure B was used. The catalyst was mixed 
with sand and was filled into the column. The parameters used were shown in 
Table 6.22. The slurry containing 46 and (S,S)-32 was stirred for 10 minutes or 1 
hour before recirculation of the ML. The reactions were sampled using similar 
sampling method described for amine 9 while the organic layer was dried with 
MgSO4 and filtered through a plug of celite. After the samples were analysed by 
achiral GC, a solution of (S)-34 (21 mg mL-1 in methanol, 70 μL) was added and 
the mixture was sonicated, dried in vacuo and analysed by 1H NMR in CDCl3 (500 
MHz). The final crystals and those from each sample were dissolved into 
methanol and dried in vacuo. The residue was dissolved into aqueous sodium 
carbonate solution (10% w/v, 700 μL) and extracted with ethyl acetate (700 μL). 
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The organic layer was dried by anhydrous MgSO4 and filtered through a plug of 
celite. A solution of (S)-34 (21 mg mL-1 in methanol, 70 μL) was added and the 






rac-46 (mmol) 1.4 1.4 
Solvent 
iPrOAc/ EtOH  
(30% by volume) 
iPrOAc/ iPrOH  
(30% by volume) 
(S,S)-32 added before ML 
recirculation (Equiv.) 
  0.9[a]   0.9[b] 
ICP of 92 (%) 7.7 7.7 
Loading of Ir (mol%) 5 6 
Internal standard, n-decane 
(mmol) 
0.1 0.1 
Sampling volume  (μL) 150 150 
Volume of diluent, EtOAc (μL) 600 600 
Racemisation T (°C) 72 80 
Crystallisation T (°C) 20 20 
Column volume (mL) 4 4 
Total RV (mL) 28.5 28.5 
Flow rate (mL min-1) 0.0333 0.0333 
Racemisation tRes (min) 120 120 
Overall tRes (min) 855 855 
No. of cycles 17 15 
Process time (h) 242 214 
Table 6.22 Parameters of the R3 processes of 46. The entries correspond to those in 
Table 3.16. [a]The slurry of 46/ (S,S)-32 was stirred for 10 min before ML recirculation. 
[b]The slurry of 46/ (S,S)-32 was stirred for 1 h before ML recirculation 
 
6.3.7. Attempted racemisation of (S)-34 
Immobilised SCRAM 92 (91.8 mg, ICP 7.4%, 0.035 mmol Ir) was added to a 
three-neck round bottom flask under nitrogen. A solution of (S)-34 (0.10 g, 0.69 
mmol) in ethyl acetate/ methanol (7:1 by volume, 5 mL) was charged and the 
reaction was heated to 60 °C for 24 hours. The reaction was sampled (200 μL) 
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before heating and during the reaction. The sample was dried in vacuo and the 
residue was re-dissolved into methanol (1 mL). The samples were analysed by 
chiral HPLC. No racemisation was observed. 
 
6.3.8. Attempted racemisation of triethylammonium (S)-mandelate 34 
Similar procedures as the racemisation of (S)-34 were employed in that of Et3N-
(S)-34. Et3N-(S)-34 (0.47 g, 1.9 mmol) was dissolved into ethyl acetate/ methanol 
(7:1 by volume, 13.6 mL). The stock solution (5 mL) was charged into a three-
neck round bottom flask containing 92 (91.3 mg, ICP 7.4%, 0.035 mmol). No 
racemisation was observed after 24 hours of heating to 60 °C but Et3N-126 was 
suspected of being formed, as observed in both chiral HPLC and 1H NMR. 
 
6.3.9. Catalyst activity check of immobilised SCRAM 92 after the R3 
processes of 9 via the racemisation of (S)-9 in flow 
Configuration B of the flow set-up (Fig. 5.24) was used in assessing the activity 
of 92 after the R3 processes of 9. The stainless steel column packed with 92 (used 
in the R3 processes of 9) was equilibrated by pumping ethyl acetate/ methanol 
7:1 (v/v) at 0.5 mL min-1 and heated to 60 °C. (S)-9 (0.4 g, 1.9 mmol) was 
dissolved into ethyl acetate/ methanol 7:1 (v/v, 31 mL). n-Hexadecane (25.8 mg, 
0.11 mmol) was added to 22.6 mL of the solution of (S)-9. The reaction mixture 
was sampled (200 μL) and diluted into ethyl acetate (800 μL). The reaction 
mixture was pumped through the column at 0.5 mL min-1 (tRes = 8 minutes). The 
first RV collected (from the first 8 minutes) was discarded and the remaining 
reaction mixture was collected after passing through the catalyst (cycle 1). The 
column was flushed with ethyl acetate/ methanol 7:1 (volume, 4 mL). The eluent 
from cycle 1 was pumped back across as described above and this process was 
repeated four times (total of 5 cycles). The eluent was sampled as described 
before pumped through the catalyst again. They were first analysed by GC, then 
the samples were dried in vacuo and re-dissolved into methanol (1 mL) and 
analysed by chiral HPLC. At the end of the reaction, the column was cooled to 





6.4 Alternative racemisation catalysts for chiral amines 
6.4.1. Racemisation catalyst screening 
In the glove box under nitrogen atmosphere, (R)-9 (0.12 g, 0.60 mmol) was 
dissolved into degassed toluene (12 mL) and was warmed to 50 °C for complete 
dissolution. Catalysts A to Q were weighed into 2 mL HPLC vials by Quantos 
Basic automated powder dispenser (QB5) from Mettler Toledo. Their average 
mole % were shown in Table 4.1. The vials were placed onto a 48-well aluminum 
plate. The solution of (R)-9 (500 μL, 25 μmol) and a stirrer disc were added into 
each vial. The well plate was heated to 105 °C with stirring at 500 rpm. After 4 
and 22 hours, the well plate was removed from the heat. The reaction mixture 
from each vial (50 μL) was removed into a clean 2 mL HPLC vial. Solvent was 
removed in vacuo and methanol (1 mL) was added into each vial. The samples 
were analysed by chiral SFC. Same procedures were employed for the catalyst 
screening in isopropyl acetate and chlorobenzene at 80 and 120 °C respectively. 
Samples were taken after 2 and 20 hours. 
 
6.4.2. Racemisation of chiral amines by catalyst E 
(a) 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 9 (Table 4.3) 
(i) Glove box (Table 4.3, entry 1): 
In the glove box under nitrogen atmosphere, (R)-9 (59.6 mg, 0.29 mmol) and 4,4’-
di-tert-butylbiphenyl (16.0 mg, 60 μmol) were dissolved into degassed toluene (3 
mL). A sample (25 μL) was removed into a clean 2 mL HPLC vial. The mixture 
was added to E (14.8 mg, 29 μmol) and was then heated to 100 °C with stirring 
at 500 rpm. Samples were taken at specific time intervals for 24 hours. All 
samples were dried in vacuo, re-dissolved into methanol (1 mL), decanted and 
analysed by chiral SFC. Same procedures were employed with spiking of more 
E (14.5 mg, 29 μmol) after 6 hours (Fig. 4.4). 
 
(ii) Nitrogen atmosphere outside the glove box (Table 4.3, entry 2): 
The stock solution of (R)-9 from Section 1 (3 mL) was added into an Amigo 
reactor tube containing E (15.3 mg, 30 μmol). The reaction mixture was degassed 
and was then heated to 100 °C under nitrogen. The reaction was automatically 
sampled by the Amigo at specific times for 24 hours by diluting 25 μL of reaction 
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mixture into methanol (500 μL). All samples collected were dried in vacuo and re-
dissolved into methanol (1 mL), decanted and analysed by chiral SFC.  
 
(iii) Air (Table 4.3, entry 3): 
(R)-9 (60.8 mg, 0.29 mmol) was dissolved into undegassed toluene (3 mL) and 
the solution was added to 4,4’-di-tert-butylbiphenyl (15.9 mg, 60 μmol). A sample 
(25 μL) was manually removed and diluted into methanol (500 μL). The reaction 
mixture was added into an Amigo reactor tube containing E (14.9 mg, 30 μmol) 
and was heated to 100 °C in air. The reaction was automatically sampled by the 
Amigo at specific times for 24 hours by diluting 25 μL of reaction mixture into 
methanol (500 μL). All samples collected were dried in vacuo, re-dissolved into 
methanol (1 mL), decanted and analysed by chiral SFC. 
 
(b) Other substrates (Table 4.4) 
(i) 2-Methylpiperidine 103 (Table 4.4, entries 1 and 2) 
Inside an atmosbag filled with nitrogen, (S)-103 (72 μL, 0.61 mmol) was dissolved 
into degassed toluene (6 mL). The solution (3 mL) was added into an ampoule 
reaction tube containing E (15.4 mg, 31 μmol) and a stirrer bar. The tube was 
sealed and the reaction was stirred and heated to 105 °C in an oil bath outside 
the atmosbag. After 24 hours, a reaction sample (40 μL) was diluted into ethyl 
acetate (1960 μL) and filtered through a plug of celite. Benzoyl chloride (10 μL) 
was added and analysed by chiral GC. An additional reaction was carried out at 
the same time with elemental mercury (0.4 mL, 27 mmol) being added into the 
reaction mixture in the atmosbag prior to heating. 
 
(ii) N-Methyl-α-methylbenzylamine 39 (Table 4.4, entry 3) 
In a glove box under nitrogen atmosphere, E (15.6 mg, 31 μmol) was weighed 
into an ampoule reaction tube containing dried (S)-39 (44 μL, 0.3 mmol), followed 
by degassed toluene (3 mL). The reaction tube was sealed and the reaction was 
stirred and heated to 100 °C in an oil bath outside the glovebox. After 24 hours, 
a reaction sample (20 μL) was diluted into ethyl acetate (980 μL). The reaction 
sample was first analysed by achiral GC, followed by the addition of trifluoroacetic 




(iii) α-Methylbenzylamine 42 (Table 4.4, entry 4) 
Similar procedures as Section 5.4.2(b)(ii) was employed for the attempted 
racemisation of (S)-42 with E. (S)-42 (39 μL, 0.3 mmol) was used. The reaction 
was sampled after 24 hours by diluting 200 μL into methanol (1800 μL) which 
was filtered and analysed by achiral GC and GCMS. Triethylamine (10 μL) and 
benzoyl chloride (5 μL) were added and further analysed by chiral HPLC.  
 
6.4.3. Attempted racemisation/ transfer dehydrogenation of 9 by catalyst K 
(a) No additional hydride donor; conventional heating (Fig. 4.6) 
The stock solution from Section 1 (3 mL) was added into an Amigo reactor tube 
containing K (5.7 mg, 32 μmol). The reaction mixture was degassed and was 
then heated to 100 °C under nitrogen. The reaction was automatically sampled 
by the Amigo at specific times for 24 hours by diluting 25 μL of reaction sample 
into methanol (500 μL). All samples collected were dried in vacuo, re-dissolved 
into methanol (1 mL), decanted and analysed by chiral SFC. 
 
Similar procedures were employed to carry out the reaction in 1:1 toluene/ alcohol 
58. (R)-9 (89.3 mg, 0.43 mmol) and 4,4’-di-tert-butylbiphenyl (15.9 mg, 60 μmol) 
were dissolved into degassed toluene (2.5 mL) and alcohol 58 (1.5 mL) 
respectively under nitrogen. The reaction mixture was prepared by adding the 
solution of (R)-9 (1.5 mL) to the solution of 4,4’-di-tert-butylbiphenyl. The reaction 
was manually sampled by diluting 25 μL into methanol (500 μL). The reaction 
mixture was charged into an Amigo reactor tube containing K (5.5 mg, 30 μmol) 
and proceeded as described above. 
 
(b) No additional hydride donor; microwave heating (Table 4.5, entry 6) 
A solution of n-hexadecane (39.5 mg, 0.17 mmol) in degassed toluene (5.2 mL) 
was added to (S)-9 (0.11 g, 0.52 mmol) under nitrogen. The mixture was sampled 
by diluting 30 μL into methanol (970 μL). The mixture (1.5 mL) was added to a 
microwave tube containing K (2.9 mg, 16 μmol). The reaction was stirred and 
heated by microwave to 165 °C. After 1 hour, the reaction was sampled and 





(c) Silanes as hydride donor; microwave heating (Table 4.5, entries 3 to 
5) 
A stock solution of (S)-9 (0.2 M) was prepared by dissolving (S)-9 (92.9 mg, 0.45 
mmol) into degassed toluene (2.24 mL). The stock solution (750 μL) and more 
toluene (450 μL) were added to n-hexadecane (11.5 mg, 0.051 mmol). The 
reaction was sampled by diluting 6 μL into methanol (194 μL). PMHS (310 μL, 
0.17 mmol) was added. The reaction mixture was added to a microwave tube 
containing K (2.7 mg, 0.015 mmol). The reaction was stirred and heated by 
microwave to 165 °C. After 1 hour, the reaction was sampled by diluting 30 μL 
into methanol (970 μL) and filtered through a plug of celite. Both samples were 
analysed by achiral GC and chiral HPLC. The above reaction was repeated with 








of (S)-9 (μL) 
Additional 
toluene (μL) 
1 PMHS (1.1) 310 750 450 
2 PhSiH3 (1.5) 28 750 750 
3 PhMe2SiH (4.5) 103 740 750 
Table 6.23 Amount of silanes, (S)-9 and toluene in the attempted racemisation of (S)-9 
by K 
 
(d) Hydrogen gas as hydrogen donor; conventional heating (Table 4.5, 
entry 2) 
(R)-9 (0.105 g, 0.51 mmol) was dissolved into degassed toluene (5 mL). The 
stock solution of (R)-9 (3 mL, 0.31 mmol of (R)-9) was added to n-hexadecane 
(68.1 mg, 0.30 mmol). The mixture was sampled by diluting 10 μL into methanol 
(990 μL), and was then added to a three-neck round bottom flask containing K 
(11.0 mg, 61 μmol) which was initially purged with nitrogen. The system was 
further purged with hydrogen using a hydrogen balloon for 3 times. The reaction 
was stirred and heated to reflux by a pre-heat hot plate. The balloon was refilled 
regularly. The reaction was sampled at specific times and stirred for 8 hours. All 
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8.1. Proton NMR titration of homogeneous SCRAM 64 with 
methylamine in d6-DMSO (Section 2.2.1(b)) 
8.1.1. NMR integrations, number of Cp* protons and identification of Ir-
MeNH2 species 
The 1H NMR integrations of dimer 64 and signals A to F upon the titration of 64 
with methylamine (2 M in methanol) were shown in Table 1.1. Signals A to C 
correspond to the Cp* protons in nearly formed iridium species whilst signals D 






















0 6 1.1 0 0 0 0 0 0 0 
0.5 6 0.75 0.11 0.13 0 0.02 0.06 0 0 
1 6 0.53 0.11 0.32 0.02 0.02 0.12 0.01 0 
2 6 0.23 0.08 0.61 0.05 0.02 0.24 0.04 0 
3 6 0.01 0.02 0.87 0.1 0 0.32 0.07 0.04 
4 6 0 0.01 0.75 0.25 0 0.26 0.17 0.13 
5 6 0 0 0.66 0.35 0 0.24 0.23 0.23 
7.5 6 0 0 0.46 0.56 0 0.18 0.37 0.58 
10 6 0 0 0.35 0.68 0 0.14 0.42 0.99 
15 6 0 0 0.25 0.8 0 0.1 0.53 1.87 
20 6 0 0 0.19 0.84 0 0.06 0.52 2.7 
30 6 0 0 0.13 0.89 0 0.06 0.56 4.53 
40 6 0 0 0.12 0.9 0 0.04 0.56 5.75 
Table 8.1 1H NMR integrations of 64, signals A-F and the CH3 of free MeNH2 by titrating 
SCRAM 64 with MeNH2 (2 M in MeOH). All integrations were obtained by integrating 
benzene (internal standard, I.S.) as 6. The value in each bracket corresponds to the 
chemical shift in ppm 
 
The number of protons corresponded to each signal was summarised in Table 
1.2 and was calculated as follows. Before any methylamine was added, the 
270 
 
integration of dimer 64 (1.87 ppm) was 1.1 which corresponds to the 30 protons 
of the Cp* ring. Therefore, integration of one proton = 1.1 ÷ 30 = 0.0367. 
Number of protons for each signal = Integration ÷ 0.0367. 
The total number of Cp* protons from dimer 64, signals A to C was calculated as 
the sum of their integrations, which was between 27 to 30, indicating that the 




















0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 30 
0.5 20.5 3.0 3.5 0.0 0.5 1.6 0.0 27 
1 14.5 3.0 8.7 0.5 0.5 3.3 0.3 27 
2 6.3 2.2 16.6 1.4 0.5 6.5 1.1 27 
3 0.3 0.5 23.7 2.7 0.0 8.7 1.9 27 
4 0.0 0.3 20.5 6.8 0.0 7.1 4.6 28 
5 0.0 0.0 18.0 9.5 0.0 6.5 6.3 28 
7.5 0.0 0.0 12.5 15.3 0.0 4.9 10.1 28 
10 0.0 0.0 9.5 18.5 0.0 3.8 11.5 28 
15 0.0 0.0 6.8 21.8 0.0 2.7 14.5 29 
20 0.0 0.0 5.2 22.9 0.0 1.6 14.2 28 
30 0.0 0.0 3.5 24.3 0.0 1.6 15.3 28 
40 0.0 0.0 3.3 24.5 0.0 1.1 15.3 28 
Table 8.2 Number of protons corresponded to each signal and total number of Cp* 
protons 
 
Based on the increasing and decreasing trends of the integrations of signals A to 
F (Fig. 2.9), signals A to C correlate to signals D to F respectively. To determine 
the number of methylamine bound to the iridium centre in each of the newly 
formed species, the ratio of the integrations of A/D, B/E and C/F were calculated 
at each equivalent of methylamine and an average value was obtained in each 
case (Table 1.3).  
 
Assuming that species A to C are monomers with only one iridium centre and one 
Cp* ring, the number of CH3 protons in bound CH3NH2 in each species can be 
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determined as 15/ ratio. The species of A to C were assigned as mono-, di- and 
tri-methylamine iridium complexes 95, 96 and 97 respectively (Fig. 8.1). 
 
MeNH2 (equiv.) A/D B/E C/F 
0 - - - 
0.5 5.5 2.2 - 
1 5.5 2.7 2.0 
2 4.0 2.5 1.3 
3 - 2.7 1.4 
4 - 2.9 1.5 
5 - 2.8 1.5 
7.5 - 2.6 1.5 
10 - 2.5 1.6 
15 - 2.5 1.5 
20 - 3.2 1.6 
30 - 2.2 1.6 
40 - 3.0 1.6 
Average 5.0 2.6 1.6 
 Table 8.3 Integration ratios of signals A/D, B/E and C/F 
 
 
Fig. 8.1 Structures of proposed Ir-MeNH2 species formed from titrating SCRAM dimer 64 
with MeNH2 
 
8.1.2. Calculations of the concentrations of dimer 64, 95, 96 and 97 in the 
proton NMR titration of dimer 64 with methylamine in d6-DMSO 
Total reaction volume = volume of MeNH2 (in MeOH) + volume of IS (benzene) + 
volume of d6-DMSO 
Concentration of IS = No. of mole of IS ÷ Total reaction volume 
The NMR integration of IS, which corresponds to 6 protons, was set to 6 in every 
spectrum. So the integration of one proton = 1. 
272 
 
When no MeNH2 was added, concentration of IS = (0.117 mmol ÷ 0.61 mL) × 
1000 = 190.99 mM 
NMR integration of 64 = 1.1, which corresponds to 30 protons. Therefore, the 
concentration of 64 = (1.1 ÷ 30) × 190.99 mM = 7 mM 
Similarly when 0.5 equiv. of MeNH2 was added, concentration of IS = (0.117 mmol 
÷ 0.611 mL) × 1000 = 190.57 mM 
Concentration of 64 = (0.75 ÷ 30) × 190.57 mM = 4.76 mM 
NMR integrations of 95 and 96 are 0.11 and 0.13 respectively, each corresponds 
to 15 protons. Therefore, concentration of 95 = (0.11 ÷ 15) × 190.57 mM = 1.4 
mM; concentration of 96 = (0.13 ÷ 15) × 190.57 mM = 1.65 mM 
The concentrations of 64, 95, 96 and 97 at different MeNH2 equivalences were 























0 0.000 0.610 190.99 7.00 0.00 0.00 0.00 0.00 
0.5 4.424 0.611 190.57 4.76 1.40 1.65 0.00 0.00 
1 8.861 0.613 190.16 3.36 1.39 4.06 0.25 0.00 
2 17.610 0.615 189.33 1.45 1.01 7.70 0.63 0.00 
3 26.316 0.618 188.52 0.06 0.25 10.93 1.26 2.51 
4 35.042 0.621 187.70 0.00 0.13 9.38 3.13 8.13 
5 43.372 0.623 186.91 0.00 0.00 8.22 4.36 14.33 
7.5 64.516 0.630 184.92 0.00 0.00 5.67 6.90 35.75 
10 85.208 0.637 182.98 0.00 0.00 4.27 8.30 60.38 
15 125.000 0.650 179.23 0.00 0.00 2.99 9.56 111.72 
20 163.172 0.663 175.64 0.00 0.00 2.22 9.84 158.08 
30 235.294 0.690 168.84 0.00 0.00 1.46 10.02 254.95 
40 301.895 0.717 162.56 0.00 0.00 1.30 9.75 311.57 
Table 8.4 Concentrations of benzene internal standard, 64, 95, 96, 97 and free MeNH2 
with increasing equivalence of MeNH2 added 
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8.2. Proton NMR titration of methylamine-bound iridium 
complexes with hydroiodic acid in d6-DMSO (Section 2.4.2) 
Similar calculations were performed for the titration of methylamine-bound iridium 
complexes 95 to 97 with aqueous hydroiodic acid to determine the number of 
protons corresponded to each signal (Table 8.5), total number of Cp* protons 
(Table 8.6) and the integration ratios of Cp* protons to their corresponding CH3 
protons of bound methylamine (Table 8.7). Based on the ratios of B/E and C/F, 
signals B and C correspond to the Cp* protons of di-methylamine and tri-
methylamine iridium species 96 and 97 respectively; whilst signals E and F 



















0 6 0.78 0 0 0 0 0 
20 6 0 0.1 0.64 0.08 0.44 2.74 
HI 
0.5 6 0 0.14 0.62 0.08 0.38 2.74 
1 6 0 0.14 0.6 0.1 0.35 2.67 
2 6 0 0.16 0.6 0.1 0.36 2.71 
5 6 0 0.24 0.46 0.16 0.26 2.63 
10 6 0.03 0.24 0.46 0.06 0.3 2.82 
15 6 0.38 0.08 0.35 0.04 0.21 3 
20 6 0.38 0.13 0.29 0.04 0.15 2.94 
 Table 8.5 1H NMR integrations of dimer 64, signals B, C, E and F, and the CH3 of free 
MeNH2 by adding methylamine (2 M in MeOH, 20 equiv.) to SCRAM 64 followed by 
titration with HI (aq) (1.5 M). All integrations were obtained by integrating benzene 


























0 30.0 0.0 0.0 0.0 0.0 30 
20 0.0 3.8 24.6 3.1 16.9 28 
HI 
0.5 0.0 5.4 23.8 3.1 14.6 29 
1 0.0 5.4 23.1 3.8 13.5 28 
2 0.0 6.2 23.1 3.8 13.8 29 
5 0.0 9.2 17.7 6.2 10.0 27 
10 1.2 9.2 17.7 2.3 11.5 28 
15 14.6 3.1 13.5 1.5 8.1 31 
20 14.6 5.0 11.2 1.5 5.8 31 
Table 8.6 Number of protons corresponded to each signal and total number of Cp* 
protons 
 
Reagent Equiv. wrt Ir B/E C/F 
MeNH2 
0 - - 
20 1.3 1.5 
HI 
0.5 1.8 1.6 
1 1.4 1.7 
2 1.6 1.7 
5 1.5 1.8 
10 4.0 1.5 
15 2.0 1.7 
20 3.3 1.9 
Average 2.1 1.7 






8.3. Proton NMR spectra for the determination of chiral amine 
racemisation via proton/ deuterium exchange in the 
presence of SCRAM 64 (Section 2.5.2(b)) 
8.3.1. N-Isopropyl-α-methylbenzylamine 101 
 
 
Fig. 8.2 1H NMR spectra of H/ D exchange of 101 with d8-
iPrOD in the presence of 
SCRAM 64. The spectra were acquired with a D6-DMSO insert. At t = 0, δH in ppm (300 
MHz, d6-DMSO): 8.66-8.56 (m, 4H, aromatics), 8.55-8.42 (m, 1H, aromatics), 5.15 (q, J 
= 6.6 Hz, 1H, Ha), 3.93 (hept, J = 6.3 Hz, 1H, Hc), 2.65 (d, J = 6.6 Hz, 3H, Hb), 2.32 (dd, 









8.3.2. N-Benzyl-α-methylbenzylamine 107 
 
 
Fig. 8.3 1H NMR spectra of H/ D exchange of 107 in d8-
iPrOD (with d8-toluene) in the 
presence of SCRAM 64. At t = 0, δH in ppm (300 MHz, d8-toluene): δ 8.29-7.96 (m, 10H, 








8.3.3. N,N-Dimethyl-α-methylbenzylamine 46 
 
 
Fig. 8.4 1H NMR spectra of H/ D exchange of 46 in d8-
iPrOD (with d8-toluene) in the 
presence of SCRAM 64. At t = 0, δH in ppm (300 MHz, d8-toluene): 8.27-8.16 (m, 4H, 
aromatics), 8.16-8.08 (m, 1H, aromatics), 4.12 (q, J = 6.7 Hz, 1H, Ha), 3.06 (s, 6H, Hc), 








8.3.4. Rasagiline (R)-109 
 
 
Fig. 8.5 1H NMR spectra of H/ D exchange of 109 in d8-
iPrOD (with d8-toluene) in the 
presence of SCRAM 64. At t = 0, δH in ppm (300 MHz, d8-toluene): 8.35-8.17 (m, 1H, 
aromatics), 8.18-7.97 (m, 3H, aromatics), 5.31 (dd, J = 6.5 and 5.6 Hz, 1H, Ha), 4.32 
(ddd, J = 19.5, 17.1 and 2.5 Hz, 2H, Hc), 3.94 (ddd, J = 15.1, 8.3 and 5.7 Hz, 1H, He), 
3.66 (ddd, J = 15.1, 8.3 and 6.3 Hz, 1H, He), 3.38 (t, J = 2.5 Hz, 1H, Hd), 3.29-3.12 (m, 






t = 0 h
t = 1 h
t = 2 h
t = 3 h
t = 4 h
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8.3.5. O-Acetyl-(1S,2R)-N-methylephedrine 111 
 
 
Fig. 8.6 1H NMR spectra of H/ D exchange of 111 in d8-
iPrOD (with d8-toluene) in the 
presence of SCRAM 64. At t = 0, δH in ppm (300 MHz, d8-toluene): 8.19 (d, J = 4.5 Hz, 
4H, aromatics), 8.14-8.06 (m, 1H, aromatics), 6.98 (d, J = 5.1 Hz, 1H, Hc), 3.74 (dd, J = 
6.9 and 5.1 Hz, 1H, Ha), 3.16 (s, 6H, Hd), 2.89 (s, 3H, He), 1.98 (d, J = 6.9 Hz, 3H, Hb)  
t = 0 h
t = 1 h
t = 2 h
t = 3 h
t = 4 h





8.4. Addition of (S)-mandelic acid 34 during the R3 processes 
of 9 (Table 3.3)  
Due to the unknown effect of (S)-34 to the activity of immobilised SCRAM 92, at 
the early stage of development of the R3 process of 9, (S)-34 was added slowly 
to the system to minimise its concentration. The result of flow racemisation of the 
ML from diastereomeric resolution of rac-9 with (S)-34 using fresh 92 (10 mol% 
Ir) at 60 °C with a tRes of 6 minutes showed a drop in ee from 38% to 11% which 
was > 20% for one pass through the catalyst (Table 2.9, entry 7). The ML was 
originally enriched with (S)-9 and the drop in ee by 20% corresponded to 10% 
increase in the amount of (R)-9. Therefore the amount of (S)-34 added into the 
system in each cycle should ideally be the same as the amount of (R)-9 produced. 
On the other hand, since the concentration of 9 was decreasing with time due to 
its precipitation with (S)-34, the addition rate of (S)-34 had to be adjusted 
accordingly so that it was not in excess in any time during the process.  
 
The calculations were shown below using the first R3 process of 9 with (S)-34 as 
an example (Table 3.3, entry 1).  
 
At the start of cycle 1 (after the addition of 0.5 equiv. of (S)-34), if 0.5 equiv. of 9 
reacted with (S)-34, no. of moles of 9 in the system = 2.8 mmol × 0.5 = 1.4 mmol 
 
Since no acid was added during cycle 1, no. of mole of 9 at the start of cycle 2 = 
1.4 mmol. 
 
Assume there was 20% drop in ee, increase in the concentration of (R)-9 in cycle 
2 = 10%. Therefore, no. of moles of (R)-9 produced during cycle 2 = 1.4 mmol × 
10% = 0.14 mmol, i.e. (S)-34 required during cycle 2 = 0.14 mmol. 
 
Since tRes = 50 min, (S)-34 added per minute during cycle 2 = 0.14 mmol ÷ 50 
min = 2.8 × 10-3 mmol min-1, which is 0.426 mg min-1. 
 
A solution of (S)-34 was prepared by dissolving 213 mg into 5 mL of reaction 
solvent (ethyl acetate/ methanol 7:1 v/v), so during cycle 2, rate of addition of (S)-




At the start of cycle 3, no. of moles of 9 in the system = 1.4 – 0.14 mmol = 1.26 
mmol. 
 
No. of moles of (R)-9 produced during cycle 3 = 1.26 mmol × 10% = 0.126 mmol, 
i.e. (S)-34 added during cycle 3 = 0.126 mmol. 
 
Similar calculations as above were carried out until all of the 0.5 equiv. of (S)-34 
was consumed (213 mg). However, more than 20 cycles were required to add all 
the acid into the system. Therefore, in the first attempt, the process was stopped 
after 17 cycles, in which about 0.92 equiv. of (S)-34 was added in total. The rates 
of addition of (S)-34 in each cycle for the first attempt of R3 of 9 were shown in 
Table 8.8. The following assumptions were made during the calculations. 
 
 The first 0.5 equiv. of (S)-34 added into the system reacted with 0.5 equiv. 
of 9; so only 0.5 equiv. of free 9 was left in the system for racemisation 
 All of the (R)-9 reacted with (S)-34 added, so the concentration of 9 dropped 
by 10% after each cycle 
 The catalyst did not lose activity throughout the R3 process; i.e. ee of the 
ML dropped by 20% which led to a 10% increase in the concentration of 
(R)-9 after each cycle 



























Rate of (S)-34 
addition  
(mL min-1) 
1 1.4 - - - - 
2 1.4 0.14 2.8 0.426 0.01 
3 1.26 0.126 2.52 0.383 0.009 
4 1.134 0.113 2.268 0.345 0.008 
5 1.021 0.102 2.041 0.311 0.007 
6 0.919 0.092 1.837 0.28 0.007 
7 0.827 0.083 1.653 0.252 0.006 
8 0.744 0.074 1.488 0.226 0.005 
9 0.67 0.067 1.339 0.204 0.005 
10 0.603 0.06 1.205 0.183 0.004 
11 0.542 0.054 1.085 0.165 0.004 
12 0.488 0.049 0.976 0.149 0.003 
13 0.439 0.044 0.879 0.134 0.003 
14 0.395 0.04 0.791 0.12 0.003 
15 0.356 0.036 0.712 0.108 0.003 
16 0.32 0.032 0.641 0.097 0.002 
17 0.288 0.029 0.576 0.088 0.002 
Table 8.8 Addition rate of (S)-34 in the each cycle in the first attempt of R3 of 9 with (S)-
34 (Table 3.3, entry 1) 
 
Due to the long cycle time for the process, the rates of addition were increased 
in each cycle in order to shorten the overall reaction time. The rate of addition in 
each cycle of the second attempt was increased by 50% while that of the third 












Rate of addition of (S)-34 solution (mL min-1)[a] 
Entry 1[b] Entry 2[b] Entry 3[b] Entry 4[b] 
1 - - - - 
2 0.010 0.015 0.020 0.020 
3 0.009 0.014 0.018 0.018 
4 0.008 0.012 0.016 0.016 
5 0.007 0.011 0.014 0.014 
6 0.007 0.011 0.014 0.014 
7 0.006 0.009 0.012 0.012 
8 0.005 0.008 0.010 0.010 
9 0.005 0.008 - - 
10 0.004 0.006 - - 
11 0.004 0.006 - - 
12 0.003 - - - 
13 0.003 - - - 
14 0.003 - - - 
15 0.003 - - - 
16 0.002 - - - 
17 0.002 - - - 
Average rate (mL min-1) 0.005 0.010 0.015 0.015 
Average rate (mg min-1) 0.22 0.43 0.63 0.63 
Total added (mg)[c] 385.5 425.9 426.0[d] 426.4[d] 
Equiv. of (S)-34 0.92 1 1 1 
Table 8.9 Addition rate of (S)-34 in each cycle in the first four attempts of R3 processes 
of 9. [a]The solution was prepared by dissolving (S)-34 (0.21 g, 1.4 mmol) into reaction 
solvent (5 mL), which corresponded to about 42 mg mL-1. [b]The entries corresponds to 
those in Table 3.3. [c]Total amount of (S)-34 is the sum of the amount added at the 
beginning of the R3 process (0.21 g, 0.5 equiv.) and that added during the reaction. [d] 
(S)-34 in the syringe (only 0.5 equiv. in all cases) was completely added into the reaction 










Identification code MK2_44_Cu 
Empirical formula C20H25NO5 
Formula weight 359.41 
Temperature/K 120.1(4) 
Crystal system orthorhombic 












Crystal size/mm3 0.11 × 0.07 × 0.03 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 10.956 to 148.354 
Index ranges -9 ≤ h ≤ 9, -10 ≤ k ≤ 10, -34 ≤ l ≤ 36 
Reflections collected 18739 
Independent reflections 3698 [Rint = 0.0379, Rsigma = 0.0263] 
Data/restraints/parameters 3698/0/239 
Goodness-of-fit on F2 1.053 
Final R indexes [I>=2σ (I)] R1 = 0.0337, wR2 = 0.0818 
Final R indexes [all data] R1 = 0.0368, wR2 = 0.0838 
Largest diff. peak/hole / e Å-3 0.44/-0.33 







Identification code MK1_96 
Empirical formula C20H25NO5 
Formula weight 359.41 
Temperature/K 120.00(16) 
Crystal system orthorhombic 












Crystal size/mm3 0.16 × 0.06 × 0.03 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 10.582 to 149.266 
Index ranges -8 ≤ h ≤ 8, -10 ≤ k ≤ 10, -35 ≤ l ≤ 27 
Reflections collected 14223 
Independent reflections 3651 [Rint = 0.0792, Rsigma = 0.0686] 
Data/restraints/parameters 3651/0/250 
Goodness-of-fit on F2 1.088 
Final R indexes [I>=2σ (I)] R1 = 0.0573, wR2 = 0.1235 
Final R indexes [all data] R1 = 0.0711, wR2 = 0.1311 
Largest diff. peak/hole / e Å-3 0.29/-0.24 






8.5.3. (R)-2-Methylpiperidinium-(S)-mandelate (R)-103-(S)-34 
 
Identification code MK2_142_b 
Empirical formula C14H21NO3 
Formula weight 251.32 
Temperature/K 120.01(14) 
Crystal system orthorhombic 












Crystal size/mm3 0.22 × 0.17 × 0.04 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 7.904 to 151.44 
Index ranges -6 ≤ h ≤ 9, -9 ≤ k ≤ 6, -53 ≤ l ≤ 55 
Reflections collected 9989 
Independent reflections 5451 [Rint = 0.0695, Rsigma = 0.1064] 
Data/restraints/parameters 5451/0/329 
Goodness-of-fit on F2 1.130 
Final R indexes [I>=2σ (I)] R1 = 0.0995, wR2 = 0.1990 
Final R indexes [all data] R1 = 0.1196, wR2 = 0.2125 
Largest diff. peak/ hole / e Å-3 0.51/-0.36 





8.5.4. (S)-2-Methylpiperidinium-(S)-mandelate (S)-103-(S)-34 
 
Identification code MK2_140 
Empirical formula C14H21NO3 
Formula weight 251.32 
Temperature/K 120.2(3) 
Crystal system orthorhombic 












Crystal size/mm3 0.43 × 0.08 × 0.06 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 10.76 to 147.418 
Index ranges -11 ≤ h ≤ 10, -11 ≤ k ≤ 12, -17 ≤ l ≤ 16 
Reflections collected 4981 
Independent reflections 2690 [Rint = 0.0213, Rsigma = 0.0273] 
Data/restraints/parameters 2690/0/176 
Goodness-of-fit on F2 1.061 
Final R indexes [I>=2σ (I)] R1 = 0.0258, wR2 = 0.0669 
Final R indexes [all data] R1 = 0.0264, wR2 = 0.0674 
Largest diff. peak/hole / e Å-3 0.19/-0.14 




8.5.5. (R)-N-Methyl-α-methylbenzylaminium-(S)-mandelate (R)-39-(S)-34 
 
Identification code MK3_48_R 
Empirical formula C17H21NO3 
Formula weight 287.35 
Temperature/K 120.0(2) 
Crystal system orthorhombic 












Crystal size/mm3 0.51 × 0.11 × 0.09 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.99 to 147.602 
Index ranges -9 ≤ h ≤ 11, -13 ≤ k ≤ 12, -14 ≤ l ≤ 18 
Reflections collected 5701 
Independent reflections 3108 [Rint = 0.0165, Rsigma = 0.0221] 
Data/restraints/parameters 3108/0/204 
Goodness-of-fit on F2 1.055 
Final R indexes [I>=2σ (I)] R1 = 0.0269, wR2 = 0.0712 
Final R indexes [all data] R1 = 0.0275, wR2 = 0.0716 
Largest diff. peak/hole / e Å-3 0.20/-0.14 




8.5.6. (S)-N-Methyl-α-methylbenzylaminium-(S)-mandelate (S)-39-(S)-34 
 
Identification code MK3_91_S 
Empirical formula C17H21NO3 
Formula weight 287.35 
Temperature/K 120.02(15) 
Crystal system monoclinic 












Crystal size/mm3 0.21 × 0.07 × 0.05 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 6.66 to 147.822 
Index ranges -17 ≤ h ≤ 15, -8 ≤ k ≤ 8, -19 ≤ l ≤ 18 
Reflections collected 11873 
Independent reflections 5777 [Rint = 0.0416, Rsigma = 0.0528] 
Data/restraints/parameters 5777/231/460 
Goodness-of-fit on F2 1.043 
Final R indexes [I>=2σ (I)] R1 = 0.0692, wR2 = 0.1654 
Final R indexes [all data] R1 = 0.0823, wR2 = 0.1769 
Largest diff. peak/hole / e Å-3 0.85/-0.31 






Identification code MK5_17_R 
Empirical formula C38H44.5N2O8.25 
Formula weight 661.25 
Temperature/K 119.99(11) 
Crystal system monoclinic 












Crystal size/mm3 0.37 × 0.12 × 0.05 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.424 to 147.936 
Index ranges -18 ≤ h ≤ 21, -8 ≤ k ≤ 8, -34 ≤ l ≤ 35 
Reflections collected 16665 
Independent reflections 6857 [Rint = 0.0322, Rsigma = 0.0369] 
Data/restraints/parameters 6857/1/467 
Goodness-of-fit on F2 1.040 
Final R indexes [I>=2σ (I)] R1 = 0.0325, wR2 = 0.0770 
Final R indexes [all data] R1 = 0.0350, wR2 = 0.0789 
Largest diff. peak/hole / e Å-3 0.19/-0.17 







Identification code JRB341_p1 
Empirical formula C38H44N2O8 
Formula weight 656.75 
Temperature/K 100.01(10) 
Crystal system triclinic 












Crystal size/mm3 0.28 × 0.14 × 0.12 
2Θ range for data collection 7.82 to 133.2° 
Index ranges -10 ≤ h ≤ 10, -11 ≤ k ≤ 11, -14 ≤ l ≤ 14 
Reflections collected 15566 
Independent reflections 6009[Rint = 0.0522] 
Data/restraints/parameters 6009/3/439 
Goodness-of-fit on F2 1.066 
Final R indexes [I>=2σ (I)] R1 = 0.0653, wR2 = 0.1898 
Final R indexes [all data] R1 = 0.0706, wR2 = 0.1968 
Largest diff. peak/hole / e Å-3 0.69/-0.29 






The data was obtained by Dr. Wim Klooster from UK NCS, University of 
Southampton. The hydrogen atoms are omitted for clarity. Only the chiral carbon, 
nitrogen and oxygen atoms are labelled. 
 
Identification code 2017ncs0535c 
Empirical formula C38H44N2O8  
Formula weight  656.75  
Temperature/K  100(1)  
Crystal system  monoclinic  
Space group  C2  
a/Å  18.0299(9)  
b/Å  8.2271(4)  
c/Å  25.1624(14)  
α/°  90  
β/°  106.762(5)  
γ/°  90  
Volume/Å3  3573.9(3)  
Z  4  
ρcalc./g cm-3  1.221  
μ/mm-1  0.697  
Crystal size/mm3  0.050 × 0.050 × 0.010  
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection 9.84 to 136.49° 
Index ranges -21 ≤ h ≤ 20, -9 ≤ k ≤ 9, -30 ≤ l ≤ 30 
Reflections collected  17325  
Independent reflections  5566 [Rint = 0.0585, Rsigma = 0.0617] 
Data/ restraints/ parameters  5566/1/439  
Goodness-of-fit on F2 1.048 
Final R indexes [I>=2σ (I)] R1 = 0.0567, wR2 = 0.1451 
Final R indexes [all data] R1 = 0.0799, wR2 = 0.1582 
Largest diff. peak/hole / e Å-3 0.149/-0.221 







Identification code  MK5_63  
Empirical formula  C19H25NO3  
Formula weight  315.40  
Temperature/K  120.2(5)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  9.7444(4)  
b/Å  11.3063(6)  
c/Å  15.9944(7)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  1762.15(14)  
Z  4  
ρcalcg/cm3  1.189  
μ/mm-1  0.638  
F(000)  680.0  
Crystal size/mm3  0.47 × 0.03 × 0.02  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  9.58 to 147.714  
Index ranges  -11 ≤ h ≤ 10, -12 ≤ k ≤ 13, -19 ≤ l ≤ 18  
Reflections collected  6367  
Independent reflections  3435 [Rint = 0.0476, Rsigma = 0.0680]  
Data/restraints/parameters  3435/0/223  
Goodness-of-fit on F2  1.004  
Final R indexes [I>=2σ (I)]  R1 = 0.0432, wR2 = 0.0871  
Final R indexes [all data]  R1 = 0.0608, wR2 = 0.0951  
Largest diff. peak/hole / e Å-3  0.16/-0.19  






The hydrogen atoms are omitted for clarity. Only the chiral carbon, nitrogen and 
oxygen atoms are labelled. 
 
Identification code  MK5_39_twin1_hklf4  
Empirical formula  C19H25NO3  
Formula weight  315.40  
Temperature/K  120.3(7)  
Crystal system  monoclinic  
Space group  P21  
a/Å  9.6391(13)  
b/Å  24.175(3)  
c/Å  22.792(3)  
α/°  90  
β/°  94.282(11)  
γ/°  90  
Volume/Å3  5296.3(12)  
Z  12  
ρcalcg/cm3  1.187  
μ/mm-1  0.637  
F(000)  2040.0  
Crystal size/mm3  0.19 × 0.09 × 0.07  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.314 to 103.92  
Index ranges  -9 ≤ h ≤ 9, -24 ≤ k ≤ 24, -23 ≤ l ≤ 13  
Reflections collected  10832  
Independent reflections  10832 [Rint = 0.068, Rsigma = 0.1455]  
Data/restraints/parameters  10832/937/1268  
Goodness-of-fit on F2  0.924  
Final R indexes [I>=2σ (I)]  R1 = 0.0692, wR2 = 0.1484  
Final R indexes [all data]  R1 = 0.1421, wR2 = 0.1688  
Largest diff. peak/hole / e Å-3  0.25/-0.23  
Flack parameter 0.7(4) 
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8.5.12 (R)-α-Methylbenzylaminium-(S)-mandelate (R)-42-(S)-34 
 
Identification code  MK5_11_R_twin1_hklf4  
Empirical formula  C16H19NO3  
Formula weight  273.32  
Temperature/K  120.4(8)  
Crystal system  triclinic  
Space group  P1  
a/Å  6.3960(2)  
b/Å  14.8252(5)  
c/Å  16.1409(5)  
α/°  75.274(3)  
β/°  82.978(3)  
γ/°  81.011(3)  
Volume/Å3  1456.59(8)  
Z  4  
ρcalcg/cm3  1.246  
μ/mm-1  0.696  
F(000)  584.0  
Crystal size/mm3  0.16 × 0.13 × 0.06  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  6.218 to 148.884  
Index ranges  -7 ≤ h ≤ 7, -18 ≤ k ≤ 18, -20 ≤ l ≤ 20  
Reflections collected  18433  
Independent reflections  18433 [Rint = 0.048, Rsigma = 0.0614]  
Data/restraints/parameters  18433/3/790  
Goodness-of-fit on F2  0.931  
Final R indexes [I>=2σ (I)]  R1 = 0.0405, wR2 = 0.0907  
Final R indexes [all data]  R1 = 0.0558, wR2 = 0.0956  
Largest diff. peak/hole / e Å-3  0.18/-0.21  




8.5.13 (S)-α-Methylbenzylaminium-(S)-mandelate (S)-42-(S)-34 
 
Identification code  MK5_11_S  
Empirical formula  C16H19NO3  
Formula weight  273.32  
Temperature/K  120.00(13)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  6.8424(4)  
b/Å  8.3269(6)  
c/Å  25.4596(18)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  1450.57(17)  
Z  4  
ρcalcg/cm3  1.252  
μ/mm-1  0.699  
F(000)  584.0  
Crystal size/mm3  0.23 × 0.06 × 0.03  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  6.944 to 147.412  
Index ranges  -8 ≤ h ≤ 8, -9 ≤ k ≤ 9, -29 ≤ l ≤ 31  
Reflections collected  5088  
Independent reflections  2815 [Rint = 0.0560, Rsigma = 0.0768]  
Data/restraints/parameters  2815/0/198  
Goodness-of-fit on F2  1.016  
Final R indexes [I>=2σ (I)]  R1 = 0.0469, wR2 = 0.0931  
Final R indexes [all data]  R1 = 0.0595, wR2 = 0.0992  
Largest diff. peak/hole / e Å-3  0.18/-0.22  








Identification code  MK5_62_R  
Empirical formula  C30H33NO8  
Formula weight  535.57  
Temperature/K  120.3(7)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  7.7211(4)  
b/Å  14.2599(9)  
c/Å  26.2847(13)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  2894.0(3)  
Z  4  
ρcalcg/cm3  1.229  
μ/mm-1  0.736  
F(000)  1136.0  
Crystal size/mm3  0.31 × 0.11 × 0.06  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  6.726 to 147.838  
Index ranges  -6 ≤ h ≤ 9, -17 ≤ k ≤ 16, -32 ≤ l ≤ 31  
Reflections collected  16428  
Independent reflections  5728 [Rint = 0.0506, Rsigma = 0.0546]  
Data/restraints/parameters  5728/0/365  
Goodness-of-fit on F2  1.018  
Final R indexes [I>=2σ (I)]  R1 = 0.0463, wR2 = 0.0984  
Final R indexes [all data]  R1 = 0.0637, wR2 = 0.1059  
Largest diff. peak/hole / e Å-3  0.18/-0.20  






Identification code  MK5_62_S  
Empirical formula  C30H33NO8  
Formula weight  535.57  
Temperature/K  120.01(10)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  8.82969(14)  
b/Å  13.8488(2)  
c/Å  23.6449(4)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  2891.32(8)  
Z  4  
ρcalcg/cm3  1.230  
μ/mm-1  0.736  
F(000)  1136.0  
Crystal size/mm3  0.34 × 0.19 × 0.08  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.398 to 147.594  
Index ranges  -10 ≤ h ≤ 10, -12 ≤ k ≤ 16, -22 ≤ l ≤ 28  
Reflections collected  10609  
Independent reflections  5649 [Rint = 0.0304, Rsigma = 0.0399]  
Data/restraints/parameters  5649/0/365  
Goodness-of-fit on F2  1.049  
Final R indexes [I>=2σ (I)]  R1 = 0.0323, wR2 = 0.0759  
Final R indexes [all data]  R1 = 0.0362, wR2 = 0.0788  
Largest diff. peak/hole / e Å-3  0.14/-0.15  




8.6. Calculations of turnover number of Fe3(CO)12 (Compound 
E) in the racemisation of (R)-9 (Fig. 4.3) 
 
Consider rac-9 as a different species than (R)-9. 
Initial no. of mole of (R)-9 = 0.3 mmol 
No. of mole of E = 0.03 mmol 
After 8 and 24 hours, ee of the system were 55 and 53% respectively. Therefore 
E was virtually fully deactivated after about 8 hours. 
Consider at 8 hours, the system contains 77.5% (R)-9 and 22.5% (S)-9 (Eqn. 2.2). 
Therefore, no. of mole of rac-9 [(R)-9-(S)-9] formed = 0.3 × 0.225 = 0.0675 mmol. 
For every mole of rac-9 formed, assume 2 moles of (R)-9 is consumed (one mole 
is converted to (S)-9, while the other mole ‘combines’ with (S)-9 to give rac-9). 
Therefore, no. of moles of (R)-9 converted to rac-9 after 8 hours = 0.0675 × 2 
mmol = 0.135 mmol. 
No. of mole of active site of E = 3 × 0.03 mmol = 0.09 mmol 
Turnover number = 0.135 mmol ÷ 0.09 mmol = 1.5 > 1 
Therefore, E is still regarded as a catalyst in the racemisation of (R)-9. However, 
the high loading (10 mol% E, 30% iron) makes it a relatively less efficient catalyst. 
